Sentence,class,file
"ISBN 3-900051-07-0, URL http://www.R-project.org.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/jane0084-0723.PMC4674981.pdf
2006 [http://apps.who.int/bmi/index.jsp?introPage=intro.html].Accessed 11 June 2013.,OADS,/arxiv_data1/oa_pdf/41/d4/bjo0122-0653.PMC4674982.pdf
Available at: http://pinker.wjh.harvard.edu/articles/media/The%20Stupidity%20of%20Dignity.htm (last accessed 14 October2014).,Non-OADS,/arxiv_data1/oa_pdf/1b/74/jep0021-0410.PMC4674983.pdf
Available at: http://www.lovdata.no/all/hl-20110624-030.html (accessed 28 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Available at: http://lovdata.no/dokument/NL/lov/1999-07-02-63 (accessed 3 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
"Norwegian Institute of Public Health, Oslo, Norway Available at: http://www.fhi.no/dav/d39d557a77.pdf(accessed 28 February 2014).",Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Avail- able at: http://www.lovdata.no/cgi-wift/ldles?doc=/sf/sf/sf-20051201-1381.html (accessed 28 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Available at: http://www.fhi.no/dav/68675aa178.pdf (accessed 1 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Available at: http://www.sykepleien.no/Content/337889/SSNs%20etiske%20retningslinjer.pdf (accessed 1 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Norwegian Directorate of Health (2003) Regulation to the Child Health Clinicsand the School Health Services .A v a i l - able at: http://www.helsedirektorat et.no/publikasjoner/veileder-til-forskrift-om-kommunens-helsefremmende-og-for ebyggende-arbeid-i-helsestasjons-og-sko lehelsetjenesten-/Publikasjoner/veileder-til-forskrift-kommunens-helsefremmen de-og-forebyggende-arbeid-i-helsestasj ons–og-skolehelsetj-.pdf (accessed 1December 2013).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Available at: http://www.helsedirektora tet.no/publikasjoner/utviklingsstrategi- for-helsestasjons-og-skolehelsetjenesten/Sider/default.aspx (accessed 1 Decem- ber 2013).,OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
26817) Available at: http://www.nsd.uib.no (accessed 1 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Avail- able at: http://www.nsd.uib.no/ The Norwegian Ministry of Health and Care Services (2012) The Coordination Reform .,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Avail- able at: http://www.regjeringen.no/upload/HOD/Dokumenter%20INFO/ Samhandling%20engelsk_PDFS.pdf (accessed 1 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Avail- able at: http://www.childrensrights.ie/ sites/default/ﬁles/submissions_reports/ﬁles/UNCRCEnglish_0.pdf (accessed 28 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Available at: http://www.ungdata.no (accessed28 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Avail- able at: http://apps.who.int/classiﬁca- tions/icd10/browse/2010/en (accessed28 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jcnur.,Non-OADS,/arxiv_data1/oa_pdf/08/2c/jocn0024-0970.PMC4674984.pdf
Available from: http://www.osa.org/en-us/about_osa/newsroom/ news_releases/2012/laser-powered_%E2%80%98needle %E2%80%99_promises_pain-free_injectio/.,Non-OADS,/arxiv_data1/oa_pdf/28/5b/IJPI-5-192.PMC4675000.pdf
Available from: http://therefusers.com/refusers-newsroom/ vaccines-to-be-delivered-via-small-needleless-high-pressure- jets-preventdisease-com [Last updated on 2012 May 26; Last  cited on 2014 Dec 18].,Non-OADS,/arxiv_data1/oa_pdf/28/5b/IJPI-5-192.PMC4675000.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/28/5b/IJPI-5-192.PMC4675000.pdf
Available from: http://www.cygn.com/press/082802.html.,Non-OADS,/arxiv_data1/oa_pdf/28/5b/IJPI-5-192.PMC4675000.pdf
Available from: http://www.fda.gov/cdrh/pdf/P990026a.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/5b/IJPI-5-192.PMC4675000.pdf
Available at: http://www.ondrugdelivery.com/publications/ Transdermal_Microneedles_NFI_March_2013/Transdermal_ Microneedles_NFI_March_2013_Low_Res.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/5b/IJPI-5-192.PMC4675000.pdf
Available from: http://www.bioject.com/ technology.,Non-OADS,/arxiv_data1/oa_pdf/28/5b/IJPI-5-192.PMC4675000.pdf
Available  from: http://www.zogenix.com/content/technology/dosepro.htm.,Non-OADS,/arxiv_data1/oa_pdf/28/5b/IJPI-5-192.PMC4675000.pdf
"Available  from: http://www.pharmatutor.org/articles/review-on-needle-free- injection-systems-novel-approach-drug-delivery?page=0,0.",Non-OADS,/arxiv_data1/oa_pdf/28/5b/IJPI-5-192.PMC4675000.pdf
: Investigation of hydrogel membranes for ocular deliveryAvailable from: http://www.astahost.com/info.php/determination- degree-crosslinkingpolyethylene_tl4478.html.,Non-OADS,/arxiv_data1/oa_pdf/70/03/IJPI-5-214.PMC4675003.pdf
Available from: http://www.drugbank.ca/drugs/DB00356.,Non-OADS,/arxiv_data1/oa_pdf/2c/eb/IJPI-5-247.PMC4675006.pdf
Available at: http://www.amazon.com/Remington-The-Science- Practice-Pharmacy/dp/0781746736.,Non-OADS,/arxiv_data1/oa_pdf/72/fa/IJPI-5-259.PMC4675007.pdf
Available at: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/72/fa/IJPI-5-259.PMC4675007.pdf
Available at: https://www.rarediseases.org/ advocacy/alliances/usp.,Non-OADS,/arxiv_data1/oa_pdf/72/fa/IJPI-5-259.PMC4675007.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/10556497.,Non-OADS,/arxiv_data1/oa_pdf/72/fa/IJPI-5-259.PMC4675007.pdf
Available from: http://www.ipec-europe.org/ UPLOADS/2004_October.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/73/IJPI-5-266.PMC4675008.pdf
Available from: http://www.ipecamericas.org/content/excipientfest- 2011-presentations.,Non-OADS,/arxiv_data1/oa_pdf/2c/73/IJPI-5-266.PMC4675008.pdf
"Lavrent yevstrasse 3,630090 Novosibirsk (Russia) and Novosibi rskState Universi ty Pirogova strasse 2,630090 Novosibirsk (Russia) Prof. Dr.A.Y.Timoshkin Institute ofChemist ry,St.Petersburg State University 198504 OldPeterho ff,St.Petersburg (Russia) Supportin ginformation forthisarticle (syntheses ,spectroscopy ,MS, DFT calculations, andX-ray analysis with alldetails) isavailab leon theWWW under http://dx.doi.org/ 10.1002/ani e.2015063 62.",Non-OADS,/arxiv_data1/oa_pdf/54/53/anie0054-13110.PMC4675074.pdf
"[*]J.A.Rees, Dr.R.Bjornsson ,[+]Prof. Dr.S.DeBeer Department ofMolecu larTheory andSpectros copy Max-Planck -Institut f(o[5[rChemische Energieko nversion Stiftstrasse 34–36, 45470 M(o[5[lheim anderRuhr (Germany) E-mail :serena.debeer@ cec.mpg.d e J.Schlesier ,D.Sippel, Prof. Dr.O.Einsle Institut f(o[5[rBiochemie andBIOSS Centre forBiological Signalling Studies, Albert-Lu dwigs-Un iversit(o[[wt Freiburg Albertstrass e21,79104 Freiburg (Germany ) J.A.Rees Department ofChemist ry,University ofWashington Box351700, Seattle, WA98195-17 00(USA) Prof. Dr.S.DeBeer Department ofChemist ryandChemical Biology Cornell Universi ty,Ithaca, NY14853 (USA) [++]Present address :Science Institute, University ofIceland Dunhaga 3,107Reykjavik (Iceland) Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201505930 .",Non-OADS,/arxiv_data1/oa_pdf/09/fb/anie0054-13249.PMC4675075.pdf
Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201503184 .,Non-OADS,/arxiv_data1/oa_pdf/77/1c/anie0054-12472.PMC4675076.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 31, Number 9, 2015DOI: 10.1089/jop.2015.0042 525",Non-OADS,/arxiv_data1/oa_pdf/97/35/jop.2015.0042.PMC4675178.pdf
"This Open Access article is distributed under the terms of the Creative Commons License Attribution-Non-Commercial Share Alike (http://creativecommons.org/licenses/by-nc-sa/4.0/).POPULATION HEALTH MANAGEMENT Volume 18, Number 5, 2015Mary Ann Liebert, Inc.DOI: 10.1089/pop.2014.0134 392",Non-OADS,/arxiv_data1/oa_pdf/f9/3b/pop.2014.0134.PMC4675180.pdf
"Introduction The aim of the Genotype-Tissue Expression (GTEx) Project of the U.S. National Institutes of Health (NIH) Common Fund (https://commonfund.nih.gov/GTEx) is to determine how genetic variation affects normal gene ex-pression in human tissues, and ultimately to assess how this relationship correlates with the development of disease.",Non-OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.BIOPRESERVATION AND BIOBANKING Volume 13, Number 5, 2015Mary Ann Liebert, Inc.DOI: 10.1089/bio.2015.0032 311",Non-OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
The training can be found at http://gtextraining.org/.,Non-OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
"Table 1.Essential GTEx Consent Elements A description that genetic and genomic research may be conducted on the donated biospecimens The donated biospecimens may be shared with researchers who are approved by an access committee, includinginternational researchers The donated biospecimens may be used for broad future research Commercial products may be developed using the donated biospecimens however the donor families will not ﬁnancially proﬁt from these products There may be a risk of loss of privacy and conﬁdentialityThe biospecimens may be withdrawn; however, molecular data may not be retrieved once it is generated No individual genetic information will be returned to the next-of-kin or legal representative; however, results fromthe collective GTEx biospecimen set will be availableon the GTEx portal ((http://www.gtexportal.org/home) and the NIH’s National Center for Biotechnology Information’s database of Genotypes and Phenotypes(dbGAP) http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000424.v1.p1312 CARITHERS ET AL.",Non-OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
"Many of these documents are available to the public, including SOPs,workﬂows and project-related tools (http://biospecimens.cancer .gov/resources/sops/library.asp).",Non-OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
"Data from the CDR was exported to the LDACC- developed GTEx web portal (http://www.gtexportal.org/ home), where members of the public can request access to GTEx samples, and to dbGAP (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000424.v1.p1), where the research community can request access to geno- mic data and corresponding biospecimen data, such as clin-ical, demographic, and biospecimen handling data.",OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
"RNA se-quencing data and expression array data generated by the LDACC, as well as clinical annotation for the GTEx bios- pecimen collection, are publicly available on dbGAP 10 (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000424.v1.p1) and are being analyzed by an international team of bioinformatics experts.1 Multiple aliquots of GTEx tissues have been made available to the scientiﬁc community through a Request for Application funding mechanism (http://grants.nih.gov/ grants/guide/rfa-ﬁles/RFA-RM-12-009.html) and a biospe-cimen access policy has been developed for already-funded investigators (http://www.gtexportal.org/static/form/GTEx_ sample_access_policy_to_the_public_v20131024.doc).",OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
"Inaddition, 40 SOPs from the GTEx project are available forpublic use and are a major contribution to the research biobanking community (http://biospecimens.cancer.gov/ resources/sops/default.asp).",Non-OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
The meeting videocast was archived and can be accessed at http://videocast.nih.gov/Summary.asp?File=19024&bhcp=1 (May 20) and http://videocast.nih.gov/Summary.asp?File=19026 &bhcp=1 (May 21).,OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
"Such availability will greatly enhance the value of GTEx resources by complementing other initiatives aimed at identifying functional elements inthe human genome, such as the ENCyclopedia Of DNA Elements (ENCODE) project (http://www.genome.gov/ 10005107) and the Library of Integrated Network-basedCellular Signatures (LINCS) program (http://commonfund .nih.gov/lincs), in translating genome-wide association study ﬁndings to help prioritize the advancement of thera-peutic targets.",Non-OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
The project has added the collection of frozen tissue samples for a limited number of tissue types based on feedback from a request for information (RFI) regarding the potential uses ofstored GTEx biospecimens (http://grants.nih.gov/grants/guide/ notice-ﬁles/NOT-RM-12-028.html).,Non-OADS,/arxiv_data1/oa_pdf/93/2b/bio.2015.0032.PMC4675181.pdf
"This Open Access article is distributed under the terms of the Creative Commons License Attribution-Non-Commercial Share Alike (http://creativecommons.org/licenses/by-nc-sa/4.0/).POPULATION HEALTH MANAGEMENT Volume 18, Number 5, 2015ªMary Ann Liebert, Inc. DOI: 10.1089/pop.2014.0148 373",Non-OADS,/arxiv_data1/oa_pdf/24/bb/pop.2014.0148.PMC4675184.pdf
"January 2007. http://www.nice.org.uk/nicemedia/pdf/CG44FullGuide line.pdf Accessed November 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/24/bb/pop.2014.0148.PMC4675184.pdf
http://www.obgmanagement.com/uploads/media/SupplOBG_Omnia1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/bb/pop.2014.0148.PMC4675184.pdf
http://www.ispor.org/workpaper/Modeling-Good-Research- Practices-Overview.asp.,Non-OADS,/arxiv_data1/oa_pdf/24/bb/pop.2014.0148.PMC4675184.pdf
December 2012. http://amcp.org/WorkArea/DownloadAsset.aspx?id = 16209.,Non-OADS,/arxiv_data1/oa_pdf/24/bb/pop.2014.0148.PMC4675184.pdf
2012. http://www.acog.org/ */media/Departments/Government% 20Relations%20and%20Outreach/2012ProtectMedicaid.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/bb/pop.2014.0148.PMC4675184.pdf
2012. http://www.nwlc .org/sites/default/ﬁles/pdfs/what_the_medicaid_eligibility_ expansion_means_for_women_10-23-12.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/bb/pop.2014.0148.PMC4675184.pdf
August 2012. http://www.urban.org/UploadedPDF/412630-opting- in-medicaid.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/bb/pop.2014.0148.PMC4675184.pdf
http://www.inca.gov.br/estimativa/2012/ .,Non-OADS,/arxiv_data1/oa_pdf/25/aa/abcd-27-01-0018.PMC4675472.pdf
METHODS A systematic literature search was conducted  using Medline/PubMed ( http://www.ncbi.nlm.nih.gov/ pubmed ) and Cochrane ( http://www2.cochrane.org/ reviews/ ).,OADS,/arxiv_data1/oa_pdf/46/35/abcd-27-01-0066.PMC4675486.pdf
Espessura Do Musculo Adutor Do Polegar: Um  Método Rápido E Confiável Na Avaliação Nutricional De Pacientes  Cirúrgicos.Rev Col Bras Cir [ periódico na internet] 2009; 36(4):  Disponível em URL: http://www.scielo.br/rcbc.,Non-OADS,/arxiv_data1/oa_pdf/0a/5b/abcd-27-01-0013.PMC4675491.pdf
Disponível em URL:  http://www.scielo.br/rcbc.,Non-OADS,/arxiv_data1/oa_pdf/0a/5b/abcd-27-01-0013.PMC4675491.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/7d/ndt-11-3007.PMC4675633.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3007–3017Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3007Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S7804 3Asenapine for bipolar disorder Thomas Scheidemantel1 irina Korobkova2 Soham Rej3,4 Martha Sajatovic1,2 1University Hospitals Case Medical  Center, 2Case western Reserve  University School of Medicine,   Cleveland, OH, USA; 3Department  of Psychiatry, University of T oronto,   T oronto, ON, 4Geri PARTy Research  Group, Jewish General Hospital,   Montreal, QC, CanadaAbstract:  Asenapine (Saphris®) is an atypical antipsychotic drug which has been approved by  the US Food and Drug Administration for the treatment of schizophrenia in adults, as well as  the treatment of acute manic or mixed episodes of bipolar I in both adult and pediatric popu - lations.",Non-OADS,/arxiv_data1/oa_pdf/9d/7d/ndt-11-3007.PMC4675633.pdf
"The majority of patients will experience  psychiatric comorbidity (eg, anxiety disorders, learning disorders, personality disor - ders) and/or alcohol or substance abuse/dependence during their lifetime.1 Physical  comorbidity occurs commonly, with patients having an average of 2.5–3.5 medical  conditions, while cognitive dysfunction occurs in up to 30% of patients, particularly in  old age.1,4 In fact, along with the depressive phase of illness,5 the most disabling aspects  of BD are physical comorbidity and cognitive dysfunction.6 These important clinical Correspondence: Martha Sajatovic University Hospitals Case Medical  Center, Case western Reserve  University School of Medicine,  10524 euclid Avenue, Cleveland,  OH 44106, USA Tel +1 216 844 2808 Fax +1 216 844 2742 email martha.sajatovic@uhhospitals.or gJournal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Scheidemantel et al Running head recto: Asenapine for bipolar disorder DOI: http://dx.doi.org/10.2147/NDT.S78043",Non-OADS,/arxiv_data1/oa_pdf/9d/7d/ndt-11-3007.PMC4675633.pdf
Available from: http://pi.actavis.,Non-OADS,/arxiv_data1/oa_pdf/9d/7d/ndt-11-3007.PMC4675633.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ nda/2009/022117s000TOC.cfm.,Non-OADS,/arxiv_data1/oa_pdf/9d/7d/ndt-11-3007.PMC4675633.pdf
Available   from: https://clinicaltrials.gov/ct2/show/NCT01244815?term=asen apine+pediatric+bipolar&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/7d/ndt-11-3007.PMC4675633.pdf
Available   from: https://clinicaltrials.gov/ct2/show/NCT01349907?term=asen apine+ped iatric+bipolar&rank= 2.,Non-OADS,/arxiv_data1/oa_pdf/9d/7d/ndt-11-3007.PMC4675633.pdf
Available from: http://www.accessdata.fda.gov/scripts/sda/ sdDetailNavigation .cfm?sd=labelingdatabase&id=14F7A847BCD30 979E053564DA8C00FF5&rownum=1 5.,OADS,/arxiv_data1/oa_pdf/9d/7d/ndt-11-3007.PMC4675633.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9d/7d/ndt-11-3007.PMC4675633.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/7d/ndt-11-3007.PMC4675633.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/48/ott-8-3621.PMC4675634.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3621–3627OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3621Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9134 7Long-term administration of high doses of  transdermal buprenorphine in cancer patients  with severe neuropathic pain Wojciech Leppert Grzegorz Kowalski Chair and Department of Palliative  Medicine, Poznan University of  Medical sciences, Poznan, PolandBackground:  Buprenorphine is often administered by the transdermal route (transdermal  buprenorphine [TB]) in cancer patients with severe neuropathic pain.",Non-OADS,/arxiv_data1/oa_pdf/e3/48/ott-8-3621.PMC4675634.pdf
"Apart from a partial agonist activity to  µ- and δ-receptors, it displays a weak agonist or antagonist effect on κ-opioid receptors Correspondence: Wojciech Leppert Chair and Department of Palliative  Medicine, Poznan University of Medical  sciences, 25a Osiedle rusa 55, Poznan 61  245, Poland Tel/fax +48 61 873 8303 email wojciechleppert@wp.p l Journal name: OncoTargets and Therapy Article Designation: Case Series Y ear: 2015 Volume: 8 Running head verso: Leppert and Kowalski Running head recto: High-dose transdermal buprenorphine in cancer-pain treatment DOI: http://dx.doi.org/10.2147/OTT.S91347",Non-OADS,/arxiv_data1/oa_pdf/e3/48/ott-8-3621.PMC4675634.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e3/48/ott-8-3621.PMC4675634.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/48/ott-8-3621.PMC4675634.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/35/pgpm-8-171.PMC4675635.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPharmacogenomics and Personalized Medicine 2015:8 171–180Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  171Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S5280 8variations in telomere maintenance and the role  of telomerase inhibition in gastrointestinal cancer Steffen Heeg Department of Medicine ii,   Gastroenterology, Hepatology,   endocrinology, and infectious  Diseases, Medical Center – University  of Freiburg, Freiburg, Germany Correspondence: Steffen Heeg   Department of Medicine ii,  Gastroenterology, Hepatology,  endocrinology, and infectious Diseases,  Medical Center – University of Freiburg,  Hugstetter Strasse  55, 79106 Freiburg,  Germany   Tel +49 761 270 33290  email steffen.heeg@uniklinik-freiburg.d eAbstract:  Immortalization is an important step toward the malignant transformation of human  cells and is critically dependent upon telomere maintenance.",Non-OADS,/arxiv_data1/oa_pdf/9d/35/pgpm-8-171.PMC4675635.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/9d/35/pgpm-8-171.PMC4675635.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/9d/35/pgpm-8-171.PMC4675635.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/81/ndt-11-2997.PMC4675636.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2997–3006Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2997Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S9186 1A review of cognitive conflicts research:  a meta-analytic study of prevalence and  relation to symptoms Adrián Montesano1 María Angeles López- González2 Luis Angel Saúl2 Guillem Feixas1 1Department of Personality,   Assessment and Psychological  Treatments, University of Barcelona,   Barcelona, 2Department of Personality,   Assessment and Psychological  Treatments, Faculty of Psychology,   National Distance education  University, Madrid, SpainAbstract:  Recent research has highlighted the role of implicative dilemmas in a variety  of clinical conditions.",Non-OADS,/arxiv_data1/oa_pdf/71/81/ndt-11-2997.PMC4675636.pdf
"IDs are a type of cognitive conflict that refers to conflicts among different aspects of Correspondence: Adrián Montesano Department of Personality, Assessment  and Psychological Treatments, University  of Barcelona, Passeig vall d’Hebron,  171, 08035 Barcelona, Spain Tel +34 93 312 5023 email adrianmontesano@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Montesano et al Running head recto: Review of cognitive conflicts research DOI: http://dx.doi.org/10.2147/NDT.S91861",Non-OADS,/arxiv_data1/oa_pdf/71/81/ndt-11-2997.PMC4675636.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/71/81/ndt-11-2997.PMC4675636.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/81/ndt-11-2997.PMC4675636.pdf
Available  from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.,Non-OADS,/arxiv_data1/oa_pdf/71/81/ndt-11-2997.PMC4675636.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/20/tcrm-11-1779.PMC4675637.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1779–1788Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1779Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8368 1Hypercalcemia of malignancy and new treatment  options Hillel Sternlicht1 ilya G Glezerman1,2 1Division of Nephrology and  Hypertension, weill Cornell Medical  College, 2Renal Service, Memorial  Sloan Kettering Cancer Center,   New Y ork, NY, USAAbstract:  Hypercalcemia of malignancy affects up to one in five cancer patients during the  course of their disease.",Non-OADS,/arxiv_data1/oa_pdf/b5/20/tcrm-11-1779.PMC4675637.pdf
"Epidemiology First described in 1921, hypercalcemia of malignancy now occurs in upward of  20% of cancer patients during the course of their disease.1–3 While exact estimates  vary as a function of the population studied and the serum calcium cutoff used, Correspondence: ilya G Glezerman Renal Service, Memorial Sloan Kettering  Cancer Center, 1275 York Avenue,  New York, NY 10065, USA Tel +1 212 639 7822 Fax +1 212 717 3250 email glezermi@mskcc.or g Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Sternlicht and Glezerman Running head recto: Hypercalcemia of malignancy and new treatment options DOI: http://dx.doi.org/10.2147/TCRM.S83681 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/b5/20/tcrm-11-1779.PMC4675637.pdf
Or use: http://youtu.be/ZiueO4V_RL Yvideo abstract,Non-OADS,/arxiv_data1/oa_pdf/b5/20/tcrm-11-1779.PMC4675637.pdf
"Available from: http://fresenius-kabi.ca/wp-content/uploads/2015/01/ EN_Web_Insert_Pamid_NL.pd f. Accessed July 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/20/tcrm-11-1779.PMC4675637.pdf
"Available from: https://www.pharma.us.novartis.com/product/ pi/pdf/Zometa.pd f. Accessed July 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/20/tcrm-11-1779.PMC4675637.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b5/20/tcrm-11-1779.PMC4675637.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/20/tcrm-11-1779.PMC4675637.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/a8/tcrm-11-1795.PMC4675638.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1795–1803Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1795ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9398 2scaling and root planning, and locally delivered  minocycline reduces the load of Prevotella  intermedia  in an interdependent pattern,  correlating with symptomatic improvements of  chronic periodontitis: a short-term randomized  clinical trial shuli Deng1 Ying Wang1 Wei sun1 hui Chen1 gang Wu2 1Department of Conservative  Dentistry, affiliated hospital of  stomatology, Medical College,   Zhejiang University, hangzhou,   People’s Republic of China;   2Department of Oral implantology  and Prosthetic Dentistry, academic  Centre for Dentistry amsterdam  (aCTa), VU University amsterdam  and University of amsterdam,   MOVe Research institute amsterdam,   amsterdam, the netherlandsBackground:  To evaluate the respective or combinatory efficacy of locally delivered 2%  minocycline (MO), and scaling and root planning (SRP) by assessing both clinical parameters  and the loads of four main periodontal pathogens in treating chronic periodontitis (CP).",Non-OADS,/arxiv_data1/oa_pdf/5a/a8/tcrm-11-1795.PMC4675638.pdf
"Bacteria including Aggregatibacter actino - mycetemcomitans  (Aa), Fusobacterium nucleatum  (Fn), Porphyromonas gingivalis   (Pg), and Prevotella intermedia  (Pi) are currently thought to be highly associated with  CP.1 The primary goal of periodontal therapy is to reduce these periodontopathogens,  so as to halt disease progression.Correspondence: hui Chen Department of Conservative Dentistry,  Affiliated Hospital of Stomatology,  Medical College, Zhejiang University,  395# Yan’an Road, hangzhou, Zhejiang  310006, People’s Republic of China Tel +86 571 8721 7437 Fax +86 571 8721 7433 email huic66@hotmail.co m  gang Wu Department of Oral implantology  and Prosthetic Dentistry, academic  Centre for Dentistry amsterdam  (aCTa), Research institute MOVe,  VU University amsterdam and University  of amsterdam, gustav Mahlerlaan 3004,  1018la amsterdam, the netherlands Tel +31 20 598 0866 Fax +31 20 598 0333 email g.wu@acta.n l Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Deng et al Running head recto: SRP and minocycline interdependently decrease Pi DOI: http://dx.doi.org/10.2147/TCRM.S93982",Non-OADS,/arxiv_data1/oa_pdf/5a/a8/tcrm-11-1795.PMC4675638.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/5a/a8/tcrm-11-1795.PMC4675638.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/a8/tcrm-11-1795.PMC4675638.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/52/tcrm-11-1805.PMC4675639.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1805–1811Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1805Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7358 1Differential pharmacology and clinical utility of  long-acting bronchodilators in COPD – focus  on olodaterol Maria Gabriella Matera1 Josuel Ora2 Mario Cazzola2,3 1Department of experimental  Medicine, Unit of Pharmacology,   Second University of Naples, Naples,   2Division of Respiratory Medicine,   University Hospital T or vergata,   3Department of Systems Medicine,   Respiratory Pharmacology Research  Unit, University of Rome T or vergata,   Rome, italyAbstract:  Olodaterol (BI 1744 CL) is a novel, once-daily long-acting β2-agonist (LABA)  designed with the aim of improving β2-adrenoreceptor selectivity and intrinsic activity.",Non-OADS,/arxiv_data1/oa_pdf/3f/52/tcrm-11-1805.PMC4675639.pdf
"However, there is evidence that long-acting β2-agonists Correspondence: Mario Cazzola Department of Systems Medicine,  Respiratory Pharmacology Research  Unit, University of Rome Tor vergata,  via Montpellier 1, 00133 Rome, italy email mario.cazzola@uniroma2.i tJournal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Matera et al Running head recto: Olodaterol in COPD DOI: http://dx.doi.org/10.2147/TCRM.S73581",Non-OADS,/arxiv_data1/oa_pdf/3f/52/tcrm-11-1805.PMC4675639.pdf
"Available from: http://guidance.nice.org.uk/CG101/Guidance/ pdf/Englis h. Accessed August 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3f/52/tcrm-11-1805.PMC4675639.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/3f/52/tcrm-11-1805.PMC4675639.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/52/tcrm-11-1805.PMC4675639.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/57/jpr-8-859.PMC4675640.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 859–870Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  859Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S8595 1Buprenorphine – an attractive opioid with  underutilized potential in treatment of   chronic pain ish K Khanna Sivaram Pillarisetti NeuroPn Therapeutics, Alpharetta,   GA, USA Correspondence: ish K Khanna   NeuroPn Therapeutics, 520 Barnesley  Lane, Alpharetta, GA, 30022, USA   Tel +1 770 330 1748   email khanna@neuropntherapeutics.co mAbstract:  Despite proven clinical utility, buprenorphine has not been used widely for the  treatment of chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/df/57/jpr-8-859.PMC4675640.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/df/57/jpr-8-859.PMC4675640.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/57/jpr-8-859.PMC4675640.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/63/d0/ibpc-8-057.PMC4675644.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pIntegrated Blood Pressure Control 2015:8 57–69Integrated Blood Pressure Control Dove press submit your manuscript | www.dovepress.co m Dove press  57RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IBPC.S6563 2Renal denervation for the management of resistant  hypertension Hitesh C Patel1 Carl Hayward1 vassilis vassiliou1 Ketna Patel2 James P Howard3 Carlo Di Mario1 1NIHR Cardiovascular Biomedical  Research Unit, Royal Brompton  Hospital, London, UK; 2Department  of Cardiology, Royal Free Hospital,   London, UK; 3National Heart and Lung  Institute, Imperial College, London,   UK Correspondence: Hitesh C Patel   NIHR Cardiovascular Biomedical  Research Unit, Royal Brompton Hospital,  London Sw3 6NP, UK   Tel +44 20 7352 8121 ext 2920   Fax +44 20 7351 8184   email dochiteshpatel@hotmail.co m;  h.patel3@rbht.nhs.u kAbstract:  Renal sympathetic denervation (RSD) as a therapy for patients with resistant   hypertension has attracted great interest.",Non-OADS,/arxiv_data1/oa_pdf/63/d0/ibpc-8-057.PMC4675644.pdf
"Integrated Blood Pressure Control Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/integrated-blood-pressure-control-journa lIntegrated Blood Pressure Control is an international, peer-reviewed  open-access journal focusing on the integrated approach to managing  hypertension and risk reduction.",Non-OADS,/arxiv_data1/oa_pdf/63/d0/ibpc-8-057.PMC4675644.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/d0/ibpc-8-057.PMC4675644.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/be/ceg-8-309.PMC4675645.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 309–325Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  309OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S8999 9Modulation of the gut microbiota composition  by rifaximin in non-constipated irri table bowel  syndrome patients: a molecular approach sara soldi1 sotirios Vasileiadis2 Francesca Uggeri1 Mariachiara Campanale3 lorenzo Morelli4 Maria Vittoria Fogli5 Fiorella Calanni5 Maria Grimaldi5 antonio Gasbarrini3 1aaT – advanced analytical  T echnologies srl, Piacenza, italy;   2Centre for Environmental risk  assessment and remediation,   University of south australia, Mawson  lakes, australia; 3internal Medicine  and Gastroenterology Division,   Catholic University of rome, rome,   italy; 4Microbiology institute, Catholic  University of Piacenza, Piacenza, italy;   5alfa Wassermann spa, Bologna, italy Correspondence: sara soldi   aaT – advanced analytical Technologies  srl, via Martiri della resistenza – Galleria  san Giuseppe 1, 29122 Piacenza, italy   Tel +39 05 2346 1483   Email sara.soldi@aat-taa.e uAbstract:  Rifaximin, with its low systemic absorption, may represent a treatment of choice for  irritable  bowel syndrome (IBS), mainly due to its ability to act on IBS pathogenesis, through  the influence on gut microbiota.",Non-OADS,/arxiv_data1/oa_pdf/6a/be/ceg-8-309.PMC4675645.pdf
"Amplicon  reconstruction was performed with the “pandaseq” script,  previously made available by Masella et al.31 Fastx-toolkit was  used for demultiplexing procedure applied to the sequences  (http://www.hannonlab.cshl.edu/fastx_toolkit /).",OADS,/arxiv_data1/oa_pdf/6a/be/ceg-8-309.PMC4675645.pdf
The sequences were  submitted at the Sequence Read Archive ( http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/6a/be/ceg-8-309.PMC4675645.pdf
nlm.nih.go v/sra) of the National Center for Biotechnology  Information ( http://www.ncbi.nlm.nih.go v) and are publicly  accessible under the BioProject number PRJNA279031.,OADS,/arxiv_data1/oa_pdf/6a/be/ceg-8-309.PMC4675645.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/6a/be/ceg-8-309.PMC4675645.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/be/ceg-8-309.PMC4675645.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/46/dddt-9-6319.PMC4675646.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6319–6325Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6319Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9689 3green tea extract as a treatment for patients  with wild-type transthyretin amyloidosis: an  observational study Fabian aus dem siepen1 ralf Bauer1 Matthias aurich1 sebastian J Buss1 henning steen1 Klaus altland2 hugo a Katus1 arnt V Kristen1 1Department of cardiology, angiology,   and respiratory Medicine, University  hospital heidelberg, heidelberg,   germany; 2institute of human  genetics, Justus-liebig-University,   giessen, germanyBackground:  Causative treatment of patients with wild-type transthyretin amyloid  cardiomyopathy (wtATTR-CM) is lacking.",Non-OADS,/arxiv_data1/oa_pdf/21/46/dddt-9-6319.PMC4675646.pdf
"Diuretics are capable of  reducing dyspnea, but standard heart failure medication does not affect amyloid depo - sition itself.7 During the course of 1 year, wtATTR-CM usually worsens, as indicated  by an increase of the left ventricular (LV) wall thickness by 0.2 mm, an increase of correspondence: Fabian aus dem siepen Department of cardiology, angiology,  and respiratory Medicine, University  hospital heidelberg, im neuenheimer  Feld 410, D-69120 heidelberg, germany Tel +49 6221 568 611 Fax +49 6221 565 515 email fabi an.ausdemsiepen@med .uni- heidelberg.d e Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: aus dem Siepen et al Running head recto: Green tea extract for wild-type transthyretin amyloidosis DOI: http://dx.doi.org/10.2147/DDDT.S96893",Non-OADS,/arxiv_data1/oa_pdf/21/46/dddt-9-6319.PMC4675646.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/21/46/dddt-9-6319.PMC4675646.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/46/dddt-9-6319.PMC4675646.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/02/cmar-7-361.PMC4675647.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 361–368Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  361ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CMAR.S9154 6Development and validation of an  immunohistochemistry assay to assess  glucocorticoid receptor expression for clinical  trials of mifepristone in breast cancer gabrielle M Baker1 Tiffany Murphy2 Thaddeus Block3,4 Dat nguyen3 Frank J lynch2 1Department of Pathology,    The University of Chicago, Chicago,   il, Usa;  2QualT ek Molecular  laboratories, newtown, P a, Usa;   3Corcept Therapeutics, Menlo Park,   Ca, Usa;  4Department of Psychiatry  and Behavioral sciences, stanford  University, stanford, C a, Usa Correspondence: gabrielle M Baker   Department of Pathology, The University  of Chicago,  5841 south Maryland avenue,  MC 6101, Room P-633, Chicago, il   60637, Usa   Tel +1 773 834 8068  Fax +1 773 702 4633  email gabrielle.baker@uchospitals.ed uBackground:  Glucocorticoid receptor (GR) activity has been associated with chemotherapy  resistance and poor outcomes in patients with triple negative breast cancer (TNBC).",Non-OADS,/arxiv_data1/oa_pdf/bc/02/cmar-7-361.PMC4675647.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/bc/02/cmar-7-361.PMC4675647.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/02/cmar-7-361.PMC4675647.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/59/9f/dddt-9-6285.PMC4675648.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6285–6302Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6285Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5804 9Synthetic biology for pharmaceutical drug  discovery Jean-Yves Trosset1 Pablo Carbonell2,3 1Bioinformation Research Laboratory,   Sup’Biotech, villejuif, France; 2Faculty  of Life Sciences, SYNBiOCHeM  Centre, Manchester institute  of Biotechnology, University of  Manchester, Manchester, UK;   3Department of experimental and  Health Sciences (DCeXS), Research  Programme on Biomedical informatics  (GRiB), Hospital del Mar Medical  Research institute ( iMiM), Universitat  Pompeu Fabra (UPF), Barcelona, SpainAbstract:  Synthetic biology (SB) is an emerging discipline, which is slowly reorienting the  field of drug discovery.",Non-OADS,/arxiv_data1/oa_pdf/59/9f/dddt-9-6285.PMC4675648.pdf
"Microorganisms (as well as plants and others) produce  secondary metabolites using gigantic biosynthetic units.6 These enzymatic modules  can be manipulated in combinatorial fashion in synthetic cells to produce new NPs Correspondence: Jean-Yves Trosset Bio-information Research Laboratory,  Sup’Biotech, 66 rue Guy Môquet, 94800  villejuif, France Tel +33 1 8051 7106 Fax +33 1 4408 0099 email j ean-yves.trosset@supbiotech.f r Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Trosset and Carbonell Running head recto: Synthetic biology for drug discovery DOI: http://dx.doi.org/10.2147/DDDT.S58049",Non-OADS,/arxiv_data1/oa_pdf/59/9f/dddt-9-6285.PMC4675648.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/59/9f/dddt-9-6285.PMC4675648.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/9f/dddt-9-6285.PMC4675648.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/43/imcrj-8-317.PMC4675649.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 317–320International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  317Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S9212 2a case report of aphallia with urorectal septum  malformation sequence in a newborn: a very  rarely seen condition Deepak sharma1 Ravinder singh2 sweta shastri3 1Department of Neonatology,   Fernandez Hospital, Hyderabad,   2Department of p ediatrics,    Civil Hospital, Hisar, Haryana,   3Department of p athology, NK p   salve Medical College, Nagpur,    Maharashtra, India Correspondence: Ravinder singh,   Department of pediatrics, Maharaja  aggarsen Civil Hospital,tayal Bagh  Colony, Hisar, Haryana, India 125001   email ravinder_dr7@rediffmail.co mAbstract:  Aphallia (absence of penis) is an extremely rare abnormality which has rarely been  described in medical literature and can be part of the urorectal septum malformation sequence  (URSMS).",Non-OADS,/arxiv_data1/oa_pdf/a9/43/imcrj-8-317.PMC4675649.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/a9/43/imcrj-8-317.PMC4675649.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/43/imcrj-8-317.PMC4675649.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/b2/cia-10-1925.PMC4675650.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1925–1934Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1925CASE SERIESopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9379 6Anatomic and physiopathologic changes affecting  the airway of the elderly patient: implications for  geriatric-focused airway management Kathleen N Johnson1 Daniel B Botros1 Leanne Groban1–4 Yvon F Bryan1 1Department of Anesthesiology,   Wake Forest School of Medicine,   Winston-Salem, NC, USA; 2Section on  Molecular Medicine, Department of  Internal Medicine, Wake Forest School  of Medicine, Winston-Salem, NC, USA;   3Sticht Center on Aging, Wake Forest  School of Medicine, Winston-Salem,   NC, USA; 4Hypertension and Vascular  Research Center, Wake Forest School  of Medicine, Winston-Salem, NC, USAAbstract:  There are many anatomical, physiopathological, and cognitive changes that occur  in the elderly that affect different components of airway management: intubation, ventilation,  oxygenation, and risk of aspiration.",Non-OADS,/arxiv_data1/oa_pdf/34/b2/cia-10-1925.PMC4675650.pdf
"Direct laryngoscopy  with a Macintosh 3 blade required two attempts to visualize the vocal cords and one Correspondence: Yvon F Bryan Department of Anesthesiology, Wake  Forest School of Medicine, Medical  Center Boulevard, Winston-Salem,  NC 27157-1009, USA Tel +1 336 716 4498 Fax +1 336 716 8190 Email ybryan@wakehealth.ed u Journal name: Clinical Interventions in Aging Article Designation: CASE SERIES Y ear: 2015 Volume: 10 Running head verso: Johnson et al Running head recto: Anatomic changes in the elderly airway DOI: http://dx.doi.org/10.2147/CIA.S93796 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/34/b2/cia-10-1925.PMC4675650.pdf
Or use: http://youtu.be/8xbnz2olGm IVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/34/b2/cia-10-1925.PMC4675650.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/34/b2/cia-10-1925.PMC4675650.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/34/b2/cia-10-1925.PMC4675650.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/77/dddt-9-6327.PMC4675651.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6327–6342Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6327Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9277 7hypoglycemic effect and mechanism of honokiol  on type 2 diabetic mice Jing sun1 Xueqi Fu1–3 Ye liu1 Y ongsen Wang1 Bo huo1 Yidi guo1 Xuefeng gao1 Wannan li1–3,* Xin hu1–3,* 1school of life sciences, 2Key  laboratory for Molecular enzymology  and engineering of Ministry of  education, 3national engineering  laboratory of aiDs Vaccine, school  of life sciences, Jilin University,   changchun, People’s republic of  china *These authors contributed equally  to this workBackground:  Honokiol is one of the main bioactive constituents of the traditional Chinese  herbal drug Magnolia bark (Cortex Magnoliae officinalis , Hou Po).",Non-OADS,/arxiv_data1/oa_pdf/30/77/dddt-9-6327.PMC4675651.pdf
"T2DM is recognized as a group of metabolic disorders, characterized by  hyperglycemia, dyslipidemia, and insulin resistance in its metabolic target tissues.2,3 Insulin, as the principal hormone controlling blood glucose, acts by stimulating  glucose influx and metabolism in muscle and adipocytes and inhibiting gluconeo - genesis in the liver.4 Under normal circumstances, insulin binds to the α-subunits of  the heterotetrameric insulin receptor (IR) ( α2, β2), increases flexibility of the activa - tion loop to allow ATP to enter the catalytic site and stabilizes the activation loop  in the active conformation by autophosphorylation on multiple tyrosyl residues,5 correspondence: Xin hu school of life sciences, Qianjin street  2699#, Jilin University, changchun  130012, People’s republic of china Tel +86 186 4311 9899 Fax +86 431 8451 5118 email huxinjilin@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Sun et al Running head recto: Hypoglycemic effect of honokiol on type 2 diabetic mice DOI: http://dx.doi.org/10.2147/DDDT.S92777",Non-OADS,/arxiv_data1/oa_pdf/30/77/dddt-9-6327.PMC4675651.pdf
"Available  from: http://www.idf.org/diabetesatla s. Accessed June 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/30/77/dddt-9-6327.PMC4675651.pdf
Available from:  http://www.who.int/features/factfiles/diabetes/en /.,Non-OADS,/arxiv_data1/oa_pdf/30/77/dddt-9-6327.PMC4675651.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/30/77/dddt-9-6327.PMC4675651.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/77/dddt-9-6327.PMC4675651.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/8b/dsv021.PMC4675708.pdf
20The assembled genome of T. castanem was downloaded in the fasta format from the web page ftp://ftp.bioinformatics.ksu.edu/pub/BeetleBase/3.0/(The third version of the assembly: Tcas_3.0) in the form of 10 chro-mosomes.,OADS,/arxiv_data1/oa_pdf/f2/8b/dsv021.PMC4675708.pdf
"The sequence of each chromosome was uploaded to Tan-dem Repeats Database (TRDB), 30https://tandem.bu.edu/cgibin/trdb/ trdb.exe and analysed using Tandem Repeats Finder (TRF) algo-rithm.",OADS,/arxiv_data1/oa_pdf/f2/8b/dsv021.PMC4675708.pdf
"37In order to extract TCAST variants from unas- sembled reads, TRF and clustering analyses were done on 2153 unas-sembled reads (ftp://ftp.bioinformatics.ksu.edu/pub/BeetleBase/3.0/)under the TRF parameters described above.",OADS,/arxiv_data1/oa_pdf/f2/8b/dsv021.PMC4675708.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/39/dsv024.PMC4675711.pdf
"6Moreover, it was the ﬁrst photosynthetic organism to have its genome sequenced,7comprising a 3.6 Mb chromosome and 7 plasmids (http://genome.microbedb.jp/cyanobase/Synechocystis), it isnaturally transformable and a number of molecular tools are available for its genetic manipulation.",OADS,/arxiv_data1/oa_pdf/9d/39/dsv024.PMC4675711.pdf
"Bioinformatics The list of the predicted/annotated ORFs of Synechocystis was re- trieved from CyanoBase (Distribution of Sequence and AnnotatedData Files, ftp://ftp.kazusa.or.jp/pub/CyanoBase/Synechocystis, ac-cessed: 08 May 2009).",OADS,/arxiv_data1/oa_pdf/9d/39/dsv024.PMC4675711.pdf
"Fromthese, the ﬁnal selection was based on the following criteria: (i) length of the putatively encoded proteins ≤301 amino acids, (ii) encoded pro- teins with no transmembrane domains predicted by the TMHMMServer v. 2.0 (http://www.cbs.dtu .dk/services/TMHMM/), (iii) nointeraction with other proteins as assessed by the two-hybrid system (CyanoBase data) and (iv) no relevant similarities found at the proteinsequence level, when comparing with other sequences using BLASTP(http://blast.ncbi.nlm.nih.gov/Blast.cgi).",OADS,/arxiv_data1/oa_pdf/9d/39/dsv024.PMC4675711.pdf
"For other pur-poses, primers were designed manually and analysed using the Inte-grated DNA Technologies web resource OligoAnalyzer v3.1 (http://eu.idtdna.com/analyzer/Applications/OligoAnalyzer/).",OADS,/arxiv_data1/oa_pdf/9d/39/dsv024.PMC4675711.pdf
"All the BioBrick parts can be found at the Registry of Standard Biological Parts website (http://parts.igem.org),and the maps and sequences (FASTA format) of the ﬁnal plasmids are available as Supplementary Figs S2 –S26.",OADS,/arxiv_data1/oa_pdf/9d/39/dsv024.PMC4675711.pdf
"33The free online tool KEGG color-mapper (http://www.genome.jp/kegg/tool/map_pathway2.html, accessed: 27 April 2015) was used to highlight430 Neutral sites in Synechocystis",OADS,/arxiv_data1/oa_pdf/9d/39/dsv024.PMC4675711.pdf
"Selection of putative neutral sites To identify putative neutral sites in the chromosome of Synechocystis , the list of annotated open reading frames (ORFs) with the respectiveencoded proteins was retrieved from CyanoBase (http://genome.kazusa.or.jp/cyanobase).",OADS,/arxiv_data1/oa_pdf/9d/39/dsv024.PMC4675711.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/4d/dsv026.PMC4675713.pdf
"Braithwaite, D. and Keegan, K. 2014, matR: Metagenomics Analysis Tools for R, http://CRAN.R-project.org/package=matR (1 August 2014, date last accessed).",OADS,/arxiv_data1/oa_pdf/b4/4d/dsv026.PMC4675713.pdf
2 The National Center for Biotechnology Information (NCBI) Gene database (http://www.ncbi.nlm.nih.gov/gene) is a collection of generecords accessible as web page entries.,OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
"Among the other existing gen- ome browsers, such as the University of California at Santa Cruz(UCSC) Genome Browser (http://ge nome-euro.ucsc.edu/cgi-bin/ hgGateway) and Ensembl (http://www.ensembl.org/index.html),NCBI Gene is the most complete, containing information aboutmore than 2 million genes from more than 350 species (eukaryoticgenes with nuclear genome annotations; the total is over 11 milliongenes from almost 13,000 species).",OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
"NCBIGene is a text searchable database through indexed ﬁelds using speci ﬁc term queries (http://www.ncbi.nlm.nih.gov/books/NBK3841/), al-though unfortunately not all ﬁelds of the database are available for searching.",OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
"4Furthermore, NCBI makes some Entrez Programming Util- ities (E-Utilities) available that can be combined to form customizeddata pipelines to extract the desired information from NCBI Gene(http://www.ncbi.nlm.nih.gov/books/NBK25497/).",OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
We have developed a Python (http://www.python.,Non-OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
20We downloaded the corresponding chromosome sequences from the NCBI Nucleotide database usingBatch Entrez (http://www.ncbi.nlm.nih.gov/sites/batchentrez) inFASTA format on 5 May 2015.,OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
"We made stand-alone software (of both GeneBase pre-loaded and empty versions), including the FileMaker runtime with a user guideincluded and the relative Python scripts for the initial data pre-processing and sequence calculations, freely available to basic usersat http://apollo11.isto.unibo.it/software/.",OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
"We used BLASTN, the standard Nu-cleotide BLAST (https://blast.ncbi.nlm.nih.gov/?Blast.cgiCMD=Web&PAGE_TYPE=BlastDocs&DOC_TYPE=References), 21toﬁnd at least two independent expressed sequence tag (EST) sequences, or one manu-ally curated RNA sequence, that encompass the intron, as a proof of ex-istence of intron sequences.",OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
Intron length distribution graphs and correlation analyses between intron and genome lengths among selected organisms were done using the R package (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
"containing information —such as gene nomenclature, structure and transcripts —in indexed ﬁelds about more than 2 million genes from more than 350 species, ranging from Plants and Fungi to Animals.This compares very favourably to, for example, the 91 species avail-able through the Gene Table download utility provided by UCSC(http://genome-euro.ucsc.edu/cgi-bin/hgTables) or the 69 available inEnsembl through the download tool BioMart (http://www.ensembl.org/biomart/).",OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
These lack experimental evi- dence as indicated in RefSeq Nucleotide entries and by the geneconﬁdence ranking provided by TAIR (The Arabidopsis Information Resource at https://www.arabidopsis.org/index.jsp) 41and were not considered further.,Non-OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
"59 Availability GeneBase (both pre-loaded and empty versions), the ‘Database Design Report ’, the user guide and the relative Python scripts for the initial data pre-processing and sequence calculations are publicly availableat http://apollo11.isto.unibo.it/software/.",OADS,/arxiv_data1/oa_pdf/a1/76/dsv028.PMC4675715.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/ec/dsv029.PMC4675716.pdf
Identi ﬁcation of CNGC proteins in plant genomes BLASTP searches were performed against sequenced genomes of green plants in Phytozome (v9.1) (http://www.phytozome.net/) andin NCBI (http://www.ncbi.nlm.nih.gov/) databases using Arabidopsisand tomato CNGC proteins as queries.,OADS,/arxiv_data1/oa_pdf/ec/ec/dsv029.PMC4675716.pdf
All retrieved non-redundant sequences were collected and subjected to domain analysis by usingthe SMART (http://smart.embl-heidelberg.de/) and Conserved Do-main Database (CDD) (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi/) programmes.,OADS,/arxiv_data1/oa_pdf/ec/ec/dsv029.PMC4675716.pdf
These sequences were compared withArabidopsis and tomato CNGC proteins using ClustalW2 program(http://www.ebi.ac.uk/Tools/msa/clustalw2/) with default settingsand were viewed by GeneDoc program.,OADS,/arxiv_data1/oa_pdf/ec/ec/dsv029.PMC4675716.pdf
"Gene structure, motif and phylogenetic analyses The exon/intron structure of CNGC genes was analysed online using the Gene Structure Display Server (GSDS) (http://gsds.cbi.pku.edu.cn/).The sequence logos were generated online at logo platform (http://weblogo.berkeley.edu/).",OADS,/arxiv_data1/oa_pdf/ec/ec/dsv029.PMC4675716.pdf
The phylogenetic tree is modi ﬁed from Phytozome (http://www.phytozome.net/).,OADS,/arxiv_data1/oa_pdf/ec/ec/dsv029.PMC4675716.pdf
A candidate genomic sequence for silkworm Fuc-T C3 was obtained by searching the silk- worm genomic database in genomic BLAST (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/67/19/iev088.PMC4675719.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/19/iev088.PMC4675719.pdf
Analyses ofthe genomic sequence revealed that silkworm Fuc-T C3 gene composed of seven exons and is localized on chromosome 7 by searching theKAIKOBLAST database; http://kaikoblast.dna.affrc.go.jp/.,OADS,/arxiv_data1/oa_pdf/67/19/iev088.PMC4675719.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/c4/iev092.PMC4675720.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/fd/iev096.PMC4675721.pdf
(http://thrips.info/wiki/Main_Page) (accessed 15 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/a5/fd/iev096.PMC4675721.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/a0/iev089.PMC4675722.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/57/iev094.PMC4675723.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/88/b5/40123_2015_Article_37.PMC4675727.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/91/86/40123_2015_Article_42.PMC4675728.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5e/54/40123_2015_Article_40.PMC4675729.pdf
Available from: http://one.aao.org/CE/PracticeGuide-lines/PPP.aspx .,Non-OADS,/arxiv_data1/oa_pdf/5e/54/40123_2015_Article_40.PMC4675729.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit tothe original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/02/00/40123_2015_Article_39.PMC4675731.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
10. http://www.prnewswire.com/news-releases/shire- reports-top-line-results-on-opus-2-a-phase-3-study- investigating-the-use-of-liﬁtegrast-50-ophthalmic-solution-in-adults-with-dry-eye-disease-234660341.html .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
11. http://www.medscape.com/viewarticle/843968 .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
21. https://clinicaltrials.gov/ct2/show/NCT01960010 .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
22. http://www.mimetogen.com/clinical-development.,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
23. http://www.mimetogen.co m/news-publications/ press-releases/51-mimetogen-pharmaceuticals-announces-topline-results-of-its-second-clinical- study-with-mim-d3-for-the-treatment-of-dry- eye-syndrome.html .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
24. http://investors.ocutx.com/phoenix.zhtml?c=2536 50&p=irol-newsArticle&ID=2032479 .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
25. http://www.ocutx.com/pipeline/dexamethasone- punctum-plug .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
26. http://investors.ocutx.com/phoenix.zhtml?c=253650 &p=irol-newsArticle&ID=2009132 .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
30. https://clinicaltrials.gov/ct2/show/NCT00831662 .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
33. https://clinicaltrials.gov/ct2/show/NCT01843894 .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
34. http://www.businesswire.com/news/home/201411 09005056/en/R-Tech-Ueno-Completion-Phase-III-Clinical-Study-.VYOo6mAXN6k .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
36. http://www.businesswire.com/news/home/201504 01005554/en/Kala-Pharmaceuticals-Announces-Positive-Results-Phase-2-.VYOvQWAXN6k .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
38. https://clinicaltrials.gov/ct2/show/NCT02313454 .,Non-OADS,/arxiv_data1/oa_pdf/06/6c/40123_2015_Article_38.PMC4675732.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anyOphthalmol Ther (2015) 4:103–113 111",Non-OADS,/arxiv_data1/oa_pdf/bc/f4/40123_2015_Article_41.PMC4675733.pdf
https://www.medicines.org.uk/emc/medicine/27636 .,Non-OADS,/arxiv_data1/oa_pdf/46/be/40123_2015_Article_35.PMC4675734.pdf
https://www.medicines.org.uk/emc/medicine/23422 .,Non-OADS,/arxiv_data1/oa_pdf/46/be/40123_2015_Article_35.PMC4675734.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/60/97/40119_2015_Article_49.PMC4675745.pdf
http://www.ncbi.nlm.nih.gov/books/n/nicecollect/ .,Non-OADS,/arxiv_data1/oa_pdf/60/97/40119_2015_Article_49.PMC4675745.pdf
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.,Non-OADS,/arxiv_data1/oa_pdf/3d/83/40119_2015_Article_50.PMC4675746.pdf
2015; Thorax doi:10.1136/thoraxjnl- 2015-207170 [online ﬁrst] via Creative Commons Open Access license: http://creativecommons.org/licenses/by-nc/4.,Non-OADS,/arxiv_data1/oa_pdf/03/2a/40119_2015_Article_46.PMC4675747.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8e/90/40119_2015_Article_53.PMC4675748.pdf
"Informed consent was obtained from all patients for being included in the study.Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/67/93/40119_2015_Article_45.PMC4675749.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/04/b2/40119_2015_Article_52.PMC4675750.pdf
The top 10 causes of death 2000 and 2012. http://www.who.int/ mediacentre/factsheets/fs310/en/ .,Non-OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
York: CRD; 2008. https://www.york.ac.uk/media/ crd/Systematic_Reviews.pdf .,Non-OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
Liverpool: The University of Liverpool;2011. http://www.nice.org.uk/guidance/ta236/doc uments/acute-coronary-syndromes-ticagrelor-evide nce-review-group-report2 .,Non-OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
"Changes to the general guidelines for economic evaluations from the Pharmaceutical Beneﬁts Board LFNAR2003:2 (TLVAR 2015:1); 2015. http://www.tlv.se/ Upload/Lagar_och_foreskrifter/TLVAR_2015_1.pdf Accessed May 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
http://www.scb.se/ sv_/Hitta-statistik/Statistik-efter-amne/Priser-och-ko nsumtion/Konsumentprisindex/Konsumentprisindex-KPI/33772/33779/Konsumentprisindex-KPI/272151/.,OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
Socialfo ¨rsa¨kringsrapport 2009;5. https://www.forsak ringskassan.se/wps/wcm/connect/6043de6a-abf1-44ac-a48d-a92eb438a50d/socialforsakringsrapport_2009 _5.pdf?MOD=AJPERES .,Non-OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
Arbetsgivaravgifternas sammansa ¨ttni ng; 2011. http://www.skatteverket.se/foretagorganis ationer/arbetsgivare/socialavgifter/arbetsgivaravgift er.4.233f91f71260075abe8800020817.html .,Non-OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
Genomsnittlig ma ˚nadslo ¨n efter sektor 1992–2011: Samtliga sektorer: 2011. http://www.scb.se/sv_/Hitta-statistik/Statistik-efter-amne/Arbetsmarknad/Loner-och-arbetskostnader/Lonestrukturstatistik-hela-ekonomin/14367/14374/ 149087/ .,Non-OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
http://www.ecb.europa.,Non-OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
Statistikdatabas fo ¨r diagnoser i sluten va ˚rd.http://www.socialstyrelsen.se/statistik/ statistikdatabas/diagnoserislutenvard .,Non-OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
http://www.scb.se/ Statistik/BE/BE0101/2013A02F/Be0101Livsl%C3% A4ngdstabeller_13_eng.xls .,OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
http://www.tlv.se/beslut/sok/ lakemedel/ .,Non-OADS,/arxiv_data1/oa_pdf/01/98/40119_2015_Article_41.PMC4675751.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/94/c7/40119_2015_Article_51.PMC4675752.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/40/13/40119_2015_Article_47.PMC4675753.pdf
Available from: http://www.pcori.org/research-results/2015/ aspirin-dosing-patient-centric-trial-assessing-beneﬁts-and-long-term .,Non-OADS,/arxiv_data1/oa_pdf/40/13/40119_2015_Article_47.PMC4675753.pdf
Available from: https://www.efﬁent.com/ .,Non-OADS,/arxiv_data1/oa_pdf/40/13/40119_2015_Article_47.PMC4675753.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e2/29/40119_2015_Article_48.PMC4675754.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/00/a1/40121_2015_Article_97.PMC4675761.pdf
Institute of Medicine.Available at: http://iom.nationalacademies.org/ */ media/Files/Report%20Files/2011/Clinical-Practice- Guidelines-We-Can-Trust/Clinical%20Practice%20 Guidelines%202011%20Insert.pdf .,Non-OADS,/arxiv_data1/oa_pdf/00/a1/40121_2015_Article_97.PMC4675761.pdf
Availableat: http://wonder.cdc.gov/natality-current.html .,OADS,/arxiv_data1/oa_pdf/00/a1/40121_2015_Article_97.PMC4675761.pdf
"Available at: https://www.marchofdimes.o rg/peristats/pdfdocs/ nicu_summary_ﬁnal.pdf .A c c e s s e dF e b6 ,2 0 1 5 .Infect Dis Ther (2015) 4:503–511 511",Non-OADS,/arxiv_data1/oa_pdf/00/a1/40121_2015_Article_97.PMC4675761.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/05/67/40121_2015_Article_89.PMC4675762.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/2b/9e/40121_2015_Article_95.PMC4675763.pdf
v 4.0; 2014. http://www.eucast.org .,Non-OADS,/arxiv_data1/oa_pdf/2b/9e/40121_2015_Article_95.PMC4675763.pdf
Version 4.0; 2014. http://www.eucast.org .,Non-OADS,/arxiv_data1/oa_pdf/2b/9e/40121_2015_Article_95.PMC4675763.pdf
http://www.srga.org .,Non-OADS,/arxiv_data1/oa_pdf/2b/9e/40121_2015_Article_95.PMC4675763.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproductionThe online version of the original article can be found under doi: 10.1007/s40121-015-0076-8 .",Non-OADS,/arxiv_data1/oa_pdf/2b/25/40121_2015_Article_90.PMC4675764.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e4/ac/40121_2015_Article_96.PMC4675765.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ce/d3/40121_2015_Article_76.PMC4675767.pdf
http://www.izsummitpartners.org/summit/archive/2012-nivs/ .,Non-OADS,/arxiv_data1/oa_pdf/ce/d3/40121_2015_Article_76.PMC4675767.pdf
http://ftp.cdc.gov/pub/health_Statistics/ NCHS/Publications/NVSR/56_09/ .,Non-OADS,/arxiv_data1/oa_pdf/ce/d3/40121_2015_Article_76.PMC4675767.pdf
2014. https://www.cms.,Non-OADS,/arxiv_data1/oa_pdf/ce/d3/40121_2015_Article_76.PMC4675767.pdf
2014.http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice/ 2014ASPFiles.html .,Non-OADS,/arxiv_data1/oa_pdf/ce/d3/40121_2015_Article_76.PMC4675767.pdf
2014. http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/ce/d3/40121_2015_Article_76.PMC4675767.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7a/ee/40121_2015_Article_91.PMC4675768.pdf
2015. http://apps.who.int/ iris/bitstream/10665/179184/2/WHO_MERS_RA_15.1_eng.pdf?ua=1 .,OADS,/arxiv_data1/oa_pdf/7a/ee/40121_2015_Article_91.PMC4675768.pdf
http://www.who.int/csr/disease/ coronavirus_infections/risk-assessment-19june2015 /en/.,Non-OADS,/arxiv_data1/oa_pdf/7a/ee/40121_2015_Article_91.PMC4675768.pdf
http://www.who.int/mediacentre/news/statements/2015/ihr-ec-mers/en/ .,Non-OADS,/arxiv_data1/oa_pdf/7a/ee/40121_2015_Article_91.PMC4675768.pdf
http://www.who.int/ medicines/emp_ebola_q_as/en/ .,Non-OADS,/arxiv_data1/oa_pdf/7a/ee/40121_2015_Article_91.PMC4675768.pdf
http://www.cdc.gov/coronavirus/mers/ about/prevention.html .,Non-OADS,/arxiv_data1/oa_pdf/7a/ee/40121_2015_Article_91.PMC4675768.pdf
Interim guidance; updated 4 June 2015. http://www.who.int/csr/disease/coronavirus_ infections/ipc-mers-cov/en/ .,Non-OADS,/arxiv_data1/oa_pdf/7a/ee/40121_2015_Article_91.PMC4675768.pdf
2013. http://hkupop.hku.hk/english/ report/postSARS/content/resources/pr.pdf .A c c e s s e d July 2015.,Non-OADS,/arxiv_data1/oa_pdf/7a/ee/40121_2015_Article_91.PMC4675768.pdf
24 June 2015. http://www.cdc.gov/vhf/ebola/outbreaks/ 2014-west-africa/distribution-map.html .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
Available from: http://onlinelibrary.wiley.com/doi/10.1038/npg.els.0001019/full .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2015. http://www.who.int/ csr/don/en/ .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
http://www.cdc.gov/vhf/ebola/outbreaks/ history/summaries.html .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2015. http://www.cdc.gov/ vhf/ebola/outbreaks/2014-west-africa/case-counts.,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2015. http://apps.who.int/ ebola/current-situation/ebola-situation-report-8- july-2015 .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2015. http://www.cdc.gov/vhf/ ebola/healthcare-us/laboratories/specimens.html .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2014. http://apps.who.int/iris/ bitstream/10665/134009/1/WHO_EVD_GUIDANCE_ LAB_14.1_eng.pdf?ua=1 .,OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2015. http://www.cdc.gov/ vhf/ebola/pdf/ebola-lab-guidance.pdf .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=21073 .386 Infect Dis Ther (2015) 4:365–390,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2015. http://investor.tekmirap harm.com/releasedetail.,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2015. https://clinicaltrials.gov/ct2/ show/NCT02329054?term=favipiravir&rank=5 .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2015. http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2014. http://www.france 24.com/en/20141004-french-nurse-cured-ebola-health-minister-msf-touraine .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
EASE (EMERGENCY Amiodarone Study Against Ebola).2015. https://clinicaltrials.gov/ct2/results?term= NCT02307591 ?&Search=Search .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
2014.http://www.searo.who.int/e ntity/emerging_diseases/ ebola/who_his_sds_2014.8_eng.pdf .,Non-OADS,/arxiv_data1/oa_pdf/65/9e/40121_2015_Article_79.PMC4675769.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ff/cd/40121_2015_Article_92.PMC4675770.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/ label/2011/050717s007lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ff/cd/40121_2015_Article_92.PMC4675770.pdf
http://www.meddramsso.com/ .,Non-OADS,/arxiv_data1/oa_pdf/ff/cd/40121_2015_Article_92.PMC4675770.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ca/9a/40121_2015_Article_93.PMC4675771.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2015.05.004 2211-3835 &2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/8b/42/main.PMC4675807.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: BMS, Bristol-Myers Squibb; CA, capsid; GSK, GlaxoSmithKline; HIV, human immunode ﬁciency virus; MA, matrix; MI, maturation inhibitor; PR, protease; PI, protease inhibitor; SIV, Simian immunode ﬁciency virus; SP1, spacer protein 1 nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/8b/42/main.PMC4675807.pdf
DFH Pharma has identi ﬁed a number of second-generation bevirimat-derived HIV-1 MIs ( http://www.croiconference.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/42/main.PMC4675807.pdf
"Bristol-Myers Squibb (BMS) recently described a potent second generation inhibitor, dubbed as BMS-955176,which is very active against bevirimat-resistant SP1 polymorphicviruses ( http://www.bms.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/42/main.PMC4675807.pdf
GlaxoSmithKline (GSK) has alsoinvested extensive effort and time in developing second-generation HIV-1 MIs ( http://www.gsk.com/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/42/main.PMC4675807.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2015.07.007 2211-3835 &2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/6b/38/main.PMC4675808.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/38/main.PMC4675808.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2015.08.001 2211-3835 &2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/96/4f/main.PMC4675809.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AD, Alzheimer's disease; Ala, alanine; ALS, amyotrophic lateral sclerosis; APP, amyloid precursor protein; APP/PS1, A βoverexpressing mice APP (K670N/M671L) and PS1 (M146L) mutants; AppLon, London familial amyloid precursor protein mutation, APP (V717I); AppSwe, Swedish amyloid precu rsor protein mutation, APP (K670N/M671L); Arg, arginine; A β,a m y l o i d β;Aβ1-42, amyloid β, 42 amino acid protein; BACE-1, β-amyloid cleaving enzyme; BBB, blood –brain barrier; CaMKII, Ca2þ/calmodulin-dependent protein kinases II; CANP, calcium-activated neutral protease; Cdk5/p35, activator of cyclin-dependent kinase 5; CNS, central nervous system; CREB, cyclic adenosine monophosphate response element binding protein; DTT, dithioerythritol; EGFR, epide rmal growth factor receptor; ERK1/2, extracellular signal-regulated kinase 1/2; Gln, glutamine; Glu, glutamic acid; Gly, glutamine; GSH, glutathione; Hsp70 .1, heat shock protein 70.1; Ile, isoleucine; isoAsp, isoaspartate; KO, knockout; Leu, leucine; Lys, lysine; MAP-2, microtubule-associated protein 2; Met, methionine; MMP-9, matrix metalloproteinase 9; NFT, neuro ﬁbrilliary tangles; Nle, norleucin e; PD, Parkinson's disease; pGl u, pyroglutamate; Phe, phenylalan ine; PK, pharmacokinetic; PKC, protein kinase C; Pro, proline; PTP1B, pro tein-tyrosine phosp hatase 1B; pyroGluA β, pyroglutamate-amyloid β; SP, senile plaques; TBI, tr aumatic brain injury; Thr, threonine; TNF, tumor necrosis facto r; Tyr, tyrosine; Val, valine; WRX, Trp-Arg containing epoxysuccinate cysteine protease inhibitor; WT, wildt ype nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/96/4f/main.PMC4675809.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ADM, adriamycin; CAM, chorioallantoic membrane; CCK-8, cell counting kit-8; DMSO, dimethylsulfoxide; EPCs, endothelial progenitor cells; FBS, fetal bovine serum; FCM, ﬂow cytometry; HRP, horseradish peroxidase; IC 50, 50% inhibitory concentration; MD, molecular dynamics; mOS, median overall survival; NS, normal saline; NSCLC, non-small cell lung cancer; PI, propidium iodide; PKB/AKT, protein kinase B; RMSD, root-mean-square deviation; Tan IIA, tanshinone IIA; tRR, tumor response rate; vdW, van der Waals force; VEGF, vascular endothelial growth factor nCorresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/35/e0/main.PMC4675810.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/e0/main.PMC4675810.pdf
The three dimensional (3D) crystalstructure of VEGFR2 was selected from PDB ( http://www.rcsb.,OADS,/arxiv_data1/oa_pdf/35/e0/main.PMC4675810.pdf
The 3D structure of Tan IIA was downloaded from The PubChemProject ( http://www.pubchem.,OADS,/arxiv_data1/oa_pdf/35/e0/main.PMC4675810.pdf
Available from: http://dx.doi.org/10.1179/1973947815Y.0000000045 .,Non-OADS,/arxiv_data1/oa_pdf/35/e0/main.PMC4675810.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/a4/main.PMC4675811.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2015.07.010 2211-3835 &2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/45/b2/main.PMC4675812.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/b2/main.PMC4675812.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2015.09.005 2211-3835 &2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/a9/d5/main.PMC4675814.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ETS, erythroblast transformation-speci ﬁc; GO, gene ontology; IFNs, interferons; IL, interleukin; JAK-STAT, Janus kinase-STAT; MAPK, mitogen-activated protein kinase; MCODE, molecular complex detection; NF- κB, nuclear factor kappa B; PIN, protein interaction network; PPIs, protein–protein interactions; STATs, signal transducer and activator of transcription complexes; TLR, toll-like receptor nCorresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/a9/d5/main.PMC4675814.pdf
ebi.ac.uk/chembl/# ) and STITCH4.0 ( http://stitch.embl.de/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/d5/main.PMC4675814.pdf
The PPI information was obtained from the online databases of String 9.1 ( http://string-db.org ) which was used to retrieve the predicted interactions for the targets 19.,OADS,/arxiv_data1/oa_pdf/a9/d5/main.PMC4675814.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2015.09.002 2211-3835 &2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/42/9c/main.PMC4675815.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: CAS, cycloartenol synthase; DXR, 1-deoxy- D-xylulose-5-phosphate reductoisomerase; DMAPP, dimethylallyl diphosphate; FPS, farnesyl pyrophosphate synthase; HDR, 1-hydroxy-2-methyl-2-( E)-butenyl-4-diphosphate reductase; HMBPP, 1-hydroxy-2-methyl-2-( E)-butenyl-4-diphosphate; IPP, iso- pentenyl diphosphate; MVA, mevalonic acid; MEP, 2-methyl- D-eryth-ritol-4-phosphate; ORF, open reading frame ; SQS, qualene synthase; SE, squalene epoxidase nCorresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/42/9c/main.PMC4675815.pdf
org/ Secondary structure Network protein Sequence analysishttp://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page ¼npsa_sopm.html Three-dimensional structure mode SWISS-MODEL http://swissmodel.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/main.PMC4675815.pdf
dk/services/SignalP/ http://www.cbs.dtu.dk/services/TargetP/ Subcellular localization signal WOLF PSORT PredictProteinhttp://www.genscript.com/psort/wolf_psort .,OADS,/arxiv_data1/oa_pdf/42/9c/main.PMC4675815.pdf
Html https://www.predictprotein.org/ Transmembrane regions HMMTOP TMHMM Server v. 2.0http://www.enzim.hu/hmmtop/html/adv_submit .,OADS,/arxiv_data1/oa_pdf/42/9c/main.PMC4675815.pdf
Html http://www.cbs.dtu.dk/services/TMHMM/Haizhou Lv et al.,Non-OADS,/arxiv_data1/oa_pdf/42/9c/main.PMC4675815.pdf
The conserved domains of HsHDR1 and HsHDR2 were predicted by Pfam ( http://pfam.xfam.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/9c/main.PMC4675815.pdf
Prediction of subcellular localization The subcellular localization of HsHDR1 and HsHDR2 was predicted using the WOLF PSORT ( http://www.genscript.com/psort/wolf psort.,OADS,/arxiv_data1/oa_pdf/42/9c/main.PMC4675815.pdf
"Furthermore, we alsoused the PredictProtein ( https://www.predictprotein.org/ )t oa n a l y z e the subcellular localization of these two proteins.",Non-OADS,/arxiv_data1/oa_pdf/42/9c/main.PMC4675815.pdf
Alignment of amino acids for phylogenetic analysis We submitted the amino acid sequences of HsHDR1 and HsHDR2 to the NCBI database ( http://blast.ncbi.nlm.nih.gov/Blast.cgi )t o search for homologous sequences.,OADS,/arxiv_data1/oa_pdf/42/9c/main.PMC4675815.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2015.09.003 2211-3835 &2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/74/b7/main.PMC4675816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/b7/main.PMC4675816.pdf
Editor: Miriam Goodman./C2112015 The Authors 0006-3495/15/12/2268/9 http://dx.doi.org/10.1016/j.bpj.2015.08.054 2268 Biophysical Journal Volume 109 December 2015 2268–2276,Non-OADS,/arxiv_data1/oa_pdf/1d/3a/main.PMC4675818.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2015.09.006 2211-3835 &2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/7a/95/main.PMC4675819.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/95/main.PMC4675819.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: BA, bile acid; cDNA, complementary DNA; CXCL, chemokine ligand; DISC, death-inducing signaling complex; DMEM, Dulbecco's modiﬁed Eagle's medium; DNA, deoxyribonucleic acid; ELISA, enzyme-linked immunosorbent assay; FADD, Fas associated death domain; FBS, fetal bovine serum; FCS, fetal calf serum; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GP, glypican; HCC, hepatocellular carcinoma; IHC,immunohistochemistry; JNK, c-Jun NH 2-terminal kinase; MAPK, mitogen-activated protein kinase; MTS, 3,4-(5-dimethylthiazol-2-yl)-5-(3-carboxy- methoxyphenyl)-2-(4-sulfophenyl)-2 H-tetrazolium salt; NDRG , N-myc downstream-regulated gene; PCR, polymerase chain reaction; RNA, ribonucleic acid; SD, standard deviation; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; siRNA, small interfering RNA; VMP, vacuole membrane protein; WME, William's medium E nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4675821.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4675821.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Hyp ertension Research website (http://www.nature.com/hr)Differences between clinic and morning home BP KS h i m a d a et al 882 Hypertension Research",Non-OADS,/arxiv_data1/oa_pdf/55/d0/hr201588a.PMC4675842.pdf
Editor: Jason Kahn./C2112015 The Authors 0006-3495/15/12/2338/14 http://dx.doi.org/10.1016/j.bpj.2015.10.016 2338 Biophysical Journal Volume 109 December 2015 2338–2351,Non-OADS,/arxiv_data1/oa_pdf/b9/50/main.PMC4675846.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) A novel recurrent EP300 –ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia Leukemia (2015) 29,2445 –2448; doi:10.1038/leu.2015.111 In pediatric patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL), approximately three-quarters harbor well- characterized, clinically relevant chromosomal alterations, includ-ing hyperdiploidy, hypodiploidy, t(12;21) ETV6/RUNX1 , t(1;19) E2A/ PBX1 , t(9;22) BCR/ABL1 and the rearrangement of MLL at 11q23, and they can facilitate diagnosis, risk strati ﬁcation and targeted therapy.1,2In the remaining patients, however, major pathogenic or driver gene abnormalities and their association with the clinicaloutcome have yet to be fully clari ﬁed.",Non-OADS,/arxiv_data1/oa_pdf/f4/37/leu2015117a.PMC4675867.pdf
Sequence variation at pheromone loci and correspondence with pheromone receptor loci Mating-pheromone loci from other Microbotryum species were obtained using pheromone sequences from M. lychnidis-dioicae as BLASTn search queries for genomic survey sequence libraries from several Microbotryum species (ENA accession numbers PRJEB6548; http://www.ebi.ac.uk).,OADS,/arxiv_data1/oa_pdf/c7/03/hdy201568a.PMC4675872.pdf
"In addition, PCR primers were designed to regions ﬂanking the mating pheromones using the web-based program Primer3 (http://frodo.wi.mit.edu/primer3/) with thedefault settings.",Non-OADS,/arxiv_data1/oa_pdf/c7/03/hdy201568a.PMC4675872.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Variation in fungal mate-recognition pheromones LX u et al 51 Heredity",Non-OADS,/arxiv_data1/oa_pdf/c7/03/hdy201568a.PMC4675872.pdf
"R: A language and environment for statistical computing .R Foundation for Statistical Computing: Vienna, Austria, ISBN 3-900051-07-0, URL http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/c7/96/hdy201570a.PMC4675874.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/4.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Effect of sample size and introgression in a wild population LI a c o l i n a et al 67 Heredity",Non-OADS,/arxiv_data1/oa_pdf/c7/96/hdy201570a.PMC4675874.pdf
"ACKNOWLEDGEMENTS We acknowledge funding for this research under the Tria 1 and Tria 2 Projects (http://www.thetriaproject.ca) from Genome Canada, the Government of Alberta through Genome Alberta and the Government of British Columbiathrough Genome British Columbia; and from Alberta Innovates Bio Solutions.",Non-OADS,/arxiv_data1/oa_pdf/c5/a4/hdy201571a.PMC4675875.pdf
Available at: http://www.nrcan.gc.ca/forests/insects-diseases/13397 (last accessed 5 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/c5/a4/hdy201571a.PMC4675875.pdf
Available at: http://www.nrcan.gc.ca/forests/insects- diseases/13381 (last accessed 5 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/c5/a4/hdy201571a.PMC4675875.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/4.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Fine-scale structure of D. ponderosae JK Janes et al 74 Heredity",Non-OADS,/arxiv_data1/oa_pdf/c5/a4/hdy201571a.PMC4675875.pdf
Editor: David Eliezer./C2112015 The Authors 0006-3495/15/12/2363/8 http://dx.doi.org/10.1016/j.bpj.2015.10.034 Biophysical Journal Volume 109 December 2015 2363–2370 2363,Non-OADS,/arxiv_data1/oa_pdf/31/ef/main.PMC4675884.pdf
"Published online September 16, 2015. http://dx.doi.org/10.1007/s12104–015–9641-z .",Non-OADS,/arxiv_data1/oa_pdf/31/ef/main.PMC4675884.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/a8/pcv145.PMC4675897.pdf
"Glucosinolate uptake/export assays 4MTB was obtained from C 2Bioengineering (Denmark), http://www.glucosino lates.com/.",Non-OADS,/arxiv_data1/oa_pdf/15/a8/pcv145.PMC4675897.pdf
Relative quantiﬁcation of Western blot bands Western blots were developed and analyzed by the standard ‘gel analysis’ tool in ImageJ (http://rsb.info.nih.gov/ij).,OADS,/arxiv_data1/oa_pdf/15/a8/pcv145.PMC4675897.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/a5/pcv146.PMC4675898.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/39/ofv160.PMC4675918.pdf
"407 http://dx.doi.org/10.3345/kjp.2015.58.11.407Korean J Pediatr 2015;58(11):407-414 Early-onset epileptic encephalopathies and the  diagnostic approach to underlying causes  Su-Kyeong Hwang, MD, PhD, Soonhak Kwon, MD Department of Pediatrics, Kyungpook National University Children’s Hospital, Daegu, Korea  Early-onset epileptic encephalopathies are one of the most severe early onset epilepsies that can lead  to progressive psychomotor impairment.",Non-OADS,/arxiv_data1/oa_pdf/d8/f0/kjped-58-407.PMC4675920.pdf
"Next-generation sequencing  (NGS) technology has revolutionized our ability to sequence DNA at the whole exome or Corresponding author: Soonhak Kwon, MD Department of Pediatrics, Kyungpook National University Children’s Hospital, 807 Hoguk-ro, Buk-ku, Daegu 41404, KoreaTel: +82-53-200-2746Fax: +82-53-425-6683E-mail: shkwon@knu.ac.kr Received: 1 September, 2015 Accepted: 28 October, 2015 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2015;58(11):407-414 http://dx.doi.org/10.3345/kjp.2015.58.11.407pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/d8/f0/kjped-58-407.PMC4675920.pdf
http://dx.doi.org/10.3345/kjp.2015.58.11.407Hwang SK and Kwon S • Diagnostic approach to EOEE 408whole genome level at an increasingly affordable price10).,Non-OADS,/arxiv_data1/oa_pdf/d8/f0/kjped-58-407.PMC4675920.pdf
409 http://dx.doi.org/10.3345/kjp.2015.58.11.407Korean J Pediatr 2015;58(11):407-414 type of seizures including infantile spasms21).,Non-OADS,/arxiv_data1/oa_pdf/d8/f0/kjped-58-407.PMC4675920.pdf
http://dx.doi.org/10.3345/kjp.2015.58.11.407Hwang SK and Kwon S • Diagnostic approach to EOEE 4107.,Non-OADS,/arxiv_data1/oa_pdf/d8/f0/kjped-58-407.PMC4675920.pdf
411 http://dx.doi.org/10.3345/kjp.2015.58.11.407Korean J Pediatr 2015;58(11):407-414 health functional foods in Korea.,Non-OADS,/arxiv_data1/oa_pdf/d8/f0/kjped-58-407.PMC4675920.pdf
http://dx.doi.org/10.3345/kjp.2015.58.11.407Hwang SK and Kwon S • Diagnostic approach to EOEE 412Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d8/f0/kjped-58-407.PMC4675920.pdf
"413 http://dx.doi.org/10.3345/kjp.2015.58.11.407Korean J Pediatr 2015;58(11):407-414 of novel data, be it on the level of common single nucleotide poly - morphisms, CNVs, or overall sequence, has led to the identification  of a vast amount of benign variation in the human genome (Fig.",OADS,/arxiv_data1/oa_pdf/d8/f0/kjped-58-407.PMC4675920.pdf
http://dx.doi.org/10.3345/kjp.2015.58.11.407Hwang SK and Kwon S • Diagnostic approach to EOEE 414myoclonic encephalopathy.,Non-OADS,/arxiv_data1/oa_pdf/d8/f0/kjped-58-407.PMC4675920.pdf
"415 http://dx.doi.org/10.3345/kjp.2015.58.11.415Korean J Pediatr 2015;58(11):415-420 Low levels of tissue inhibitor of metallopro­ teinase ­2 at birth may be associated with sub­ sequent development of bronchopulmonary dysplasia in preterm infants Choae Lee, MD1,*, Jaewoo An, MD2,*, Ji Hee Kim, MD3,4, Eun Sun Kim, MD, PhD5, Soo Hyun Kim, MD4,6, Yeon Kyung Cho, MD4,6, Dong Hyun  Cha, MD, PhD4,6, Man Yong Han, MD2,4, Kyu Hyung Lee, MD, PhD2,4, Youn Ho Sheen, MD, PhD3,4 1Graduate School, CHA University, Pocheon, 2Department of Pediatrics, CHA University Bundang Medical Center, Seongnam, 3Department of Pediatrics, CHA  University Gangnam Medical Center, Seoul, 4CHA University School of Medicine, Pocheon, 5Department of Pediatrics, Kangwon National University School of  Medicine, Chuncheon, 6Department of Obstetrics and Gynecology, CHA University Gangnam Medical Center, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/71/2a/kjped-58-415.PMC4675921.pdf
"Received: 9 March, 2015 Revised: 7 July, 2015Accepted: 20 August, 2015 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(11):415­420 http://dx.doi.org/10.3345/kjp.2015.58.11.415pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/71/2a/kjped-58-415.PMC4675921.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.415Lee C, et al.",OADS,/arxiv_data1/oa_pdf/71/2a/kjped-58-415.PMC4675921.pdf
417 http://dx.doi.org/10.3345/kjp.2015.58.11.415Korean J Pediatr 2015;58(11):415-420 <0.05.,Non-OADS,/arxiv_data1/oa_pdf/71/2a/kjped-58-415.PMC4675921.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.415Lee C, et al.",OADS,/arxiv_data1/oa_pdf/71/2a/kjped-58-415.PMC4675921.pdf
419 http://dx.doi.org/10.3345/kjp.2015.58.11.415Korean J Pediatr 2015;58(11):415-420 lungs through extracellular matrix remodeling.,Non-OADS,/arxiv_data1/oa_pdf/71/2a/kjped-58-415.PMC4675921.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.415Lee C, et al.",OADS,/arxiv_data1/oa_pdf/71/2a/kjped-58-415.PMC4675921.pdf
"421 http://dx.doi.org/10.3345/kjp.2015.58.11.421Korean J Pediatr 2015;58(11):421-426 Usefulness of serum cystatin C to determine the  dose of vancomycin in neonate Jeong Eun Shin, MD, Soon Min Lee, MD, Ho Seon Eun, MD, Min Soo Park, MD, Kook In Park, MD, Ran Namgung, MD Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea Purpose:  The vancomycin dosage regimen is regularly modified according to the patient’s glomerular  filtration rate (GFR).",Non-OADS,/arxiv_data1/oa_pdf/e2/9d/kjped-58-421.PMC4675922.pdf
"Corresponding author: Min Soo Park, MD Department of Pediatrics, Severance Children’s Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTel: +82-2-2228-0400Fax: +82-2-392-0668E-mail: minspark@yuhs.ac Received: 26 August, 2014 Revised: 5 November, 2014Accepted: 7 November, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(11):421-426 http://dx.doi.org/10.3345/kjp.2015.58.11.421pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/e2/9d/kjped-58-421.PMC4675922.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.421Shin JE, et al.",OADS,/arxiv_data1/oa_pdf/e2/9d/kjped-58-421.PMC4675922.pdf
423 http://dx.doi.org/10.3345/kjp.2015.58.11.421Korean J Pediatr 2015;58(11):421-426 compartment (K12)=1.12 ±0.28/hr; Rate constant for distribution  from peripheral to central compartment (K21)=0.48 ±0.12/hr.,OADS,/arxiv_data1/oa_pdf/e2/9d/kjped-58-421.PMC4675922.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.421Shin JE, et al.",OADS,/arxiv_data1/oa_pdf/e2/9d/kjped-58-421.PMC4675922.pdf
"425 http://dx.doi.org/10.3345/kjp.2015.58.11.421Korean J Pediatr 2015;58(11):421-426 macokinetic model of vancomycin using NONMEM software (Icon  Development Solutions, Ellicott City, MD, USA) from a total of  1,373 vancomycin concentration measurements in 678 Korean  patients whose serum creatinine concentrations were lower than  1.2 mg/dL were noted.",OADS,/arxiv_data1/oa_pdf/e2/9d/kjped-58-421.PMC4675922.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.421Shin JE, et al.",OADS,/arxiv_data1/oa_pdf/e2/9d/kjped-58-421.PMC4675922.pdf
"427 http://dx.doi.org/10.3345/kjp.2015.58.11.427Korean J Pediatr 2015;58(11):427-433 Severe vitamin D deficiency in preterm infants:  maternal and neonatal clinical features Sook-Hyun Park, MD, PhD, Gi-Min Lee, MD, Jung-Eun Moon, MD, Heng-Mi Kim, MD, PhD Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea Purpose: We investigated the vitamin D status of preterm infants to determine the incidence of vitamin  D deficiency.",Non-OADS,/arxiv_data1/oa_pdf/c1/ae/kjped-58-427.PMC4675923.pdf
"The major determining factor for vitamin D con - centrations during the fetal and newborn periods is the maternal vitamin D concen-Corresponding author: Heng-Mi Kim, MD, PhD Department of Pediatrics, Kyungpook National University Hospital, Kyungpook National University School of Medicine, 130 Dongdeok-ro, Jung-gu, Daegu 41944, KoreaTel: +82-53-200-5704Fax: +82-53-425-6683E-mail: hmkim@knu.ac.kr Received: 21 August, 2015 Revised: 1 October, 2015Accepted: 7 October, 2015 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(11):427-433 http://dx.doi.org/10.3345/kjp.2015.58.11.427pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/c1/ae/kjped-58-427.PMC4675923.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.427Park S, et al.",OADS,/arxiv_data1/oa_pdf/c1/ae/kjped-58-427.PMC4675923.pdf
429 http://dx.doi.org/10.3345/kjp.2015.58.11.427Korean J Pediatr 2015;58(11):427-433 Results 1.,Non-OADS,/arxiv_data1/oa_pdf/c1/ae/kjped-58-427.PMC4675923.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.427Park S, et al.",OADS,/arxiv_data1/oa_pdf/c1/ae/kjped-58-427.PMC4675923.pdf
"431 http://dx.doi.org/10.3345/kjp.2015.58.11.427Korean J Pediatr 2015;58(11):427-433 months, there were not significant differences in the incidence of  severe vitamin D deficiency and 25-OHD concentrations.",Non-OADS,/arxiv_data1/oa_pdf/c1/ae/kjped-58-427.PMC4675923.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.427Park S, et al.",OADS,/arxiv_data1/oa_pdf/c1/ae/kjped-58-427.PMC4675923.pdf
433 http://dx.doi.org/10.3345/kjp.2015.58.11.427Korean J Pediatr 2015;58(11):427-433 with respiratory syncytial virus bronchiolitis.,Non-OADS,/arxiv_data1/oa_pdf/c1/ae/kjped-58-427.PMC4675923.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.434Park SY, et al.",OADS,/arxiv_data1/oa_pdf/a0/c1/kjped-58-434.PMC4675924.pdf
"The use of high­dose aspirin sometimes causes various side effects such as abdominal  pain, acute hepatitis, hearing loss, tinnitus, gastric ulcer, gastro  intestinal bleeding, and Corresponding author: Young Hwan Lee, MD, PhD Department of Pediatrics, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea Tel: +82-53-620-4381Fax: +82-53-629-2292 E-mail: yhlee@med.yu.ac.kr Received: 11 September, 2014 Revised: 21 October, 2014Accepted: 7 November, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(11):434-439 http://dx.doi.org/10.3345/kjp.2015.58.11.434pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/a0/c1/kjped-58-434.PMC4675924.pdf
435 http://dx.doi.org/10.3345/kjp.2015.58.11.434Korean J Pediatr 2015;58(11):434-439 electrolyte abnormality3).,OADS,/arxiv_data1/oa_pdf/a0/c1/kjped-58-434.PMC4675924.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.434Park SY, et al.",OADS,/arxiv_data1/oa_pdf/a0/c1/kjped-58-434.PMC4675924.pdf
"437 http://dx.doi.org/10.3345/kjp.2015.58.11.434Korean J Pediatr 2015;58(11):434-439 manifestations, general blood tests, and echocardiographic results;  and the serum levels of aspirin and its metabolite (salicylic acid)  were measured to find their association with sensorineural hearing  loss.",OADS,/arxiv_data1/oa_pdf/a0/c1/kjped-58-434.PMC4675924.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.434Park SY, et al.",OADS,/arxiv_data1/oa_pdf/a0/c1/kjped-58-434.PMC4675924.pdf
439 http://dx.doi.org/10.3345/kjp.2015.58.11.434Korean J Pediatr 2015;58(11):434-439 ciated with Kawasaki disease.,Non-OADS,/arxiv_data1/oa_pdf/a0/c1/kjped-58-434.PMC4675924.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.440Chun JH, et al.",OADS,/arxiv_data1/oa_pdf/0c/74/kjped-58-440.PMC4675925.pdf
"Here, we intended to discover clinical characteristics that Corresponding author: Kyung Lim Yoon, MD, PhD Department of Pediatrics, Kyung Hee University Hospital at Gandong, 892 Dongnam-ro, Gang-dong-gu, Seoul 05278, KoreaTel: +82-2-440-7000Fax: +82-2-440-7175E-mail: ykr3215@hanmail.net Received: 15 September, 2014 Revised: 7 November, 2014Accepted: 16 November, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(11):440-445 http://dx.doi.org/10.3345/kjp.2015.58.11.440pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/0c/74/kjped-58-440.PMC4675925.pdf
441 http://dx.doi.org/10.3345/kjp.2015.58.11.440Korean J Pediatr 2015;58(11):440-445 may be useful in the diagnosis of some critical diseases that may  manifest as chest pain in children and adolescents.,Non-OADS,/arxiv_data1/oa_pdf/0c/74/kjped-58-440.PMC4675925.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.440Chun JH, et al.",OADS,/arxiv_data1/oa_pdf/0c/74/kjped-58-440.PMC4675925.pdf
"443 http://dx.doi.org/10.3345/kjp.2015.58.11.440Korean J Pediatr 2015;58(11):440-445 Arrhythmia was found in 13 patients, of whom 6 had paroxys- mal supraventricular tachycardia and 3 had ventricular premature  contraction.",Non-OADS,/arxiv_data1/oa_pdf/0c/74/kjped-58-440.PMC4675925.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.440Chun JH, et al.",OADS,/arxiv_data1/oa_pdf/0c/74/kjped-58-440.PMC4675925.pdf
445 http://dx.doi.org/10.3345/kjp.2015.58.11.440Korean J Pediatr 2015;58(11):440-445 revealed by evaluating the mood of the individual due to circum - stances and their environment25).,Non-OADS,/arxiv_data1/oa_pdf/0c/74/kjped-58-440.PMC4675925.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.446Jin D, et al.",OADS,/arxiv_data1/oa_pdf/67/ef/kjped-58-446.PMC4675926.pdf
"Therefore, if the diagnosis of enteroviral meningitis is definite, it Corresponding author: Baik-Lin Eun, MD, PhD Department of Pediatrics, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea Tel: +82-2-2626-1227Fax: +82-2-2626-1249E-mail: bleun@chollian.net Received: 1 September, 2014 Revised: 6 November, 2014Accepted: 7 November, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(11):446-450 http://dx.doi.org/10.3345/kjp.2015.58.11.446pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/67/ef/kjped-58-446.PMC4675926.pdf
447 http://dx.doi.org/10.3345/kjp.2015.58.11.446Korean J Pediatr 2015;58(11):446-450 is possible to avoid unnecessary antibiotic use.,Non-OADS,/arxiv_data1/oa_pdf/67/ef/kjped-58-446.PMC4675926.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.446Jin D, et al.",OADS,/arxiv_data1/oa_pdf/67/ef/kjped-58-446.PMC4675926.pdf
"449 http://dx.doi.org/10.3345/kjp.2015.58.11.446Korean J Pediatr 2015;58(11):446-450 The authors investigated multiple factors associated with en - teroviral meningitis, but it is difficult to differentiate etiologies  based on symptoms alone.",Non-OADS,/arxiv_data1/oa_pdf/67/ef/kjped-58-446.PMC4675926.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.446Jin D, et al.",OADS,/arxiv_data1/oa_pdf/67/ef/kjped-58-446.PMC4675926.pdf
"451 http://dx.doi.org/10.3345/kjp.2015.58.11.451Korean J Pediatr 2015;58(11):451-453 Diphyllobothrium latum  infection in a child with  recurrent abdominal pain Seung Hyun Lee, MD1, Hyun Park, MD2, Seung Taek Yu, MD1 Departments of 1Pediatrics, 2Parasitology and Tropical Medicine, Wonkwang University School of Medicine, Iksan, Korea Diphyllobothrium latum  infection in humans is not common in Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/6f/d5/kjped-58-451.PMC4675927.pdf
"Blood chemistry and serology were within Corresponding author: Seung Taek Yu, MD Department of Pediatrics, Wonkwang University  School of Medicine, 460 Iksan-daero, Iksan  54538, Korea Tel: +82-63-859-1516 Fax: +82-63-853-3670 E-mail: yudoc@wonkwang.ac.kr Received: 3 September, 2015 Revised: 18 October, 2015 Accepted: 23 October, 2015 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2015;58(11):451-453 http://dx.doi.org/10.3345/kjp.2015.58.11.451 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/6f/d5/kjped-58-451.PMC4675927.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.451Lee SH, et al.",OADS,/arxiv_data1/oa_pdf/6f/d5/kjped-58-451.PMC4675927.pdf
453 http://dx.doi.org/10.3345/kjp.2015.58.11.451Korean J Pediatr 2015;58(11):451-453 Only history taking and considering the possibility of parasitic  infection can avoid further invasive evaluation.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/kjped-58-451.PMC4675927.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.454Park HJ, et al.",OADS,/arxiv_data1/oa_pdf/e7/5d/kjped-58-454.PMC4675928.pdf
"Corresponding author: Dong In Suh, MD Department of Pediatrics, Seoul National University  Hospital, Seoul National University College of Med-icine, 101 Daehak-ro, Jongno-gu, Seoul 03080, KoreaTel: +82-2-2072-3625Fax: +82-2-743-3455E-mail: dongins0@snu.ac.kr Received: 25 October, 2013 Revised: 13 May, 2014Accepted: 16 May, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case report Korean J Pediatr 2015;58(11):454-458 http://dx.doi.org/10.3345/kjp.2015.58.11.454 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/e7/5d/kjped-58-454.PMC4675928.pdf
"455 http://dx.doi.org/10.3345/kjp.2015.58.11.454Korean J Pediatr 2015;58(11):454-458 The veins of pediatric patients are short, small in vascular caliber,  and fragile6), which makes extravasation occurs more often.",Non-OADS,/arxiv_data1/oa_pdf/e7/5d/kjped-58-454.PMC4675928.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.454Park HJ, et al.",OADS,/arxiv_data1/oa_pdf/e7/5d/kjped-58-454.PMC4675928.pdf
457 http://dx.doi.org/10.3345/kjp.2015.58.11.454Korean J Pediatr 2015;58(11):454-458 increased the risk of extravasation in the present case.,Non-OADS,/arxiv_data1/oa_pdf/e7/5d/kjped-58-454.PMC4675928.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.11.454Park HJ, et al.",OADS,/arxiv_data1/oa_pdf/e7/5d/kjped-58-454.PMC4675928.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–7 doi:10.1093/ijnp/pyv070 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/09/pyv070.PMC4675981.pdf
"independently extracted, checked, and entered the data into the Review Manager software (Version 5.3 for Windows, Cochrane Collaboration, http://tech.cochrane.org/Revman).",OADS,/arxiv_data1/oa_pdf/b9/09/pyv070.PMC4675981.pdf
"The Cochrane risk of bias criteria (Cochrane Collaboration, http://www.cochrane.org/) was used to perform methodological quality control.",OADS,/arxiv_data1/oa_pdf/b9/09/pyv070.PMC4675981.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–12 doi:10.1093/ijnp/pyv073 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/29/pyv073.PMC4675982.pdf
"Bacteriological analytical manual online.2001.Available  at: http://www.fda.gov/Food/ScienceResearch/LaboratoryMethods/  BacteriologicalAnalytical ManualBAM/default.htm  [16] Bauer AW, Kirby WWM.",Non-OADS,/arxiv_data1/oa_pdf/c6/2b/TOMICROJ-9-26.PMC4676039.pdf
REFERENCES  [1] http://www.who.int/mediacentre/factsheets/fs 117/en [Accessed: 02- 01-2015].,Non-OADS,/arxiv_data1/oa_pdf/97/15/TOMICROJ-9-33.PMC4676044.pdf
Available at:  http://www.who.int/tdr/ publications/documents/dengue- diagnosis.pdf [Accessed: 07-01-2015].,Non-OADS,/arxiv_data1/oa_pdf/97/15/TOMICROJ-9-33.PMC4676044.pdf
[24] http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/97/15/TOMICROJ-9-33.PMC4676044.pdf
[30] http://www.cdc.gov/Dengue/clinicalLab/laboratory.html [Accessed:  02-01-2015].,Non-OADS,/arxiv_data1/oa_pdf/97/15/TOMICROJ-9-33.PMC4676044.pdf
"Available from:  http://journals.plos.org/plospathogens/article?id=10.1371/journal.p pat.1002356  [9] Vadia S, Seveau S. Fluxes of Ca 2+ and K+ are required for the liste- riolysin O-dependent internalization pathway of Listeria monocy- togenes .",Non-OADS,/arxiv_data1/oa_pdf/7f/bb/TOMICROJ-9-81.PMC4676048.pdf
"Available from:  http://perspectivesinmedicine.cshlp.org/content/2/11/a010 009.long  [18] Disson O, Grayo S, Huillet E, et al.",OADS,/arxiv_data1/oa_pdf/7f/bb/TOMICROJ-9-81.PMC4676048.pdf
Available from:  http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/7f/bb/TOMICROJ-9-81.PMC4676048.pdf
"Available at: http://www.unaids.org/en/ resources/presscentre/featurestories/2015/july/20150702_condoms_prevention [2] Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission.",Non-OADS,/arxiv_data1/oa_pdf/6c/0b/TOAIDJ-9-104.PMC4676051.pdf
"Available at: http://apps.who.int/rhl/hiv_aids/cd0 03255/en/ [3] Pinkerton SD, Abramson PR.",Non-OADS,/arxiv_data1/oa_pdf/6c/0b/TOAIDJ-9-104.PMC4676051.pdf
"Available at: http://www.nacc.or.ke/ima ges/KASF_F_web.compressed.pdf [5] Agha S, Kusanthan T, Longfield K, Klein M, Berman J.",Non-OADS,/arxiv_data1/oa_pdf/6c/0b/TOAIDJ-9-104.PMC4676051.pdf
Available at: http://pdf.usaid.gov/pdf_docs/pnacq124.pdf [6] Adair T. Men’s condom use in higher-risk sex: trends in five Sub-Saharan African countries.,Non-OADS,/arxiv_data1/oa_pdf/6c/0b/TOAIDJ-9-104.PMC4676051.pdf
Available at: http://www.nacc.or.ke/images/documents/KAIS-2012.,Non-OADS,/arxiv_data1/oa_pdf/6c/0b/TOAIDJ-9-104.PMC4676051.pdf
"Available at: http://pai.org/wp-content/uploads/2012/01/english_condomscount.pdf [10] Kennedy C, O’Reilly K, Medley A, Sweat M. The impact of HIV treatment on risk behavior in developing countries: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/6c/0b/TOAIDJ-9-104.PMC4676051.pdf
Available at: http://www.crakenya.org/county/kisii/ [14] CARE International 2012.,Non-OADS,/arxiv_data1/oa_pdf/6c/0b/TOAIDJ-9-104.PMC4676051.pdf
"Available at http://www.unaids.org/sites/default/files/ media_asset/20121120_UNAIDS_Global_Report_2012_with_annexes_en_1.pdf   Received: July 19, 2015 Revised: August 21, 2015 Accepted: August 26, 2015  © Emmanuel et al.",Non-OADS,/arxiv_data1/oa_pdf/6c/0b/TOAIDJ-9-104.PMC4676051.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/0b/TOAIDJ-9-104.PMC4676051.pdf
Availabe from  http://www2.datasus.,Non-OADS,/arxiv_data1/oa_pdf/6f/74/TOMICROJ-9-43.PMC4676052.pdf
Available from http://www.cens o2010.ibge.gov.br/agsn2/2010  [11] Empresa Agropecuária do Estado do Rio Grande do Norte  (EMPARN).,Non-OADS,/arxiv_data1/oa_pdf/6f/74/TOMICROJ-9-43.PMC4676052.pdf
Available from http://www.emparn.rn.,Non-OADS,/arxiv_data1/oa_pdf/6f/74/TOMICROJ-9-43.PMC4676052.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/db/TORJ-9-77.PMC4676053.pdf
http://dsm.psychiatryonline.org/book.aspx?,Non-OADS,/arxiv_data1/oa_pdf/16/71/40263_2014_Article_180.PMC4676085.pdf
[Available at http://www.dtic.mil/dtic/tr/fulltext/u2/a426948.pdf.],Non-OADS,/arxiv_data1/oa_pdf/22/f3/ggge0016-0925.PMC4676195.pdf
Available from:  http://www.commons.emich.edu/cgi/viewcontent.cgi?,Non-OADS,/arxiv_data1/oa_pdf/5f/67/IJPsyM-37-381.PMC4676201.pdf
Available from: http://www.nimhans.kar.,Non-OADS,/arxiv_data1/oa_pdf/5f/67/IJPsyM-37-381.PMC4676201.pdf
Available from: https://www.sadm.,Non-OADS,/arxiv_data1/oa_pdf/5f/67/IJPsyM-37-381.PMC4676201.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/IJPsyM-37-388.PMC4676202.pdf
"Transcranial direct current stimulation procedure Transcranial direct current stimulation was given using  a standard equipment (Neuroconn DC Stimulator  Plus, http://www.neuroconn.de/dc-stimulator_plus_en/)  as per previous description[6] with stringent safety  measures.",Non-OADS,/arxiv_data1/oa_pdf/9d/17/IJPsyM-37-419.PMC4676208.pdf
"After ascertaining  normality of data distribution using Shapiro–Wilk test,  statistical analyses were done using paired samples t-test  (R version-3.1.1; http://www.R-project.org/).",OADS,/arxiv_data1/oa_pdf/9d/17/IJPsyM-37-419.PMC4676208.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/18/3f/IJPsyM-37-460.PMC4676218.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/b5/e3/IJPsyM-37-462.PMC4676219.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/b5/e3/IJPsyM-37-462.PMC4676219.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/2d/9a/IJPsyM-37-467.PMC4676221.pdf
Available from: http://www.aagbi.org/sites/default/files/infection02.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7f/89/JOACP-31-440.PMC4676229.pdf
"Telephone: +91-80 04 904595FAX: +91-522- Cell: +91 98 39 450244E-mail: 2015icpm@gmail.comhttp://www.icpm2015lko.com/ 7 th Annual Conference-Indian  College of AnaesthesiologistsIcacon 2015November  13-15, 2015 Hotel Savera,  Dr. Radhakrishnan Road, Chennai - 600 004Dr.",Non-OADS,/arxiv_data1/oa_pdf/0c/12/JOACP-31-466.PMC4676234.pdf
Randomization  was done by means of odd and even numbers retrieved from a computer-generated table (http://www.randomizer.org) corresponding to the N 2O and to the air group respectively.,OADS,/arxiv_data1/oa_pdf/97/ad/JOACP-31-511.PMC4676242.pdf
Available from: http://www.archive.ispub.com/journal/the-internet-journal-of-anesthesiology/volume-16-number-2/the-pro-seal-lmatm-and-the-tracheal- tube-a-comparison-of-events-at-insertion-of-the-airway-device.,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/JOACP-31-517.PMC4676243.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/ef/c9/JOACP-31-517.PMC4676243.pdf
Available at: http://ispub.com/IJA/20/1/3015.,Non-OADS,/arxiv_data1/oa_pdf/a0/4b/JOACP-31-522.PMC4676244.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2015  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2015 |  103  | e52899 | Page 1 of 8Video Article Electrophysiological Motor Unit Number Estimation (MUNE) Measuring Compound Muscle Action Potential (CMAP) in Mouse Hindlimb Muscles W. David Arnold1,2,3, Kajri A. Sheth1, Christopher G. Wier4, John T. Kissel1,3, Arthur H. Burghes1,3,4, Stephen J. Kolb1,3,4 1Department of Neurology, The Ohio State University Wexner Medical Center 2Department of Physical Medicine and Rehabilitation, The Ohio State University 3Department of Neuroscience, The Ohio State University Wexner Medical Center 4Department of Biochemistry and Pharmacology, The Ohio State University Wexner Medical Center Correspondence to: W. David Arnold at William.Arnold@osumc.edu URL: http://www.jove.com/video/52899 DOI: doi:10.3791/52899 Keywords: Behavior, Issue 103, neuromuscular diseases, compound muscle action potential, motor unit number estimation, electrophysiology, electrodiagnosis, sciatic nerve, mouse Date Published: 9/25/2015 Citation: Arnold, W.D., Sheth, K.A., Wier, C.G., Kissel, J.T., Burghes, A.H., Kolb, S.J.",Non-OADS,/arxiv_data1/oa_pdf/bd/c8/jove-103-52899.PMC4676269.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52899/ Introduction Motor unit number estimation (MUNE) was originally described by McComas et al.,OADS,/arxiv_data1/oa_pdf/bd/c8/jove-103-52899.PMC4676269.pdf
Clin Micro- biol Rev 23:382– 438. http://dx.doi.org/10.1128/CMR.00073-09 .,OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1111/petr.12378 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
"Biomed Res Int 2014: , http://dx.doi.org/10.1155/2014/ 465603 .",OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
J Clin Microbiol 49:4379 – 4381. http://dx.doi.org/10.1128/ JCM.05129-11 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/ 10.1186/2049-3258-72-S1-O8 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1007/s00216-012-6485-6 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/ 10.1099/mic.0.27607-0 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.2147/ OPTH.S39934 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1002/ ajh.10272 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
Front Cell Infect Micro-biol 4:99. http://dx.doi.org/10.3389/fcimb.2014.00099 .,OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1086/656047 .,OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
Mol Microbiol 85:67– 88. http://dx.doi.org/10.1111/j.1365-2958.2012.08090.x .,OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1128/JCM.02848-12 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.3791/4392 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1007/s11746-997-0138-5 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1371/ journal.pone.0038054 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1371/ journal.pone.0061404 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1371/journal.pone.000273 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1038/nrmicro1384 .,OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1007/ s12223-010-0089-3 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
Nat Commun 5:4352. http://dx.doi.org/10.1038/ncomms5352 .,OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1128/AAC.00285-12 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/ 10.1093/jac/dkt072 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1128/JB.00774-06 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
J Bacte- riol190:6351– 6364. http://dx.doi.org/10.1128/JB.00505-08 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/ 10.1073/pnas.1204307109 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1128/IAI.01487-13 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/ 10.1128/AAC.05904-11 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.3390/antibiotics2010100 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1016/j.femsre.2003.09.002 .,OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1111/j.1365-2958.2009.06605.x .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
Appl Environ Microbiol 77:4105– 4118. http://dx.doi.org/10.1128/ AEM.00374-11 .,OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1128/AEM.00201-13 .,Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/10.1016/j.ijfoodmicro.2010.08.025 .,OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
"Clinicalbreakpoints— bacteria, version 3.1. http://www.eucast.org/ antimicrobial_susceptibility_testing/disk_diffusion_methodology/ .",Non-OADS,/arxiv_data1/oa_pdf/89/69/mBio.01172-15.PMC4676280.pdf
http://dx.doi.org/ 10.1126/science.7997879 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/ 10.1002/ijc.21731 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/ 10.1016/S0093-7754(01)90092-2 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1126/science.274.5293.1739 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1038/nm0397-287 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1128/JVI.02723-09 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
J Virol83:6874 – 6882. http://dx.doi.org/10.1128/JVI.02625-08 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1182/ blood.V98.10.3042 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/ 10.1182/blood.V97.7.2173 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/ 10.1182/blood-2011-09-377705 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1002/1096 -9071(200007)61:3 /H11021332::AID-JMV8 /H110223.0.CO;2-3 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1371/journal.pone.0053145 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1016/ B978-0-12-800098-4.00002-7 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1016/S0198-8859(99)00083-X .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1074/jbc.272.31.19625 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1074/ jbc.M407382200 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/ 10.1128/JVI.00511-14 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/ 10.1128/JVI.05782-11 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1038/nm1295-1274 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
Cancer Metastasis Rev 32:643– 671. http://dx.doi.org/10.1007/s10555 -013-9444-6 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
Int J ColorectalDis22:869 – 874. http://dx.doi.org/10.1007/s00384-006-0247-x .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1007/s00262-009-0740-5 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1309/AJCP24KXJVBZXENS .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1200/JCO.2002.05.033 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1016/j.lungcan.2008.03.020 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
Pan-creas 34:436 – 443. http://dx.doi.org/10.1097/MPA.0b013e3180333ae3 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
Eur Urol 57: 648 – 654. http://dx.doi.org/10.1016/j.eururo.2009.05.040 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
Cancer Res 64:8932– 8938. http://dx.doi.org/10.1158/0008-5472.CAN-04-0505 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1038/sj.onc.1210077 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1074/jbc.M409407200 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1182/blood-2004-09 -3618 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
Oncogene 30:4275– 4288. http://dx.doi.org/10.1038/ onc.2011.146 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/ 10.1016/S1097-2765(00)80426-8 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1128/mBio.02035-14 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/ 10.1038/sj.onc.1202935 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.4415/ANN_12_02_09 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1002/ijc.26072 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1128/JVI.00767-06 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1073/ pnas.0609757104 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1016/j.virol.2004.03.049 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1128/JVI.78.7.3601 -3620.2004 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
Cancer Res 68:4640 – 4648. http://dx.doi.org/10.1158/0008-5472.CAN-07-5988 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
JVirol 77:4205– 4220. http://dx.doi.org/10.1128/JVI.77.7.4205-4220.2003 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1182/ blood.V97.7.2130 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
Proc Natl Acad Sc iUSA 96:-4546 – 4551. http://dx.doi.org/ 10.1073/pnas.96.8.4546 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1182/blood.V97.8.2526 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1053/hupa.2001.21131 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/ 10.1074/jbc.M109.039115 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1371/journal.pone.0006317 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1002/ eji.201444593 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1053/ j.gastro.2009.11.049 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1016/ j.virol.2004.07.008 .,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
Nat Commun 6:6217. http://dx.doi.org/10.1038/ ncomms7217 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1091/mbc.11.1.65 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1083/jcb.200904150 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1158/0008 -5472.CAN-03-3653 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
http://dx.doi.org/10.1128/JVI.02590-07 .,Non-OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
Nat Methods 9:671– 675. http://dx.doi.org/ 10.1038/nmeth.2089 .Gifﬁn et al.,OADS,/arxiv_data1/oa_pdf/7d/45/mBio.01499-15.PMC4676281.pdf
We then repeated this analysis using publically available RNA sequencing data from The Cancer Genome Atlas (TCGA) (http://cancergenome.nih.gov/) for 18 c-CHB tissue samples and 6matched CHB tissue samples as well as 18 c-CHC tissue samplesand 5 matched CHC tissue samples.,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
"We repeated this analysis using publically available small-RNA sequencing data from TCGA (http://cancergenome.nih.gov/) for12 c-CHB tissue samples and 6 matched CHB tissue samples aswell as 18 c-CHC tissue samples and 5 matched CHC tissue sam-TABLE 2 Top 10 most signiﬁcantly enriched pathways by pathway enrichment analysis of cancer Most signiﬁcantly enriched pathway ( Pvalue) using DE genes from the following disease group(s)a: c-CHB all c-CHB only c-CHB and c-CHC overlap c-CHC all c-CHC only FXR/RXR activation(1.00E/H1100223)FXR/RXR activation(2.00E/H1100214)LXR/RXR activation(1.1E/H1100208)LXR/RXR activation(4.27E/H1100209)Pathogenesis of multiple sclerosis(7.94E/H1100205) LPS/IL-1- mediatedinhibition ofRXR function(2.51E/H1100218)LPS/IL-1- mediatedinhibition ofRXR function(2.95E/H1100210)FXR/RXR activation(2.88E/H1100208)LPS/IL-1- mediatedinhibition ofRXR function(1.20E/H1100207)Cell cycle G 1/S checkpoint regulation (3.89E/H1100203) LXR/RXR activation(2.51E/H1100216)Acute-phase responsesignaling(3.72E/H1100210)LPS/IL-1- mediatedinhibition ofRXR function(5.25E/H1100208)FXR/RXR activation(8.71E/H1100207)Protein kinase A signaling(5.50E/H1100203) Acute-phase responsesignaling(1.58E/H1100212)LXR/RXR activation(1.02E/H1100207)Chemokine signaling(1.17E/H1100204)Complement system(7.41E/H1100205)Small cell lung cancer signaling(5.62E/H1100203) Blood ﬂow/ coagulationsystem(3.31E/H1100209)Intrinsic prothrombinactivationpathway(6.17E/H1100207)Aryl hydrocarbon receptor signaling(3.55E/H1100204)Phosphatidylcholine biosynthesis(3.31E/H1100204)Cyclins and cell cycle regulation(7.76E/H1100203) Intrinsic prothrombinactivationpathway(4.27E/H1100208)Extrinsic prothrombinactivationpathway(6.46E/H1100207)Fatty acid /H9251-oxidation (6.76E/H1100204)Hepatic cholestasis (4.07E/H1100204)RAR activation (8.71E/H1100203) Complement system(6.31E/H1100208)Phenylalanine degradation(2.34E/H1100206)Dopamine degradation(7.24E/H1100204)Aryl hydrocarbon receptor signaling(4.27E/H1100204)Granulocyte adhesion and diapedesis(8.91E/H1100203) Estrogen biosynthesis(7.94E/H1100208)Blood ﬂow/ coagulationsystem(6.46E/H1100206)Atherosclerosis signaling(7.41E/H1100204)Bile acid biosynthesis, neutral pathway(5.50E/H1100204)Glioma signaling (1.55E/H1100202) Xenobiotic metabolismsignaling(1.02E/H1100207)Xenobiotic metabolismsignaling(2.29E/H1100205)Complement system(7.76E/H1100204)Chemokine signaling (6.76E/H1100204)Type I diabetes mellitus signaling(2.45E/H1100202) Valine degradation(1.2E/H1100207)Valine degradation(2.63E/H1100205)Blood ﬂow/ coagulationsystem(1.12E/H1100203)Blood ﬂow/ coagulationsystem(6.92E/H1100204)IL-17A signaling in gastric cells(2.57E/H1100202) aTop ten most signiﬁcantly enriched pathways from Ingenuity Pathway Analysis using either all differentially expressed (DE) genes of a disease group (“all”), DE genes of a disease group with no overlap with any other group (“only”), or DE genes shared between two disease groups (“overlap”).",Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1038/nrc3449 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
Lipids Health Dis 5:4.http://dx.doi.org/10.1186/ 1476-511X-5-4 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
J Zhejiang Univ Sci B 8:398 – 409. http://dx.doi.org/10.1631/ jzus.2007.B0398 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1055/s-0033 -1358524 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/ 10.1097/MOL.0b013e3283428d9d .,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1016/ j.metabol.2012.04.009 .,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1194/jlr.R034801 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1016/j.cmet.2006.01.005 .,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1126/science.1113329 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1111/acel.12135 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1126/science.1189862 .Transcriptomic Analysis of Hepatitis and Liver Cancer November/December 2015 Volume 6 Issue 6 e01500-15®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1038/nm.3200 .,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/ 10.2337/db13-1015 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C. Sci Rep5:7675. http://dx.doi.org/10.1038/srep07675 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
Nat Rev Genet 10:57– 63. http://dx.doi.org/10.1038/ nrg2484 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1677/JOE-09 -0271 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1016/S1537-1891(02)00175 -1.,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1002/hep.25571 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1371/journal.pone.0073240 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1003248 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1002/hep.27634 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
"http://dx.doi.org/10.1016/ j.antiviral.2010.08.008 .34.Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, Zhu Z, Jiao H, Lin J, Jiang K, Ding L, Zhang H, Cheng L, Fu H, Song Y, Jiang Y, Liu J, WangR, Du N, Ye Q .",OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
J Clin Invest 123:630 – 645. http://dx.doi.org/ 10.1172/JCI64265 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/ 10.1371/journal.pone.0065336 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1139/bcb-2013 -0128 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1002/hep.26659 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.3748/wjg.v20.i41.15343 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1002/hep.25846 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1016/j.molcel.2007.05.018 .,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1007/s11095-011-0473-y .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1093/ nar/gkq012 .,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1074/jbc.M110.209973 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
Nature 460: 479 – 486. http://dx.doi.org/10.1038/nature08170 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
Hepatology 57:432– 434. http://dx.doi.org/ 10.1002/hep.25960 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
Atherosclerosis 234: 54 – 64. http://dx.doi.org/10.1016/j.atherosclerosis.2014.02.008 .Selitsky et al.,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
Int J Mol Med 35: 847– 853. http://dx.doi.org/10.3892/ijmm.2015.2076 .,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1038/nm820 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1016/ j.jhep.2010.12.020 .,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/10.1002/hep.26905 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
Identiﬁcation of microRNAs associated with allergic airway disease using a genetically diverse mouse population.BMC Genomics 16:633. http://dx.doi.org/10.1186/s12864-015-1732-9 .,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
Sci Rep 5:12911. http://dx.doi.org/10.1038/srep12911 .,OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
http://dx.doi.org/ 10.1097/MIB.0000000000000478 .Transcriptomic Analysis of Hepatitis and Liver Cancer November/December 2015 Volume 6 Issue 6 e01500-15®mbio.asm.org 13,Non-OADS,/arxiv_data1/oa_pdf/5a/e0/mBio.01500-15.PMC4676282.pdf
Nucleic Acids Res 11: 6319 – 6330. http://dx.doi.org/10.1093/nar/11.18.6319 .,OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
Plasmid 17:37– 45. http://dx.doi.org/10.1016/0147-619X(87)90006-0 .,OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/ 10.1016/0147-619X(88)90028-5 .,OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/10.1007/ BF00282811 .,Non-OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/10.1128/AAC.01407-08 .,Non-OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/10.1089/mdr.2010.0042 .,OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
Mol Gen Genet 198:84 – 89. http://dx.doi.org/10.1007/BF00328705 .,OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/10.1007/BF00425660 .,Non-OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/10.1007/BF00337820 .,Non-OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
Plasmid 14:80 – 89. http://dx.doi.org/10.1016/0147-619X(85)90034-4 .,OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/10.1128/mBio.01801-14 .,Non-OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/10.1093/jac/dks317 .,Non-OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/10.1128/AAC.47.1.342-349.2003 .,Non-OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/ 10.1016/0147-619X(90)90047-G .,OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
Microb Drug Resist 20:416 – 423. http://dx.doi.org/10.1089/mdr.2014.0012 .,Non-OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
Nucleic Acids Res 14: 8625– 8635. http://dx.doi.org/10.1093/nar/14.21.8625 .,OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
http://dx.doi.org/10.1093/nar/7.6.1513 .,Non-OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
J Antimicrob Chemother 69:77– 80. http://dx.doi.org/ 10.1093/jac/dkt312 .IS26-Mediated Translocatable Unit Excision November/December 2015 Volume 6 Issue 6 e01866-15®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/89/60/mBio.01866-15.PMC4676283.pdf
Annu Rev Microbiol 59:451– 485. http://dx.doi.org/10.1146/ annurev.micro.58.030603.123630 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1016/S0378-1097(03)00430-0 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/ 10.1046/j.1365-2958.2001.02502.x .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/ 10.1111/j.1365-2958.2005.04521.x .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1038/ nrmicro753 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
Nat Commun 6:6453. http://dx.doi.org/10.1038/ncomms7453 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1128/ JB.187.10.3486-3495.2005 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1111/j.1462-5822.2010.01499.x .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1126/science.1166101 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1038/nature08588 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1038/ emboj.2013.58 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1093/nar/gku194 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
Res Microbiol 164:620 – 639. http://dx.doi.org/ 10.1016/j.resmic.2013.03.012 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/ 10.1128/IAI.01384-09 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1128/ JB.00726-09 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/ 10.1039/b917761b .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1128/JB.01341-07 .28.,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
J Bacteriol 188: 882– 893. http://dx.doi.org/10.1128/JB.188.3.882 -893.2006 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1038/ng.2007.38 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1016/S1369 -5274(99)80005-8 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1016/S0966-842X(98)01308-0 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
Mol Microbiol 34:799 – 809. http://dx.doi.org/10.1046/j.1365 -2958.1999.01642.x .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1128/IAI.00956-06 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1128/JB.00430-13 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1038/nrmicro2382 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1111/j.1462-5822.2008.01171.x .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1046/j.1365-2958.2003.03650.x .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1371/journal.ppat.1000946 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1371/journal.pone.0041447 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/ 10.1111/mmi.12396 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1371/journal.pone.0004833 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
FEMS Microbiol Rev 39:47– 80. http://dx.doi.org/10.1111/1574 -6976.12084 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1128/ 9781555817336.ch3 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
"Structures of two core subunits of the bacterial type IV secretionsystem, VirB8 from Brucella suis and ComB10 from Helicobacter pylori.Proc Natl Acad Sc iUSA 102: 4596 – 4601. http://dx.doi.org/10.1073/ pnas.0408927102 .",OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1128/JB.186.17.5842-5855.2004 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1073/ pnas.0600862103 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
Biochemistry49:4483– 4493. http://dx.doi.org/10.1021/bi902201y .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/ 10.1371/journal.pone.0051597 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1007/BF00297277 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/ 10.1099/00221287-148-5-1439 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1073/ pnas.0609535104 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1099/mic.0.28326-0 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1128/JB.182.3.758-763.2000 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1111/j.1365-2958.2011.07930.x .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1074/jbc.M112.428847 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
Molecular and structural analysis of Legionella DotI gives insights into an inner membrane complex essential for type IV secretion.Sci Rep 5:10912. http://dx.doi.org/10.1038/srep10912 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1099/mic.0.28216-0 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1099/mic.0.28984-0 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
Biochem Cell Biol 84:890 – 899. http://dx.doi.org/ 10.1139/o06-148 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1128/IAI.00993-10 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1016/ j.chembiol.2012.07.007 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1080/ 10635150701472164 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1093/bioinformatics/btu033 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1093/molbev/msh112 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1080/ 10635150500433722 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1093/bioinformatics/ btp368 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1186/1471 -2148-7-S1-S4 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
Genome BiolEvol 5:621– 645. http://dx.doi.org/10.1093/gbe/evt036 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1371/journal.pone.0030520 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
Independent genome reduction and phylogenetic reclassiﬁcation of the oceanic SAR11 clade.Mol Biol Evol 29:599 – 615. http://dx.doi.org/10.1093/molbev/msr203 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
Syst Biol 62:611– 615. http://dx.doi.org/10.1093/sysbio/ syt022 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/ 10.1006/jmbi.2000.4315 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/ 10.1101/gr.849004 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1093/nar/gkq1189 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1107/S1744309111018367 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1107/ S1744309111017374 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1007/s10969 -011-9102-6 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1016/0022 -2836(81)90465-4 .,OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1002/elps.1150181505 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1093/nar/28.1.235 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1002/prot.22488 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/10.1073/ pnas.95.10.5752 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
Nature 428: 37– 43. http://dx.doi.org/ 10.1038/nature02340 .,Non-OADS,/arxiv_data1/oa_pdf/93/e5/mBio.01867-15.PMC4676284.pdf
http://dx.doi.org/ 10.1016/S0168-6445(03)00055-X .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1007/s00775-014-1136-3 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2006.05028.x .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Annu Rev Microbiol 57: 395– 418. http://dx.doi.org/10.1146/annurev.micro.57.030502.090938 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/ 10.1002/wrna.102 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Mol Microbiol 26:799 – 808. http://dx.doi.org/ 10.1046/j.1365-2958.1997.6211987.x .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1074/ jbc.M303381200 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
J Bacteriol 196:4315– 4323. http://dx.doi.org/10.1128/JB.01975-14 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
J Bacteriol 190: 8244 – 8247. http://dx.doi.org/10.1128/ JB.01161-08 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Mol Microbiol 52:861– 872. http://dx.doi.org/10.1111/j.1365-2958.2004.04025.x .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
J Bacteriol 183: 4806 – 4813. http://dx.doi.org/10.1128/ JB.183.16.4806-4813.2001 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Mol Microbiol 9:53– 63. http://dx.doi.org/ 10.1111/j.1365-2958.1993.tb01668.x .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1111/j.1365-2958.2011.07593.x .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Mol Microbiol 75:637– 657. http://dx.doi.org/10.1111/j.1365-2958.2009.06977.x .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Biometals23:601– 611. http://dx.doi.org/10.1007/s10534-010-9361-x .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Nat Commun 5:4910. http://dx.doi.org/10.1038/ncomms5910 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1111/j.1574-6968.1981.tb07606.x .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/ 10.1111/j.1365-2958.1994.tb00373.x .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2006.05439.x .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2007.05733.x .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1101/gad.1127103 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/ 10.1101/gad.2001711 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1016/ 0968-0004(91)90125-F .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Res Microbiol 145: 437– 450. http://dx.doi.org/10.1016/0923-2508(94)90092-2 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
J Biol Chem 281:4802– 4815. http://dx.doi.org/10.1074/jbc.M512312200 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1128/JB.187.3.1135-1160.2005 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1371/journal.pgen.1003565 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/ 10.1016/S0005-2728(97)00034-0 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1093/nar/gkl356 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1093/ bioinformatics/btr189 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1016/S0022 -2836(02)00849-5 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/ 10.1128/JB.185.7.2194-2202.2003 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Nucleic Acids Res 35: 6762– 6777. http://dx.doi.org/10.1093/nar/gkm631 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1111/j.1365-2958.2006.05220.x .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1093/nar/ gkq1143 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1038/ emboj.2013.205 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Biochem Biophys Res Commun 229:635– 642. http://dx.doi.org/10.1006/ bbrc.1996.1856 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1042/BJ20120514 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Mol Microbiol 87:478 – 492. http://dx.doi.org/10.1111/mmi.12052 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1038/emboj.2009.116 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1146/ annurev.biochem.77.061606.161055 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1128/JB.05990-11 .Beauchene et al.,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1046/ j.1365-2958.1996.424950.x .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1046/j.1365-2958.2000.01774.x .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1371/ journal.pgen.1004977 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1016/ j.mib.2010.09.013 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Mol Syst Biol 2:2006.0008. http://dx.doi.org/10.1038/msb4100050 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/ 10.1038/ncb2225 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
J Bacteriol 186: 8018 – 8025. http://dx.doi.org/10.1128/ JB.186.23.8018-8025.2004 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1093/bioinformatics/ btq281 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1038/nmeth.1923 .75.,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/ 10.1007/978-1-62703-514-9_12 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1198/jasa.2011.ap09706 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/ 10.1093/bioinformatics/btr605 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1101/gad.196741.112 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1093/nar/gng015 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/ 10.1371/journal.pcbi.1003118 .,Non-OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
Spec-trochim Acta B At Spectrosc 63:638 – 644. http://dx.doi.org/10.1016/ j.sab.2008.03.016 .,OADS,/arxiv_data1/oa_pdf/cb/54/mBio.01947-15.PMC4676285.pdf
http://dx.doi.org/10.1146/annurev.micro.61.080706.093426 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1111/mmi.12432 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1128/JB.01287-13 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1128/MMBR.00043-12 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1073/ pnas.0511090103 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1128/AEM.00299-14 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1111/j.1462 -2920.2007.01554.x .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/ 10.1038/nrmicro2203 .,OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1371/journal.pbio.1000588 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1074/jbc.M110.196220 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1101/ gad.222679.113 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1371/ journal.pbio.1000587 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.7554/eLife.03650 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1128/JB.00984-12 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
J Bacteriol 186:4476 – 4485. http://dx.doi.org/ 10.1128/JB.186.14.4476-4485.2004 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1107/S090744491104039X .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1128/mBio.00183-10 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1371/journal.pgen.1003744 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1101/gad.289504 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
J Bacte- riolhttp://dx.doi.org/10.1128/JB.00369-15 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
Mol Mi-crobiol 75:827– 842. http://dx.doi.org/10.1111/j.1365-2958.2009.06991.x .,OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1016/ j.cell.2008.04.040 .,OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
J Bacteriol 189:8165– 8178. http://dx.doi.org/10.1128/ JB.00586-07 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
http://dx.doi.org/10.1073/ pnas.95.10.5752 .,Non-OADS,/arxiv_data1/oa_pdf/cc/85/mBio.01978-15.PMC4676286.pdf
"R Foundation for Statistical Computing, Vienna, Austria.ISBN 3-900051-07-0, URL http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/04/69/ele0018-0660.PMC4676290.pdf
"R package version 2.2-3. http://CRAN.R-project.org/package=coxme.Vucetich, JA, Peterson, RO & Waite, TA (2004).",OADS,/arxiv_data1/oa_pdf/04/69/ele0018-0660.PMC4676290.pdf
Supporting information and ORCID(s) from the author(s) forthis article are available on the WWW under http://dx.doi.org/10.1002/ejoc.201501249.,OADS,/arxiv_data1/oa_pdf/92/6e/ejoc2015-7544.PMC4676292.pdf
2013. http://www.who.int/ medicines/publications/essentialmedicines/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/34/ae/epi0056-0915.PMC4676304.pdf
http://www.hpa.gov.tw/BHPNet/English/ClassShow.,Non-OADS,/arxiv_data1/oa_pdf/bb/87/cncr0121-3221.PMC4676309.pdf
http://tcr.cph.ntu.edu.tw/uploadimages/ Y92-ALL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/87/cncr0121-3221.PMC4676309.pdf
"Inventory of colorectal can- cer screening activities in ICSN countries, May 2008. http://appliedre-search.cancer.gov/icsn/colorectal/screening.html.",Non-OADS,/arxiv_data1/oa_pdf/bb/87/cncr0121-3221.PMC4676309.pdf
http://www.cancers creening.gov.au/internet/screening/publishing.nsf/Content/9C0493AFEB3FD33CCA257D720005C9F2/ $File/final-eval.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/87/cncr0121-3221.PMC4676309.pdf
"[11]While a unimo- [a] Grand Valley State University, Department of Chemistry 1 Campus Drive, Allendale, MI 49401, USAE-mail: koricha@gvsu lordri@gvsu.edu http://www.gvsu.edu/chem Supporting information for this article is available on theWWW under http://dx.doi.org/10.1002/ejoc.201501042.",Non-OADS,/arxiv_data1/oa_pdf/66/91/ejoc2015-7460.PMC4676310.pdf
"marti@uv .es [d]Dr.J.E.Warren Schoo lofMaterial s,TheUniversi tyofManc hester Sackvill eStreet, Manch ester ,M13BB(UK) Supportin ginformat ionforthisarticle isavailab leontheWWW under http://dx.doi.or g/10.10 02/chem.20 1502098.",Non-OADS,/arxiv_data1/oa_pdf/2c/0f/chem0021-16027.PMC4676333.pdf
"2nd ed, April 2009. http://www.psanz.com.au/special-interest/perinatal- mortality-group/psanzcpg.",Non-OADS,/arxiv_data1/oa_pdf/5d/14/pthy-47-51.PMC4676351.pdf
http://CRAN.R-project.org/package ¼OptimalCutpoints.,Non-OADS,/arxiv_data1/oa_pdf/5d/14/pthy-47-51.PMC4676351.pdf
"For thepresent study, we contracted with Renovo Neural(http://www.renovoneural.com/cuprizone-model-of-remyelination), whose modified protocol usingrapamycin injection during cuprizone feeding eliminates this confound.",Non-OADS,/arxiv_data1/oa_pdf/aa/81/NEURIMMINFL2015007104.PMC4676354.pdf
Available at: http://fiji.sc/ Coloc_2.,Non-OADS,/arxiv_data1/oa_pdf/aa/81/NEURIMMINFL2015007104.PMC4676354.pdf
Disponível em:  http://dx.doi.org/10.3402/ljm.v9.23441 12.,Non-OADS,/arxiv_data1/oa_pdf/af/38/abcd-27-03-0184.PMC4676365.pdf
Disponível em: http://www.bsg.org.,Non-OADS,/arxiv_data1/oa_pdf/af/38/abcd-27-03-0184.PMC4676365.pdf
"Bethesda,  MD, http://seer.cancer.gov/csr/1975_2010/ 11.",Non-OADS,/arxiv_data1/oa_pdf/36/ec/abcd-27-03-0216.PMC4676383.pdf
Download Video 1 via http://dx.doi.org/10.1530/ERP-14-0075-v1 Video 2 Transthoracic echocardiogram from the long-axis para- sternal showing the large mass in the interventricular septum.,Non-OADS,/arxiv_data1/oa_pdf/fa/ac/echo-02-I5.PMC4676427.pdf
Download Video 2 via http://dx.doi.org/10.1530/ ERP-14-0075-v2 Figure 2 Computed tomography (CT) scan image of the heart showing the largeinterventricular hydatid cyst with calciﬁed borders.Open AccessR Salehi and others Hydatid cyst of the interventricular septumID: 14-0075; March 2015 DOI: 10.1530/ERP-14-0075 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 InternationalLicense .q2015 The authors www.echorespract.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/fa/ac/echo-02-I5.PMC4676427.pdf
Download Video 3 via http://dx.doi.org/10.1530/ ERP-14-0075-v3R Salehi and others Hydatid cyst of the interventricular septumID: 14-0075; March 2015 DOI: 10.1530/ERP-14-0075 www.echorespract.com I6,Non-OADS,/arxiv_data1/oa_pdf/fa/ac/echo-02-I5.PMC4676427.pdf
Supplementary data This is linked to the online version of the paper at http://dx.doi.org/10.1530/ ERP-15-0015 .,Non-OADS,/arxiv_data1/oa_pdf/e3/47/echo-02-89.PMC4676429.pdf
Download Video 1 via http://dx.doi.org/10.1530/ERP-14-0022-v1 .,Non-OADS,/arxiv_data1/oa_pdf/46/9c/echo-01-I5.PMC4676432.pdf
Download Video 2 via http://dx.doi.org/10.1530/ERP-14-0022-v2 .,Non-OADS,/arxiv_data1/oa_pdf/46/9c/echo-01-I5.PMC4676432.pdf
Download Video 1 via http://dx.doi.org/10.1530/ERP-14-0034-v1 Figure 1 Transthoracic parasternal long-axis echocardiogram showing the thin-walled cavity anterior to RVOT.Video 2 Transthoracic parasternal short axis echocardiogram show- ing the thin-walled cavity anterior to RVOT.,Non-OADS,/arxiv_data1/oa_pdf/a1/97/echo-01-K5.PMC4676435.pdf
Download Video 2 via http://dx.doi.org/10.1530/ERP-14-0034-v2 Figure 2 Transthoracic parasternal short axis echocardiogram showing the thin-walled cavity anterior to RVOT.Video 3 Transoesophageal echocardiogram showing the aneurys- mal dilatation of RAAA.,Non-OADS,/arxiv_data1/oa_pdf/a1/97/echo-01-K5.PMC4676435.pdf
Download Video 5 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/97/echo-01-K5.PMC4676435.pdf
Download Video 6 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/97/echo-01-K5.PMC4676435.pdf
"International Summary 2014 (https://www.elso.org/Registry/Statistics/Reports.aspx (accessed 15th December 2014)), 2014.",OADS,/arxiv_data1/oa_pdf/ba/d3/echo-02-D1.PMC4676436.pdf
"In the mid 1990s, the introduction of the Amplatzer septal occluder (ASO) ( http://health.sjm.com/amplatzer-septal-occluder ), a nitinol device with a central waist manufactured by the AGA Corporation ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/5a/1b/echo-02-R73.PMC4676437.pdf
†Occlutech Figulla occluder ( http://www.occlutech.com ).,Non-OADS,/arxiv_data1/oa_pdf/5a/1b/echo-02-R73.PMC4676437.pdf
†Cera (Lifetech) occluder ( http://www.lifetechmed.com ).,OADS,/arxiv_data1/oa_pdf/5a/1b/echo-02-R73.PMC4676437.pdf
†PFM Nit-Occlud device ( http://www.pfmmedical.,Non-OADS,/arxiv_data1/oa_pdf/5a/1b/echo-02-R73.PMC4676437.pdf
†Gore Cardioform septal occluder (formerly Gore Septal Occluder (GSO)) ( http://www.goremedical.com/eu/ cardioform/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/1b/echo-02-R73.PMC4676437.pdf
†Cocoon septal occluder ( http://sanaremedprod.com/ cocoon-septal-occluder/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/1b/echo-02-R73.PMC4676437.pdf
"Analysis of an updated contemporary MAUDE dataset identiﬁed over 100 poten- tial erosions leading to a readjustment of the likelyincidence of erosion to 1–3 cases per 1000 implants,based on approximate worldwide sales of 250 000 ASOdevices ( 9,10) As a result, the FDA issued guidelines to both physicians and patients: http://www.fda.gov/Medical Devices/Safety/AlertsandNotices/ucm371145.htm .",Non-OADS,/arxiv_data1/oa_pdf/5a/1b/echo-02-R73.PMC4676437.pdf
(available at: http://www.fda.gov/AdvisoryCommittees/Committees MeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/ucm300073.htm )J D R Thomson and S A QureshiSecundum ASD’s and the risk of cardiac erosionID: 15-0023; December 2015 DOI: 10.1530/ERP-15-0023 www.echorespract.com R77,Non-OADS,/arxiv_data1/oa_pdf/5a/1b/echo-02-R73.PMC4676437.pdf
(available at: https://www.gov.uk/government/ publications/quality-standards-for-coronary-heart-disease-care ; accessed 16 April 2014) 4 National Institute for Health and Care Excellence 2010 Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin (CG95).,Non-OADS,/arxiv_data1/oa_pdf/ca/93/echo-01-17.PMC4676440.pdf
"NICE: London, UK (available at: http://www.nice.org.uk/ guidance/CG95 ; accessed 24 April 2014).",Non-OADS,/arxiv_data1/oa_pdf/ca/93/echo-01-17.PMC4676440.pdf
"This ensures optimum conditions for a detailedstudy, reduces the risk of musculoskeletal disordersfor echocardiographers ( http://www.hse.gov.uk/health- services/management-of-mus culoskeletal-disorders-in- sonography-work.pdf ), and may reduce the risk of hospital-acquired infection.",Non-OADS,/arxiv_data1/oa_pdf/06/29/echo-02-G9.PMC4676441.pdf
Download Video 2 via http://dx.doi.org/10.1530/ ERP-14-0008-v2Video 1 Apical four-chamber view showing pericardial effusion with RA collapse (considered an echocardiographic early sign of cardiac tamponade).,Non-OADS,/arxiv_data1/oa_pdf/dd/1d/echo-01-D1.PMC4676442.pdf
( http://pact.esicm.org/media/HaemMon %20and%20Mgt%208%20April%202013%20ﬁnal.pdf as accessed on 1st March 2014).,Non-OADS,/arxiv_data1/oa_pdf/dd/1d/echo-01-D1.PMC4676442.pdf
"( http://ccforum.com/content/16/5/R188 )(doi:10.1186/ cc11672 ) 20 Feissel M, Michard F, Faller JP & Teboul JL 2004 The respiratory variation in inferior vena cava diameter as a guide to ﬂuid therapy.",Non-OADS,/arxiv_data1/oa_pdf/dd/1d/echo-01-D1.PMC4676442.pdf
Download Video 1 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/95/echo-02-I13.PMC4676446.pdf
Download Video 2 via http://dx.doi.org/ 10.1530/ERP-15-0016-v2 .,Non-OADS,/arxiv_data1/oa_pdf/c7/95/echo-02-I13.PMC4676446.pdf
Download Video 3 via http://dx.doi.org/10.1530/ERP-15-0016-v3 .,Non-OADS,/arxiv_data1/oa_pdf/c7/95/echo-02-I13.PMC4676446.pdf
Download Video 4 via http://dx.doi.org/ 10.1530/ERP-15-0016-v4 .D I Naji and others Transapical aortic valve replacementID: 15-0016; September 2015 DOI: 10.1530/ERP-15-0016 www.echorespract.com I14,Non-OADS,/arxiv_data1/oa_pdf/c7/95/echo-02-I13.PMC4676446.pdf
Download Video 1 via http://dx.doi.org/10.1530/ ERP-15-0017-v1 .,Non-OADS,/arxiv_data1/oa_pdf/6f/1a/echo-02-I11.PMC4676448.pdf
Download Video 2 via http://dx.doi.org/10.1530/ERP-15- 0017-v2 .D I Naji and others Mechanical prosthetic valve endocarditisID: 15-0017; September 2015 DOI: 10.1530/ERP-15-0017 www.echorespract.com I12,Non-OADS,/arxiv_data1/oa_pdf/6f/1a/echo-02-I11.PMC4676448.pdf
"(available at: https://www.nice.org.uk/ guidance/cg95 ) 2 Pryor DB, Shaw L, McCants CB, Lee KL, Mark DB, Harrell FE, Jr, Muhlbaier LH & Califf RM 1993 Value of the history and physical inidentifying patients at increased risk for coronary artery disease.",Non-OADS,/arxiv_data1/oa_pdf/95/a7/echo-02-41.PMC4676449.pdf
"(available at: http://www.gmccsn.nhs.uk/ﬁles/9413/5246/5334/ Pathways_for_Cardiology_Symptoms_in_Primary_Care.pdf ) 4 Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C et al.",Non-OADS,/arxiv_data1/oa_pdf/95/a7/echo-02-41.PMC4676449.pdf
"(available at: https://www.bhf.org.uk/~/ media/ﬁles/research/heart-statistics/bhf-trends-in-coronary-heart-disease.pdf ) 11 Chow CK, Pell AC, Walker A, O’Dowd C, Dominiczak AF & Pell JP 2007 Families of patients with premature coronary heart disease: anobvious but neglected target for primary prevention.",Non-OADS,/arxiv_data1/oa_pdf/95/a7/echo-02-41.PMC4676449.pdf
Data available at http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM256586.pdfa.,OADS,/arxiv_data1/oa_pdf/5e/fd/echo-02-R55.PMC4676450.pdf
Available at http://www.optisonima- ging.com/us/wp-content/uploads/2013/10/optison_pi.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5e/fd/echo-02-R55.PMC4676450.pdf
Available at http://www.deﬁnityima- ging.com/pdf/DEFINITY%20Prescribing%20Information%20515987- 0413.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5e/fd/echo-02-R55.PMC4676450.pdf
Available at http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/5e/fd/echo-02-R55.PMC4676450.pdf
Available at http://www3.gehealth- care.co.kr/ko-kr/products/categories/contrast_media/sonazoid .,Non-OADS,/arxiv_data1/oa_pdf/5e/fd/echo-02-R55.PMC4676450.pdf
"(accessed 3/6/2015, available at http://www.fda.gov/ohrms/dockets/ac/08/brieﬁng/2008- 4369b1-01.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/5e/fd/echo-02-R55.PMC4676450.pdf
"http://www.bsecho.org/tte-minimum-dataset/ (27 February 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/90/56/echo-02-49.PMC4676452.pdf
"Download Video 1 via http://dx.doi.org/10.1530/ERP-14-0077-v1 Video 2 Example of a 3D echocardiographic reconstruction of a patient with pulmonary hypertension (end-diastolic volume 200 ml, end-systolic volume 137 ml, ejectionfraction 31 %) showing an enlarged right ventricle (green) with a ﬂattened septum in diastole (mesh) and even more so in systole.",Non-OADS,/arxiv_data1/oa_pdf/38/fb/echo-02-R1.PMC4676454.pdf
Download Video 2 via http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/38/fb/echo-02-R1.PMC4676454.pdf
Download Video 3 via http://dx.doi.org/10.1530/ERP-14-0077-v3E Ostenfeld and F A FlachskampfRight ventricular volumes ID: 14-0077; March 2015 DOI: 10.1530/ERP-14-0077 www.echorespract.com R7,Non-OADS,/arxiv_data1/oa_pdf/38/fb/echo-02-R1.PMC4676454.pdf
Download Video 3 via http://dx.doi.org/ 10.1530/ERP-15-0007-v3A Pantazis and others Diagnosis and management of HCMID: 15-0007; March 2015 DOI: 10.1530/ERP-15-0007 www.echorespract.com R46,Non-OADS,/arxiv_data1/oa_pdf/03/f8/echo-02-R45.PMC4676455.pdf
Download Video 4 via http://dx.doi.org/ 10.1530/ERP-15-0007-v4 Video 5 Parasternal long axis view of patient with FRDA showing concentric LVH without LVOT obstruction.,Non-OADS,/arxiv_data1/oa_pdf/03/f8/echo-02-R45.PMC4676455.pdf
Download Video 5 via http://dx.doi.org/10.1530/ERP-15-0007-v5 Video 6 Patient with FRDA.,Non-OADS,/arxiv_data1/oa_pdf/03/f8/echo-02-R45.PMC4676455.pdf
"Download Video 6 viahttp://dx.doi.org/10.1530/ERP-15-0007-v6Video 7 Patient with amyloidosis, 4-chamber view showing con- centric LVH, more prominent in the septum.",Non-OADS,/arxiv_data1/oa_pdf/03/f8/echo-02-R45.PMC4676455.pdf
Download Video 7 via http://dx.doi.org/10.1530/ ERP-15-0007-v7A Pantazis and others Diagnosis and management of HCMID: 15-0007; March 2015 DOI: 10.1530/ERP-15-0007 www.echorespract.com R47,Non-OADS,/arxiv_data1/oa_pdf/03/f8/echo-02-R45.PMC4676455.pdf
"Download Video 1 via http://dx.doi.org/10.1530/ERP- 14-0044-v1 Video 2 Transthoracic echocardiography, 3-dimensional image, demonstrating a large apical mural thrombus.",Non-OADS,/arxiv_data1/oa_pdf/40/61/echo-01-K13.PMC4676456.pdf
"Download Video 2 via http://dx.doi.org/10.1530/ERP-14-0044-v2 Video 3 Transthoracic echocardiogra phy, apical four-chamber view, showing a thrombus originating in the left ven- tricular outﬂow tract.",Non-OADS,/arxiv_data1/oa_pdf/40/61/echo-01-K13.PMC4676456.pdf
Download Video 3 via http://dx.doi.org/ 10.1530/ERP-14-0044-v3T Khachatryan and others Inextricabilis Syndrome ID: 14-0044; December 2014 DOI: 10.1530/ERP-14-0044 www.echorespract.com K14,Non-OADS,/arxiv_data1/oa_pdf/40/61/echo-01-K13.PMC4676456.pdf
Download Video 5 via http://dx.doi.org/10.1530/ERP-14-0044-v5Video 4 Transesophageal echocardiography with color Doppler demonstrating moderate mitral regurgitation due to a ﬂail posterior mitral leaﬂet and a ruptured chordae.,Non-OADS,/arxiv_data1/oa_pdf/40/61/echo-01-K13.PMC4676456.pdf
Download Video 4 via http://dx.doi.org/10.1530/ERP- 14-0044-v4 Video 6 Transesophageal echocardiography demonstrating moderate aortic regurgitation and moderate mitralregurgitation.,Non-OADS,/arxiv_data1/oa_pdf/40/61/echo-01-K13.PMC4676456.pdf
Download Video 6 via http://dx.doi.org/ 10.1530/ERP-14-0044-v6 Video 7 Transesophageal echocardiography demonstrating a large left atrial thrombus.,Non-OADS,/arxiv_data1/oa_pdf/40/61/echo-01-K13.PMC4676456.pdf
Download Video 7 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/61/echo-01-K13.PMC4676456.pdf
Download Video 1 via http://dx.doi.org/10.1530/ERP-14-0072-v1 .J K Teoh and R P Steeds Cardiac CAT ID: 14-0072; March 2015 DOI: 10.1530/ERP-14-0072 www.echorespract.com I10,Non-OADS,/arxiv_data1/oa_pdf/81/c3/echo-02-I9.PMC4676457.pdf
Download Video 1 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/e7/echo-02-I7.PMC4676459.pdf
Download Video 1 via http://dx.doi.org/10.1530/ERP-14-0033-v1 .,Non-OADS,/arxiv_data1/oa_pdf/67/b3/echo-01-I7.PMC4676461.pdf
Download Video 2 via http://dx.doi.org/10.1530/ERP-14-0033-v2 .,Non-OADS,/arxiv_data1/oa_pdf/67/b3/echo-01-I7.PMC4676461.pdf
Download Video 3 via http://dx.doi.org/ 10.1530/ERP-14-0033-v3 .,Non-OADS,/arxiv_data1/oa_pdf/67/b3/echo-01-I7.PMC4676461.pdf
Download Video 4 via http://dx.doi.org/ 10.1530/ERP-14-0033-v4 .,Non-OADS,/arxiv_data1/oa_pdf/67/b3/echo-01-I7.PMC4676461.pdf
Download Video 1 via http://dx.doi.org/10.1530/ ERP-14-0009-v1 Figure 4 LV angiogram end-diastolic (A) and end-systolic (B) frames.,Non-OADS,/arxiv_data1/oa_pdf/b0/52/echo-01-I1.PMC4676469.pdf
"Download Video 3 via http://dx.doi.org/ 10.1530/ERP-14-0009-v3 Video 4 TTE apical four-chamber view 48 h after heart failure onset, with complete recovery of LV dysfunction and wall motion abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/b0/52/echo-01-I1.PMC4676469.pdf
Download Video 4 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/52/echo-01-I1.PMC4676469.pdf
Download Video 5 via http://dx.doi.org/10.1530/ERP-14- 0009-v5 Video 6 Cardiac MRI after 2 weeks.,Non-OADS,/arxiv_data1/oa_pdf/b0/52/echo-01-I1.PMC4676469.pdf
Download Video 6 via http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b0/52/echo-01-I1.PMC4676469.pdf
"1530/ERP-14-0009-v6 Figure 5 Two weeks after acute heart failure onset, no signiﬁcant changes werenoted in the cardiac late gadolinium enhancement imaging.Video 2 TTE apical three-chamber view, showing functional MR. Download Video 2 via http://dx.doi.org/10.1530/ERP-14- 0009-v2R Teixeira and others Iatrogenic reverse takotsubo cardiomyopathyID: 14-0009; September 2014 DOI: 10.1530/ERP-14-0009 www.echorespract.com I3",Non-OADS,/arxiv_data1/oa_pdf/b0/52/echo-01-I1.PMC4676469.pdf
The ﬁrst is Focused Intensive Care Echocardiography (FICE) – a foundation process applicable to all critically illpatients ( http://www.ics.ac.uk/ics-homepage/accreditation- modules/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/20/echo-02-57.PMC4676470.pdf
"Washington, DC: The White House, Ofﬁce of the Press Secretary, 2009. http://www.whitehouse.gov/the_press_ofﬁce/Remarks-by-the- President-to-a-Joint-Session-of-Congress-on-Health-Care .",Non-OADS,/arxiv_data1/oa_pdf/11/20/echo-02-57.PMC4676470.pdf
"London: Department of Health, 2008. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAnd- Guidance/DH_085825 .",Non-OADS,/arxiv_data1/oa_pdf/11/20/echo-02-57.PMC4676470.pdf
"London: Department of Health, 2013. http://www.midstaff- spublicinquiry.com/report .",Non-OADS,/arxiv_data1/oa_pdf/11/20/echo-02-57.PMC4676470.pdf
"London: BSE, 2013. http://www.bsecho.org/media/103691/accreditation_pack_-__cc_ october_20132.pdf .",Non-OADS,/arxiv_data1/oa_pdf/11/20/echo-02-57.PMC4676470.pdf
(http://cdn1.cache.twofourdigital.net/u/bsecho/media/14864/ december_2009.pdf ) Accessed 23/09/2013.,Non-OADS,/arxiv_data1/oa_pdf/11/20/echo-02-57.PMC4676470.pdf
"Canberra: Australian Government, 2010. http://www.health.gov.au/internet/ main/publishing.nsf/Content/19C5BFB38B563D56CA257BF000204744/ $File/DIASGuidanceMaterials-Nov2010%20%28Jan%2011%20& %20Feb%2012%20update%29.pdf .",Non-OADS,/arxiv_data1/oa_pdf/11/20/echo-02-57.PMC4676470.pdf
(http://cdn1.cache.twofourdigital.net/ u/bsecho/media/102651/echo_82_web.pdf ) Accessed 23/09/2013.,Non-OADS,/arxiv_data1/oa_pdf/11/20/echo-02-57.PMC4676470.pdf
"London: Intensive Care Society, 2013. http://www.ics.ac.uk/ics-homepage/guidelines-and-standards/ .",Non-OADS,/arxiv_data1/oa_pdf/11/20/echo-02-57.PMC4676470.pdf
"London: MHRA, 2014. http://www.mhra.gov.uk/home/ groups/dts-bs/documents/publication/con2025143.pdf .",Non-OADS,/arxiv_data1/oa_pdf/11/20/echo-02-57.PMC4676470.pdf
Download Video 1 via http://dx.doi.org/10.1530/ERP-14-0058-v1 .,Non-OADS,/arxiv_data1/oa_pdf/25/e9/echo-02-R25.PMC4676471.pdf
Download Video 2 viahttp://dx.doi.org/10.1530/ERP-14-0058-v2 .R M Cooper and others Intervention in HCM: ASA ID: 14-0058; March 2015 DOI: 10.1530/ERP-14-0058 www.echorespract.com R26,Non-OADS,/arxiv_data1/oa_pdf/25/e9/echo-02-R25.PMC4676471.pdf
Download Video 4 viahttp://dx.doi.org/10.1530/ERP-14-0058-v4 .Video 3 Parasternal long axis view 6 months post alcohol ablation.,Non-OADS,/arxiv_data1/oa_pdf/25/e9/echo-02-R25.PMC4676471.pdf
Download Video 3 via http://dx.doi.org/10.1530/ ERP-14-0058-v3 .R M Cooper and others Intervention in HCM: ASA ID: 14-0058; March 2015 DOI: 10.1530/ERP-14-0058 www.echorespract.com R27,Non-OADS,/arxiv_data1/oa_pdf/25/e9/echo-02-R25.PMC4676471.pdf
Supplementary data This is linked to the online version of the paper at http://dx.doi.org/10.1530/ ERP-14-0058 .,Non-OADS,/arxiv_data1/oa_pdf/25/e9/echo-02-R25.PMC4676471.pdf
Download Video 3 via http://dx.doi.org/10.1530/ ERP-15-0003-v3 .Video 1 RT3DE transthoracic atrial en face normal mitral valve.,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
Download Video 1 via http://dx.doi.org/10.1530/ERP-15- 0003-v1 .,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
Download Video 2 via http://dx.doi.org/10.1530/ ERP-15-0003-v2 .K Rice and J Simpson 3D echocardiography of the left atrioventricular valveID: 15-0003; March 2015 DOI: 10.1530/ERP-15-0003 www.echorespract.com R16,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
Download Video 6 via http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
Download Video 4 via http://dx.doi.org/10.1530/ ERP-15-0003-v4 .,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
Download Video 5 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
Download Video 7 via http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
Download Video 8 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
Download Video 11 viahttp://dx.doi.org/10.1530/ERP-15-0003-v11 .K Rice and J Simpson 3D echocardiography of the left atrioventricular valveID: 15-0003; March 2015 DOI: 10.1530/ERP-15-0003 www.echorespract.com R20,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
Download Video 12 via http://dx.doi.org/10.1530/ERP-15- 0003-v12 .,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
Download Video 13 via http://dx.doi.org/10.1530/ERP-15- 0003-v13 .,Non-OADS,/arxiv_data1/oa_pdf/36/47/echo-02-R13.PMC4676473.pdf
"(Online) Available at:http://www.ics.ac.uk/ics-homepage/events/ﬁce-bse/focused-inten- sive-care-echo-ﬁce , accessed 03/05/2014, 2012.",Non-OADS,/arxiv_data1/oa_pdf/19/4a/echo-02-K11.PMC4676475.pdf
"(Online) Available at:http://www.guideline.gov/content.aspx?d Z35134 , accessed 20/05/ 2014, 2012.",Non-OADS,/arxiv_data1/oa_pdf/19/4a/echo-02-K11.PMC4676475.pdf
Download Video 1 via http://dx.doi.org/10.1530/ERP-14-0054-v1 .,Non-OADS,/arxiv_data1/oa_pdf/e9/86/echo-02-I1.PMC4676478.pdf
Download Video 2 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/86/echo-02-I1.PMC4676478.pdf
Download Video 3 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/86/echo-02-I1.PMC4676478.pdf
Download Video 4 viahttp://dx.doi.org/10.1530/ERP-14-0054-v4 .N Dewey and others Vein graft aneurysm with mural thrombusID: 14-0054; March 2015 DOI: 10.1530/ERP-14-0054 www.echorespract.com I2,Non-OADS,/arxiv_data1/oa_pdf/e9/86/echo-02-I1.PMC4676478.pdf
BJCA echocardiography toolkit provides a succinct summary of training requirements and proposed time line toachieve this http://www.bcs.com/documents/Toolkit_for_New_Cardiology_Trainees_Final_2013_update-Appendix_D.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/91/f1/echo-01-D9.PMC4676481.pdf
References 1 GMC National training survey: 2012. http://www.gmc-uk.org/ education/surveys.asp 2 GMC National training survey: 2013. http://www.gmc-uk.org/ education/surveys.asp 3 British Junior Cardiologists Association (BJCA) survey of cardiology trainees: 2013.,Non-OADS,/arxiv_data1/oa_pdf/91/f1/echo-01-D9.PMC4676481.pdf
http://www.bcs.,Non-OADS,/arxiv_data1/oa_pdf/91/f1/echo-01-D9.PMC4676481.pdf
"Down- load Video 1 via http://dx.doi.org/10.1530/ERP-14-0066-v1 Video 2 The initial right ventricular mass attached to the tricuspid valve chordae apparatus on echocardiography, in apical four-chamber view.",Non-OADS,/arxiv_data1/oa_pdf/41/f1/echo-02-I3.PMC4676482.pdf
Download Video 2 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/f1/echo-02-I3.PMC4676482.pdf
"Download Video 3 via http://dx.doi.org/10.1530/ERP-14-0066-v3Video 4 Repeat echocardiogram demonstrating enlargement of the original mass and an additional mass, in apical four-chamber view.",Non-OADS,/arxiv_data1/oa_pdf/41/f1/echo-02-I3.PMC4676482.pdf
Download Video 4 via http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/41/f1/echo-02-I3.PMC4676482.pdf
Download Video 1 via http://dx.doi.org/10.1530/ERP- 14-0064-v1 Video 2 Modiﬁed PSAX view showing a large ball valve thrombus and a clear left atrial appendage (LAA).,Non-OADS,/arxiv_data1/oa_pdf/1c/3a/echo-01-I9.PMC4676483.pdf
Download Video 2 viahttp://dx.doi.org/10.1530/ERP-14-0064-v2Open AccessB Kumar and others Large ball valve thrombus in the left atriumID: 14-0064; December 2014 DOI: 10.1530/ERP-14-0064 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0International License .q2014 The authors www.echorespract.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/1c/3a/echo-01-I9.PMC4676483.pdf
Download Video 1 via http://dx.doi.org/10.1530/ERP- 15-0002-v1 Table 2 Analysis scores for ICE vs TTE.,Non-OADS,/arxiv_data1/oa_pdf/cb/fd/echo-02-9.PMC4676484.pdf
Download Video 2 via http://dx.doi.org/10.1530/ERP-15-0002-v2 Video 3 An area of previous infarct is visible in the mid septum.,Non-OADS,/arxiv_data1/oa_pdf/cb/fd/echo-02-9.PMC4676484.pdf
"British Society of Echocardiography Minimum Dataset; A Standard Transthoracic Echo2012; http://www.bsecho.org/tte-minimum-dataset/ , 2012.",Non-OADS,/arxiv_data1/oa_pdf/cb/fd/echo-02-9.PMC4676484.pdf
Download Video 2 via http://dx.doi.org/10.1530/ERP-14- 0068-v2 Figure 3 (A) Transesophageal echocardiography mid-esophageal AV LAX showing incomplete opening of the aortic valve leaﬂets.,Non-OADS,/arxiv_data1/oa_pdf/c5/e3/echo-02-K1.PMC4676487.pdf
Download Video 3 via http://dx.doi.org/10.1530/ERP-14- 0068-v3 Video 4 TOE AV LAX with zoom on prosthetic valve.,Non-OADS,/arxiv_data1/oa_pdf/c5/e3/echo-02-K1.PMC4676487.pdf
Download Video 4 via http://dx.doi.org/10.1530/ERP-14-0068-v4 Video 5 TOE AV LAX with colour Doppler showing turbulent ﬂow across the prosthesis.,Non-OADS,/arxiv_data1/oa_pdf/c5/e3/echo-02-K1.PMC4676487.pdf
Download Video 5 via http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/e3/echo-02-K1.PMC4676487.pdf
Download Video 6 via http://dx.doi.org/ 10.1530/ERP-14-0068-v6A Roshdy and others Acute obstruction of a mechanical aortic valveID: 14-0068; March 2015 DOI: 10.1530/ERP-14-0068 www.echorespract.com K3,Non-OADS,/arxiv_data1/oa_pdf/c5/e3/echo-02-K1.PMC4676487.pdf
"( doi:10.1093/ eurheartj/ehu199 ) 4 Masani N, Wharton G, Allen J, Chambers J, Graham J, Jones R, Rana B 2011 British Society of Echocardiography Guidelines for ChamberQuantiﬁcation; http://www.bsecho.org/media/40506/chamber-ﬁnal- 2011_2_.pdf 5 Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA & Evangelista A 2009Recommendations for the evaluation of left ventricular diastolicfunction by echocardiography.",Non-OADS,/arxiv_data1/oa_pdf/ce/87/echo-02-G1.PMC4676492.pdf
"The modulation of afferent input by the  This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/d2/99/prm-20-285.PMC4676495.pdf
"This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/dd/4e/prm-20-288.PMC4676497.pdf
"Sous forme de traitement unique de première ligne,  l’hydromorphone par SOLO assurait un contrôle rapide de la douleur.a prospective multicentre study to evaluate the efficacy  and tolerability of osmotic release oral system (oros®)  hydromorphone in opioid-naive cancer patients:   results of the Korean south West oncology group study Eun-Kee Song MD PhD1, Hyunjeong Shim MD PhD2, Hye-Suk Han MD PhD3, DerSheng Sun MD PhD4,   Soon-Il Lee MD PhD5, Myung Hee Kang MD PhD6, KyuTaek Lee MD PhD7, DoYeun Cho MD PhD8,   In Sung Cho MD PhD9, Suk Young Park MD PhD10, Samyong Kim MD PhD11, Chang-Yeol Yim MD PhD1 This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/71/65/prm-20-293.PMC4676498.pdf
"<http://nationalpaincentre.mcmaster.ca/opioid/cgop_b_app_b08.html> (Accessed March 25, 2015).",Non-OADS,/arxiv_data1/oa_pdf/30/db/prm-20-300.PMC4676499.pdf
"All eligible patients were able to understand the study  This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/36/2a/prm-20-305.PMC4676500.pdf
"Although several concerns regarding the deleterious effects of N 2O have been raised in recent years, qualitative  reviews of current controversies (19,20) have concluded that N2O  This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/e3/b7/prm-20-309.PMC4676501.pdf
"Due to the unique anatomical position of the Gasserian ganglion, the Tew electrode was developed as a new  This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/1a/55/prm-20-316.PMC4676502.pdf
"This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/d9/86/prm-20-327.PMC4676504.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/eb/copd-10-2627.PMC4676507.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2627–2632International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2627OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8894 6Increased hypoxemia in patients with COPD  and pulmonary hypertension undergoing  bronchoscopy with biopsy Y oram neuman1,3 Matthew Koslow2,3 alona Matveychuk2,3 avigdor Bar-sef1 alexander guber2,3 David shitrit2,3 1Division of Cardiology, 2Pulmonary  Department, Meir Medical Center,   Kfar saba, Israel; 3sackler Faculty of  Medicine, T el aviv University, T el aviv,   IsraelBackground and objective:  Patients with pulmonary hypertension (PH) are considered to be  at risk for complications associated with flexible bronchoscopy (FB), but data concerning the  degree of PH are often lacking.",Non-OADS,/arxiv_data1/oa_pdf/fe/eb/copd-10-2627.PMC4676507.pdf
"Studies have shown that patients with PH are at increased risk for adverse hemo - dynamic events after noncardiac surgery,6 with the highest risk among patients with  severe PH.7 In contrast, invasive procedures that require intravenous sedation have  been reported as low risk.8 Bronchoscopy has been shown to affect hemodynamics, including a significant  increase in pulmonary capillary wedge pressure.9 An acute pulmonary hypertensive Correspondence: David shitrit Pulmonary Department, Meir Medical  Center, 59 Tchernichovsky street,   Kfar saba 44281, Israel Tel +972 9 747 2512 Fax +972 9 740 4832 email davids3@clalit.org.i l Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Neuman et al Running head recto: Bronchoscopy in pulmonary hypertension DOI: http://dx.doi.org/10.2147/COPD.S88946",Non-OADS,/arxiv_data1/oa_pdf/fe/eb/copd-10-2627.PMC4676507.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fe/eb/copd-10-2627.PMC4676507.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/eb/copd-10-2627.PMC4676507.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/19/dddt-9-6363.PMC4676508.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6363–6377Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6363Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9316 6effects of intravitreal injection of netrin-1 in retinal  neovascularization of streptozotocin-induced  diabetic rats Yao Yu,1,2,* Jing Zou,3,* Yun han,4 luowa Quyang,4  hui he,4 Peihong hu,2   Yi shao,2 Ping T u1 1nanchang Key laboratory  of Diabetes, Department of  endocrinology and Metabolism,   The Third hospital of nanchang,   Jiangxi, People’s republic of china;   2Department of Ophthalmology,   The First affiliated hospital of  nanchang University, Jiangxi Province  clinical Ophthalmology institute,   Jiangxi, People’s republic of china;   3Department of Ophthalmology,   Xiangya hospital, central south  University, hunan, People’s republic  of china; 4Fujian Provincial Key  laboratory of Ophthalmology  and Visual science, eye institute  of Xiamen University, Fujian,   People’s  republic of china *These authors have contributed  equally to this workBackground:  In a previous study, we confirmed that netrin-1 acts as an antiangiogenic factor  by inhibiting alkali burn-induced corneal neovascularization in rats.",Non-OADS,/arxiv_data1/oa_pdf/bd/19/dddt-9-6363.PMC4676508.pdf
"The incidence of retinopathy  in Chinese diabetic patients is 25.2%, and more than 70,000 people suffer from  DR-related blindness every year in the People’s Republic of China.2,3 Consequently,  ophthalmological studies have intensively investigated the pathogenesis, prevention, correspondence: Yi shao Department of Ophthalmology, The  First Affiliated Hospital of Nanchang  University, 17 YongWai Zheng street,  Donghu District, nanchang 330006,  Jiangxi, People’s republic of china Tel +86 791 8869 2520 email freebee99@163.co m  Ping Tu Department of endocrinology and  Metabolism, The Third hospital of  nanchang, 1 Qianjin road, Xihu District,  nanchang 330009, Jiangxi, People’s  republic of china Tel +86 791 8859 6614 email tuping8877@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Yu et al Running head recto: Effects of intravitreal injection of netrin-1 in retinal neovascularization DOI: http://dx.doi.org/10.2147/DDDT.S93166",Non-OADS,/arxiv_data1/oa_pdf/bd/19/dddt-9-6363.PMC4676508.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bd/19/dddt-9-6363.PMC4676508.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/19/dddt-9-6363.PMC4676508.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/95/dddt-9-6379.PMC4676509.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6379–6387Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6379Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9182 3effect of oral N-acetylcysteine on cOPD patients  with microsatellite polymorphism in the heme  oxygenase-1 gene promoter Jia-Qiang Zhang Jian-Qing Zhang li-Zhou Fang ling liu Wei-Ping Fu lu-Ming Dai The second Department of  respiratory Medicine, The First  affiliated hospital of Kunming Medical  University, Kunming, People’s republic  of chinaBackground:  Heme oxygenase-1 (HO-1) plays a protective role as an antioxidant in the lung,  and HO-1 gene promoter polymorphism has been shown to be associated with the severity and  prognosis of COPD patients.",Non-OADS,/arxiv_data1/oa_pdf/c6/95/dddt-9-6379.PMC4676509.pdf
"In 2020, COPD is projected to rank fifth  worldwide in terms of burden of disease and third in terms of mortality.1 COPD is an  inflammatory disease, and lung and systemic inflammation intensifies during most  COPD exacerbations.2 In COPD, repeated exposure to noxious particles, usually  tobacco smoke, can trigger a distinct inflammatory cascade in the small airways and  lung parenchyma involving several different cell types and inflammatory mediators.3  So, reducing oxidative stress and airway inflammation is supposed to be effective correspondence: lu-Ming Dai The second Department of respiratory  Medicine, The First Affiliated Hospital of  Kunming Medical University, 295 Xichang  road, Wuhua District, Kunming, Yunnan,  650000, People’s republic of china email dailuming6622@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: Effect of oral N-acetylcysteine on COPD patients DOI: http://dx.doi.org/10.2147/DDDT.S91823",Non-OADS,/arxiv_data1/oa_pdf/c6/95/dddt-9-6379.PMC4676509.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c6/95/dddt-9-6379.PMC4676509.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/95/dddt-9-6379.PMC4676509.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/e8/dddt-9-6343.PMC4676510.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 6343–6362Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6343Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7938 8Tanshinone iia ameliorates dextran sulfate  sodium-induced inflammatory bowel disease  via the pregnane X receptor Xianxie Zhang1 Yuguang Wang2 Zengchun Ma2 Qiande liang2 Xianglin Tang2 Donghua hu2 hongling Tan2 chengrong Xiao2 Yue gao2 1air Force general hospital of  People’s Liberation Army, Beijing,   People’s Republic of China;   2Department of Pharmacology and  Toxicology, Beijing Institute of  Radiation Medicine, Beijing, People’s  Republic of ChinaAbstract:  Tanshinone IIA (Tan IIA) (C19H18O3) is one of the major active lipophilic  components in a conventional Chinese medicine called danshen, and it has long been used in  the People’s Republic of China and other neighboring countries to treat patients suffering from  inflammatory bowel disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/fa/e8/dddt-9-6343.PMC4676510.pdf
"In as early as 2004, Langmann et al, in addition to other authors, found low levels Correspondence: Yue Gao;   Yuguang Wang Beijing Institute of Radiation Medicine,  Taiping Road 27, Beijing 100850,  People’s Republic of China Tel +86 10 6693 1312; 86 10 6693 2201 Fax +86 10 6821 4653; 86 10 6821 4653 email  gaoyue@bmi.ac.c n;   wangyg@bmi.ac.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: Tanshinone IIA acts via pregnane X receptor to ameliorate IBD DOI: http://dx.doi.org/10.2147/DDDT.S79388",Non-OADS,/arxiv_data1/oa_pdf/fa/e8/dddt-9-6343.PMC4676510.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fa/e8/dddt-9-6343.PMC4676510.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/e8/dddt-9-6343.PMC4676510.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/62/copd-10-2633.PMC4676511.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2633–2656International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2633OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9404 3systems pharmacology-based approach for  dissecting the active ingredients and potential  targets of the Chinese herbal Bufei Jianpi formula  for the treatment of COPD Correspondence: Jiansheng li Key laboratory of Chinese Internal  Medicine, henan University of Traditional  Chinese Medicine, 1 Jinshui road,  Zhengzhou 450046, People’s republic  of China email li_js8@163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhao et al Running head recto: Bufei Jianpi formula for the treatment of COPD DOI: http://dx.doi.org/10.2147/COPD.S94043 Peng Zhao1,2 Jiansheng li1,2 Ya li1,2 Yange Tian1,2 Y onghua Wang2,3 Chunli Zheng3 1Key laboratory of Chinese Internal  Medicine, henan University of  Traditional Chinese Medicine, 2Key  laboratory of Chinese Internal  Medicine, Collaborative Innovation  Center for respiratory Disease  Diagnosis and Treatment and Chinese  Medicine Development of henan  Province, Zhengzhou, 3Center of  Bioinformatics, College of life  science, northwest a&F University,   Yangling, People’s republic of ChinaBackground:  The Chinese herbal Bufei Jianpi formula (BJF) provides an effective treatment  option for chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/3e/62/copd-10-2633.PMC4676511.pdf
"Dataset construction All ingredients from the 12 herbs of BJF were collected  mainly from the Chinese Academy of Sciences Chemistry  Database ( http://www.organchem.csdb.c n), Chinese Herbal  Drug Database, and the literature.17–20 For orally adminis - tered drugs, glucosides can be metabolized extensively to  their deglycosylation products by enteric bacteria in the  intestinal tract;21 thus, both glucosides and deglycosylation  products are considered to be the constituents of herbal drugs.",OADS,/arxiv_data1/oa_pdf/3e/62/copd-10-2633.PMC4676511.pdf
"Drug-likeness prediction The drug-likeness index was used to evaluate the structural  similarity between the herbal ingredients and the drugs in  the DrugBank database ( http://www.drugbank.ca /) and help  remove compounds that are considered to be chemically and  pharmacologically unsuitable as drugs.24 In this study, the  database-dependent drug-likeness prediction approach was  calculated as follows:  TABAB AB AB,()= +−⋅ ⋅22  (1) where A represents the herbal compounds and B represents  the average molecular drug-likeness index of all com - pounds in the DrugBank database.",OADS,/arxiv_data1/oa_pdf/3e/62/copd-10-2633.PMC4676511.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/3e/62/copd-10-2633.PMC4676511.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/62/copd-10-2633.PMC4676511.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/41/rjv150.PMC4676512.pdf
Documented clinical VT with right bundle branch block–like morphology Circ Arrhythm Electrophysiol is available at http://circep.ahajournals.org DOI: 10.1161/CIRCEP.115.003080Original Article Background—Fascicular ventricular tachycardia (FVT) is a common form of sustained idiopathic left ventricular tachycardia  with an Asian preponderance.,Non-OADS,/arxiv_data1/oa_pdf/b4/07/hae-8-1443.PMC4676513.pdf
"*Drs Liu and Fang contributed equally.The Data Supplement is available at http://circep.ahajournals.org/lookup/suppl/doi:10.1161/CIRCEP.115.003080/-/DC1.Correspondence to Fengxiang Zhang, MD, Section of Pacing and Electrophysiology, Division of Cardiology, First Affiliated Hospital of Nanjing Medical  University, Guangzhou Road 300, Nanjing, 210029, China.",Non-OADS,/arxiv_data1/oa_pdf/b4/07/hae-8-1443.PMC4676513.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/95/jiv429.PMC4676548.pdf
"Annual report of the European Antimicrobial Resis- tance Surveillance Network (EARS-Net), 2012 .http://ecdc.europa.eu/en/ publications/Publications/antimicrobial-resistance-surveillance-europe-2012.pdf.",Non-OADS,/arxiv_data1/oa_pdf/94/95/jiv429.PMC4676548.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/47/imcrj-8-321.PMC4676612.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 321–326International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  321Case seRIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IMCRJ.S8997 0effects of sub-T enon’s capsule triamcinolone  acetonide injection combined with microa-  neurysm photocoagulation on diabetic  macular edema T oshiyuki Oshitari sakiko Nonomura Miyuki arai Y oko Takatsuna eiju sato Takayuki Baba shuichi Yamamoto Department of Ophthalmology and  Visual science, Graduate school of  Medicine, Chiba University, Chuo-ku,   Chiba, Japan Correspondence: Toshiyuki Oshitari   Department of Ophthalmology and Visual  science, Graduate school of Medicine,  Chiba University, Inohana 1-8-1,  Chuo-ku, Chiba 260 8670, Japan   Tel +81 43 226 2124   Fax +81 43 224 4162   email t arii@aol.co m; oshitari@faculty.",Non-OADS,/arxiv_data1/oa_pdf/8c/47/imcrj-8-321.PMC4676612.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/8c/47/imcrj-8-321.PMC4676612.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/47/imcrj-8-321.PMC4676612.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/75/imcrj-8-327.PMC4676613.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 327–331International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  327Case seRIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IMCRJ.S9334 7Clinical features of infectious keratitis at a tertiary  referral center in a rural area of Korea seung-Jun Lee1,* Jang Hun Lee1,* Moosang Kim1 sang Beom Han1 Joon Y oung Hyon2 1Department of Ophthalmology,   Kangwon National University  Hospital, Kangwon National  University Graduate school of  Medicine, Chuncheon, 2Department  of Ophthalmology, seoul National  University Bundang Hospital, seoul  National University College of  Medicine, seongnam, Korea *These authors contributed equally to  this work.",Non-OADS,/arxiv_data1/oa_pdf/f0/75/imcrj-8-327.PMC4676613.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/f0/75/imcrj-8-327.PMC4676613.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/75/imcrj-8-327.PMC4676613.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/4f/ott-8-3629.PMC4676614.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3629–3638OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3629Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8803 7Potential role for mammalian target of rapamycin  inhibitors as first-line therapy in hormone  receptor–positive advanced breast cancer J Thaddeus Beck Highlands Oncology Group,   Fayetteville, AR, USAAbstract:  Despite advances in cytotoxic chemotherapy and targeted therapies, 5-year  survival  rates remain low for patients with advanced breast cancer at diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/00/4f/ott-8-3629.PMC4676614.pdf
"The majority of advanced breast cancers are considered incurable.5  Tumor stage, tumor grade, hormone receptor (HR; ie, estrogen receptor [ER] or  progesterone receptor), and human epidermal growth factor receptor 2 (HER2) status Correspondence: J Thaddeus Beck Highlands Oncology Group,  3232 N North Hills Blvd,  Fayetteville, AR 72703, USA Tel +1 479 587 1700 email tbeck@hogonc.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Beck Running head recto: mTOR inhibitors as first-line therapy in advanced breast cancer DOI: http://dx.doi.org/10.2147/OTT.S88037",Non-OADS,/arxiv_data1/oa_pdf/00/4f/ott-8-3629.PMC4676614.pdf
It has completed enrollment (N =202)  and has an estimated study-completion date of December 2016  (https://clinicaltrials.gov/ct2/show/NCT0169891 8).,Non-OADS,/arxiv_data1/oa_pdf/00/4f/ott-8-3629.PMC4676614.pdf
Available from: http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/00/4f/ott-8-3629.PMC4676614.pdf
Available from: http://seer.cancer.,Non-OADS,/arxiv_data1/oa_pdf/00/4f/ott-8-3629.PMC4676614.pdf
"Available  from: http://www.nccn.org/patient s. Accessed April 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/00/4f/ott-8-3629.PMC4676614.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/00/4f/ott-8-3629.PMC4676614.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/4f/ott-8-3629.PMC4676614.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/ef/ott-8-3639.PMC4676615.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3639–3648OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3639Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9156 0Downregulation of microrna-132 by Dna  hypermethylation is associated with cell invasion  in colorectal cancer Jun Qin Jing Ke Junfei Xu Feiran Wang Y oulang Zhou Yasu Jiang Zhiwei Wang Department of general surgery,   affiliated hospital of nantong  University, nantong, Jiangsu Province,   People’s republic of chinaAbstract:  microRNAs (miRNAs) are small, noncoding RNAs that are involved in many biologi - cal processes, and aberrant regulation of miRNAs is always associated with cancer progression  and development.",Non-OADS,/arxiv_data1/oa_pdf/07/ef/ott-8-3639.PMC4676615.pdf
"In this study, we show that miRNA-132 (miR-132), transcribed  from an intergenic region on human chromosome 17, is aberrantly expressed in lung correspondence: Zhiwei Wang Department of General Surgery, Affiliated  hospital of nantong University, 20 Xisi  road, nantong 226001, Jiangsu Province,  People’s republic of china email youyi701@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Qin et al Running head recto: Downregulation of microRNA-132 in colorectal cancer  DOI: http://dx.doi.org/10.2147/OTT.S91560",Non-OADS,/arxiv_data1/oa_pdf/07/ef/ott-8-3639.PMC4676615.pdf
Bisulfite-modified DNA was amplified by methylation- unbiased primers designed using the MethPrimer program  (http://www.urogene.org/cgi-bin/methprimer/methprimer.,Non-OADS,/arxiv_data1/oa_pdf/07/ef/ott-8-3639.PMC4676615.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/07/ef/ott-8-3639.PMC4676615.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/ef/ott-8-3639.PMC4676615.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/76/jmdh-8-527.PMC4676616.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 527–534Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  527Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S9357 9Joining the patient on the path to customized  prophylaxis: one hemophilia team explores   the tools of engagement Deborah gue1,2 sandra squire1 Kam Mcintosh1 claude Bartholomew1 nicole summers1 Haowei sun1 Ming Yang1 shannon Jackson1,3 1British columbia Provincial Bleeding  Disorders Program – adult Division,   st Paul’s Hospital, 2school of n ursing,   3Division of Hematology, Department  of Medicine, University of British  columbia, Vancouver, Bc , canada correspondence: Deborah gue   British columbia Provincial Bleeding  Disorders Program – adult Division,  st Paul’s Hospital, room 474, Burrard  West, 1081 Burrard street, Vancouver,  Bc V6Z 1Y6, canada   Tel +1 604 806 8855   Fax +1 604 806 8784   email dgue@providencehealth.bc.c aBackground:  The relationship between hemophilia team interventions and achievement of  optimal clinical outcomes remains to be elucidated.",Non-OADS,/arxiv_data1/oa_pdf/03/76/jmdh-8-527.PMC4676616.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/03/76/jmdh-8-527.PMC4676616.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/76/jmdh-8-527.PMC4676616.pdf
"Avail - able from: http://www.iaf-world.org/index/certification/Competenciesfor   Certification.asp x. Accessed March 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/03/76/jmdh-8-527.PMC4676616.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/bc/ott-8-3665.PMC4676617.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3665–3678OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3665Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8965 9Crosstalk with cancer-associated fibroblasts  induces resistance of non-small cell lung cancer  cells to epidermal growth factor receptor  tyrosine kinase inhibition chungyoul choe1,* Y ong-sung shin1,* changhoon Kim2 so-Jung choi1 Jinseon lee1 so Y oung Kim1 Y ong Beom cho3 Jhingook Kim1,4 1samsung Biomedical research  institute, samsung Medical center  sungkyunkwan University, school  of Medicine, 2Department of  Biomedical science, graduate  school of Biomedical & engineering,   hanyang University, 3Department of  surgery, 4Department of Thoracic  surgery, samsung Medical center,   sungkyunkwan University, school of  Medicine, Seoul, Republic of Korea *These authors contributed equally  to this workAbstract:  Although lung cancers with activating mutations in the epidermal growth factor  receptor (EGFR) are highly sensitive to selective EGFR tyrosine kinase inhibitors (TKIs), these  tumors invariably develop acquired drug resistance.",Non-OADS,/arxiv_data1/oa_pdf/5b/bc/ott-8-3665.PMC4676617.pdf
"Epidermal growth factor receptor (EGFR), a member of a family of closely related  growth factor receptor tyrosine kinases, is overexpressed or amplified in 62% of cases of correspondence: Jhingook Kim Department of Thoracic surgery,  samsung Medical center, sungkyunkwan  University school of Medicine, 81,  irwon-ro, guangnam-gu, seoul 135-710,  Republic of Korea Tel +82 2 3410 3483 Fax +82 2 2148 7385 email jkimsmc@skku.ed u Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Choe et al Running head recto: Effect of CAFs on drug resistance in lung cancer DOI: http://dx.doi.org/10.2147/OTT.S89659",Non-OADS,/arxiv_data1/oa_pdf/5b/bc/ott-8-3665.PMC4676617.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5b/bc/ott-8-3665.PMC4676617.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/bc/ott-8-3665.PMC4676617.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/ott-8-3679.PMC4676618.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3679–3690OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3679Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9535 3association between MDM2 snP309 T .g  polymorphism and the risk of bladder cancer:  new data in a chinese population and an updated  meta-analysis linguo Xie1,2,* Yan sun2,* Tao chen1,2,* Dawei Tian1,2 Yujuan li3 Yu Zhang1,2 na Ding2 Zhonghua shen1,2 hao Xu1,2 Xuewu n ian4 nan sha1,2 ruifa han1,2 hailong hu1,2 changli Wu1,2 1Department of Urology, The  second hospital of Tianjin Medical  University, 2Tianjin Key laboratory of  Urology, Tianjin institute of Urology,   3Department of Dermatology, The  second hospital of Tianjin Medical  University, 4Department of Urology,   Tianjin n ankai hospital, Tianjin,   People’s republic of china *These authors contributed equally  to this workObjective:  Human murine double minute 2 protein (MDM2) is mainly a negative regulator  of p53 tumor suppressor pathway.",Non-OADS,/arxiv_data1/oa_pdf/a5/c6/ott-8-3679.PMC4676618.pdf
"Keywords:  bladder cancer, MDM2, single nucleotide polymorphism, rs2279744, recurrence,  meta-analysis Introduction Bladder cancer has become a significant threat to the public health, with a high  incidence rate of 9.5/100,000 and 3.3/100,000 in the more developed and less developed  region, respectively.1 According to the data provided by the International Agency for  Research on Cancer, an estimated 429,800 new cases of bladder cancer and 165,100  deaths occurred in 2012 worldwide.1,2 For the population in the People’s Republic of  China, 55,486 new cases and 26,820 deaths were estimated in 2012, which indicate  that bladder cancer is the 15th most commonly diagnosed cancer and the 17th leading correspondence: hailong hu;  changli Wu Department of Urology, The second  hospital of Tianjin Medical University,  23 Pingjiang road, hexi District, Tianjin  300211, People’s republic of china Tel +86 22 282 732 11 Fax +86 22 282 732 11 email hhllove2004@163.co m;  wujygc2003@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xie et al Running head recto: MDM2 SNP309 T .G polymorphism and bladder cancer risk DOI: http://dx.doi.org/10.2147/OTT.S95353",Non-OADS,/arxiv_data1/oa_pdf/a5/c6/ott-8-3679.PMC4676618.pdf
"Available from: http://globocan.iarc.f r. Accessed June 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a5/c6/ott-8-3679.PMC4676618.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a5/c6/ott-8-3679.PMC4676618.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/ott-8-3679.PMC4676618.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/bf/opth-9-2291.PMC4676619.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2291–2298Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2291Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9063 6Ocular hypertension and hypotony as  determinates of outcomes in uveitis rabia aman1 stephanie B engelhard1 asima Bajwa1 James Patrie2 ashvini K reddy1 1Department of Ophthalmology,   2Department of Public health  sciences, University of Virginia,   Charlottesville, V a, UsaPurpose:  To assess ocular hypertension (OHT) and hypotony as outcomes of uveitis in patients  managed in a mid-Atlantic tertiary care center.",Non-OADS,/arxiv_data1/oa_pdf/6a/bf/opth-9-2291.PMC4676619.pdf
"Cytokine release and the presence of inflammatory cells can alter the  anatomy of the anterior chamber, leading to an increase in intraocular pressure (IOP) by  affecting aqueous outflow.1,2 Furthermore, corticosteroids, a mainstay in the treatment  of inflammation associated with uveitis, also cause increased IOP in patients who are  steroid responders.1–3 Reports suggest that between 10% and 46% of uveitis patients  develop elevated IOP; however, secondary glaucoma is most common in patients with  chronic uveitis and in those with Fuchs heterochromic iridocyclitis, Posner–Schlossman  syndrome, and uveitis associated with varicella zoster virus and herpes simplex virus.1,3  Elevated IOP in the setting of uveitis is associated with poor visual outcomes.4 Hypotony in uveitis, while less common than OHT, has been reported in up to 10%  of uveitis patients and appears to be most prevalent in the pediatric setting, especially in Correspondence: ashvini K reddy Department of Ophthalmology,  University of Virginia, 1300 Jefferson Park  avenue, OMs 2860B, Charlottesville,  Va 22908, Usa Tel +1 434 924 0070 Fax +1 434 924 5180 email akr5u@virginia.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Aman et al Running head recto: Ocular hypertension and hypotony in uveitis DOI: http://dx.doi.org/10.2147/OPTH.S90636",Non-OADS,/arxiv_data1/oa_pdf/6a/bf/opth-9-2291.PMC4676619.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6a/bf/opth-9-2291.PMC4676619.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/bf/opth-9-2291.PMC4676619.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/8d/lra-8-105.PMC4676620.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 105–111Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  105Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S8868 5Impact of volume expansion on the efficacy and  pharmacokinetics of liposome bupivacaine Admir Hadzic1,2 John A Abikhaled3 william J Harmon4 1Department of Anesthesiology,   The New York School of Regional  Anesthesia (NYSORA), New Y ork, NY,   USA; 2Department of Anesthesiology,   Ziekenhouse Oost Limburgh, Genk,   Belgium; 3Austin Surgeons, Austin, TX,   4Urology San Antonio, San Antonio,   TX, USA Correspondence: Admir Hadzic   The New York School of Regional   Anesthesia (NYSORA),   2753 Broadway, Suite 183,   New York, NY, USA 10025   email admir@nysora.co mAbstract:  Liposome bupivacaine is a prolonged-release liposomal formulation of bupivacaine  indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia of  longer duration than traditional local anesthetics.",Non-OADS,/arxiv_data1/oa_pdf/bb/8d/lra-8-105.PMC4676620.pdf
Available  from: http://www.iars.org/assets/1/7/2009_Abstract_Supplement.pd f  14.,OADS,/arxiv_data1/oa_pdf/bb/8d/lra-8-105.PMC4676620.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/bb/8d/lra-8-105.PMC4676620.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/8d/lra-8-105.PMC4676620.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/be/opth-9-2299.PMC4676621.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 2299–2304Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2299Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9217 6Outcome of therapeutic penetrating keratoplasty  in a tertiary eye care center in nepal leena Bajracharya reeta gurung Department of Cornea, Tilganga  institute of Ophthalmology,   Kathmandu, nepalBackground:  Corneal ulcer is an important cause of blindness in developing countries.",Non-OADS,/arxiv_data1/oa_pdf/ba/be/opth-9-2299.PMC4676621.pdf
"TPK constitutes a significant proportion of keratoplasty performed in Asian and  other developing countries.2 In the Tilganga Institute of Ophthalmology, which is  a tertiary center for cornea service in Nepal, TPK accounts for 41% of all grafts Correspondence: leena Bajracharya Department of Cornea, Tilganga institute  of Ophthalmology, Bagmati Bridge, PO  Box 561, gaushala, Kathmandu, nepal Tel +977 1 449 3775 Fax +977 1 447 4937 email lbajra@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Bajracharya and Gurung Running head recto: Outcome of therapeutic penetrating keratoplasty DOI: http://dx.doi.org/10.2147/OPTH.S92176",Non-OADS,/arxiv_data1/oa_pdf/ba/be/opth-9-2299.PMC4676621.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ba/be/opth-9-2299.PMC4676621.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/be/opth-9-2299.PMC4676621.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/53/ijgm-8-361.PMC4676622.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 361–372International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  361RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S6629 0Integrating complementary/alternative   medicine into primary care: evaluating   the evidence and appropriate implementation Stanley F wainapel1 Stephanie Rand1 Loren M Fishman2 Jennifer Halstead-Kenny1 1The Arthur S Abramson  Department of Physical Medicine and  Rehabilitation, Montefiore Medical  Center, Albert einstein College of  Medicine, Bronx, 2Department of  Rehabilitation and Regenerative  Medicine, College of Physicians  and Surgeons, Columbia University,   New Y ork, NY, USA Correspondence: Stephanie Rand   The Arthur S Abramson Department  of Physical Medicine and Rehabilitation,  Montefiore Medical Center, 111 East  210th Street, Bronx, NY 10467, USA   Tel +1 718 920 2751   Fax +1 718 920 9212   email srand@montefiore.or gAbstract:  The frequency with which patients utilize treatments encompassed by the term  complementary/alternative medicine (CAM) is well documented.",Non-OADS,/arxiv_data1/oa_pdf/1b/53/ijgm-8-361.PMC4676622.pdf
"Available from: http://www.osteopathic.org/osteopathic- health/about-dos/about-osteopathic-medicine/Pages/frequently-asked- questions.asp x. Accessed January 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1b/53/ijgm-8-361.PMC4676622.pdf
"Available from: http://www.lcom.org.uk/ course.htm l. Accessed February 4, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1b/53/ijgm-8-361.PMC4676622.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/1b/53/ijgm-8-361.PMC4676622.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/53/ijgm-8-361.PMC4676622.pdf
"Available from: http://www.tsca.edu/ site/alumni-services/articles/european-acupuncture-licensing-and- educatio n. Accessed March 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1b/53/ijgm-8-361.PMC4676622.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/f7/vhrm-11-613.PMC4676623.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 613–622Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  613ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S6832 8Fractional flow reserve-guided percutaneous  coronary intervention: where to after FAMe 2?,Non-OADS,/arxiv_data1/oa_pdf/8c/f7/vhrm-11-613.PMC4676623.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/8c/f7/vhrm-11-613.PMC4676623.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/f7/vhrm-11-613.PMC4676623.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/44/ndt-11-2989.PMC4676624.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2989–2996Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2989OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9352 0Psychological changes in alcohol-dependent patients  during a residential rehabilitation program ines giorgi1 Marcella Ottonello2,3 giovanni Vittadini4 giorgio Bertolotti5 1Psychology Unit, salvatore Maugeri  Foundation, clinica del lavoro  e  della riabilitazione, irccs,   Pavia, 2Department of Physical &  rehabilitation Medicine, salvatore  Maugeri Foundation, clinica del  lavoro e della riabilitazione, irccs,   genoa, 3Department of Medicine,   PhD Program in advanced sciences  and Technologies in rehabilitation  Medicine and sport, Università  di T or Vergata, rome, 4alcohol  rehabilitation Unit, salvatore Maugeri  Foundation, clinica del lavoro e  della riabilitazione, irccs, Pavia,   5Psychology Unit, salvatore Maugeri  Foundation, clinica del lavoro e della  riabilitazione, irccs, Tradate, italyBackground:  Alcohol-dependent patients usually experience negative affects under the  influence of alcohol, and these affective symptoms have been shown to decrease as a result  of alcohol-withdrawal treatment.",Non-OADS,/arxiv_data1/oa_pdf/03/44/ndt-11-2989.PMC4676624.pdf
"Furthermore, professional staff members are available correspondence: Marcella Ottonello Department of Physical & rehabilitation  Medicine, salvatore Maugeri Foundation,  clinica del lavoro e della riabilitazione,  irccs, 14 via Missolungi, Nervi,  genoa 16167, italy Fax +39 010 3079 1269 email marcella.ottonello@fsm.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Giorgi et al Running head recto: Psychological changes in alcoholics during treatment DOI: http://dx.doi.org/10.2147/NDT.S93520",Non-OADS,/arxiv_data1/oa_pdf/03/44/ndt-11-2989.PMC4676624.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/03/44/ndt-11-2989.PMC4676624.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/44/ndt-11-2989.PMC4676624.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/37/ppa-9-1721.PMC4676625.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1721–1731Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1721OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9210 8Patient experiences with self-monitoring renal  function after renal transplantation: results from  a single-center prospective pilot study céline l van lint1 Paul JM van der Boog1 Wenxin Wang2,3 Willem-Paul Brinkman2 T on JM rövekamp3 Mark A neerincx2 T on J rabelink1 sandra van Dijk1,4 1Department of nephrology, leiden  University Medical centre (lUM c),   leiden, 2Faculty of electrical  engineering, Mathematics and  computer science, Delft University  of T echnology, Delft, 3Department of  Technology in healthcare, Prevention  and health, Dutch Organization for  Applied scientific research (Tn O),   leiden, 4Department of health,   Medical and n europsychology,   Faculty of social and Behavioural  sciences, leiden University, leiden,   the n etherlandsBackground:  After a kidney transplantation, patients have to visit the hospital often to monitor  for early signs of graft rejection.",Non-OADS,/arxiv_data1/oa_pdf/72/37/ppa-9-1721.PMC4676625.pdf
"correspondence: céline l van lint Department of nephrology, leiden  University Medical centre (lUMc),  PO Box 9600, leiden 2300 rc,  the netherlands Tel +31 71 526 2214 email c.l.van_lint@lumc.n l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: van Lint et al Running head recto: Self-monitoring kidney function after renal transplantation DOI: http://dx.doi.org/10.2147/PPA.S92108",Non-OADS,/arxiv_data1/oa_pdf/72/37/ppa-9-1721.PMC4676625.pdf
"Available from: http://www.uptodate.com/ contents/clinical-manifestations-and-diagnosis-of-acute-renal-allograft- rejectio n. Accessed October 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/72/37/ppa-9-1721.PMC4676625.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/72/37/ppa-9-1721.PMC4676625.pdf
"Journal of  Preventive Medicine  & Public Health 301 Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:301-309    •  http://dx.doi.org/10.3961/jpmph.15.011 A 9-year Trend in the Prevalence of Allergic Disease Based  on National Health Insurance Data Byoungin Yoo, Yoonhyung Park, Kwanjun Park*, Hoseob Kim Department of Preventive Medicine, Soonchunhyang University College of Medicine, Chunan, KoreaOriginal Article Objectives: To investigate trends in the prevalence of allergic disease over a 9-year period.",Non-OADS,/arxiv_data1/oa_pdf/8f/f0/jpmph-48-6-301.PMC4676638.pdf
"Key words:  Asthma, Allergic rhinitis, Atopic dermatitis, Prevalence Received:  February 17, 2015 Accepted:  October 26, 2015 Corresponding author:  Yoonhyung Park, MD, PhD 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 31151, Korea  Tel: +82-41-570-2406, Fax:  +82-41-575-2406 E-mail:  parky@sch.ac.kr *Current affiliation: Division of Infectious Disease Control, Korea Centers For Dis - ease Control and Prevention, Cheongju, Korea   This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Globally, three million individuals live with asthma and four  million individuals live with allergic rhinitis [1,2].",Non-OADS,/arxiv_data1/oa_pdf/8f/f0/jpmph-48-6-301.PMC4676638.pdf
Available from:http://yhs.cdc.go.kr/(Koean).,Non-OADS,/arxiv_data1/oa_pdf/8f/f0/jpmph-48-6-301.PMC4676638.pdf
Available  from: https://knhanes.cdc.go.kr/knhanes/index.do (Korean).,Non-OADS,/arxiv_data1/oa_pdf/8f/f0/jpmph-48-6-301.PMC4676638.pdf
Available from: http://www.kma.,Non-OADS,/arxiv_data1/oa_pdf/8f/f0/jpmph-48-6-301.PMC4676638.pdf
"Journal of  Preventive Medicine  & Public Health 271 Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:271-273    •  http://dx.doi.org/10.3961/jpmph.15.059 Implementation of Quaternary Prevention in the Korean  Healthcare System: Lessons From the 2015 Middle East  Respiratory Syndrome Coronavirus Outbreak in the Re - public of Korea Jong-Myon Bae Department of Preventive Medicine, Jeju National University School of Medicine, Jeju, KoreaPerspective   Quaternary prevention should be implemented to minimize harm to patients because the ultimate goal of medicine is to prevent dis - ease and promote health.",Non-OADS,/arxiv_data1/oa_pdf/57/d1/jpmph-48-6-271.PMC4676639.pdf
"Key words:  Prevention, Delivery of health care, Health promotion, Patient safety Received:  October 23, 2015 Accepted:  November 24, 2015 Corresponding author:  Jong-Myon Bae, MD, PhD 102 Jejudaehak-ro, Jeju 63243, Korea   Tel: +82-64-755-5567, Fax:  +82-64-725-2593 E-mail:  jmbae@jejunu.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Medicine’s ultimate aim is to prevent disease and to pro - mote health.",Non-OADS,/arxiv_data1/oa_pdf/57/d1/jpmph-48-6-271.PMC4676639.pdf
Available from:  http://www.hankookilbo.com/v/3466b8b917614333b667b2 8ff77303a0 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/57/d1/jpmph-48-6-271.PMC4676639.pdf
Available from: http://www.ph3c.org/PH3C/docs/27/000103/ Table 1.,Non-OADS,/arxiv_data1/oa_pdf/57/d1/jpmph-48-6-271.PMC4676639.pdf
"Journal of  Preventive Medicine  & Public Health 330 Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:330-341    •  http://dx.doi.org/10.3961/jpmph.15.058 Current Status of Infection Prevention and Control Programs  for Emergency Medical Personnel in the Republic of Korea Hyang Soon Oh1, Dong Choon Uhm2  1Department of Nursing, Woosong University, Daejeon; 2Department of Emergency Medical Technology, Daejeon University, Daejeon, KoreaOriginal Article Objectives: Emergency medical personnel (EMPs) are pre-hospital emergency responders who are at risk of exposure to infections  and may also serve as a source for the transmission of infections.",Non-OADS,/arxiv_data1/oa_pdf/fe/b1/jpmph-48-6-330.PMC4676640.pdf
"Key words:  Cross infection, Emergency medical technicians, Emergency responders, Infection control, Health personnel Received:  October 6, 2015 Accepted:  November 17, 2015 Corresponding author:  Dong Choon Uhm, PhD 62 Daehak-ro, Dong-gu, Daejeon 34520, Korea Tel: +82-42-280-2941, Fax:  +82-42-280-2946 E-mail:  dchuhm@dju.kr  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION  During the Middle East Respiratory Syndrome (MERS) out - break in the Republic of Korea (hereafter Korea) from May to  July 2015, two emergency medical personnel were infected  with MERS, among a total of 39 healthcare workers who de - veloped MERS occupationally [1].",Non-OADS,/arxiv_data1/oa_pdf/fe/b1/jpmph-48-6-330.PMC4676640.pdf
Available from: http://www.mers.,Non-OADS,/arxiv_data1/oa_pdf/fe/b1/jpmph-48-6-330.PMC4676640.pdf
Available from:  http://www.law.go.kr/lsSc.do?menuId =0&p1=&subMenu =1 &nwYn =&section =&tabNo =&query =#undefined (Korean).,OADS,/arxiv_data1/oa_pdf/fe/b1/jpmph-48-6-330.PMC4676640.pdf
Available from: http://www.cdc.gov/hicpac/ Disinfection_Sterilization/toc.html?s_cid =w_c_CustomRss - Widget_frm_001.,OADS,/arxiv_data1/oa_pdf/fe/b1/jpmph-48-6-330.PMC4676640.pdf
"Journal of  Preventive Medicine  & Public Health 277 Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:277-279    •  http://dx.doi.org/10.3961/jpmph.15.069 A New Measure for Assessing the Public Health Response to  a Middle East Respiratory Syndrome Coronavirus Outbreak Sung-il Cho Graduate School of Public Health and Institute of Health and Environment, Seoul National University, Seoul, KoreaPerspective Contact monitoring is an essential component of the public health response to a Middle East respiratory syndrome coronavirus out - break, and is required for an effective quarantine to contain the epidemic.",Non-OADS,/arxiv_data1/oa_pdf/fd/0c/jpmph-48-6-277.PMC4676641.pdf
"Key words:  Contact tracing, Quarantine, Isolation, Surveillance, Transmission, Republic of Korea Received:  November 27, 2015 Accepted:  November 30, 2015 Corresponding author:  Sung-il Cho, MD, ScD 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea Tel: +82-2-880-2717, Fax:  +82-2-743-8240 E-mail:  scho@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.The outbreak of Middle East respiratory syndrome coronavi - rus (MERS-CoV) in the Republic of Korea this year resulted in 186  confirmed patients, with 38 deaths (20.4%) and a loss of 0.3% in  the gross domestic product [1,2].",Non-OADS,/arxiv_data1/oa_pdf/fd/0c/jpmph-48-6-277.PMC4676641.pdf
Avail - able from: http://www.mers.go.kr/mers/html/jsp/main.jsp  (Korean).,Non-OADS,/arxiv_data1/oa_pdf/fd/0c/jpmph-48-6-277.PMC4676641.pdf
Available from: http://www.who.int/csr/disease/coronavirus_ infections/MERS_CoV_investigation_guideline_Jul13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fd/0c/jpmph-48-6-277.PMC4676641.pdf
Available from: http://www.who.int/mediacentre/ news/mers/briefing-notes/update-1-july-2015/en/.,Non-OADS,/arxiv_data1/oa_pdf/fd/0c/jpmph-48-6-277.PMC4676641.pdf
Int J Infect Dis 2015.  http://dx.doi.org/10.1016/j.ijid.2015.10.025.,OADS,/arxiv_data1/oa_pdf/fd/0c/jpmph-48-6-277.PMC4676641.pdf
"Journal of  Preventive Medicine  & Public Health 287 Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:287-300    •  http://dx.doi.org/10.3961/jpmph.15.048 Determinants of Poor Self-rated Health in Korean Adults  With Diabetes Hwi-Won Lee1,2, Minkyo Song1,2, Jae Jeong Yang1,3, Daehee Kang1,2,4 1Department of Preventive Medicine, Seoul National University College of Medicine, Seoul; 2Department of Biomedical Sciences, Seoul National  University Graduate School, Seoul; 3Institute of Environmental Medicine, Seoul National University Medical Research Center, Seoul; 4Cancer Research  Institute, Seoul National University, Seoul, KoreaOriginal Article Objectives: Self-rated health is a measure of perceived health widely used in epidemiological studies.",Non-OADS,/arxiv_data1/oa_pdf/b8/1e/jpmph-48-6-287.PMC4676642.pdf
"Key words:  Epidemiology, Self-rated health, Diabetes mellitus, Cohort studies, Health Examinees, Korea Received:  July 31, 2015 Accepted:  October 21, 2015 Corresponding author:  Daehee Kang, MD, PhD 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-740-8407, Fax:  +82-2-747-4830 E-mail:  dhkang@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Perceptions of health are currently considered to encom - pass both physical and psychological dimensions.",Non-OADS,/arxiv_data1/oa_pdf/b8/1e/jpmph-48-6-287.PMC4676642.pdf
Available from: http://www.oecd.org/els/health-sys - tems/Health-at-a-Glance-2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b8/1e/jpmph-48-6-287.PMC4676642.pdf
Available from: http://www.diabetes.or.kr/ temp/diabetes_factsheet_2013111.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b8/1e/jpmph-48-6-287.PMC4676642.pdf
"Journal of  Preventive Medicine  & Public Health 265 Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:265-270    •  http://dx.doi.org/10.3961/jpmph.15.066 Structural Factors of the Middle East Respiratory Syndrome  Coronavirus Outbreak as a Public Health Crisis in Korea  and Future Response Strategies Dong-Hyun Kim Department of Social and Preventive Medicine, Hallym University College of Medicine, Chuncheon, KoreaSpecial Article  The recent Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak has originated from a failure in the national quaran - tine system in the Republic of Korea as most basic role of protecting the safety and lives of its citizens.",Non-OADS,/arxiv_data1/oa_pdf/1f/36/jpmph-48-6-265.PMC4676643.pdf
"Key words:  Middle East respiratory syndrome coronavirus, Infectious disease outbreak, Public health, Healthcare systems, Korea Received:  November 18, 2015 Accepted:  November 21, 2015 Corresponding author:  Dong-Hyun Kim, MD, PhD 1 Hallimdaehak-gil, Chuncheon 24252, Korea Tel: +82-33-248-2660, Fax:  +82-33-256-1675 E-mail:  dhkims@hallym.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION From the occurrence of the index case on May 11, 2015 and  the final (186th) patient on July 4, to the announcement by  the public health authorities on July 28 that no risk of infec - tion remained, the Middle East respiratory syndrome corona -pISSN 1975-8375 eISSN 2233-4521  virus (MERS-CoV) epidemic in South Korea (hereafter Korea)  has been the largest mass outbreak of MERS-CoV outside the  Arabian Peninsula, after its first report in Saudi Arabia in 2012  [1].",Non-OADS,/arxiv_data1/oa_pdf/1f/36/jpmph-48-6-265.PMC4676643.pdf
Available from: http://ecdc.europa.eu/ en/publications/Publications/RRA-Middle-East-respiratory- syndrome-coronavirus-Korea.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/36/jpmph-48-6-265.PMC4676643.pdf
Available from: http://www.who.int/csr/ disease/coronavirus_infections/maps-charts/en.,Non-OADS,/arxiv_data1/oa_pdf/1f/36/jpmph-48-6-265.PMC4676643.pdf
Available from: http://www.who.int/csr/disease/coronavirus_ infections/MERS_CoV_investigation_guideline_Jul13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/36/jpmph-48-6-265.PMC4676643.pdf
"Journal of  Preventive Medicine  & Public Health 280 Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:280-286    •  http://dx.doi.org/10.3961/jpmph.15.054 Hormonal Replacement Therapy and the Risk of Lung  Cancer in Women: An Adaptive Meta-analysis of Cohort  Studies Jong-Myon Bae, Eun Hee Kim Department of Preventive Medicine, Jeju National University School of Medicine, Jeju, KoreaReview Objectives: Approximately 10% to 15% of lung cancer cases occur in never-smokers.",Non-OADS,/arxiv_data1/oa_pdf/71/03/jpmph-48-6-280.PMC4676644.pdf
"Key words:  Lung neoplasms, Risk factor, Hormone replacement therapy, Meta-analysis Received:  September 18, 2015 Accepted:  October 28, 2015 Corresponding author:  Jong-Myon Bae, MD, PhD 102 Jejudaehak-ro, Jeju 63243, Korea Tel: +82-64-755-5567, Fax:  +82-64-725-2593 E-mail:  jmbae@jejunu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION  Lung cancer is the largest cause of cancer deaths among  Koreans [1], and smoking is known to be the main cause of  lung cancer [2,3].",Non-OADS,/arxiv_data1/oa_pdf/71/03/jpmph-48-6-280.PMC4676644.pdf
"Journal of  Preventive Medicine  & Public Health 319 Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:319-329    •  http://dx.doi.org/10.3961/jpmph.15.057 Factors Determining Children’s Private Health Insurance  Enrolment and Healthcare Utilization Patterns: Evidence  From the 2008 to 2011 Health Panel Data Jawoon Shin1,2, Tae-Jin Lee2, Sung-il Cho2, Seung Ah Choe1,2 1Preventive Medicine Program, Graduate School of Public Health, Seoul National University, Seoul; 2Graduate School of Public Health, Seoul National  University, Seoul, Korea Original Article Objectives: Parental socioeconomic status (SES) exerts a substantial influence on children’s health.",Non-OADS,/arxiv_data1/oa_pdf/e8/2c/jpmph-48-6-319.PMC4676645.pdf
"Key words:  Child, Parents, Health status, Insurance, Social class Received:  October 5, 2015 Accepted:  November 16, 2015 Corresponding author:  Tae-Jin Lee, PhD 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea Tel: +82-2-880-2726, Fax:  +82-2-745-9104 E-mail:  tjlee@snu.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION It is a well-known fact that, of numerous factors influencing  health status, socioeconomic status (SES) exerts a considerable  impact [1,2].",Non-OADS,/arxiv_data1/oa_pdf/e8/2c/jpmph-48-6-319.PMC4676645.pdf
Available  from: http://www.oecd.org/els/health-systems/49818570.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/2c/jpmph-48-6-319.PMC4676645.pdf
"Journal of  Preventive Medicine  & Public Health 310 Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:310-318    •  http://dx.doi.org/10.3961/jpmph.15.001 The Relationship of Socioeconomic and Behavioral Risk  Factors With Trends of Overweight in Korea Jin Hee Shin1, Matthew E. Dupre1,2, Truls Østbye1,3, Gwen Murphy1, Mina Silberberg1 1Department of Community and Family Medicine, Duke University Medical Center, Durham, NC; 2Duke Clinical Research Institute, Duke University,  Durham, NC; 3Duke Global Health Institute, Duke University, Durham, NC, USAOriginal Article Objectives: Previous studies have shown that overweight (including obesity) has increased significantly in Korea in recent decades.",Non-OADS,/arxiv_data1/oa_pdf/c2/7a/jpmph-48-6-310.PMC4676646.pdf
"Key words:  Obesity, Overweight, Socioeconomic factors, Health Behavior, Trends, Korea Received:  January 7, 2015 Accepted:  November 9, 2015 Corresponding author:  Mina Silberberg, PhD Box 104006, Durham, NC 27710, USA Tel: +1-919-681-3185, Fax:  +1-919-613-6899 E-mail:  mina.silberberg@duke.edu This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION More than 1.4 billion individuals are currently overweight or  obese worldwide [1].",Non-OADS,/arxiv_data1/oa_pdf/c2/7a/jpmph-48-6-310.PMC4676646.pdf
Available from: http://www.who.int/ healthinfo/global_burden_disease/GlobalHealthRisks_re - port_Front.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c2/7a/jpmph-48-6-310.PMC4676646.pdf
Available from: http://kosis.kr/eng/statisticsList/ statisticsList_01List.jsp?vwcd =MT_ETITLE&parentId =I#SubCont.,OADS,/arxiv_data1/oa_pdf/c2/7a/jpmph-48-6-310.PMC4676646.pdf
"Journal of  Preventive Medicine  & Public Health 274 Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:274-276    •  http://dx.doi.org/10.3961/jpmph.15.064 Costly Lessons From the 2015 Middle East Respiratory  Syndrome Coronavirus Outbreak in Korea Sang-il Lee Department of Preventive Medicine, University of Ulsan College of Medicine, Seoul, KoreaPerspective  Since the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea (hereafter Korea) began on May 11, 2015, a total  of 186 persons have been infected by the MERS coronavirus, 38 of whom have died.",Non-OADS,/arxiv_data1/oa_pdf/0c/34/jpmph-48-6-274.PMC4676647.pdf
"Key words:  Middle East respiratory syndrome, Republic of Korea, Outbreak Received:  November 13, 2015 Accepted:  November 21, 2015 Corresponding author:  Sang-il Lee, MD, PhD 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-4284, Fax:  +82-2-477-2898 E-mail:  sleemd@amc.seoul.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Since the Middle East respiratory syndrome (MERS) out - break in the Republic of Korea (hereafter Korea) began on May  11, 2015, a total of 186 persons have been infected by the  MERS coronavirus (MERS-CoV), 38 of whom have died [1].",Non-OADS,/arxiv_data1/oa_pdf/0c/34/jpmph-48-6-274.PMC4676647.pdf
Avail - able from http://www.mers.go.kr/mers/html/jsp/main.jsp  (Korean).,Non-OADS,/arxiv_data1/oa_pdf/0c/34/jpmph-48-6-274.PMC4676647.pdf
Available from: http://www.who.int/ mediacentre/news/statements/2015/ihr-ec-mers/en/.,OADS,/arxiv_data1/oa_pdf/0c/34/jpmph-48-6-274.PMC4676647.pdf
Avail - able from: http://news.sciencemag.org/asiapacific/2015/06/ communication-gaps-fuel-mers-worries-korea.,Non-OADS,/arxiv_data1/oa_pdf/0c/34/jpmph-48-6-274.PMC4676647.pdf
Available from http://www.who.int/csr/disease/coronavi - rus_infections/MERS_home_care.pdf?ua =1.,Non-OADS,/arxiv_data1/oa_pdf/0c/34/jpmph-48-6-274.PMC4676647.pdf
Available  from https://en.wikipedia.org/wiki/Kaldor%E2%80%93Hicks_ef - ficiency.,Non-OADS,/arxiv_data1/oa_pdf/0c/34/jpmph-48-6-274.PMC4676647.pdf
"Copyright © 2015 Korean Society of Gastrointestinal Endoscopy   563CASE REPORT Clin Endosc  2015;48:563-565 http://dx.doi.org/10.5946/ce.2015.48.6.563 Print ISSN 2234-2400 / On-line ISSN 2234-2443 Utility of Over-the-Scope Clipping for Closure of a Persistent Post- Percutaneous Endoscopic Gastrostomy Fistula under Long-Term  Steroid Therapy Yoshihisa Arao, Yuichi Sato, Satoru Hashimoto, Hiroki Honda, Kazumi Yoko, Masaaki Takamura, Ken-ichi Mizuno and Masaaki  Kobayashi Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan A 50-year-old woman had a percutaneous endoscopic gastrostomy (PEG) tube placed after surgery for pharyngeal cancer.",Non-OADS,/arxiv_data1/oa_pdf/14/c0/ce-48-6-563.PMC4676652.pdf
"Following the removal of the en - doclips, the mucosa around the fistula was aspirated into the Received:  November 21, 2014     Revised:  January 9, 2015   Accepted:  January 27, 2015 Correspondence: Y oshihisa Arao Division of Gastroenterology and Hepatology, Niigata University Graduate  School of Medical and Dental Sciences, 1-757 Asahimachi, Niigata 951-8510,  Japan Tel: +81-25-227-2207, Fax: +81-25-227-0776, E-mail: yokkun0903@yahoo.co.jp cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/c0/ce-48-6-563.PMC4676652.pdf
"Copyright © 2015 Korean Society of Gastrointestinal Endoscopy   461COMMENTARY Clin Endosc  2015;48:461-463 http://dx.doi.org/10.5946/ce.2015.48.6.461 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Narrow Band Imaging as an Efficient and Economical Tool in  Diagnosing Colorectal Polyps Naoki Muguruma and Tetsuji Takayama Department of Gastroenterology and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan See “ A Randomized Controlled Clinical Study Comparing the Diagnostic Accuracy of the Histologic Prediction for Colorectal Polyps  Depending on the Use of Either Magnified or Nonmagnified Narrow Band Imaging” by Jin Joo Kim, Kyoung Sup Hong, Joo Sung  Kim and Hyun Chae Jung, on page 528-533.Open Access INTRODUCTION Colorectal cancer (CRC) is one of the leading causes of  cancer-related death in males and females of the Western  world, and is one of the most prevalent cancers amongst  populations (including within Asian countries).1 Screening  for CRC should be considered a medical priority in all health  systems and reduced mortality from CRC could be achieved  by improving the available screening methods.",Non-OADS,/arxiv_data1/oa_pdf/ff/ea/ce-48-6-461.PMC4676653.pdf
"The NICE classification is a simple  category classification consisting of three types (1, 2, and 3)  based on three separate characteristics: (1) lesion color, (2)  microvascular architecture, and (3) surface pattern.12 The in -Received:  November 9, 2015     Accepted:  November 11, 2015 Correspondence:  Naoki Muguruma Department of Gastroenterology and Oncology, Institute of Biomedical Sciences,  Tokushima University Graduate School, 3-18-15, Kuramoto-cho, Tokushima 770- 8503, Japan  Te l: +81-88-633-7124, Fax: +81-88-633-9235, E-mail:  muguruma.clin.med@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/ea/ce-48-6-461.PMC4676653.pdf
"Copyright © 2015 Korean Society of Gastrointestinal Endoscopy   511FOCUSED REVIEW SERIES: Image Enhanced Endoscopy Clin Endosc  2015;48:511-515 http://dx.doi.org/10.5946/ce.2015.48.6.511 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Usefulness and Future Prospects of Confocal Laser Endomicroscopy  for Gastric Premalignant and Malignant Lesions Sang Kil Lee Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine,  Seoul, Korea Confocal laser endomicroscopy (CLE) is a new technology enabling endoscopists to visualize tissue at the cellular level.",Non-OADS,/arxiv_data1/oa_pdf/18/dc/ce-48-6-511.PMC4676654.pdf
"Currently, the only method Received:  October 21, 2015     Revised:  November 16, 2015   Accepted:  November 17, 2015 Correspondence:  Sang Kil Lee Division of Gastroenterology, Department of Internal Medicine, Y onsei Institute  of Gastroenterology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seo - daemun-gu, Seoul 03722, Korea Tel: +82-2-2228-1996, Fax: +82-2-393-6884, E-mail:  sklee@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/dc/ce-48-6-511.PMC4676654.pdf
"Copyright © 2015 Korean Society of Gastrointestinal Endoscopy   491FOCUSED REVIEW SERIES: Image Enhanced Endoscopy Clin Endosc  2015;48:491-497 http://dx.doi.org/10.5946/ce.2015.48.6.491 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Polyp Detection, Characterization, and Management Using Narrow- Band Imaging with/without Magnification  Takahiro Utsumi, Mineo Iwatate, Wataru Sano, Hironori Sunakawa, Santa Hattori, Noriaki Hasuike and Yasushi Sano Gastrointestinal Center and Institution of Minimally Invasive Endoscopic Care (iMEC), Sano Hospital, Kobe, Japan Narrow-band imaging (NBI) is a new imaging technology that was developed in 2006 and has since spread worldwide.",Non-OADS,/arxiv_data1/oa_pdf/09/1c/ce-48-6-491.PMC4676655.pdf
"With the development  and dissemination of NBI, a number of randomized con - trolled trials for evaluating the efficacy of NBI in screening  colonoscopy have been conducted, and meta-analysis of these  trials has concluded that high-definition (HD) NBI colonos - copy is better than standard-definition WL colonoscopy and  equal to HD-WL colonoscopy for detection of colorectal  adenomas and polyps.8,9 Therefore, at present, screening colo -Received:  November 3, 2015     Accepted:  November 4, 2015 Correspondence:  Takahiro Utsumi Gastrointestinal Center and Institution of Minimally Invasive Endoscopic Care  (iMEC), Sano Hospital, 2-5-1 Shimizugaoka, Tarumi-ku, Kobe 655-0031, Japan  Tel: +81-78-785-1000, Fax: +81-78-785-0077, E-mail:  barce10_ronald@yahoo.co.jp cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/1c/ce-48-6-491.PMC4676655.pdf
"528  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy ORIGINAL ARTICLE Clin Endosc  2015;48:528-533 http://dx.doi.org/10.5946/ce.2015.48.6.528 Print ISSN 2234-2400 • On-line ISSN 2234-2443 A Randomized Controlled Clinical Study Comparing the Diagnostic  Accuracy of the Histologic Prediction for Colorectal Polyps  Depending on the Use of Either Magnified or Nonmagnified Narrow  Band Imaging Jin Joo Kim1, Kyoung Sup Hong2, Joo Sung Kim2 and Hyun Chae Jung2 1Division of Gastroenterology, Center for Health Promotion, Seoul National University Hospital, Seoul National University College of  Medicine, Seoul, 2Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea Background/Aims:  The aim of this study was to compare the diagnostic capabilities of narrow band imaging (NBI) colonoscopy with  and without optical magnification in differentiating neoplastic from nonneoplastic colorectal polyps.",Non-OADS,/arxiv_data1/oa_pdf/83/e0/ce-48-6-528.PMC4676656.pdf
"Ideally, the indication for colonoscopic polyp - ectomy should be limited to neoplastic polyps that have the Received:  January 2, 2015     Revised:  March 12, 2015   Accepted:  March 13, 2015 Correspondence: Kyoung Sup Hong Department of Internal Medicine, Seoul National University Hospital, Seoul Na - tional University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080,  Korea Tel: +82-2-2072-0360, Fax: +82-2-762-9662, E-mail: kshong1@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/e0/ce-48-6-528.PMC4676656.pdf
"Copyright © 2015 Korean Society of Gastrointestinal Endoscopy   503FOCUSED REVIEW SERIES: Image Enhanced Endoscopy Clin Endosc  2015;48:503-510 http://dx.doi.org/10.5946/ce.2015.48.6.503 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Advanced Imaging Technology Other than Narrow Band Imaging Jun-Hyung Cho  Digestive Disease Center, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea  To improve the detection rate of gastrointestinal tumors, image-enhanced endoscopy has been widely used during screening and  surveillance endoscopy in Korea.",Non-OADS,/arxiv_data1/oa_pdf/bf/e5/ce-48-6-503.PMC4676657.pdf
"For superficial esophageal  carcinoma, AFI was less useful than NBI and Lugol chromo - endoscopy.4 In contrast, AFI could detect 79% of superficial  esophageal SCCs, compared to only 51% by white light endos - copy (WLE) ( p<0.05).5 Received:  October 12, 2015     Revised:  November 4, 2015   Accepted:  November 11, 2015 Correspondence:  Jun-Hyung Cho  Digestive Disease Center, Soonchunhyang University Hospital, Soonchunhyang  University College of Medicine, 59 Daesagwan-ro, Y ongsan-gu, Seoul 04401, Korea Tel: +82-2-709-9202, Fax: +82-2-709-9696, E-mail:  chojhmd@naver.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/e5/ce-48-6-503.PMC4676657.pdf
"476  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy FOCUSED REVIEW SERIES: Image Enhanced Endoscopy Clin Endosc  2015;48:476-480 http://dx.doi.org/10.5946/ce.2015.48.6.476 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Narrow Band Imaging: Technology Basis and Research and  Development History Kazuhiro Gono Endoscopic Technology Department, OLYMPUS Corporation, Tokyo, Japan The first launch of narrow band imaging (NBI) was in 2005.",Non-OADS,/arxiv_data1/oa_pdf/69/81/ce-48-6-476.PMC4676658.pdf
"A different wavelength is visually perceived as Received:  November 4, 2015     Revised:  November 17, 2015   Accepted:  November 18, 2015 Correspondence:  Kazuhiro Gono Endoscopic Technology Department, OLYMPUS Corporation, Shinjuku Mono - lith, 3-1 Nishi-Shinjuku 2-chome, Shinjuku-ku, Tokyo 163-0914, Japan Tel: +81-3-3340-2111, Fax: +82-2-958-8200, E-mail:  k_gono@ot.olympus.co.jp cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/81/ce-48-6-476.PMC4676658.pdf
"522  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy ORIGINAL ARTICLE Clin Endosc  2015;48:522-527 http://dx.doi.org/10.5946/ce.2015.48.6.522 Print ISSN 2234-2400 • On-line ISSN 2234-2443 The AIMS65 Score Is a Useful Predictor of Mortality in Patients with  Nonvariceal Upper Gastrointestinal Bleeding: Urgent Endoscopy in  Patients with High AIMS65 Scores Sun Wook Park, Young Wook Song, Dae Hyun Tak, Byung Moo Ahn, Sun Hyung Kang, Hee Seok Moon, Jae Kyu Sung and   Hyun Yong Jeong Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National  University School of Medicine, Daejeon, Korea Background/Aims:  To validate the AIMS65 score for predicting mortality of patients with nonvariceal upper gastrointestinal bleeding  and to evaluate the effectiveness of urgent (<8 hours) endoscopic procedures in patients with high AIMS65 scores.",Non-OADS,/arxiv_data1/oa_pdf/01/78/ce-48-6-522.PMC4676659.pdf
"The AIMS65 scale is a simple and accurate risk  assessment score that has been shown in some studies to  pre- dict in-hospital mortality, length of hospitalization, and treat - ment cost in patients with acute upper GI bleeding.13-16 An  AIMS65 score of 2 has been indicated as a cut-off value for  mortality risk.13 However, some studies have suggested that Received:  January 28, 2015     Revised:  April 21, 2015   Accepted:  April 29, 2015 Correspondence: Hee Seok Moon Division of Gastroenterology and Hepatology, Department of Internal Medicine,  Chungnam National University Hospital, Chungnam National University School  of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 35015, Korea Tel: +82-42-280-7164, Fax: +82-42-253-3287, E-mail: mhs1357@cnuh.co.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/78/ce-48-6-522.PMC4676659.pdf
"576  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy CASE REPORT Clin Endosc  2015;48:576-578 http://dx.doi.org/10.5946/ce.2015.48.6.576 Print ISSN 2234-2400 / On-line ISSN 2234-2443 Successful Palliation of a Malignant Cologastric Fistula with a  Covered Self-Expanding Metal Stent Mathilde Therese Winther Breitenbauch and Anders Tøttrup Department of Surgical Gastroenterology, Aarhus University Hospital, Aarhus, Denmark When patients present with malignant cologastric fistulas, the tumor stage is often advanced and management is only palliative.",Non-OADS,/arxiv_data1/oa_pdf/47/9d/ce-48-6-576.PMC4676660.pdf
"A covered COMVI enteral colonic stent Received:  October 15, 2014     Revised:  March 4, 2015   Accepted:  March 25, 2015 Correspondence: Mathilde Therese Winther Breitenbauch Department of Surgical Gastroenterology, Aarhus University Hospital,  Tage-Hansens Gade 2 DK-8000 Aarhus, Denmark Tel: +45-23390689, Fax: +45-78463779, E-mail: mathbrei@rm.dk cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/9d/ce-48-6-576.PMC4676660.pdf
"516  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy ORIGINAL ARTICLE Clin Endosc  2015;48:516-521 http://dx.doi.org/10.5946/ce.2015.48.6.516 Print ISSN 2234-2400 • On-line ISSN 2234-2443 An Ultrathin Endoscope with a 2.4-mm Working Channel Shortens  the Esophagogastroduodenoscopy Time by Shortening the Suction  Time Satoshi Shinozaki1,2, Yoshimasa Miura2, Yuji Ino2, Kenjiro Shinozaki1, Alan Kawarai Lefor3 and Hironori Yamamoto2 1Department of Gastroenterology, Shinozaki Medical Clinic, Tochigi, 2Division of Gastroenterology, Department of Medicine, 3Department of  Surgery, Jichi Medical University School of Medicine, Shimotsuke, Japan  Background/Aims:  Poor suction ability through a narrow working channel prolongs esophagogastroduodenoscopy (EGD).",Non-OADS,/arxiv_data1/oa_pdf/3e/78/ce-48-6-516.PMC4676661.pdf
"One of the major limitations of using an existing ultrathin  endoscope is the narrow working channel (2.0 mm) that leads  to poor suction ability and the inability to perform therapeu -Received:  January 8, 2015     Revised:  April 15, 2015   Accepted:  April 15, 2015 Correspondence: Hironori Yamamoto Division of Gastroenterology, Department of Medicine, Jichi Medical University  School of Medicine, 3311-1 Y akushiji, Shimotsuke, Tochigi 329-0498, Japan Tel: +81-285-58-7347, Fax: +81-285-40-6598, E-mail: ireef@jichi.ac.jp cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/78/ce-48-6-516.PMC4676661.pdf
"542  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy ORIGINAL ARTICLE Clin Endosc  2015;48:542-548 http://dx.doi.org/10.5946/ce.2015.48.6.542 Print ISSN 2234-2400 • On-line ISSN 2234-2443 The Clinical Usefulness of Simultaneous Placement of Double  Endoscopic Nasobiliary Biliary Drainage Hong Jun Kim1, Sung Koo Lee2, Choong Heon Ryu3, Do Hyun Park2, Sang Soo Lee2, Dong Wan Seo2 and Myung-Hwan Kim2 1Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, 2Department of Internal Medicine, Asan  Medical Center, University of Ulsan College of Medicine, Seoul, 3Department of Internal Medicine, Hanmaeum Hospital, Jeju, Korea  Background/Aims:  To evaluate the technical feasibility and clinical efficacy of double endoscopic nasobiliary drainage (ENBD) as a  new method of draining multiple bile duct obstructions.",Non-OADS,/arxiv_data1/oa_pdf/1d/b8/ce-48-6-542.PMC4676662.pdf
"This procedure was performed to drain multiseg -Received:  February 26, 2015     Accepted:  May 28, 2015 Correspondence:  Sung Koo Lee Department of Internal Medicine, Asan Medical Center, University of Ulsan  College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3186, Fax: +82-2-3010-8043, E-mail:  sklee@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/b8/ce-48-6-542.PMC4676662.pdf
Copyright © 2015 Korean Society of Gastrointestinal Endoscopy   459COMMENTARY Clin Endosc  2015;48:459-460 http://dx.doi.org/10.5946/ce.2015.48.6.459 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Can AIMS65 Save the Endoscopists from Midnight Calls?,Non-OADS,/arxiv_data1/oa_pdf/d4/c6/ce-48-6-459.PMC4676663.pdf
"However, patients in the urgent endoscopy group also had Received:  November 4, 2015     Revised:  November 6, 2015   Accepted:  November 7, 2015 Correspondence:  Byung-Wook Kim Division of Gastroenterology, Department of Internal Medicine, Incheon  St. Mary’s Hospital, College of Medicine, The Catholic University of Korea,   56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Korea Tel: +82-32-280-5051, Fax: +82-32-280-5082, E-mail:  gastro@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/c6/ce-48-6-459.PMC4676663.pdf
"Copyright © 2015 Korean Society of Gastrointestinal Endoscopy   481FOCUSED REVIEW SERIES: Image Enhanced Endoscopy Clin Endosc  2015;48:481-490 http://dx.doi.org/10.5946/ce.2015.48.6.481 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Clinical Application of Magnifying Endoscopy with Narrow-Band  Imaging in the Stomach Kenshi Yao Department of Endoscopy, Fukuoka University Chikushi Hospital, Chikushino, Japan Magnifying endoscopy with narrow-band imaging (M-NBI) can visualize superficial microanatomies in the stomach.",Non-OADS,/arxiv_data1/oa_pdf/f1/40/ce-48-6-481.PMC4676664.pdf
"The hood is soft enough Received:  November 3, 2015     Revised:  November 11, 2015   Accepted:  November 13, 2015 Correspondence:  Kenshi Y ao Department of Endoscopy, Fukuoka University Chikushi Hospital, 1-1-1   Zokumyoin, Chikushino 818-8502, Japan Tel: +81-92-921-1011, Fax: +81-92-921-1011, E-mail:  yao@fukuoka-u.ac.jp cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution, Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/40/ce-48-6-481.PMC4676664.pdf
http://dx.doi.org/10.1111/den.12519.,Non-OADS,/arxiv_data1/oa_pdf/f1/40/ce-48-6-481.PMC4676664.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/40/ce-48-6-481.PMC4676664.pdf
"498  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy FOCUSED REVIEW SERIES: Image Enhanced Endoscopy Clin Endosc  2015;48:498-502 http://dx.doi.org/10.5946/ce.2015.48.6.498 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Advanced Imaging Technology in Biliary Tract Diseases:   Narrow-Band Imaging of the Bile Duct Hyun Jong Choi, Jong Ho Moon and Yun Nah Lee Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University School of Medicine,   Bucheon, Korea Newly introduced direct peroral cholangioscopy and the development of video choledochoscopes have enabled more defined  observation of bile duct mucosal lesions with clearer images.",Non-OADS,/arxiv_data1/oa_pdf/36/b6/ce-48-6-498.PMC4676665.pdf
"Direct POC also enables image-enhanced endoscopy such as Received:  October 9, 2015     Revised:  November 4, 2015   Accepted:  November 4, 2015 Correspondence:  Jong Ho Moon Digestive Disease Center and Research Institute, Soonchunhyang University Bu - cheon Hospital, Soonchunhyang University School of Medicine, 170 Jomaru-ro,  Wonmi-gu, Bucheon 14584, Korea Tel: +82-32-621-5094, Fax: +82-32-621-5080, E-mail:  jhmoon@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/b6/ce-48-6-498.PMC4676665.pdf
http://dx.doi.org/10.1016/j.gie.2015.08.021.,OADS,/arxiv_data1/oa_pdf/36/b6/ce-48-6-498.PMC4676665.pdf
"570  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy CASE REPORT Clin Endosc  2015;48:570-575 http://dx.doi.org/10.5946/ce.2015.48.6.570 Print ISSN 2234-2400 / On-line ISSN 2234-2443 Unexpected Delayed Colon Perforation after the Endoscopic  Submucosal Dissection with Snaring of a Laterally Spreading Tumor Young Bo Ko, Jeong-Mi Lee, Wan Soo Kim, Min Seob Kwak, Ji Wan Lee, Dong Yeol Shin, Dong-Hoon Yang and Jeong-Sik Byeon Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Colonic perforation may occur as a complication of diagnostic and therapeutic colonoscopy.",Non-OADS,/arxiv_data1/oa_pdf/19/33/ce-48-6-570.PMC4676666.pdf
"A sub - mucosal cushion was created with a saline injection, and no Received:  April 3, 2015     Revised:  May 11, 2015   Accepted:  May 15, 2015 Correspondence: Jeong-Sik Byeon Department of Gastroenterology, Asan Medical Center, University of Ulsan Col - lege of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea  Tel: +82-2-3010-3905, Fax: +82-2-476-0824, E-mail: jsbyeon@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/33/ce-48-6-570.PMC4676666.pdf
"534  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy ORIGINAL ARTICLE Clin Endosc  2015;48:534-541 http://dx.doi.org/10.5946/ce.2015.48.6.534 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Endoluminal Closure of Colon Perforation with Endoscopic Band  Ligation: Technical Feasibility and Safety in an In Vivo  Canine Model Joung-Ho Han1,*, Myounghwan Kim2,*, Tae Hoon Lee3, Hyun Kim1, Yunho Jung3, Seon Mee Park1, Heebok Chae1, Seijin Youn1,   Ji Yun Shin4, In-Kwang Lee4, Tae Soo Lee4 and Seok Hwa Choi2 1Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, 2Department of Veterinary Surgery,  Chungbuk National University College of Veterinary Medicine, Cheongju, 3Department of Internal Medicine, Soonchunhyang University  Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, 4Department of Biomedical Engineering, Chungbuk National  University College of Medicine, Cheongju, Korea Background/Aims:  Endoscopic band ligation (EBL) is an accepted method in the management of variceal bleeding; however, there is  little evidence on the safety and feasibility of EBL for the closure of bowel perforation.",Non-OADS,/arxiv_data1/oa_pdf/00/79/ce-48-6-534.PMC4676667.pdf
"cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/79/ce-48-6-534.PMC4676667.pdf
"Copyright © 2015 Korean Society of Gastrointestinal Endoscopy   579CASE REPORT Clin Endosc  2015;48:579-582 http://dx.doi.org/10.5946/ce.2015.48.6.579 Print ISSN 2234-2400 / On-line ISSN 2234-2443 Endoscopic Extraction of Biliary Fascioliasis Diagnosed Using  Intraductal Ultrasonography in a Patient with Acute Cholangitis Ji Su Ha, Hyun Jong Choi, Jong Ho Moon, Yun Nah Lee, Jae Woong Tae, Moon Han Choi, Tae Hoon Lee and Sang-Woo Cha  Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University School of Medicine, Bucheon  and Seoul, Korea Fasciola hepatica  infection may result in biliary obstruction with or without cholangitis in the chronic biliary phase.",Non-OADS,/arxiv_data1/oa_pdf/a9/68/ce-48-6-579.PMC4676668.pdf
"He had no Received:  February 4, 2015     Revised:  March 14, 2015   Accepted:  March 15, 2015 Correspondence: Hyun Jong Choi Soonchunhyang University School of Medicine, Digestive Disease Center, Soon - chunhyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon  14584, Korea Tel: +82-32-621-5211, Fax: +82-32-621-5080, E-mail: joseph@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/68/ce-48-6-579.PMC4676668.pdf
"2B, Supplementary Video 1 [available on - line at http://www.e-ce.org/]).",Non-OADS,/arxiv_data1/oa_pdf/a9/68/ce-48-6-579.PMC4676668.pdf
"2C, Supplementary Video 2 [available online  at http://www.e-ce.org/]).",Non-OADS,/arxiv_data1/oa_pdf/a9/68/ce-48-6-579.PMC4676668.pdf
464  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy COMMENTARY Clin Endosc  2015;48:464-465 http://dx.doi.org/10.5946/ce.2015.48.6.464 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Can Endoscopic Nasobiliary Drainage Involving Two Catheters Be  Used to Treat Various Conditions?,Non-OADS,/arxiv_data1/oa_pdf/90/97/ce-48-6-464.PMC4676669.pdf
"In fact, only three patients were included in the Mirizzi  syndrome group, and the p-value was 0.312, despite a major Received:  November 12, 2015     Revised:  November 17, 2015   Accepted:  November 17, 2015 Correspondence:  Ho Gak Kim Department of Internal Medicine, Catholic University of Daegu School of Medi - cine, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 42472, Korea  Te l: +82-53-650-4041, Fax: +82-53-624-3281, E-mail:  hgkim@cu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/97/ce-48-6-464.PMC4676669.pdf
"558  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy CASE REPORT Clin Endosc  2015;48:558-562 http://dx.doi.org/10.5946/ce.2015.48.6.558 Print ISSN 2234-2400 / On-line ISSN 2234-2443 Eosinophilic Gastritis Presenting as Tissue Necrosis Yong Min Jo1, Jin Seok Jang1, Seung Hee Han1, Sang Hyun Kang1, Woo Jae Kim1 and Jin Sook Jeong2 Departments of 1Internal Medicine and 2Pathology, Dong-A University College of Medicine, Busan, Korea  Eosinophilic gastroenteritis is very rare disorder that is characterized by eosinophilic infiltration of the gastrointestinal tract in the  absence of any definite causes of eosinophilia.",Non-OADS,/arxiv_data1/oa_pdf/56/a8/ce-48-6-558.PMC4676670.pdf
"The tests for viral markers included hepatitis A, B, and C  virus and human immunodeficiency virus; those for autoim -Received:  November 6, 2014     Revised:  May 8, 2015   Accepted:  May 8, 2015 Correspondence: Jin Seok Jang Department of Internal Medicine, Dong-A University College of Medicine, 26  Daesingongwon-ro, Seo-gu, Busan 49201, Korea Tel: +82-51-240-5627, Fax: +82-51-240-2087, E-mail: jsjang@dau.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/a8/ce-48-6-558.PMC4676670.pdf
"Copyright © 2015 Korean Society of Gastrointestinal Endoscopy   549CASE REPORT Clin Endosc  2015;48:549-552 http://dx.doi.org/10.5946/ce.2015.48.6.549 Print ISSN 2234-2400 / On-line ISSN 2234-2443 Esophageal Lymphoepithelioma-Like Carcinoma with Unique  Daisy-Like Appearance Sehmus Olmez1, Alper Can2, Alpaslan Yavuz3, Umit Haluk İliklerden4 and Gulay Bulut5 Departments of 1Gastroenterology, 2Medical Oncology, 3Radiology, 4Surgery, and 5Pathology, Yuzuncu Yil University Medical Faculty, Van,  Turkey Due to differences in prognosis and management, it is important to subclassify esophageal carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/e0/c6/ce-48-6-549.PMC4676671.pdf
"Sclerotherapy (adrenalin 4 mL 1/10,000) was administered in Received:  November 9, 2014     Accepted:  February 18, 2015 Correspondence: Sehmus Olmez Department of Gastroenterology, Yuzuncu Yil University Medical Faculty, Van,  Turkey Te l: +90-432-216-7325, Fax: +90-432-216-7325, E-mail: drsehmusolmez@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/c6/ce-48-6-549.PMC4676671.pdf
"566  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy CASE REPORT Clin Endosc  2015;48:566-569 http://dx.doi.org/10.5946/ce.2015.48.6.566 Print ISSN 2234-2400 / On-line ISSN 2234-2443 Delayed Pneumoperitoneum and Acute Pulmonary Edema  Secondary to Acute Gastric Dilatation  Jae Yun Ahn and Jong Kun Kim Department of Emergency Medicine, Kyungpook National University School of Medicine, Daegu, Korea Pneumoperitoneum caused by acute gastric dilatation (AGD) is a very rare complication.",Non-OADS,/arxiv_data1/oa_pdf/e0/76/ce-48-6-566.PMC4676672.pdf
"She was immediately trans -Received:  January 2, 2015     Accepted:  February 3, 2015 Correspondence: Jong Kun Kim Department of Emergency Medicine, Kyungpook National University School of  Medicine, 130 Dongdeok-ro, Jung-gu, Daegu 41944, Korea Tel: +82-53-200-6400, Fax: +82-53-200-2109, E-mail: kim7155@knu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/76/ce-48-6-566.PMC4676672.pdf
"Copyright © 2015 Korean Society of Gastrointestinal Endoscopy   553CASE REPORT Clin Endosc  2015;48:553-557 http://dx.doi.org/10.5946/ce.2015.48.6.553 Print ISSN 2234-2400 / On-line ISSN 2234-2443 Endoscopic Submucosal Dissection for Recurrent or Residual  Superficial Esophageal Cancer after Chemoradiotherapy: Two Cases Changhyeok Hwang1, Young Hoon Youn1, Sung-eun Choi2, Young Hak Jung1, Hae Yeul Park1, Jae Jun Park1, Jie Hyun Kim1 and  Hyojin Park1 Departments of 1Internal Medicine and 2Diagnostic Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul,  Korea We report two cases of endoscopic submucosal dissection (ESD) for recurrent or residual esophageal squamous cell carcinoma (ESCC)  lesions after chemoradiotherapy for advanced esophageal cancer.",Non-OADS,/arxiv_data1/oa_pdf/ef/db/ce-48-6-553.PMC4676673.pdf
"Computed tomography (CT) and positron emission tomog - raphy (PET) showed subcarinal lymph node metastasis; how -Received:  November 25, 2014     Revised:  January 24, 2015   Accepted:  March 15, 2015 Correspondence: Y oung Hoon Y oun Department of Internal Medicine, Gangnam Severance Hospital, Y onsei Univer - sity College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea Tel: +82-2-2019-3453, Fax: +82-2-3463-3882, E-mail: DRYOUN@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/db/ce-48-6-553.PMC4676673.pdf
"466  Copyright © 2015 Korean Society of Gastrointestinal Endoscopy FOCUSED REVIEW SERIES: Image Enhanced Endoscopy Clin Endosc  2015;48:466-475 http://dx.doi.org/10.5946/ce.2015.48.6.466 Print ISSN 2234-2400 • On-line ISSN 2234-2443 The Past, Present, and Future of Image-Enhanced Endoscopy Jae-Young Jang Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea Despite the remarkable progress recently made to enhance the resolution of white-light endoscopy, detection, and diagnosis  of premalignant lesions, such as adenomas and subtle early-stage cancers, remains a great challenge.",Non-OADS,/arxiv_data1/oa_pdf/07/4c/ce-48-6-466.PMC4676674.pdf
"The aim of this article is to  give a brief history of the development endoscopy systems, Received:  October 29, 2015     Accepted:  November 7, 2015 Correspondence:  Jae-Young Jang Division of Gastroenterology, Department of Internal Medicine, Kyung Hee Uni - versity School of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447,  Korea  Tel: +82-2-958-8150, Fax: +82-2-958-8200, E-mail:  jyjang@khu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/4c/ce-48-6-466.PMC4676674.pdf
2014 http://data.uis.unesco.org/Index.aspx?queryid=192 .,Non-OADS,/arxiv_data1/oa_pdf/f8/69/nihms709421.PMC4676715.pdf
http://www.hptn.org/research_studies/hptn068.asp .,Non-OADS,/arxiv_data1/oa_pdf/f8/69/nihms709421.PMC4676715.pdf
"Data analysis was performed using SPM8 (http://www.fil.ion.ucl.ac.uk/spm/) and the CONN-fMRI functional connectivity toolbox, version 13.p (http://www.nitrc.",OADS,/arxiv_data1/oa_pdf/d7/54/NEUROLOGY2015659672.PMC4676759.pdf
"To provide an additional methodo- logic control, we included a complementary data-driven spatial independent component analysis18to decompose data into statistically independent spatial and temporal components19 (http://icatb.sourceforge.net).",OADS,/arxiv_data1/oa_pdf/d7/54/NEUROLOGY2015659672.PMC4676759.pdf
A standard template of the default- mode network (DMN) was used to identify network componentson a subject-by-subject basis.20SPM8 (http://www.fil.ion.ucl.ac.,OADS,/arxiv_data1/oa_pdf/d7/54/NEUROLOGY2015659672.PMC4676759.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source,provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7b/03/40122_2015_Article_40.PMC4676765.pdf
Available from URL: https://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/7b/03/40122_2015_Article_40.PMC4676765.pdf
Available from URL: http://www.salute.gov.,Non-OADS,/arxiv_data1/oa_pdf/7b/03/40122_2015_Article_40.PMC4676765.pdf
Available from URL:http://www.snlg-iss.it/cms/ﬁles/LG_SIP_febbre.pdf .,OADS,/arxiv_data1/oa_pdf/7b/03/40122_2015_Article_40.PMC4676765.pdf
Available from URL: http://www.sinpia.eu/atom/allegato/153.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7b/03/40122_2015_Article_40.PMC4676765.pdf
Available at URL: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2009/09/WC500003782.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7b/03/40122_2015_Article_40.PMC4676765.pdf
Available from URL: http://www.who.int/ medicines/publications/essentialmedicines/4th_ EMLc_FINAL_web_8Jul13.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7b/03/40122_2015_Article_40.PMC4676765.pdf
This is an open access articledistributed under the terms of the Creative CommonsAttribution License ( http://creativecommons.org/licenses/ by/2.0 )Pain Ther (2015) 4:135–147 141,Non-OADS,/arxiv_data1/oa_pdf/d5/54/40122_2015_Article_39.PMC4676766.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, pro- vide a link to the Creative Commons license,and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d5/54/40122_2015_Article_39.PMC4676766.pdf
2015. http://www.neurology.org/content/80/8/697/reply# neurology_el;64113 .,Non-OADS,/arxiv_data1/oa_pdf/d5/54/40122_2015_Article_39.PMC4676766.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/90/f5/40122_2015_Article_38.PMC4676767.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/79/c3/40122_2015_Article_41.PMC4676768.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c0/84/40266_2015_Article_319.PMC4676788.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), whicheGFR Improvement in Statin-Treated Older Patients 1063",Non-OADS,/arxiv_data1/oa_pdf/77/c8/40266_2015_Article_328.PMC4676790.pdf
http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM290774.pdf .,Non-OADS,/arxiv_data1/oa_pdf/77/c8/40266_2015_Article_328.PMC4676790.pdf
Available at: http://www.healthypeople.gov/2020/topics- objectives/topic/immunization-and-infectious-diseases/objectives#4658 .,Non-OADS,/arxiv_data1/oa_pdf/e8/22/ofv165.PMC4676800.pdf
Available at: http://www.ncbi.nlm.nih.gov/books/NBK241377/ .,Non-OADS,/arxiv_data1/oa_pdf/e8/22/ofv165.PMC4676800.pdf
Available at: http://www.cdc.gov/hepatitis/pdfs/iom- hepatitisandlivercancerreport.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a6/01/ofv162.PMC4676801.pdf
2014 ;2 4 .A v a i l a b l ea t : http://www.cdc.gov/hiv/pdf/statistics_2012_ HIV_Surveillance_Report_vol_24.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a6/01/ofv162.PMC4676801.pdf
Available at: http://ecdc.europa.eu/en/ publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51- 4aed-4d32-b960-af70113dbb90&ID=971 .,Non-OADS,/arxiv_data1/oa_pdf/a6/01/ofv162.PMC4676801.pdf
Available at: http://www.sante.gouv.fr/IMG/pdf/Rapport_Morlat_2013_Mise_en_ ligne.pdf .2013 .,Non-OADS,/arxiv_data1/oa_pdf/a6/01/ofv162.PMC4676801.pdf
Available at:http://www.afef.asso.fr/rc/org/afef/nws/news/2015/20150717-114851- 940/src/nws_fulltext/fr/french%20report%20dhumeaux.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a6/01/ofv162.PMC4676801.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/7f/kev267.PMC4676905.pdf
ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 2 September 2014] 2014.,Non-OADS,/arxiv_data1/oa_pdf/2c/1a/CD010994.PMC4676908.pdf
"http://www.jhpiego.org/files/ BMNCrevmanEN.pdf (JHPIEGO/MNH Program: Baltimore, MD) 2004.",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/CD010994.PMC4676908.pdf
"http://www.un.org/millenniumgoals/ [accessed 1 Sept 2015] 2013. van Eijk 2006 van/uni00A0Eijk/uni00A0AM, Bles/uni00A0HM, Odhiambo/uni00A0F, Ayisi/uni00A0JG, Blokland/uni00A0IE, Rosen/uni00A0DH, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/CD010994.PMC4676908.pdf
http://www.who.int/healthinfo/statistics/ indmaternalmortality/en/ [accessed 1 Sept 2015].,OADS,/arxiv_data1/oa_pdf/2c/1a/CD010994.PMC4676908.pdf
http://www.who.int/ reproductivehealth/publications/maternal_   perinatal_   health/ rhr_  11_   12/en/ [accessed 1 Sept 2015] 2011. WHO 2012b WHO.,Non-OADS,/arxiv_data1/oa_pdf/2c/1a/CD010994.PMC4676908.pdf
http://www.who.int/malaria/mpac/ sep2012/iptp_  sp_   erg_   meeting_   report_   july2012.pdf [accessed 1 Sept 2015] 2012. WHO 2012c WHO.,Non-OADS,/arxiv_data1/oa_pdf/2c/1a/CD010994.PMC4676908.pdf
http://www.who.int/mediacentre/ factsheets/fs348/en/ [accessed 1 Sept 2015] 2012. WHO 2013 WHO.,OADS,/arxiv_data1/oa_pdf/2c/1a/CD010994.PMC4676908.pdf
"http://www.who.int/gho/maternal_   health/reproductive_   health/antenatal_   care_   text/en/ [accessed 1 Sept 2015] 2013. WHO 2013a WHO, UNICEF, UNFPA, The World/uni00A0Bank, the United Nations Population/uni00A0Division.",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/CD010994.PMC4676908.pdf
Trends in Maternal Mortality: 1990 to 2013. http://www.who.int/reproductivehealth/publications/ Health system and community level interventions for improving antenatal care coverage and health outcomes (Review) Copyright © 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/1a/CD010994.PMC4676908.pdf
DOI: http://dx.doi.org/10.5888/ pcd10.120156 [Epub ahead of print]15.,Non-OADS,/arxiv_data1/oa_pdf/31/79/cob0005-0154.PMC4676909.pdf
URL http://www.choosemyplate.gov (accessedMarch 2014).22.,Non-OADS,/arxiv_data1/oa_pdf/31/79/cob0005-0154.PMC4676909.pdf
Available from URL:http://www.fda.gov/Drugs/DrugSafety/ucm376389.htm.Accessed 4 November2014.,Non-OADS,/arxiv_data1/oa_pdf/27/60/dom0017-0949.PMC4676911.pdf
"Brussels: International Diabetes Federation, 0000.Available from URL: http://www.idf.org/guidelines/type-2-diabetes.",Non-OADS,/arxiv_data1/oa_pdf/11/aa/dom0017-0675.PMC4676912.pdf
AvailablefromURL:http://www.jds.or.jp/common/fckeditor/editor/filemanager/connectors/php/transfer.php?file =/uid000025_54726561746D656E745F4775 6964655F666F725F44696162657465735F323031322D323031332E706466.Accessed10June2014.,OADS,/arxiv_data1/oa_pdf/11/aa/dom0017-0675.PMC4676912.pdf
Available from URL:http://www.safetyandquality.gov.au/wp-content/uploads/2012/04/Australian-SandQ-Framework1.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/2a/ba/emm0027-0216.PMC4676924.pdf
Available from URL: http://www.nhpa.gov.au/internet/nhpa/publishing.nsf/Content/PAF 9.,Non-OADS,/arxiv_data1/oa_pdf/2a/ba/emm0027-0216.PMC4676924.pdf
]Available from URL: http://stat.abs.gov.au/itt/r.jsp?databyregion#/ 11.,OADS,/arxiv_data1/oa_pdf/2a/ba/emm0027-0216.PMC4676924.pdf
Available atURL: http://www.health.qld.gov.au/publications/medai-report/ﬁnal_medai_report.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/2a/ba/emm0027-0216.PMC4676924.pdf
Available from URL:https://www.hamilton.ca / NR /rdonlyres/51175727-E619-43FF-8B1F-9BD65DB60863/0/Mar25_5_3__CS13014__Dedicated_Ofﬂoad_Nurses_t.pdf 27.,Non-OADS,/arxiv_data1/oa_pdf/2a/ba/emm0027-0216.PMC4676924.pdf
]Available from URL: http://www.anzsgm.org/ManagementofOlderPatientsintheEmergencyDepartment.pdf.pdf 28.,Non-OADS,/arxiv_data1/oa_pdf/2a/ba/emm0027-0216.PMC4676924.pdf
http://www.cdc.gov/diabetes/pubs/ pdf/ndfs_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/ce/dmrr0031-0707.PMC4676929.pdf
Diabetes report card 2012.http://www.cdc.gov/diabetes/pubs/pdf/diabetesreportcard.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/ce/dmrr0031-0707.PMC4676929.pdf
Natl Vital Stat Rep 2013; 62. http://www.cdc.gov/nchs/data/nvsr/ nvsr62/nvsr62_01.pdf.,OADS,/arxiv_data1/oa_pdf/86/ce/dmrr0031-0707.PMC4676929.pdf
"June 10, 2014. http://www.cdc.gov/media/releases/ 2014/p0610-diabetes-report.html.",Non-OADS,/arxiv_data1/oa_pdf/86/ce/dmrr0031-0707.PMC4676929.pdf
"Healthcare cost and utilization project statistical brief #102, December 2010. https://www.hcup-us.Impact and Cost of Diabetes in Pregnancy 715 © 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/86/ce/dmrr0031-0707.PMC4676929.pdf
http://diabetes.niddk.nih.gov/dm/pubs/ america/pdf/chapter36.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/ce/dmrr0031-0707.PMC4676929.pdf
"Mutations of PROM1  have been associated with a  variety of retinal phenotypes, including autosomal recessive  retinitis pigmentosa with macular degeneration (RP41), auto - somal dominant Stargardt-like macular dystrophy (STGD4), Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > Received 10 September 2015 | Accepted 6 December 2015 | Published 8 December 2015© 2015 Molecular Vision 1295An intronic deletion in the PROM1  gene leads to autosomal  recessive cone-rod dystrophy Osnat Eidinger,1 Rina Leibu,2 Hadas Newman,3,4 Leah Rizel,1 Ido Perlman,1,3 Tamar Ben-Yosef1 1Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; 2Alberto Moscona  Department of Ophthalmology, Rambam Health Care Center, Haifa, Israel; 3Department of Ophthalmology, Tel-Aviv Souraski  Medical Center, Tel-Aviv, Israel; 4Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Purpose:  To investigate the genetic basis for autosomal recessive cone-rod dystrophy (CRD) in a consanguineous Israeli  Jewish family.",Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
"Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  1296autosomal dominant bull’s-eye macular dystrophy (MCDR2),  autosomal dominant CRD (CORD12), and autosomal reces - sive CRD [ 6-9].",Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  1297with a slightly modified protocol compared to International  Society for Clinical Electrophysiology of Vision (ISCEV)  standards [ 10].,Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
"Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  1298exons 21, 22, and 23, each flanked by 68–232 bp of intronic  sequences, were PCR amplified from the genomic DNA  of patients and controls.",Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  1299 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  1300 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
"Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  1301light stimuli were normal, reflecting normal conductance  of the visual pathways (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  1302Table  2.,Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  1303(Figure 2B; cDNA position refers to GenBank accession  number NM_006017; genomic positions refer to reference  genome GRCh37/hg19).,Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  1304The PROM1 protein is 865 amino acids (aa) long.,Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
"Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  1305intronic mutation located in PROM1  intron 18, which leads  to pseudoexon activation, was recently reported [ 17].",Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
Molecular Vision  2015; 21:1295-1306 <http://www.molvis.org/molvis/v 21/1295 > © 2015 Molecular Vision  130612.,Non-OADS,/arxiv_data1/oa_pdf/a2/24/mv-v21-1295.PMC4676936.pdf
A similar figure is featured in http://www.toposnomos.com/huto/tis.html.,Non-OADS,/arxiv_data1/oa_pdf/ad/87/cyto0087-0696.PMC4676937.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 17, Number 12, 2015 DOI: 10.1089/dia.2015.0118 860",Non-OADS,/arxiv_data1/oa_pdf/57/23/dia.2015.0118.PMC4677112.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/db/ofv156.PMC4677157.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/24/ehv367.PMC4677272.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/a8/ehv444.PMC4677273.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/28/ehv511.PMC4677274.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/b8/rjv154.PMC4677275.pdf
"(Accessed  August 20, 2015, at  http://www.cdc.gov/cancer/prostate/ statistics/race.htm).",Non-OADS,/arxiv_data1/oa_pdf/80/8d/NAJMS-7-436.PMC4677467.pdf
"(Accessed May 21, 2015, at http://www.cdc.",Non-OADS,/arxiv_data1/oa_pdf/5a/4e/NAJMS-7-438.PMC4677468.pdf
"(Accessed January 15, 2015, at http://www.query.nytimes.com/gst/fullpage.html?res=9D02EED81331F93AA25751C1A9609C8B63).",Non-OADS,/arxiv_data1/oa_pdf/4b/6e/NAJMS-7-452.PMC4677470.pdf
"(Accessed November 25, 2014, at http://www.cas.gov.",Non-OADS,/arxiv_data1/oa_pdf/4b/6e/NAJMS-7-452.PMC4677470.pdf
"(Accessed December 22, 2014, at http://www.assessmentpsychology.com/icbmi.htm).",Non-OADS,/arxiv_data1/oa_pdf/34/b5/NAJMS-7-467.PMC4677472.pdf
"(Accessed December 22, 2014, at http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/BP.pdf).",OADS,/arxiv_data1/oa_pdf/34/b5/NAJMS-7-467.PMC4677472.pdf
"(Accessed December 10, 2014, at http://www.ncbi.nlm.nih.gov/books/NBK56070/).",Non-OADS,/arxiv_data1/oa_pdf/34/b5/NAJMS-7-467.PMC4677472.pdf
"(Accessed December 22, 2014, at http://www.iofbonehealth.org/preventing-osteoporosis).27.",Non-OADS,/arxiv_data1/oa_pdf/34/b5/NAJMS-7-467.PMC4677472.pdf
"(Accessed December 22, 2014, at https://www.aad.org/media-resources/stats-andfacts/prevention-and-care/vitamin-d).",Non-OADS,/arxiv_data1/oa_pdf/34/b5/NAJMS-7-467.PMC4677472.pdf
"(Accessed June 22, 2015, at http://www.nccn.org/).",Non-OADS,/arxiv_data1/oa_pdf/b1/2c/NAJMS-7-476.PMC4677473.pdf
"(Accessed March 24, 2015, at http://www.nidcr.nih.gov/oralhealth/Topics/TMJ/TMJDisorders.htm).",Non-OADS,/arxiv_data1/oa_pdf/b2/9d/NAJMS-7-480.PMC4677474.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/3a/iev075.PMC4677489.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/46/iev047.PMC4677490.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/d7/iev078.PMC4677491.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/5d/iev079.PMC4677495.pdf
(http://www.R-project.org/).,Non-OADS,/arxiv_data1/oa_pdf/83/5d/iev079.PMC4677495.pdf
"Tree: Classiﬁcation and regression trees, version 1.0, package for R. (http://cran.r-project.org/web/packages/tree/).",OADS,/arxiv_data1/oa_pdf/83/5d/iev079.PMC4677495.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/93/iev058.PMC4677496.pdf
"Chitin deacetylases (CDAs, EC 3.5.1.41) convert chitin into chitosan, the N-deacetylated form of chitin, and belong to a carbohydrate esterase family 4 of the carbohydrate-ac-tive enzymes database (http://www.cazy.org) ( Kramer and Muthukrishnan 1997 ).",Non-OADS,/arxiv_data1/oa_pdf/5f/ed/iev076.PMC4677497.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/ed/iev076.PMC4677497.pdf
"Prediction of putative transmembrane helices, thesignal peptide, protein domain, and N-glycosylation sites were carriedout with the TMHMM (http://www.cbs.dtu.dk/services/TMHMM/), SignalP 4.0 (http://www.cbs.dtu.dk/services/SignalP/), BLAST (http:// blast.ncbi.nlm.nih.gov/Blast.cgi), and NetOGlyc (http://www.cbs.dtu.dk/services/NetOGlyc/) programs, respectively.",OADS,/arxiv_data1/oa_pdf/5f/ed/iev076.PMC4677497.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/9a/iev087.PMC4677499.pdf
"(http://thrips.info/wiki/Main Page) (accessed 26 April 2015).Toda, S., and S. Komazaki.",OADS,/arxiv_data1/oa_pdf/00/9a/iev087.PMC4677499.pdf
The open reading frames (ORFs) of genes were predicted using ORF finder (http://www.ncbi.nlm.nih.gov/gorf/gorf.html).,OADS,/arxiv_data1/oa_pdf/b8/be/iev082.PMC4677501.pdf
Theoretical isoelectric points and molecular weights ofdeduced proteins were calculated using an ExPASy tool (http://web.expasy.org/compute_pi/).,OADS,/arxiv_data1/oa_pdf/b8/be/iev082.PMC4677501.pdf
"Signal peptide and transmembrane domain were predicted using SignalP (http://www.cbs.dtu.dk/services/SignalP/) and TMHMM (http://www.cbs.dtu.dk/services/TMHMM/), respectively.Homology searches were performed using BLAST (http://blast.ncbi.nlm.nih.gov/blast.cgi).",OADS,/arxiv_data1/oa_pdf/b8/be/iev082.PMC4677501.pdf
Catalytic residues were predicted by searchingthe NCBI Conserved Domain Database (http://www.ncbi.nlm.nih.gov/ structure/cdd/cdd.shtml).,OADS,/arxiv_data1/oa_pdf/b8/be/iev082.PMC4677501.pdf
The protein sequences of CXEs and GSTs from C. suppressalis and other insect species were aligned using Clustal Omega (http://www.ebi.ac.uk/tools/msa/clustalo/).,OADS,/arxiv_data1/oa_pdf/b8/be/iev082.PMC4677501.pdf
Primer pairs for quantitative polymerase chain reaction (qPCR) were designed using BatchPrimer3 (http://probes.pw.usda.gov/batch-primer3/) and are listed in Supp Table 2 (online only).,OADS,/arxiv_data1/oa_pdf/b8/be/iev082.PMC4677501.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercialuse, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e4/e8/hgtb.2015.100.PMC4677538.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License(http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribu-tion, and reproduction in any medium, provided the original author(s) and the source are credited.ZEBRAFISH Volume 12, Number 6, 2015DOI: 10.1089/zeb.2015.1148 470",Non-OADS,/arxiv_data1/oa_pdf/de/f4/zeb.2015.1148.PMC4677546.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT Volume 5, Number 4, 2015DOI: 10.1089/ther.2015.0012 217",Non-OADS,/arxiv_data1/oa_pdf/ac/54/ther.2015.0012.PMC4677568.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all no n-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29342 - http://dx.doi.org/10.3402/jchimp.v5.29342 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c1/a7/JCHIMP-5-29342.PMC4677577.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29342 - http://dx.doi.org/10.3402/jchimp.v5.29342",Non-OADS,/arxiv_data1/oa_pdf/c1/a7/JCHIMP-5-29342.PMC4677577.pdf
"12 and 13.Erythema induration of Bazin Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29342 - http://dx.doi.org/10.3402/jchimp.v5.29342 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c1/a7/JCHIMP-5-29342.PMC4677577.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29342 - http://dx.doi.org/10.3402/jchimp.v5.29342",Non-OADS,/arxiv_data1/oa_pdf/c1/a7/JCHIMP-5-29342.PMC4677577.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 28984 - http://dx.doi.org/10.3402/jchimp.v5.28984 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e5/cf/JCHIMP-5-28984.PMC4677578.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 28984 - http://dx.doi.org/10.3402/jchimp.v5.28984",Non-OADS,/arxiv_data1/oa_pdf/e5/cf/JCHIMP-5-28984.PMC4677578.pdf
"doi: http://dx.doi.org/10.1086/525258Bilateral aspergillus endophthalmitis Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 28984 - http://dx.doi.org/10.3402/jchimp.v5.28984 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e5/cf/JCHIMP-5-28984.PMC4677578.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), pe rmitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29589 - http://dx.doi.org/10.3402/jchimp.v5.29589 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f1/5d/JCHIMP-5-29589.PMC4677579.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29589 - http://dx.doi.org/10.3402/jchimp.v5.29589",Non-OADS,/arxiv_data1/oa_pdf/f1/5d/JCHIMP-5-29589.PMC4677579.pdf
"Analysis of the national multicenter study (1976 to 1985).N Engl J Med 1988; 319: 1557 /C162.Acetaminophen overdose and double concentration peaks Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29589 - http://dx.doi.org/10.3402/jchimp.v5.29589 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f1/5d/JCHIMP-5-29589.PMC4677579.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29589 - http://dx.doi.org/10.3402/jchimp.v5.29589",Non-OADS,/arxiv_data1/oa_pdf/f1/5d/JCHIMP-5-29589.PMC4677579.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 28982 - http://dx.doi.org/10.3402/jchimp.v5.28982 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cc/82/JCHIMP-5-28982.PMC4677580.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 28982 - http://dx.doi.org/10.3402/jchimp.v5.28982",Non-OADS,/arxiv_data1/oa_pdf/cc/82/JCHIMP-5-28982.PMC4677580.pdf
"J Investig Med High Impact Case Rep 2013; 1(1): 1 /C17.Partially reversible bortezomib-induced cardiotoxicity Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 28982 - http://dx.doi.org/10.3402/jchimp.v5.28982 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cc/82/JCHIMP-5-28982.PMC4677580.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), pe rmitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29054 - http://dx.doi.org/10.3402/jchimp.v5.29054 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3c/be/JCHIMP-5-29054.PMC4677581.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29054 - http://dx.doi.org/10.3402/jchimp.v5.29054",Non-OADS,/arxiv_data1/oa_pdf/3c/be/JCHIMP-5-29054.PMC4677581.pdf
"The repeat PET/CT scan done 3 months after the initial PET/CT scan showing diminished metabolic activity in previously seen right subcarinal region with SUV up to 3.9compared to 5.6 on the previous scan.Kaposi sarcoma can also involve the heart Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29054 - http://dx.doi.org/10.3402/jchimp.v5.29054 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3c/be/JCHIMP-5-29054.PMC4677581.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29054 - http://dx.doi.org/10.3402/jchimp.v5.29054",Non-OADS,/arxiv_data1/oa_pdf/3c/be/JCHIMP-5-29054.PMC4677581.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29203 - http://dx.doi.org/10.3402/jchimp.v5.29203 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29203 - http://dx.doi.org/10.3402/jchimp.v5.29203",Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
"In addition, theeffects of any single intervention would be expected to beadditive on prior interventions, making it more difficult todetermine the relative effect of any single intervention.Given that the order of interventions was chosen basedon local needs as determined by the RRD, the effectIterative interventions increase research productivity Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29203 - http://dx.doi.org/10.3402/jchimp.v5.29203 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29203 - http://dx.doi.org/10.3402/jchimp.v5.29203",Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
"(25)IM residents (n/C3087/year)4x x x x4-week required course; funding topresent if accepted2 publications/1 year (0.02 pubs/res/year)Iterative interventions increase research productivity Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29203 - http://dx.doi.org/10.3402/jchimp.v5.29203 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
"6 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29203 - http://dx.doi.org/10.3402/jchimp.v5.29203",Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
Available from: http://acgme.org/acgmeweb/tabid/430/ProgramandInstitutionalAccreditation/NextAccreditationSystem/Milestones.aspx [cited24 February 2014].,OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1007/s11606-009- 0970-4 3.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1001/jamasurg.2013.180 11.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/ 10.1097/ACM.0000000000000281 12.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/ 10.1016/j.juro.2008.09.022 13.,OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
BMC Med Educ 2006; 6: 52. doi: http://dx.doi.org/ 10.1186/1472-6920-6-52 14.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1111/j.1525-1497.2005.04157.x 15.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
"Acad Med 2003; 78(1):61/C18.Iterative interventions increase research productivity Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29203 - http://dx.doi.org/10.3402/jchimp.v5.29203 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1016/ j.amjmed.2005.12.001 17.,OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1207/s15328015tlm1704_3 18.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1176/appi.ap.33.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1542/peds.2008-3700 22.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1080/08858190701348133 23.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/ 10.1197/j.aem.2005.12.016 27.,OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.3109/0142159X.2014.911269 28.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/ 10.1207/s15328015tlm1702_10 30.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1001/jamaoto.,OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/ 10.1097/ACM.0b013e3181722d31 33.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1213/ane.0b013e31818ca31c 34.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
Available from: http://thequalityweb.com/menu.html; http://thequality- web.com/measure3.html [cited 18 November 2014].,OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1901/ jaba.2012.45-821 38.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.1097/01.QMH.0000308633.81979.7b 39.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/ 10.1300/J075v23n02_05 40.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/ 10.1097/ACM.0000000000000058 41.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/10.2106/JBJS.E.00243 43.,OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
doi: http://dx.doi.org/ 10.1097/ACM.0b013e3181bb2364 44.,Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
"8 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29203 - http://dx.doi.org/10.3402/jchimp.v5.29203",Non-OADS,/arxiv_data1/oa_pdf/03/23/JCHIMP-5-29203.PMC4677582.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29647 - http://dx.doi.org/10.3402/jchimp.v5.29647 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3d/4c/JCHIMP-5-29647.PMC4677583.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29647 - http://dx.doi.org/10.3402/jchimp.v5.29647",Non-OADS,/arxiv_data1/oa_pdf/3d/4c/JCHIMP-5-29647.PMC4677583.pdf
"Ann Intern Med 1992; 117(7): 560 /C16.Pulmonic valve endocarditis Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29647 - http://dx.doi.org/10.3402/jchimp.v5.29647 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3d/4c/JCHIMP-5-29647.PMC4677583.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), pe rmitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29624 - http://dx.doi.org/10.3402/jchimp.v5.29624 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/24/a1/JCHIMP-5-29624.PMC4677584.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29624 - http://dx.doi.org/10.3402/jchimp.v5.29624",Non-OADS,/arxiv_data1/oa_pdf/24/a1/JCHIMP-5-29624.PMC4677584.pdf
"Heart Lung 2014;43(6): 574 /C16.A case of primary pulmonary leiomyosarcoma Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29624 - http://dx.doi.org/10.3402/jchimp.v5.29624 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/24/a1/JCHIMP-5-29624.PMC4677584.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29937 - http://dx.doi.org/10.3402/jchimp.v5.29937 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"Ferguson 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29937 - http://dx.doi.org/10.3402/jchimp.v5.29937",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2011; 1: 6350, doi: http://dx.doi.org/10.3402/jchimp.v1i1.6350 2.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2013; 3: 23202, doi: http://dx.doi.org/10.3402/ jchimp.v3i3-4.23202.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
Available from http://www.jchimp.net/in- dex.php/jchimp/article/view/23202 [cited 2 October 2015].,OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2012; 2: 19690, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
Available from: http://www.jchimp.net/index.php/jchimp/article/view/19690 [cited 1 October 2015].,OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2012; 1: 15884, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
Available from: http://www.jchimp.net/index.php/jchimp/article/view/15884 [cited 1 October2015].,Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern MedPerspect 2015; 5: 29428, doi: http://dx.doi.org/10.3402/jchimp.",OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 29713, doi: http://dx.doi.org/10.3402/jchimp.v5.29713 7.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 29203, doi: http://dx.doi.org/10.3402/jchimp.v5.29203 8.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community HospIntern Med Perspect 2015; 5: 29426, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 28982, doi: http://dx.doi.org/10.3402/jchimp.v5.28982 10.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern MedPerspect 2015; 5: 29054, doi: http://dx.doi.org/10.3402/jchimp.",OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"JCommunity Hosp Intern Med Perspect 2015; 5: 29419, doi: http://dx.doi.org/10.3402/jchimp.v5.29419 12.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 29704, doi: http://dx.doi.org/10.3402/jchimp.v5.29704 13.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern MedPerspect 2015; 5: 29446, doi: http://dx.doi.org/10.3402/jchimp.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 29689, doi: http://dx.doi.org/10.3402/jchimp.v5.29689 16.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J CommunityHosp Intern Med Perspect 2015; 5: 29624, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp InternMed Perspect 2015; 5: 28984, doi: http://dx.doi.org/10.3402/ jchimp.v5.28984JCHIMP at 5 years: growth and development Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29937 - http://dx.doi.org/10.3402/jchimp.v5.29937 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 29342, doi: http://dx.doi.org/10.3402/jchimp.v5.29342 19.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community Hosp Intern Med Perspect 2015; 5: 29589, doi: http://dx.doi.org/10.3402/jchimp.v5.29589 20.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"J Community HospIntern Med Perspect 2015; 5: 29677, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"Ferguson 4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29937 - http://dx.doi.org/10.3402/jchimp.v5.29937",Non-OADS,/arxiv_data1/oa_pdf/30/5d/JCHIMP-5-29937.PMC4677585.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29704 - http://dx.doi.org/10.3402/jchimp.v5.29704 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f6/00/JCHIMP-5-29704.PMC4677587.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29704 - http://dx.doi.org/10.3402/jchimp.v5.29704",Non-OADS,/arxiv_data1/oa_pdf/f6/00/JCHIMP-5-29704.PMC4677587.pdf
"(a, b) Coronary angiogram showing no signiﬁcant coronary artery disease.Takotsubo cardiomyopathy precipitation Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29704 - http://dx.doi.org/10.3402/jchimp.v5.29704 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f6/00/JCHIMP-5-29704.PMC4677587.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29704 - http://dx.doi.org/10.3402/jchimp.v5.29704",Non-OADS,/arxiv_data1/oa_pdf/f6/00/JCHIMP-5-29704.PMC4677587.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29426 - http://dx.doi.org/10.3402/jchimp.v5.29426 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/bf/4d/JCHIMP-5-29426.PMC4677588.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29426 - http://dx.doi.org/10.3402/jchimp.v5.29426",Non-OADS,/arxiv_data1/oa_pdf/bf/4d/JCHIMP-5-29426.PMC4677588.pdf
"Odds ratio /C300.5967, 95% confidence limits (0.478 /C10.7449).Effect of pulse pressure on mortality Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29426 - http://dx.doi.org/10.3402/jchimp.v5.29426 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/bf/4d/JCHIMP-5-29426.PMC4677588.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29426 - http://dx.doi.org/10.3402/jchimp.v5.29426",Non-OADS,/arxiv_data1/oa_pdf/bf/4d/JCHIMP-5-29426.PMC4677588.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), pe rmitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29689 - http://dx.doi.org/10.3402/jchimp.v5.29689 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0c/6f/JCHIMP-5-29689.PMC4677589.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29689 - http://dx.doi.org/10.3402/jchimp.v5.29689",Non-OADS,/arxiv_data1/oa_pdf/0c/6f/JCHIMP-5-29689.PMC4677589.pdf
"Transthoracic echocardiogram (four-chamber view) showing vegetation on tricuspid valve (see arrow).TVE complicated by Mobitz type II heart block Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29689 - http://dx.doi.org/10.3402/jchimp.v5.29689 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0c/6f/JCHIMP-5-29689.PMC4677589.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29689 - http://dx.doi.org/10.3402/jchimp.v5.29689",Non-OADS,/arxiv_data1/oa_pdf/0c/6f/JCHIMP-5-29689.PMC4677589.pdf
"Tu ¨rk Fiz TIp Rehab Derg 2014; 60: 348 /C152.TVE complicated by Mobitz type II heart block Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29689 - http://dx.doi.org/10.3402/jchimp.v5.29689 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0c/6f/JCHIMP-5-29689.PMC4677589.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all no n-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29419 - http://dx.doi.org/10.3402/jchimp.v5.29419 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/92/d5/JCHIMP-5-29419.PMC4677590.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29419 - http://dx.doi.org/10.3402/jchimp.v5.29419",Non-OADS,/arxiv_data1/oa_pdf/92/d5/JCHIMP-5-29419.PMC4677590.pdf
"Arrow pointingto the anterior leaﬂet.LVOT obstruction and MR in TCM patients Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29419 - http://dx.doi.org/10.3402/jchimp.v5.29419 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/92/d5/JCHIMP-5-29419.PMC4677590.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29419 - http://dx.doi.org/10.3402/jchimp.v5.29419",Non-OADS,/arxiv_data1/oa_pdf/92/d5/JCHIMP-5-29419.PMC4677590.pdf
"J Am Soc Echocardiogr 2015; 28: 57 /C174.LVOT obstruction and MR in TCM patients Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29419 - http://dx.doi.org/10.3402/jchimp.v5.29419 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/92/d5/JCHIMP-5-29419.PMC4677590.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29713 - http://dx.doi.org/10.3402/jchimp.v5.29713 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/eb/12/JCHIMP-5-29713.PMC4677591.pdf
"Survey questions used to assess frequency of core behaviors of practice-based learning and improvement.Matthew F. Hollon 2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29713 - http://dx.doi.org/10.3402/jchimp.v5.29713",Non-OADS,/arxiv_data1/oa_pdf/eb/12/JCHIMP-5-29713.PMC4677591.pdf
"The height of the bar is the number of residents recording this magnitude of change.Learning and enhancing medical knowledge Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29713 - http://dx.doi.org/10.3402/jchimp.v5.29713 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/eb/12/JCHIMP-5-29713.PMC4677591.pdf
"Mean proportion of knowledge questions residents answered correctly prior to seeing the faculty post (prior toblogging) and at the end of the project (after blogging).Matthew F. Hollon 4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29713 - http://dx.doi.org/10.3402/jchimp.v5.29713",Non-OADS,/arxiv_data1/oa_pdf/eb/12/JCHIMP-5-29713.PMC4677591.pdf
Available from: http://www.acgme.org/acgmeweb/Portals/0/PDFs/Milestones/ InternalMedicineMilestones.pdf [cited 31 March 2015].,OADS,/arxiv_data1/oa_pdf/eb/12/JCHIMP-5-29713.PMC4677591.pdf
BMC Med Educ 2006; 6: 41. doi: http://dx.doi.org/10.1186/1472-6920-6-41 9.,Non-OADS,/arxiv_data1/oa_pdf/eb/12/JCHIMP-5-29713.PMC4677591.pdf
doi: http://dx.doi.org/10.1097/ACM.0000000000000189 10.,Non-OADS,/arxiv_data1/oa_pdf/eb/12/JCHIMP-5-29713.PMC4677591.pdf
"Dermatol Online J 2006; 12: 5.Learning and enhancing medical knowledge Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29713 - http://dx.doi.org/10.3402/jchimp.v5.29713 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/eb/12/JCHIMP-5-29713.PMC4677591.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29677 - http://dx.doi.org/10.3402/jchimp.v5.29677 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9b/18/JCHIMP-5-29677.PMC4677592.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29677 - http://dx.doi.org/10.3402/jchimp.v5.29677",Non-OADS,/arxiv_data1/oa_pdf/9b/18/JCHIMP-5-29677.PMC4677592.pdf
"Secondary aortoenteric ﬁstula: diagnostic assessment Diagnosis (2 /C15, 7, 9, 12, 13, 15, 18, Exploratory laparotomy Sensitivity and specificity 91 /C1100% 20, 23, 25, 29 /C134) Computerized tomography scan Sensitivity 40 /C1100%; specificity 33.3 /C1100% Computerized tomography angiography Sensitivity 33 /C1100% EGD Sensitivity 10 /C180%, specificity 8.3 /C175%, accuracy 30% Radionuclide scanning with technetium-99-labeled leukocytesSensitivity 0%, specificity 0 /C180% Nuclear medicine RBC Sensitivity 0%Critical gastrointestinal bleed Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29677 - http://dx.doi.org/10.3402/jchimp.v5.29677 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9b/18/JCHIMP-5-29677.PMC4677592.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29677 - http://dx.doi.org/10.3402/jchimp.v5.29677",Non-OADS,/arxiv_data1/oa_pdf/9b/18/JCHIMP-5-29677.PMC4677592.pdf
"J Vasc Interv Radiol 2007; 18: 497 /C1504.Critical gastrointestinal bleed Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29677 - http://dx.doi.org/10.3402/jchimp.v5.29677 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9b/18/JCHIMP-5-29677.PMC4677592.pdf
"6 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29677 - http://dx.doi.org/10.3402/jchimp.v5.29677",Non-OADS,/arxiv_data1/oa_pdf/9b/18/JCHIMP-5-29677.PMC4677592.pdf
"Appendix A- The Search Strategy Pubmed (secondary, arotoenteric, aorto-enteric) OR secondary, ao rtoduodenal, aorto-duodenal) OR secondary, aorto-esophageal, aortoesophageal) ((((‘‘secondary’’[Subheading] OR ‘‘secondary’’[All Fields] OR ‘‘neoplasm metastasis’’[MeSH Terms] OR (‘‘neoplasm’’[All Fields] AND ‘‘metastasis’’[All Fields]) OR ‘‘neoplasm metastasis’’[All Fields]) AND aorto-enteric[All Fields])OR ((‘‘secondary’’[Subheading] OR ‘‘secondary’’[All Fields] OR ‘‘neoplasm metastasis’’[MeSH Terms] OR (‘‘neoplasm’’[All Fields] AND ‘‘metastasis’’[All Fields]) OR ‘‘neoplasm metastasis’’[All Fields]) AND aortoduodenal[All Fields] ANDaorto-duodenal[All Fields])) OR ((‘‘secondary’’[Subheading] OR ‘‘secondary’’[All Fields] OR ‘‘neoplasm metastasis’’[MeSH Terms] OR (‘‘neoplasm’’[All Fields] AND ‘‘metastasis ’’[All Fields]) OR ‘‘neoplasm metastasis’’ [All Fields]) AND aorto-esophageal[All Fields] AND aortoesophageal[All Fields])) AND English[lang] Scopus Aortoenteric ﬁstula, secondary aortoenteric ﬁstula OR secondary, aortoduodenal, aorto-duodenal.Critical gastrointestinal bleed Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29677 - http://dx.doi.org/10.3402/jchimp.v5.29677 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9b/18/JCHIMP-5-29677.PMC4677592.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permi tting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29428 - http://dx.doi.org/10.3402/jchimp.v5.29428 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29428 - http://dx.doi.org/10.3402/jchimp.v5.29428",Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
"Managing inpatient general internists can also include screening for vitamin D defi- ciency and starting or optimizing medical care to reducefuture fracture risks (27).Graying of the HIV epidemic Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29428 - http://dx.doi.org/10.3402/jchimp.v5.29428 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
Available from: http://www.nia.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
Available from: http://napca.org/wp-content/uploads/2014/07/DEC-HIV-and-Aging-Policy-Report_web.pdf [cited 14September 2015].5.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
Available from: http://www.nia.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
Available from: https://www.aids.gov/hiv-aids-basics/ staying-healthy-with-hiv-aids/taking-care-of-yourself/aging-with-hiv-aids/ [ cited 14 September 2015].,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1097/ QAI.0b013e3181bcdc16 8.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
Available from: http://www.naswdc.org/ practice/hiv_aids/AgingOfHIVFactSheet.pdf [cited 14 September 2015].,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/ 10.1097/MLR.0b013e3181f81c4a 12.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
Available from: http://www.cdc.gov/hiv/testing/clinical/ [cited 14 September 2015].,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm[cited 14 September 2015].,OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1093/ntr/ntq093 16.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1001/jamainternmed.2013.3728 20.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1016/j.jacc.2012.,OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29428 - http://dx.doi.org/10.3402/jchimp.v5.29428",Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1016/j.amjcard.2012.05.045 24.,OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.7326/M14-0954 25.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/ 10.1089/apc.2008.0082 26.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1097/SMJ.0b013e31829680ff 27.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1111/ j.1532-5415.2012.03948.x.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb162.pdf [cited13 September 2015].,OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/ 10.1007/s40266-013-0093-9 34.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1097/PTS.0b013e318286f87d 38.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1093/ cid/cis491 39.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1007/s11606- 013-2449-6 40.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1093/jac/dkr248 41.,OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.2146/ajhp120050 42.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/ 10.1097/COH.0000000000000080 45.,OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
doi: http://dx.doi.org/10.1111/j.1532-5415.2010.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
Available from: http://aidsinfo.nih.gov/contentﬁles/lvguidelines/AA_Recommendations.,Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
"pdf [cited 14 September 2015].Graying of the HIV epidemic Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29428 - http://dx.doi.org/10.3402/jchimp.v5.29428 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a9/22/JCHIMP-5-29428.PMC4677594.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29446 - http://dx.doi.org/10.3402/jchimp.v5.29446 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/66/c2/JCHIMP-5-29446.PMC4677595.pdf
"2 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29446 - http://dx.doi.org/10.3402/jchimp.v5.29446",Non-OADS,/arxiv_data1/oa_pdf/66/c2/JCHIMP-5-29446.PMC4677595.pdf
"Found on ECHO post-TAVR Post-TAVR SOB, shortness of breath; ACS, acute coronary syndrome; TAVR, transcatheter aortic valve replacement; HOCM, hypertrophic obstructive cardiomyopathy.Subsequent complete heart block Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29446 - http://dx.doi.org/10.3402/jchimp.v5.29446 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/66/c2/JCHIMP-5-29446.PMC4677595.pdf
"4 (page number not for citation purpose)Citation: Journal of Community Hospital Internal Medicine Perspectives 2015, 5: 29446 - http://dx.doi.org/10.3402/jchimp.v5.29446",Non-OADS,/arxiv_data1/oa_pdf/66/c2/JCHIMP-5-29446.PMC4677595.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/e6/aabc-8-049.PMC4677596.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances and Applications in Bioinformatics and Chemistry 2015:8 49–63Advances and Applications in Bioinformatics and Chemistry Dove press submit your manuscript | www.dovepress.co m Dove press  49O R I G I N A L  R E S E A R C H open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AABC.S8852 2Identification of potential drug targets by  subtractive genome analysis of Escherichia coli   O157:H7: an in silico approach Shakhinur Islam Mondal1,6,* Sabiha Ferdous1,* Nurnabi Azad Jewel1 Arzuba Akter2,6 Zabed Mahmud1 Md Muzahidul Islam1 Tanzila Afrin3 Nurul Karim4,5 1Genetic Engineering and  Biotechnology Department, Shahjalal  University of Science and T echnology,   Sylhet, Bangladesh; 2Biochemistry  and Molecular Biology Department,   Shahjalal University of Science and  T echnology, Sylhet, Bangladesh;   3Department of Pharmacy, East West  University, Aftabnagar, Bangladesh;   4Biochemistry and Molecular  Biology Department, Jahangirnagar  University, Savar, Bangladesh;   5Division of Parasitology, 6Division  of Microbiology, Department of  Infectious Diseases, Faculty of  Medicine, University of Miyazaki,   Miyazaki, Japan *These authors contributed equally to  this workAbstract:  Bacterial enteric infections resulting in diarrhea, dysentery, or enteric fever constitute  a huge public health problem, with more than a billion episodes of disease annually in developing  and developed countries.",Non-OADS,/arxiv_data1/oa_pdf/e7/e6/aabc-8-049.PMC4677596.pdf
All human protein sequences were retrieved from Refseq  database ftp site ( ftp://ftp.ncbi.nlm.nih.gov/genomes/H_ sapiens/protein /) and essential proteins were subjected to  BLASTP search against the human proteins with BioEdit.,OADS,/arxiv_data1/oa_pdf/e7/e6/aabc-8-049.PMC4677596.pdf
"Advances and Applications in Bioinformatics and Chemistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com /advances-and-applications-in-bioinformatics-and-chemistry-journalAdvances and Applications in Bioinformatics and Chemistry is an inter - national, peer-reviewed open-access journal that publishes articles in the  following fields: Computational biomodeling; Bioinformatics; Compu - tational genomics; Molecular modeling; Protein structure modeling and  structural genomics; Systems Biology; Computational Biochemistry; Computational Biophysics; Chemoinformatics and Drug Design; In silico  ADME/Tox prediction.",Non-OADS,/arxiv_data1/oa_pdf/e7/e6/aabc-8-049.PMC4677596.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/e6/aabc-8-049.PMC4677596.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/4a/amep-6-641.PMC4677597.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 641–656Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  641OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S9162 4health-profession students’ teaching and learning  expectations in Ugandan medical schools: pre- and  postcommunity placement comparison Edith K Wakida1 gad ruzaaza1 Kintu Muggaga2 Peter Akera3 hussein Oria4 sarah Kiguli4 1Medical school, Mbarara University  of science and T echnology,   Mbarara, 2Medical school, Kampala  international University, Kampala,   3Medical school, gulu University, gulu,   4Medical school, Makerere University  Kampala, Kampala, Uganda correspondence: Edith K Wakida   Mbarara University of science and  Technology, PO Box 1410, Mbarara  University road, Mbarara 00256, Uganda   Tel +256 78 268 5541   Email ediwakida@must.ac.u gPurpose:  The benefits of community-based medical education for both students and teachers  are becoming increasingly clear.",Non-OADS,/arxiv_data1/oa_pdf/d7/4a/amep-6-641.PMC4677597.pdf
Or use: http://youtu.be/62k4R6IHyr I,Non-OADS,/arxiv_data1/oa_pdf/d7/4a/amep-6-641.PMC4677597.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d7/4a/amep-6-641.PMC4677597.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/4a/amep-6-641.PMC4677597.pdf
The nucleotide consensus EV -D68 VP1 sequences were compared and aligned against other sequences retrieved from the GenBank database using the program  CLUSTAL X (version 1.83; http://www.clustal.org/).,OADS,/arxiv_data1/oa_pdf/39/0a/inf-35-45.PMC4677598.pdf
Available at: http://www.eurosurveillance.org/ViewArticle.,Non-OADS,/arxiv_data1/oa_pdf/39/0a/inf-35-45.PMC4677598.pdf
Data relating to the 15th percentile of lung attenuation (Perc15) and mean lung attenuation for inspiratory scans are provided in Supplemental DigitalContent 1 (http://links.lww.com/IGC/A318).,Non-OADS,/arxiv_data1/oa_pdf/29/3b/rti-31-29.PMC4677600.pdf
"Models for the visually scored subset adjusting for CN presence and extent are pro- vided in Supplemental Digital Content 1, http://link-s.lww.com/IGC/A318.",Non-OADS,/arxiv_data1/oa_pdf/29/3b/rti-31-29.PMC4677600.pdf
"Models for Perc15 and mean lung attenuationshowed similar trends to those seen for %LAA I-950and %LAA E-856, and are provided in Supplemental Digital Content 1 (http://links.lww.com/IGC/A318).",Non-OADS,/arxiv_data1/oa_pdf/29/3b/rti-31-29.PMC4677600.pdf
Available at: http://www.slicer.org/.,Non-OADS,/arxiv_data1/oa_pdf/29/3b/rti-31-29.PMC4677600.pdf
"conceived the experiments, analyzed results, and wrote the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/49/0d/srep06070.PMC4677634.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6070 | DOI: 10.1038/srep06070 4",Non-OADS,/arxiv_data1/oa_pdf/49/0d/srep06070.PMC4677634.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/49/0d/srep06070.PMC4677634.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/af/dddt-9-6401.PMC4677648.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6401–6405Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6401Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9594 6Phase ii trial of docetaxel combined with  nedaplatin for patients with recurrent and  metastatic nasopharyngeal carcinoma Pei-Jian Peng1,* Bao-Jun lv2,* con Tang2,* hai liao3 Zhong lin1 Yu-Meng liu4 Zhi-hui Wang1 si-Yang Wang5 Zhi-Bin cheng5 1Department of Medical Oncology,   2Department of surgical Oncology,   The Fifth affiliated hospital of  sun Yat-sen University, Zhuhai,   3Department of Medical Oncology,   cancer centre, sun Yat-sen University,   guangzhou, 4Department of Oncology,   People’s hospital of Zhongshan city,   Zhongshan, 5Department of radiation  Oncology, The Fifth affiliated hospital  of sun Yat-sen University, Zhuhai,   guangdong Province, People’s  republic of china *These authors contributed equally  to this workPurpose:  This Phase II trial was designed to evaluate the efficacy and safety of docetaxel  combined with nedaplatin as first-line treatment for patients with recurrent or metastatic  nasopharyngeal carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/a4/af/dddt-9-6401.PMC4677648.pdf
"As a single agent, docetaxel is effective in the patients with disseminated NPC  who were refractory to platinum-based chemotherapy.8 In addition, a clinical study  has indicated that docetaxel plus cisplatin is active as first-line chemotherapy in the  patients with metastatic NPC.9 Nedaplatin is a second-generation platinum derivative, correspondence: Zhi-Bin cheng Department of radiation Oncology,  The Fifth Affiliated Hospital of Sun Yat- sen University, 52 Mei hua road east,  Zhu hai 519000, guangdong Province,  People’s republic of china Tel +86 756 252 8020 Fax +86 756 252 8045 email drczb@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Peng et al Running head recto: Phase II trial of docetaxel combined with nedaplatin DOI: http://dx.doi.org/10.2147/DDDT.S95946",Non-OADS,/arxiv_data1/oa_pdf/a4/af/dddt-9-6401.PMC4677648.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a4/af/dddt-9-6401.PMC4677648.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/af/dddt-9-6401.PMC4677648.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/0a/ijn-10-7307.PMC4677649.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7307–7317International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7307OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9367 0Highly efficient mesenchymal stem cell proliferation  on poly-ε-caprolactone nanofibers with embedded  magnetic nanoparticles Jana Daňková1,2 Matej Buzgo1,3,4 Jana Vejpravová5 Simona Kubíčková5 Věra Sovková1,2 Lucie Vysloužilová4,6 Alice Mantlíková5 Alois Nečas7 Evžen Amler1–3 1Laboratory of Tissue Engineering,   Institute of experimental Medicine,   academy of sciences of the czech  Republic, Prague, Czech Republic;   2Institute of Biophysics, second  Faculty of Medicine, charles  University in Prague, Prague, Czech  Republic; 3Faculty of Biomedical  engineering, czech T echnical  University in Prague, Kladno, Czech  Republic; 4University center for  energy efficient Buildings, czech  T echnical University in Prague,   Bustehrad, Czech Republic;   5Department of Magnetic  Nanosystems, Institute of Physics,   academy of sciences of the czech  Republic, Prague, Czech Republic;   6Department of Nonwoven T extiles,   Faculty of T extile engineering,   T echnical University of Liberec,   Liberec, Czech Republic; 7Faculty  of Veterinary Medicine, University  of Veterinary and Pharmaceutical  Sciences Brno, Brno, Czech RepublicAbstract:  In this study, we have developed a combined approach to accelerate the proliferation  of mesenchymal stem cells (MSCs) in vitro, using a new nanofibrous scaffold made by needleless  electrospinning from a mixture of poly- ε-caprolactone and magnetic particles.",Non-OADS,/arxiv_data1/oa_pdf/b7/0a/ijn-10-7307.PMC4677649.pdf
"Particles smaller than 50 nm evade opsonization and can circulate for a longer period, Correspondence: Jana Daňková Laboratory of Tissue Engineering,  Institute of experimental Medicine,  academy of sciences of the czech  Republic, 1083 Vídeňská, Prague 142 20,  Czech Republic Tel +420 296 442 387 Fax +420 296 442 387 email jana_dankova@labdemo.c z Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Da ňková et al Running head recto: Scaffold with magnetic particles for mesenchymal stem cell proliferation DOI: http://dx.doi.org/10.2147/IJN.S93670",Non-OADS,/arxiv_data1/oa_pdf/b7/0a/ijn-10-7307.PMC4677649.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b7/0a/ijn-10-7307.PMC4677649.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/0a/ijn-10-7307.PMC4677649.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/32/ijn-10-7333.PMC4677650.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7333–7343International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7333OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9209 9Hydroxyapatite-doped polycaprolactone nanofiber  membrane improves tendon–bone interface healing  for anterior cruciate ligament reconstruction Fei han1,* Peng Zhang2,* Yaying Sun2 Chao Lin1 Peng Zhao1 Jiwu Chen2 1Shanghai East Hospital, The Institute  for Biomedical Engineering and  Nanoscience, Tongji University  School of Medicine, T ongji University,   2Department of Sports Medicine,   Huashan Hospital, Fudan University,   Shanghai, People’s Republic of China *These authors contributed equally  to this workAbstract:  Hamstring tendon autograft is a routine graft for anterior cruciate ligament (ACL)  reconstruction.",Non-OADS,/arxiv_data1/oa_pdf/9c/32/ijn-10-7333.PMC4677650.pdf
"In the past 2 decades, these nanoscaffolds containing biodegradable materials such as  polycaprolactone (PCL), chitosan, and collagen (Col) present a great potential for ACL  repair.8–10 A co-electrospun based on PCL and Col onto opposite ends of a mandrel was  fabricated to create a scaffold with three regions to repair muscle–tendon junctions.11 Correspondence: Peng Zhao Room 220, Shixun Building, 1239 Siping  Road, Shanghai East Hospital, The  Institute for Biomedical Engineering and  Nanoscience, Tongji University School  of Medicine, Tongji University, Shanghai,  200092, People’s Republic of China Tel +86 21 6598 8029 Fax +86 21 6598 3706; Extn 0 email zp@tongji.edu.c n  Jiwu Chen Department of Sports Medicine, Huashan  Hospital, Fudan University, 12 Wulumuqi  Middle Road, Shanghai, 200040, People’s  Republic of China email jiwuchen@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Han et al Running head recto: Bone-mimetic nanofiber for anterior cruciate ligament reconstruction DOI: http://dx.doi.org/10.2147/IJN.S92099",Non-OADS,/arxiv_data1/oa_pdf/9c/32/ijn-10-7333.PMC4677650.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9c/32/ijn-10-7333.PMC4677650.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/32/ijn-10-7333.PMC4677650.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/83/ijn-10-7359.PMC4677651.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7359–7370International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7359OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9190 6ph-responsive glycol chitosan-cross-linked  carboxymethyl- β-cyclodextrin nanoparticles for  controlled release of anticancer drugs Yiwen Wang* Fei Qin* haina Tan Yan Zhang Miao Jiang Mei lu Xin Yao school of chemistry and chemical  engineering, University of chinese  academy of sciences, Beijing, People’s  republic of china *These authors contributed equally  to this workAbstract:  Carboxymethyl- β-cyclodextrin (CM β-CD)-modified glycol chitosan (GCS)  nanoparticles (GCS-CM β-CD NPs) were synthesized, and their pH-sensitive drug-release  properties were investigated.",Non-OADS,/arxiv_data1/oa_pdf/46/83/ijn-10-7359.PMC4677651.pdf
"Furthermore,  they are mucoadhesive and are able to open the tight junctions between the epithelial correspondence:  Xin Yao school of chemistry and chemical  engineering, University of chinese  academy of sciences, No 19a Yuquan  road, Beijing 100049, People’s republic  of china   Tel/fax +86 10 8825 6902 email yaox@ucas.ac.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: Chitosan-cyclodextrin NPs DOI: http://dx.doi.org/10.2147/IJN.S91906",Non-OADS,/arxiv_data1/oa_pdf/46/83/ijn-10-7359.PMC4677651.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/46/83/ijn-10-7359.PMC4677651.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/83/ijn-10-7359.PMC4677651.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/3b/ceg-8-327.PMC4677652.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 327–332Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  327OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S9196 4Gastrointestinal motility during sleep assessed   by tracking of telemetric capsules combined   with polysomnography – a pilot study anne-Mette haase1 sibylle Fallet2 Marit Otto3 s Mark scott4 Vincent schlageter5 Klaus Krogh1 1Department of hepatology and  Gastroenterology, aarhus University  hospital, aarhus, Denmark; 2swiss  Federal institute of Technology  (EPFl), lausanne, switzerland;  3Department of neurophysiology,  aarhus University hospital, aarhus,  Denmark; 4neurogastroenterology  Group, Gastrointestinal Physiology  Unit, Queen Mary University, london,  UK; 5Motilis Medica sa, lausanne,  switzerland Correspondence: anne-Mette haase   Department of hepatology and  Gastroenterology, aarhus University  hospital, noerrebrogade 44, Building 1C,  1st Floor, 8000 aarhus C, Denmark   Tel +45 6165 8483   Fax +45 7846 2860   Email annemette.haase@gmail.co mAbstract:  Studies of gastrointestinal function during sleep are hampered by lack of applicable  techniques.",Non-OADS,/arxiv_data1/oa_pdf/d7/3b/ceg-8-327.PMC4677652.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/d7/3b/ceg-8-327.PMC4677652.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/3b/ceg-8-327.PMC4677652.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/d2/ijn-10-7371.PMC4677653.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7371–7384International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7371OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9086 6Investigation and optimization of formulation  parameters on preparation of targeted anti- cD205 tailored Plga nanoparticles sheikh Tasnim Jahan azita haddadi Division of Pharmacy, college of  Pharmacy and Nutrition, University  of saskatchewan, saskatoon, sK,   canadaAbstract:  The purpose of this study was to assess the effect of various formulation parameters  on anti-CD205 antibody decorated poly( d, l-lactide co-glycolide) (PLGA) nanoparticles (NPs) in  terms of their ability to target dendritic cells (DCs).",Non-OADS,/arxiv_data1/oa_pdf/b6/d2/ijn-10-7371.PMC4677653.pdf
"Engagement of anti-CD205  mAb to target CD205 receptors shows high consensus to deliver vaccine utilizing an  appropriate delivery system.5correspondence: azita haddadi college of Pharmacy and Nutrition,  University of saskatchewan, 3D01.01,  D Wing health sciences, 107 Wiggins  road, saskatoon sK, s7N 5e5, canada Tel +1 306 966 6495 Fax +1 306 966 6377 email azita.haddadi@usask.c a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Jahan and Haddadi Running head recto: Investigation and optimization of formulation parameters of PLGA NPs DOI: http://dx.doi.org/10.2147/IJN.S90866",Non-OADS,/arxiv_data1/oa_pdf/b6/d2/ijn-10-7371.PMC4677653.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b6/d2/ijn-10-7371.PMC4677653.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/d2/ijn-10-7371.PMC4677653.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7319–7331International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7319PersPectIvesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJN.S9648 0Nanomedicine concepts in the general medical  curriculum: initiating a discussion Aldrin e sweeney center for teaching & Learning,   ross University school of Medicine,   roseau, commonwealth of DominicaAbstract:  Various applications of nanoscale science to the field of medicine have resulted in  the ongoing development of the subfield of nanomedicine.",Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"Over the  past 25 years or so – since approximately 1990 – such advances have been occurring correspondence: Aldrin e sweeney center for teaching & Learning, ross  University school of Medicine, PO  Box 266, roseau, commonwealth of  Dominica email a ldrinsweeney@rossu.ed u Journal name: International Journal of Nanomedicine Article Designation: Perspectives Y ear: 2015 Volume: 10 Running head verso: Sweeney Running head recto: Nanomedicine concepts in the medical curriculum DOI: http://dx.doi.org/10.2147/IJN.S96480",Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"Available from: http://www.esf.org/fileadmin/ Public_documents /Publications/Nanomedicine.pd f. Accessed  November 25, 2015.",OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
Available from: http://www.aaas.,Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"Available from: http://report.nih.gov/categorical_spending.asp x.  Accessed October 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
Available from: http://www.britishsocietynanomedicine.org/ existing -nanomedicines .html.,Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"Available from: http://www.nanosphere.us/products/verigene- syste m. Accessed November 3, 2015.",OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"Available from:  http://www.emdt.co.uk/article/nanoscience-and-future-trends-medical- technologie s. Accessed May 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
Available from: http://www.sunycnse.,Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"Available from: https://medicine.tamhsc.edu/ md-phd/index.htm l. Accessed August 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
Available  from: https://med.uth.edu/oep/medical-education/student-programs/ scholarly-concentrations-progra m/.,Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"Available from: http://weill.cornell.edu/ education/curriculum/aoc.htm l. Accessed August 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
Available from:  https://students-residents.aamc.org/applying-medical-school/article/ whats-mcat-exa m/.,Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"Available from:  http://www.usmle.org/pdfs/step-1/2015content_step1.pd f. Accessed  August 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"Available from: http://www.usmle.org/pdfs/step-2-ck/2015_ Step2CK_Content.pd f. Accessed August 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/35/ijn-10-7319.PMC4677654.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/d3/ijnrd-8-159.PMC4677656.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 159–163International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  159ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S9492 3effect of zinc supplementation on body mass  index and serum levels of zinc and leptin in  pediatric hemodialysis patients ahmed Nabih el-shazly1 soha abd el-hady Ibrahim1 ghada Mohamed  el-Mashad2 Jehan h sabry3 Nashwa said sherbini1 1Department of Pediatrics, Faculty of  Medicine, Benha University, Banha,   2Department of Pediatrics, Faculty of  Medicine, Menoufia University, shibin  al Kawm, 3Department of clinical  and chemical Pathology, Faculty of  Medicine, Benha University, Banha,   egypt correspondence: Nashwa said sherbini   Pediatric Department, Benha T eaching  hospital, 1 Bahary el-Taameen el-sehy  street Benha, Qualyuobeya 13111, egypt   Tel +20 10 0493 0982   email n ashwa_sherbeny@yahoo.co mIntroduction:  Zinc is an essential trace element for human nutrition, and its deficiency is  associated with anorexia, poor food efficiency, growth retardation, and impaired neurological  and immune systems.",Non-OADS,/arxiv_data1/oa_pdf/85/d3/ijnrd-8-159.PMC4677656.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/85/d3/ijnrd-8-159.PMC4677656.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/d3/ijnrd-8-159.PMC4677656.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/3a/bctt-7-381.PMC4677657.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 381–388Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  381Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S9451 6Correlation of clinicopathological outcomes with  changes in ihC4 status after na CT in locally  advanced breast cancers: do pre-na CT er/Pr  status act as better prognosticators?,Non-OADS,/arxiv_data1/oa_pdf/bc/3a/bctt-7-381.PMC4677657.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/bc/3a/bctt-7-381.PMC4677657.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/86/cia-10-1945.PMC4677658.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2015:10 1945–1946Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1945Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S10113 9ethnicity and culture: is it associated with falls?",Non-OADS,/arxiv_data1/oa_pdf/88/86/cia-10-1945.PMC4677658.pdf
"1998;30(5):   607–616.Correspondence: Amin Zarghami Department of Neurology, Ayatollah  rohani Hospital, Babol University of  Medical Sciences, Ganjafrouz Street,  Babol, Iran tel +98 911 212 0205 email aminzarghami18@yahoo.co m Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2015 Volume: 10 Running head verso: Anissian and Zarghami Running head recto: Ethnicity and falls DOI: http://dx.doi.org/10.2147/CIA.S101139",Non-OADS,/arxiv_data1/oa_pdf/88/86/cia-10-1945.PMC4677658.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/88/86/cia-10-1945.PMC4677658.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/88/86/cia-10-1945.PMC4677658.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/6f/ijn-10-7345.PMC4677660.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7345–7358International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7345OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9375 8Inhibition of heat-shock protein 90 sensitizes liver  cancer stem-like cells to magnetic hyperthermia  and enhances anti-tumor effect on hepatocellular  carcinoma-burdened nude mice rui Yang1,* Qiusha Tang1,* Fengqin Miao1 Yanli an2 Mengfei li1 Y ong han1 Xihui Wang1 Juan Wang3 Peidang liu1 rong chen4 1school of Medicine, southeast  University, 2Jiangsu Key laboratory  of Molecular and Functional Imaging,   Department of radiology, Zhongda  hospital, Nanjing, 3Department of  Infectious Disease, The Third People’s  hospital of Nantong, Nangtong;   4Department of Oncology, Zhongda  hospital, Nangjing, Jiangsu Province,   People’s republic of china *These authors contributed equally  to this workPurpose:  To explore the thermoresistance and expression of heat-shock protein 90 (HSP90)  in magnetic hyperthermia-treated human liver cancer stem-like cells (LCSCs) and the effects  of a heat-shock protein HSP90 inhibitor 17-allylamino-17-demethoxgeldanamycin (17-AAG)  on hepatocellular carcinoma-burdened nude mice.",Non-OADS,/arxiv_data1/oa_pdf/66/6f/ijn-10-7345.PMC4677660.pdf
"It has often been  given by intravenous injection in an organic solvent due to its poor solubility in water correspondence: Qiusha Tang school of Medicine, southeast University,  87 Dingjiaqiao road, Nanjing 210009,  Jiangsu Province, People’s republic  of china Tel +86 25 8327 2373 Fax +86 25 8327 2541 email panyixi-tqs@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Y ang et al Running head recto: Elimination of liver cancer stem cells through magnetic hyperthermia DOI: http://dx.doi.org/10.2147/IJN.S93758",Non-OADS,/arxiv_data1/oa_pdf/66/6f/ijn-10-7345.PMC4677660.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/66/6f/ijn-10-7345.PMC4677660.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/6f/ijn-10-7345.PMC4677660.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/30/ijn-10-7385.PMC4677661.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 7385–7396International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  7385OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9273 3enhanced human bone marrow mesenchymal  stem cell functions on cathodic arc plasma- treated titanium Wei Zhu1 george T eel1 christopher M O’Brien1 Taisen Zhuang1 Michael Keidar1 lijie grace Zhang1–3 1Department of Mechanical and  aerospace engineering, 2Department  of Biomedical engineering,   3Department of Medicine, The george  Washington University, Washington,   Dc, UsaAbstract:  Surface modification of titanium for use in orthopedics has been explored for years;  however, an ideal method of integrating titanium with native bone is still required to this day.",Non-OADS,/arxiv_data1/oa_pdf/13/30/ijn-10-7385.PMC4677661.pdf
"Considering the endurance of current orthopedic implants (10–15  years), younger and  more active patients (men younger than 60 years and women younger than 55 years)  will inevitably need more than one revision surgery in their lives.1 In the United States  by 2030, it was estimated that the demand for primary total hip and knee replace - ments is estimated to grow by 174% to 572,000 and 673% to 3.48 million procedures,  respectively.2 Nearly 17% of hip replacements and 8% of knee replacements will go  on to need revision procedures of previously failed hip and knee replacements.3 Due  to the strikingly increasing number of patients who need various medical implants and  the relatively high percentage of revision procedures performed around the world, it  is highly desirable to significantly lengthen the service lifetime of current orthopedic  implants and, thus, dramatically reduce patient pain and health insurance costs.correspondence: lijie grace Zhang Department of Mechanical and aerospace  engineering, The george Washington  University, science and engineering hall,  room 3590, 800 22nd street Northwest,  Washington, Dc 20052, Usa Tel +1 202 994 2479 Fax +1 202 994 0238 email lgzhang@gwu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhu et al Running head recto: Plasma nanocoating for improved stem cell functions DOI: http://dx.doi.org/10.2147/IJN.S92733",Non-OADS,/arxiv_data1/oa_pdf/13/30/ijn-10-7385.PMC4677661.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/13/30/ijn-10-7385.PMC4677661.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/30/ijn-10-7385.PMC4677661.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/12/dddt-9-6389.PMC4677662.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 6389–6399Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6389Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9420 7Identification of covalent active site inhibitors of  dengue virus protease Xiaoying Koh-stenta1 Joma Joy1 si Fang Wang1 Perlyn Zekui Kwek1 John liang Kuan Wee1 Kah Fei Wan2 shovanlal gayen1 angela shuyi chen1 congBao Kang1 May ann lee1 anders Poulsen1 Subhash G Vasudevan3 Jeffrey Hill1 Kassoum nacro1 1experimental Therapeutics centre,   Agency for Science, T echnology and  research (a*sT ar), singapore;   2Novartis Institute for Tropical  Diseases, singapore; 3Program  in Emerging Infectious Diseases,   Duke- nUs graduate Medical  school, singaporeAbstract:  Dengue virus (DENV) protease is an attractive target for drug development; however,  no compounds have reached clinical development to date.",Non-OADS,/arxiv_data1/oa_pdf/c2/12/dddt-9-6389.PMC4677662.pdf
"Recent successes of human immunodeficiency virus  and hepatitis C virus protease inhibitors in the clinic have also renewed focus on viral  protease inhibition as a proven strategy for anti-viral therapy.10–13 Several approaches have been taken to develop DENV protease inhibitors, including  peptidic substrate-based inhibition,14,15 high-throughput screening (HTS),9,16,17 and in  silico docking.18 No compounds have reached clinical development to date, mainly due correspondence: Kassoum nacro experimental Therapeutics centre,  a*sTar, 11 Biopolis Way, helios   03-10, 138669, singapore Tel +65 6407 0343 Fax +65 6478 8768 email knacro@etc.a-star.edu.s g  Xiaoying Koh-stenta experimental Therapeutics centre,  a*sTar, 31 Biopolis Way, nanos   03-01, 138669, singapore Tel +65 6407 4135 Fax +65 478 8768 email ckohstenta@etc.a-star.edu.s g Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Koh-Stenta et al Running head recto: Covalent inhibition of dengue virus NS2B/NS3 protease DOI: http://dx.doi.org/10.2147/DDDT.S94207",Non-OADS,/arxiv_data1/oa_pdf/c2/12/dddt-9-6389.PMC4677662.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs117/en /.,Non-OADS,/arxiv_data1/oa_pdf/c2/12/dddt-9-6389.PMC4677662.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c2/12/dddt-9-6389.PMC4677662.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/12/dddt-9-6389.PMC4677662.pdf
" Case Rep Ophthalmol  2015;6:373 –379  DOI: 10.1159/000442084   Published online: November 21, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/15/0063‒0373$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/f4/7f/cop-0006-0373.PMC4677696.pdf
"The dorsal visual stream seems specifically more  Published online: November 24, 2015 EXTRA  Annachiara Cagnin   Department of Neurosciences   University of Padova Medical School   Via Giustiniani 5, IT–35128 Padova (Italy)   E-Mail annachiara.cagnin   @   unipd.it www.karger.com/dee DOI: 10.1159/000441184  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/6b/51/dee-0005-0442.PMC4677697.pdf
" Case Rep Oncol  2015;8:487 –492  DOI: 10.1159/000441413   Published online: November 13, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0487$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/75/f9/cro-0008-0487.PMC4677698.pdf
Available at  http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/75/f9/cro-0008-0487.PMC4677698.pdf
Available at http://globocan.iarc.fr/ia/asia/atlas.html.,Non-OADS,/arxiv_data1/oa_pdf/75/f9/cro-0008-0487.PMC4677698.pdf
Available at  http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm314438.htm.,Non-OADS,/arxiv_data1/oa_pdf/75/f9/cro-0008-0487.PMC4677698.pdf
" Case Rep Dermatol 2015;7:329 –334  DOI: 10.1159/000442017   Published online: November 19, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6567/15/0073‒0329$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/0e/2d/cde-0007-0329.PMC4677700.pdf
karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).,Non-OADS,/arxiv_data1/oa_pdf/da/f4/crg-0009-0366.PMC4677703.pdf
" Case Rep Oncol  2015;8:509 –514  DOI: 10.1159/000441835   Published online: November 21, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0509$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/ac/eb/cro-0008-0509.PMC4677704.pdf
" Case Rep Oncol 2015;8:482 –486  DOI: 10.1159/000439519   Published online: November 10, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/15/0083‒0482$39.50/0   www.karg er.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/32/e4/cro-0008-0482.PMC4677705.pdf
" Case Rep Oncol  2015;8:530 –535  DOI: 10.1159/000442347   Published online: November, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0530$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/ad/32/cro-0008-0530.PMC4677708.pdf
"Sex, race, hyper-tension, myocardial infarction, estimated glomerul ar filtration rate, high-sensitivity C-reactive  Published online: November 11, 2015 EXTRA  Henry E. Wang, MD, MS   Department of Emergency Medicine   University of Alabama at Birmingham    619 19th Street South, OHB 251, Birmingham, AL 35249 (USA)   E-Mail hwang   @   uabmc.edu www.karger.com/nne DOI: 10.1159/000441505  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f7/ef/nne-0005-0087.PMC4677710.pdf
A full list of particip ating REGARDS investigators and  institutions can be found at http://www.regardsstudy.org and ht tp://www.regardssepsis.,Non-OADS,/arxiv_data1/oa_pdf/f7/ef/nne-0005-0087.PMC4677710.pdf
"2005, 2012. http://www.niaaa.nih.gov/guide.",Non-OADS,/arxiv_data1/oa_pdf/f7/ef/nne-0005-0087.PMC4677710.pdf
" Case Rep Oncol  2015;8:503 –508  DOI: 10.1159/000441019   Published online: November 18, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0503$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/47/a2/cro-0008-0503.PMC4677711.pdf
" Case Rep Ophthalmol 2015;6:380 –384  DOI: 10.1159/000442018   Published online: November 21, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/15/0 063‒0380$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/4f/87/cop-0006-0380.PMC4677714.pdf
" Case Rep Oncol  2015;8:520 –525  DOI: 10.1159/000441837   Published online: November 25, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0520$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/7a/2e/cro-0008-0520.PMC4677715.pdf
" Case Rep Oncol 2015;8:493 –497  DOI: 10.1159/000441839   Published online: November 14, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/15/0083‒0493$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribu tion-NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/20/1c/cro-0008-0493.PMC4677718.pdf
" Case Rep Oncol  2015;8:498 –502  DOI: 10.1159/000440662   Published online: November 14, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0498$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/09/ea/cro-0008-0498.PMC4677721.pdf
"Version  3.2014.  http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#occult (accessed  November 30,  2014 ).",Non-OADS,/arxiv_data1/oa_pdf/09/ea/cro-0008-0498.PMC4677721.pdf
" Case Rep Oncol 2015;8:515 –519  DOI: 10.1159/000442149   Published online: November 24, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/15/0083‒0515$39.50/0   www.karger.com/cro   This artic le is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/cb/d6/cro-0008-0515.PMC4677722.pdf
" Case  Rep Oncol  2015;8:526 –529  DOI: 10.1159/000442045   Published online: November 26, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/15/0083‒0526$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/9d/8a/cro-0008-0526.PMC4677723.pdf
" Case Rep Gastroenterol 2015;9:353 –360  DOI: 10.1159/000441385   Published online: November 12, 2015  © 2015 The Author(s)   Published by S. Karger AG, Basel   1662‒0631/15/0093‒0353$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/66/fb/crg-0009-0353.PMC4677725.pdf
" Case Rep Gastroenterol  2015;9:361 –365  DOI: 10.1159/000441999   Published online: November 14, 2015  © 2015 The Author(s)   Published  by S. Karger AG, Basel   1662‒0631/15/0093‒0361$39.50/0   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/99/22/crg-0009-0361.PMC4677735.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f2/93/tcrm-11-1817.PMC4677756.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2015:11 1817–1818Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1817CoMMenT aRyopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9622 2Lung ultrasound for the diagnosis of childhood  pneumonia: a safe and accurate imaging mode Mohamed ata Hendaus1,2 Fatima ahmed Jomha3 ahmed Hassan alhammadi1,2 1Department of Pediatrics, academic  General Pediatrics Division, Hamad  Medical Corporation, Doha,   2Weill Cornell Medical College-Qatar,   al Rayyan, Qatar; 3School of Pharmacy,   Lebanese International University,   Khiara, LebanonAbstract:  Pneumonia is the most common infectious cause of mortality in children worldwide.",Non-OADS,/arxiv_data1/oa_pdf/f2/93/tcrm-11-1817.PMC4677756.pdf
"Lung ultrasound (LUS) has been Correspondence: Mohamed ata Hendaus Department of Pediatrics, academic  General Pediatrics Division, Hamad  Medical Corporation, Doha 3050, Qatar Tel +974 44 392 239 Fax +974 44 439 571 email mhendaus@yahoo.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Commentary Y ear: 2015 Volume: 11 Running head verso: Hendaus et al Running head recto: Lung ultrasound for the diagnosis of childhood pneumonia DOI: http://dx.doi.org/10.2147/TCRM.S96222",Non-OADS,/arxiv_data1/oa_pdf/f2/93/tcrm-11-1817.PMC4677756.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/f2/93/tcrm-11-1817.PMC4677756.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/93/tcrm-11-1817.PMC4677756.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/48/ott-8-3691.PMC4677757.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3691–3701OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3691Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S7880 5Profile of nintedanib in the treatment of solid  tumors: the evidence to date Niranjan Awasthi1 Roderich e Schwarz1,2 1Department of Surgery, Indiana  University School of Medicine, South  Bend, iN, USA; 2indiana University  Health Goshen Center for Cancer  Care, Goshen, iN, USAAbstract:  Angiogenesis is an essential process for tumor growth and metastasis, and remains  a promising therapeutic target process in cancer treatment for several cancer types.",Non-OADS,/arxiv_data1/oa_pdf/c2/48/ott-8-3691.PMC4677757.pdf
"Bevacizumab, a monoclonal antibody that blocks angiogenesis by  binding VEGF-A (a ligand for VEGFR1 and VEGFR2), was the first antiangiogenic Correspondence: Niranjan Awasthi Department of Surgery, Indiana  University School of Medicine, 1234 N   Notre Dame Avenue, South Bend,  IN 46617, USA Tel +1 574 631 5780 Fax +1 574 631 7821 email nawasthi@iupui.ed uJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Awasthi and Schwarz Running head recto: Nintedanib in the treatment of solid tumors DOI: http://dx.doi.org/10.2147/OTT.S78805",Non-OADS,/arxiv_data1/oa_pdf/c2/48/ott-8-3691.PMC4677757.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets­and­therapy­journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c2/48/ott-8-3691.PMC4677757.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/48/ott-8-3691.PMC4677757.pdf
"Available  from: http://trials.boehringer-ingelheim.com/content/dam/internet/opu/ clinicaltrial/com_EN/results/1199/1199.51_U12-2578-02_DR.pd f.  Accessed June 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c2/48/ott-8-3691.PMC4677757.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/4b/ott-8-3707.PMC4677758.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3707–3713OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3707Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9281 5Non-leukemic myeloid sarcoma involving the  vulva, vagina, and cervix: a case report and  literature review Yuan Yu1 Xuemei Qin1 shuxin Yan1 Wenxia Wang2 Yanlin sun3 Maohong Zhang1 1Department of Hematology,   2Department of Gynecology,   3Department of pathology, Qilu  Hospital, shandong University, Jinan,   people’s republic of ChinaAbstract:  Myeloid sarcoma (MS) is defined as a tumor mass consisting of myeloid blast with  or without maturation occurring at an anatomical site other than bone marrow with normal archi - tectural effacement.",Non-OADS,/arxiv_data1/oa_pdf/de/4b/ott-8-3707.PMC4677758.pdf
"We herein report Correspondence: Xuemei Qin Department of Hematology, Qilu  Hospital, shandong University,  107 Wenhua W road, Lixia, shandong  250012, people’s republic of China Tel +86 185 6008 7027 Fax +86 531 8216 9896  email qxmzqw21@126.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Yu et al Running head recto: Non-leukemic myeloid sarcoma involving the vulva, vagina and cervix DOI: http://dx.doi.org/10.2147/OTT.S92815",Non-OADS,/arxiv_data1/oa_pdf/de/4b/ott-8-3707.PMC4677758.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/de/4b/ott-8-3707.PMC4677758.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/4b/ott-8-3707.PMC4677758.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/c6/tcrm-11-1819.PMC4677759.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1819–1827Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1819ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8996 2early myocardial damage assessment in  dystrophinopathies using 99Tcm-MiBi gated  myocardial perfusion imaging li Zhang1,* Zhe liu2,* Ke-Y ou hu3 Qing-Bao Tian3 ling-ge Wei4 Zhe Zhao5 hong-Rui shen5 Jing hu5 1Department of Cardiovascular  Disorders, 2Department of geriatrics,   The Third hospital of hebei Medical  University, 3The Public health  Department, hebei Medical University,   4Department of n uclear Medicine,   5Department of neuromuscular  Disorders, The Third hospital of  hebei Medical University, shijiazhuang,   People’s Republic of China *li Zhang and Zhe liu are first  coauthors of this paperBackground:  Early detection of muscular dystrophy (MD)-associated cardiomyopathy is  important because early medical treatment may slow cardiac remodeling and attenuate symptoms  of cardiac dysfunction; however, no sensitive and standard diagnostic method for MD at an  earlier stage has been well-recognized.",Non-OADS,/arxiv_data1/oa_pdf/af/c6/tcrm-11-1819.PMC4677759.pdf
"DMD  patients have a completely inactive dystrophin protein and BMD patients have reduced  expression of dystrophin, which accounts for the differences between the two types of  MD.2 Patients with DMD and BMD have progressive muscle weakness and muscle  atrophy, which usually appears first in calf skeletal muscles and gradually extends  to the shoulder girdle muscles, smooth muscles, and cardiac muscles.3 Respiratory  failure and/or heart failure are major causes of death for these patients.4 Although skin  biopsies, DNA testing, and electromyography are well-recognized tests for diagnos - ing MD, a standard method in the early detection of the pathophysiologic changes in  cardiac muscle does not exist.5,6Correspondence: Jing hu Department of neuromuscular  Disorders, The Third hospital of hebei  Medical University, nO 139, Ziqiang  Road, 050051 shijiazhuang, hebei  Province, People’s Republic of China Tel +86 311 8860 2057 Fax +86 311 8860 2057 email jinghu201501@sina.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Zhang et al Running head recto: 99Tcm-MIBI G-MPI in cardiac dystrophinopathies DOI: http://dx.doi.org/10.2147/TCRM.S89962",Non-OADS,/arxiv_data1/oa_pdf/af/c6/tcrm-11-1819.PMC4677759.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/af/c6/tcrm-11-1819.PMC4677759.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/c6/tcrm-11-1819.PMC4677759.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/ee/ott-8-3703.PMC4677760.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3703–3706OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3703Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9027 2correlations between plasma endothelin-1 levels  and breakthrough pain in patients with cancer Xue-bin Yan T uo-chao Peng Dong huang Department of anesthesiologist, The  Third Xiangya hospital of central  south University, changsha, hunan  Province, People’s republic of chinaAbstract:  Endothelin-1 (ET-1) may be involved in driving pain in patients with advanced  cancer.",Non-OADS,/arxiv_data1/oa_pdf/4a/ee/ott-8-3703.PMC4677760.pdf
"Subcutaneous administration of ET-1  to a rat induces pain-like behavior and excites the nociceptive fibers selectively through  the activation of ETA receptors.8,10 The levels of ET-1 are significantly increased in  blister fluid in the complex regional pain syndrome type 1.11 ET-1 may be directly or  indirectly involved in driving pain in patients with advanced cancer.12 However, there  are a few studies13 that focus on the role of ET-1 in BP.correspondence: Dong huang Department of anesthesiologist,  The Third Xiangya hospital of central  south University, 138 Tongzipo road,  Yuelu District, changsha 410013, hunan  Province, People’s republic of china Tel +86 731 8861 8150 Fax +86 731 8861 8151 email donghuanghd@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Y an et al Running head recto: Correlations between ET-1 level and BP DOI: http://dx.doi.org/10.2147/OTT.S90272",Non-OADS,/arxiv_data1/oa_pdf/4a/ee/ott-8-3703.PMC4677760.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4a/ee/ott-8-3703.PMC4677760.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/ee/ott-8-3703.PMC4677760.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/44/ppa-9-1733.PMC4677761.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1733–1740Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1733OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9212 5Patient-reported adverse drug reactions and  their influence on adherence and quality of life  of chronic myeloid leukemia patients on per oral  tyrosine kinase inhibitor treatment Meri Kekäle1 Marikki Peltoniemi2 Marja Airaksinen1 1Clinical Pharmacy Group, Division of  Pharmacology and Pharmacotherapy,   2Division of Pharmaceutical Chemistry  and T echnology, Faculty of Pharmacy,   University of Helsinki, Helsinki,   FinlandPurpose:  To evaluate adverse drug reactions (ADRs) experienced by chronic myeloid leukemia  (CML) patients during per oral tyrosine kinase inhibitor (TKI) treatment and correlation of ADR  symptoms with medication adherence and perceived quality of life (QoL).",Non-OADS,/arxiv_data1/oa_pdf/95/44/ppa-9-1733.PMC4677761.pdf
"CML patients treated with TKIs have good survival rates: patients treated  with imatinib have been shown to have an estimated overall survival rate of 85% Correspondence: Meri Kekäle Clinical Pharmacy Group, Division of  Pharmacology and Pharmacotherapy,  Faculty of Pharmacy, University of  Helsinki, Linderinpolku 51, Hyvinkää  05720, Finland Tel +358 40 777 7080 email meri.kekale@helsinki.fi  Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kekäle et al Running head recto: Influence of patient-reported ADRs on QoL in CML patients on TKI inhibitors DOI: http://dx.doi.org/10.2147/PPA.S92125",Non-OADS,/arxiv_data1/oa_pdf/95/44/ppa-9-1733.PMC4677761.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/95/44/ppa-9-1733.PMC4677761.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/4e/ndt-11-3019.PMC4677762.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3019–3021Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3019Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9177 1severe arrhythmia induced by orally disintegrating  aripiprazole tablets (Bosiqing®): a case report Qing shao1,2,* Wei Quan1,2,* Xiaoni Jia1 Jianbo Chen1 shanbo Ma3 Xiaohong Zhang1 1Xi’an Mental Health Center, Institute  of Mental Health, Xi’an Medical  University, Xi’an, shaanxi, people’s  republic of China; 2Institute of  Materia Medica, school of p harmacy,   Fourth Military Medical University,   Xi’an, shaanxi, people’s republic of  China; 3Department of pharmacy,   Xijing Hospital, Fourth Military  Medical University, Xi’an, shaanxi,   people’s republic of China *These authors contributed equally  to this workAbstract:  Psychotropic medications have been known to cause cardiac conduction disturbances.",Non-OADS,/arxiv_data1/oa_pdf/d0/4e/ndt-11-3019.PMC4677762.pdf
"An ambulatory electrocardiogram (ECG) examination taken at Xi’an Children’s  Hospital indicated negative results, and normal results were obtained from all other  examinations, including blood biochemistry, prolactin levels, thyroid function, and Correspondence: Xiaohong Zhang Xi’an Mental Health Center, Institute of  Mental Health, Xi’an Medical University,  No 15 Yanyin road, Qujiang New  District, Xi’an, shaanxi 710061, people’s  republic of China Tel +86 29 8555 1351 email xajwzxyjk@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Shao et al Running head recto: Severe arrhythmia induced by orally disintegrating aripiprazole tablets DOI: http://dx.doi.org/10.2147/NDT.S91771",Non-OADS,/arxiv_data1/oa_pdf/d0/4e/ndt-11-3019.PMC4677762.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d0/4e/ndt-11-3019.PMC4677762.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/4e/ndt-11-3019.PMC4677762.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/ab/ott-8-3649.PMC4677763.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3649–3664OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3649Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9451 3echinacoside induces apoptotic cancer cell death  by inhibiting the nucleotide pool sanitizing enzyme  MTh1 liwei Dong1 hongge Wang1 Jiajing niu1 Mingwei Zou2 nuoting Wu1 Debin Yu1 Ye Wang1 Zhihua Zou1 1Key laboratory for Molecular  enzymology and engineering of the  Ministry of education, national  engineering laboratory for aiDs  Vaccine, school of life sciences,   Jilin University, changchun, Jilin  Province, People’s republic of china;   2Department of Psychology, college  of liberal arts and social sciences,   University of houston, houston,   TX, UsaAbstract:  Inhibition of the nucleotide pool sanitizing enzyme MTH1 causes extensive oxidative  DNA damages and apoptosis in cancer cells and hence may be used as an anticancer strategy.",Non-OADS,/arxiv_data1/oa_pdf/08/ab/ott-8-3649.PMC4677763.pdf
"Nucleotide pool sanitizing enzymes hydrolyze oxi - dized dNTPs and NTPs, thus preventing their incorporation into DNA and RNA  molecules.11,12 MTH1, a member of the Nudix hydrolase superfamily (hence also called  NUDT1),13 is a triphosphatase responsible for removing oxidized purine NTPs and  dNTPs (8-oxodGTP, 2-OH-dATP, 8-OH-GTP, and 2-OH-ATP) from the nucleotide  pools.14 Since 8-oxoguanine (8-oxoG) is the major oxidized base inside cells, MTH1 is correspondence: Zhihua Zou school of life sciences, Jilin University,  2699 Qianjin street, changchun, Jilin  Province 130012, People’s republic  of china Tel +86 431 8515 5349 Fax +86 431 8515 5349 email zouzh@jlu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Dong et al Running head recto: Echinacoside induces apoptotic cancer cell death by inhibiting MTH1 DOI: http://dx.doi.org/10.2147/OTT.S94513",Non-OADS,/arxiv_data1/oa_pdf/08/ab/ott-8-3649.PMC4677763.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/08/ab/ott-8-3649.PMC4677763.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/ab/ott-8-3649.PMC4677763.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/06/7f/ndt-11-3041.PMC4677764.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3041–3048Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3041OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9655 9coping strategies and quality of life in  schizophrenia: cross-sectional study Michaela holubova1 Jan Prasko1,2 radovan hruby3 Dana Kamaradova1,2 Marie Ociskova1,2 Klara latalova1,2 ales grambal1,2 1Department of Psychiatry, Faculty  of Medicine and Dentistry, Palacký  University, Olomouc, czech republic;   2Department of Psychiatry, University  hospital Olomouc, czech Ministry  of health, Olomouc, czech republic;   3Psychiatric Outpatient Department,   Martin, slovak republicBackground:  The modern psychiatric view of schizophrenia spectrum disorders and their  treatment has led to an increasing focus on coping strategies and the quality of life of these  patients.",Non-OADS,/arxiv_data1/oa_pdf/06/7f/ndt-11-3041.PMC4677764.pdf
"People  with psychotic disorders have been found to use predominately maladaptive cop - ing strategies.4 Ritsner et al5 addressed the question whether diverse coping styles correspondence: Michaela holubova Department of Psychiatry, Faculty  of Medicine and Dentistry, Palacký  University Olomouc, i.P.Pavlova 6, 77520  Olomouc, czech republic Tel +420 732 536 374 email holubova.mi@seznam.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Holubova et al Running head recto: Coping strategies and quality of life in schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S96559",Non-OADS,/arxiv_data1/oa_pdf/06/7f/ndt-11-3041.PMC4677764.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/06/7f/ndt-11-3041.PMC4677764.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/7f/ndt-11-3041.PMC4677764.pdf
"Avail - able from: http://www.ema.europa.eu/pdfs/human/ich/013595en.pd f.  Accessed March 20, 2009.",Non-OADS,/arxiv_data1/oa_pdf/06/7f/ndt-11-3041.PMC4677764.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/66/lra-8-113.PMC4677765.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 113–117Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  113Comment ARyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/LRA.S9625 3evolution of transversus abdominis plane  infiltration techniques for postsurgical analgesia  following abdominal surgeries Jeffrey Gadsden1 Sabry Ayad2 Jeffrey J Gonzales3 Jaideep mehta4 Jan Boublik5 Jacob Hutchins6,7 1Department of Anesthesiology, Duke  University medical Center, Durham,   nC, 2Department of Anesthesiology  and Pain management, Cleveland  Clinic, Cleveland, oH, 3Department  of Anesthesiology, University of  Colorado Hospital, Aurora, Co ,   4Department of Anesthesiology, U t  Health, the University of texas Health  Science Center at Houston, Houston,   tX, 5Department of Anesthesiology,   nyU Langone medical Center –  Hospital for Joint Diseases, new york,   ny, 6Department of Anesthesiology,   7Department of Surgery, University of  minnesota, minneapolis, mn, USA Correspondence: Jeffrey Gadsden   Department of Anesthesiology,   Duke University medical Center,   2301 erwin Road, Durham,   nC 27705-4699, USA   tel +1 919 681 6437  Fax +1 919 684 8994  email jeffgadsden@gmail.co mAbstract:  Transversus abdominis plane (TAP) infiltration is a regional anesthesia technique  that has been demonstrated to be effective for management of postsurgical pain after abdomi - nal surgery.",Non-OADS,/arxiv_data1/oa_pdf/b5/66/lra-8-113.PMC4677765.pdf
"2008;24(1):  24–29.13 http://www.wfsahq.org/resources/update-in-anaesthesi a. Abbreviations:  EX OBL, external oblique; LAT DORSI, latissimus dorsi.",Non-OADS,/arxiv_data1/oa_pdf/b5/66/lra-8-113.PMC4677765.pdf
"Rijeka, Croatia:  InTech;  2012:69–94 ( https://creativecommons.org/licenses/by-nc/4.0 /).19 Abbreviations:  EO, external oblique; IO, internal oblique; TA, transversus abdominis; PC, peritoneal cavity.",Non-OADS,/arxiv_data1/oa_pdf/b5/66/lra-8-113.PMC4677765.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/b5/66/lra-8-113.PMC4677765.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/66/lra-8-113.PMC4677765.pdf
"Available from: http://www.nysora.com/regional-anesthesia/4340- keys-to-success-with-peripheral-nerve-blocks.htm l. Accessed June  30,  2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/66/lra-8-113.PMC4677765.pdf
"Available from: http://www.nysora.com/educational- tools/3222-nysora-educational-posters.htm l. Accessed June  30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/66/lra-8-113.PMC4677765.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/75/ndt-11-3031.PMC4677766.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3031–3040Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3031OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9506 7Milnacipran treatment and potential biomarkers  in depressed patients following an initial ssri  treatment failure: a prospective, open-label,   24-week study Tasuku hashimoto1,2 Daiji sakurai1 Yasunori Oda1 Tadashi hasegawa3 Nobuhisa Kanahara4 Tsuyoshi sasaki3 hideki Komatsu3,5 Junpei Takahashi1,5 Takahiro Oiwa6 Y oshimoto sekine4,5 hiroyuki Watanabe1 Masaomi iyo1,3 1Department of Psychiatry, chiba  University graduate school of  Medicine, 2sodegaura satsukidai  hospital, 3Department of Psychiatry,   chiba University hospital, 4Division   of Medical Treatment and  rehabilitation, centre for Forensic  Mental health, chiba University,   5choshi Kokoro clinic, 6Mobara  shinkeika hospital, chiba, JapanBackground:  We assessed the effect of switching patients with major depressive disorder to  milnacipran following an initial selective serotonin reuptake inhibitor treatment failure, and  explored potential biomarkers in their blood.",Non-OADS,/arxiv_data1/oa_pdf/c5/75/ndt-11-3031.PMC4677766.pdf
"As the name suggests, mil - nacipran inhibits both serotonin and norepinephrine reuptake through high-affinity correspondence: Tasuku hashimoto Department of Psychiatry, chiba  University graduate school of Medicine,  1-8-1 inohana, chuo-ku, chiba 260-8670,  Japan Tel +81 43 226 2148 Fax +81 43 226 2150 email t-hashimoto@faculty.chiba-u.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Hashimoto et al Running head recto: Milnacipran and biomarkers in major depression DOI: http://dx.doi.org/10.2147/NDT.S95067",Non-OADS,/arxiv_data1/oa_pdf/c5/75/ndt-11-3031.PMC4677766.pdf
"Reference values provided by SRL on the basis of data from more  than 100 healthy people were whole blood levels of serotonin,  57–230 (ng/mL); plasma levels of 5-HIAA, 1.0–6.0 (ng/mL);   HVA, 4.4–15.1 (ng/mL); and MHPG 3.2–5.9 (ng/mL) (SRL,  http://www.srl-group.co.jp /).",Non-OADS,/arxiv_data1/oa_pdf/c5/75/ndt-11-3031.PMC4677766.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c5/75/ndt-11-3031.PMC4677766.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/75/ndt-11-3031.PMC4677766.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/28/ijwh-7-949.PMC4677767.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 949–955International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  949OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S9468 0comparison of obstetric anal sphincter injuries in  nulliparous women before and after introduction  of the ePIscIssOrs-60® at two hospitals in  the United Kingdom Yves van roon1 ciara Kirwin2 nadia rahman3 latha Vinayakarao2 louise Melson2 nikki Kester1 sangeeta Pathak1 ashish Pradhan1 1Department of Obstetrics and  gynecology, Hinchingbrooke Hospital,  Huntingdon, 2Department of Obstetrics  and gynecology, Poole Hospital, Poole,   3Department of Obstetrics and  gynecology,  addenbrookes Hospital,  cambridge, UKAim:  To assess whether the introduction of episiotomy scissors specially designed to achieve a  cutting angle of 60 °, EPISCISSORS-60®, in two hospitals in the UK would result in a reduction  in obstetric anal sphincter injuries (OASIS) in nulliparous women.",Non-OADS,/arxiv_data1/oa_pdf/23/28/ijwh-7-949.PMC4677767.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/23/28/ijwh-7-949.PMC4677767.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/28/ijwh-7-949.PMC4677767.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/22/ndt-11-3023.PMC4677768.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 3023–3029Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3023OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9240 8Stress and its association with working efficiency  of junior doctors during three postgraduate  residency training programs hamza Mohammad  abdulghani1 Mohammed Meteb al-harbi2 Mohammad irshad1 1Department of Medical education,   2Department of Family and  community Medicine, college of  Medicine, King saud University,   riyadh, Kingdom of saudi arabiaBackground:  The residency training period in the medical profession is well known for  physical and mental stress, which may affect cognitive function and practical life.",Non-OADS,/arxiv_data1/oa_pdf/ec/22/ndt-11-3023.PMC4677768.pdf
"Keywords:  postgraduate, stress, residency training, specialties Introduction Emotional impairment, depression, and burnout are commonly reported during  residency training programs.1,2 These symptoms generally increase due to the high  expectation of proficient clinicians, educators, researchers, and administrators at the  end of the training programs.3 Some recent studies reported that during residency  training, residents are becoming more cynical, less humanistic, depressive, and even  reach the burnout stage.4–6correspondence: hamza Mohammad  abdulghani Department of Medical education,  college of Medicine, King saud  University, PO Box 230 155, riyadh  11321, Kingdom of saudi arabia Tel +966 11 469 9177 Fax +966 11 467 1967 email hamzaabg@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Abdulghani et al Running head recto: Stress during postgraduate training programs DOI: http://dx.doi.org/10.2147/NDT.S92408 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/ec/22/ndt-11-3023.PMC4677768.pdf
Or use: http://youtu.be/L3mD1IGSbA IVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/ec/22/ndt-11-3023.PMC4677768.pdf
"Available from: http://learn.fi.edu/learn/brain/ stress.htm l. Accessed June 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ec/22/ndt-11-3023.PMC4677768.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ec/22/ndt-11-3023.PMC4677768.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/22/ndt-11-3023.PMC4677768.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8f/6b/tcrm-11-1813.PMC4677769.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1813–1816Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1813Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9048 8Docetaxel-related interstitial pneumonitis Chung-Jen Wang Hou-Tai Chang Cheng-Yu Chang Division of Chest Medicine,   Department of Internal Medicine,   Far eastern Memorial Hospital, New  Taipei City, TaiwanAbstract:  Docetaxel (Taxotere®) is an agent that is indicated for the treatment of patients with  locally advanced or metastatic non-small-cell lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/8f/6b/tcrm-11-1813.PMC4677769.pdf
"He also received serological tests, sputum culture, blood culture, Legionella  pneumophila , Mycoplasma pneumoniae , Chlamydophila pneumonia , influenza virus Correspondence: Cheng-Yu Chang Division of Chest Medicine, Department  of Internal Medicine, Far eastern  Memorial Hospital, No 21, section 2,   Nanya s Road, Banciao District, New  Taipei City 220, Taiwan Tel +886 2 8966 7000 ext 88252 Fax +886 2 7738 0708 email koala2716@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Wang et al Running head recto: Docetaxel-related interstitial lung disease DOI: http://dx.doi.org/10.2147/TCRM.S90488",Non-OADS,/arxiv_data1/oa_pdf/8f/6b/tcrm-11-1813.PMC4677769.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/8f/6b/tcrm-11-1813.PMC4677769.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/6b/tcrm-11-1813.PMC4677769.pdf
"We also would like tothank all the NASA DC8 crew for their assistance to integrate, maintain, and deintegrate the instrument on the airplane.The data are publicly available at NASAdata achieve https://www-air.larc.nasa.gov/ cgi-bin/ArcView/dc3-seac4rs and http:// www-air.larc.nasa.gov/missions/seac4rs/index.html.",Non-OADS,/arxiv_data1/oa_pdf/7d/ef/jgrd0120-2990.PMC4677836.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/25/dev293.PMC4677967.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/63/dev294.PMC4677968.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/fc/bhv232.PMC4677985.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/43/bhv262.PMC4677987.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/35/43/bhv262.PMC4677987.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/9e/bhv269.PMC4677988.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3f/26/4524.PMC4678010.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4f/2d/4532.PMC4678011.pdf
"Dictyostelium  (http://dictybase.org ) and  Arabidopsis  (www.arabidopsis.org) are particularly well-developed  systems; although not mentioned explicitly here, work in the api - complexan Toxoplasma gondii  (Kim and Weiss, 2004) and the exca - vate Trypanosoma brucei  (Barry et al.",Non-OADS,/arxiv_data1/oa_pdf/4f/2d/4532.PMC4678011.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fc/8f/4539.PMC4678012.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/55/ec/4541.PMC4678013.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/04/e8/4552.PMC4678014.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/65/ca/4562.PMC4678015.pdf
"MT-interacting CH domain is marked in red, EB1-homology motif in blue,  and predicted NLS in yellow (we used both SeqNLS [http://mleg.cse.sc.edu/seqNLS/; Lin et al.",OADS,/arxiv_data1/oa_pdf/65/ca/4562.PMC4678015.pdf
", 2012] and cNLSmapper  [http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi; Kosugi et al.",OADS,/arxiv_data1/oa_pdf/65/ca/4562.PMC4678015.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/78/ca/4577.PMC4678016.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/23/7c/4589.PMC4678017.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/88/14/4607.PMC4678018.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1c/af/4618.PMC4678019.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/73/40/4631.PMC4678020.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/17/98/4646.PMC4678021.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative  Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ec/3c/4660.PMC4678022.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/87/37/4674.PMC4678023.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c8/85/4686.PMC4678024.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0c/de/4700.PMC4678025.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/35/3a/4718.PMC4678026.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/89/civ680.PMC4678103.pdf
"The Ebola medical treatment team in the 34th Regiment Hospital Freetown, Sierra Leone, has been administering CWB, as per WHO guidance, for compassionate use from De-cember 2014 to March 2015 ( http://awoko.org/2014/12/09/ sierra-leone-news-convalesce nt-blood-treatment-started/ ).",Non-OADS,/arxiv_data1/oa_pdf/d9/89/civ680.PMC4678103.pdf
"During the EVD out-break, effective plasmapheresis teams were assembled relatively quickly, mainly in mobile plasma units or “plasma mobiles ” (http://www.gatesfoundation.org/Media-Center/Press-Releases/ 2014/11/Support-to-Ebola-Affected-Countries-Announcement ), and national blood transfusion teams trained.",Non-OADS,/arxiv_data1/oa_pdf/d9/89/civ680.PMC4678103.pdf
Animal production of hyperim- mune globulins is also under exploration ( http://www.fabentechcom/technologie/technology/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/89/civ680.PMC4678103.pdf
"Putative transcription factor binding sites  in the human OSX gene promoter sequence were identified  using online PROMO software (http://alggen.lsi.upc.es/cgi-bin/ promo_v3/promo/promoinit.cgi?dirDB=TF_8.3) , as previously  described  (11,12).Stable transfection and lentiviral transduction.",OADS,/arxiv_data1/oa_pdf/a2/d0/ijmm-36-06-1572.PMC4678161.pdf
"13 Prior studies of patiromer have focused on its efficacy, safety, and tolerability in the treatment of hyperkalemichttp://www.kidney-international.org clinical trial © 2015 International Society of Nephrology Correspondence: David A. Bushinsky, Division of Nephrology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 675, Rochester, NewYork 14642, USA.",Non-OADS,/arxiv_data1/oa_pdf/a2/19/ki2015270a.PMC4678168.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Kidney International (2015) 88, 1427 –1433 1433DA Bushinsky et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/19/ki2015270a.PMC4678168.pdf
"The evidencehttp://www.kidney-international.org clinical investigation © 2015 International Society of Nephrology Correspondence: Giacomo Garibotto, Department of Internal Medicine, Nephrology Division, University of Genoa, Viale Benedetto, XV, 6, Genoa16132, Italy.",Non-OADS,/arxiv_data1/oa_pdf/e0/91/ki2015247a.PMC4678169.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc- nd/4.0/ 1426 Kidney International (2015) 88, 1419 –1426clinical investigation G Garibotto et al.",Non-OADS,/arxiv_data1/oa_pdf/e0/91/ki2015247a.PMC4678169.pdf
Creative Commons Attribution Non-Commercial No Derivatives 3.0 License: https://creativecommons.org/licenses/by-nc-nd/3.0/us/ INTRODUCTION Lung cancer remains the leading cause of cancer- related mortality in the United States.1Small-cell lung cancer (SCLC) represents approximately 15%of new lung cancer diagnoses each year.,Non-OADS,/arxiv_data1/oa_pdf/e7/51/zlj4240.PMC4678178.pdf
"Creative Commons Attribution Non-Commercial No Derivatives 3.0 License: https://creativecommons.org/licenses/by-nc-nd/3.0/us/ INTRODUCTION Pancreatic cancer (PC) is the fourth leading cause of cancer mortality in the United States, with 38,460deaths annually.",Non-OADS,/arxiv_data1/oa_pdf/89/ac/zlj4284.PMC4678179.pdf
Creative Commons Attribution Non-Commercial No Derivatives 3.0 License: https://creativecommons.org/licenses/by-nc-nd/3.0/us/ INTRODUCTION Ovarian cancer (OC) and endometrial cancer (EC) account for almost 40% of deaths from gynecologiccancers and share some similarities.,Non-OADS,/arxiv_data1/oa_pdf/c2/ab/zlj4293.PMC4678180.pdf
Creative Commons Attribution Non-Commercial No Derivatives 3.0 License: https://creativecommons.org/licenses/by-nc-nd/3.0/us/ INTRODUCTION Endometrial cancer (EC) is the second most com- mon malignancy in patients with Lynch syndrome(LS).,Non-OADS,/arxiv_data1/oa_pdf/1e/71/zlj4301.PMC4678181.pdf
Normal DNA from 51 patient cases of probable mutation with sufﬁcient high-quality DNA available were tested for LS mutations using ColoSeq(http://tests.labmed.washington.edu/COLOSEQ ).,OADS,/arxiv_data1/oa_pdf/1e/71/zlj4301.PMC4678181.pdf
"Keywords:  Knee, Arthroplasty, Korean, Ethnic differenceReview Article Knee Surg Relat Res 2015;27(4):199-206 http://dx.doi.org/10.5792/ksrr.2015.27.4.199 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received August 23, 2015; Revised September 23, 2015;   Accepted September 24, 2015 Correspondence to: Kang-Il Kim, MD Department of Orthopaedic Surgery, Center for Joint Diseases and  Rheumatism, Kyung Hee University Hospital at Gangdong, 892  Dongnam-ro, Gangdong-gu, Seoul 05278, Korea Tel: +82-2-440-6151, Fax: +82-2-440-6296 E-mail: khuknee@gmail.com 199This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/7d/ksrr-27-199.PMC4678240.pdf
http://dx.doi.org/10.3109/17453 674.2015.1073539.,Non-OADS,/arxiv_data1/oa_pdf/f9/7d/ksrr-27-199.PMC4678240.pdf
"Keywords:  Knee, Osteoarthritis, Osteotomy, Bone graft, Meta-analysisReview Article Knee Surg Relat Res 2015;27(4):207-220 http://dx.doi.org/10.5792/ksrr.2015.27.4.207 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received September 21, 2014; Revised (1st) May 10, 2015;   (2nd) September 14, 2015; Accepted September 17, 2015 Correspondence to: Kyung-Wook Nha, MD Department of Orthopaedic Surgery, Inje University Ilsan Paik Hospital,  170 Juhwa-ro, Ilsanseo-gu, Goyang 10380, Korea Tel: +82-31-910-7312, Fax: +82-31-910-7319 E-mail: kwnhamj@hotmail.com 207This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/cb/ksrr-27-207.PMC4678241.pdf
"Keywords:  Knee, Osteoarthritis, Arthroplasty, Octogenarian, Clinical assessment scoresOriginal Article Knee Surg Relat Res 2015;27(4):221-227 http://dx.doi.org/10.5792/ksrr.2015.27.4.221 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received November 25, 2014; Revised (1st) April 1, 2015;   (2nd) May 12, 2015; (3rd) May 18, 2015; (4th) July 18, 2015;   (5th) July 21, 2015; Accepted July 30, 2015 Correspondence to: Byung Hoon Lee, MD Department of Orthopaedic Surgery, Hallym University Kangdong  Sacred Heart Hospital, 150 Seongan-ro, Gangdong-gu, Seoul 05355,  Korea Tel: +82-2-3410-3509, Fax: +82-2-3410-0061 E-mail: oselite@naver.com 221This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/bc/ksrr-27-221.PMC4678242.pdf
"Keywords:  Knee, Osteoarthritis, Intra-articular injectionOriginal Article Knee Surg Relat Res 2015;27(4):228-232 http://dx.doi.org/10.5792/ksrr.2015.27.4.228 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 13, 2015; Accepted April 13, 2015 Correspondence to: Tae Kyun Kim, MD Department of Orthopaedic Surgery, Seoul National University Bundang  Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620,  Korea Tel: +82-31-787-7196, Fax: +82-31-787-4056 E-mail: osktk@snubh.org 228This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/db/ksrr-27-228.PMC4678243.pdf
"Keywords:  Knee, Arthroplasty, Stiffness, ManipulationOriginal Article Knee Surg Relat Res 2015;27(4):233-239 http://dx.doi.org/10.5792/ksrr.2015.27.4.233 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received May 12, 2015; Revised August 1, 2015;   Accepted August 17, 2015 Correspondence to: Hyun-Cheol Oh, MD Department of Orthopedic Surgery, National Health Insurance  Corporation Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 10444,  Korea Tel: +82-31-900-0441, Fax: +82-31-900-0343 E-mail: hyuncoh@hanmail.net 233This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/59/ksrr-27-233.PMC4678244.pdf
"Keywords:  Knee, Arthroplasty, Prosthesis design, Quadriceps muscle, Muscle strength dynamometerOriginal Article Knee Surg Relat Res 2015;27(4):240-246 http://dx.doi.org/10.5792/ksrr.2015.27.4.240 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received June 10, 2015; Revised September 21, 2015;   Accepted October 19, 2015 Correspondence to: Kang-Il Kim, MD Department of Orthopaedic Surgery, Center for Joint Diseases and  Rheumatism, Kyung Hee University Hospital at Gangdong, 892  Dongnam-ro, Gangdong-gu, Seoul 05278, Korea Tel: +82-2-440-6151, Fax: +82-2-440-6296 E-mail: drkim@khu.ac.kr 240This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/22/ksrr-27-240.PMC4678245.pdf
"Keywords:  Knee, Anterior cruciate ligament, Outside-in technique, Tunnel enlargementOriginal Article Knee Surg Relat Res 2015;27(4):247-254 http://dx.doi.org/10.5792/ksrr.2015.27.4.247 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received May 20, 2015; Revised (1st) September 26, 2015;   (2nd) October 4, 2015; Accepted October 5, 2015 Correspondence to: Jae-Doo Y oo, MD Department of Orthopedic Surgery, Ewha Womans University Mokdong  Hospital, 1071 Anyangcheon-ro, Y angcheon-gu, Seoul 07985, Korea Tel: +82-2-2650-6142, Fax: +82-2-2642-0349 E-mail: koreanknee@gmail.com 247This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/68/ksrr-27-247.PMC4678246.pdf
"Keywords:  Knee, Popliteal ganglion cyst, Intra-articular, Magnetic resonance imaging, Combined excisionOriginal Article Knee Surg Relat Res 2015;27(4):255-262 http://dx.doi.org/10.5792/ksrr.2015.27.4.255 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received May 8, 2015; Revised June 22, 2015;   Accepted June 23, 2015 Correspondence to: Jae-Jung Jeong, MD Department of Orthopedic Surgery, Daejeon St. Mary Hospital, The  Catholic University of Korea College of Medicine, 64 Daeheung-ro,  Jung-gu, Daejeon 34943, Korea Tel: +82-42-220-9530, Fax: +82-42-221-0429 E-mail: jjeong@catholic.ac.kr 255This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/e5/ksrr-27-255.PMC4678247.pdf
"Keywords:  Osteochondritis dissecans, Autologous transplantation , Internal fixationCase Report Knee Surg Relat Res 2015;27(4):263-268 http://dx.doi.org/10.5792/ksrr.2015.27.4.263 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 13, 2015; Revised May 6, 2015;   Accepted June 1, 2015 Correspondence to: Byoung Min Kim, MD Department of Orthopedic Surgery, Soonchunhyang University  Hospital, 59 Daesagwan-ro, Y ongsan-gu, Seoul 04401, Korea Tel: +82-2-709-9253, Fax: +82-2-794-9414 E-mail: stompower@hanmail.net 263This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/dc/ksrr-27-263.PMC4678248.pdf
"Keywords:  Knee, Tibial cyst, Anterior cruciate ligament reconstruction, Interference screw, MetalCase Report Knee Surg Relat Res 2015;27(4):269-273 http://dx.doi.org/10.5792/ksrr.2015.27.4.269 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received November 14, 2014; Revised (1st) January 7, 2015;  (2nd) April 12, 2015; Accepted May 14, 2015 Correspondence to: Deepu Bhaskar, MS  Department of Trauma and Orthopaedics, Blackpool Victoria Hospital,  Whinney Heys Road, Blackpool, Lancashire, FY3 8NR, UK Tel: +44-01253-300000, Fax: +44-01253-300000 E-mail: deepu.bhaskar@gmail.com 269This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/6f/ksrr-27-269.PMC4678249.pdf
"Keywords:  Posterior cruciate ligament, Popliteal artery, Tibial inlay techniqueCase Report Knee Surg Relat Res 2015;27(4):274-277 http://dx.doi.org/10.5792/ksrr.2015.27.4.274 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received July 27, 2015; Revised October 13, 2015;   Accepted November 3, 2015 Correspondence to: Jin Hyeok Seo, MD Department of Orthopedics, Bumin Hospital, 380-4 Deokcheon 1-dong,  Buk-gu, Busan 46555, Korea Tel: +82-51-330-3082, Fax: +82-51-330-3075 E-mail: md98hyuk@hanmail.net 274This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/88/ksrr-27-274.PMC4678250.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
"Apart from the nodeslider move that affects two branch lengths, stand-alone branch multipliers are used to integrate overbranches in MrBayes (for details on any of the aforementioned proposals, see Supplementary Materialon Dryad at http://dx.doi.org/10.5061/dryad.63pm5 ).",Non-OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
Associated log posteriordensity curves show a short left tail and a longright tail (see Supplementary Figure 2 on Dryad athttp://dx.doi.org/10.5061/dryad.63pm5 ).,OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
"Finally , we observeda linear relationship between the skewness and thecoefﬁcient of variation (deﬁned as cv= /.0027 /.0022) of posterior distributions (see Supplementary Figure 3 on Dryad athttp://dx.doi.org/10.5061/dryad.63pm5 ).",Non-OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
"Given an empiricallyinferred branch CPD and a candidate proposal densityqwith parameters (ﬁtted to this CPD), we analytically derived the expected acceptance ratio for using qas an independence branch sampler to integrate over thisbranch length (see Supplementary Material on Dryad athttp://dx.doi.org/10.5061/dryad.63pm5 ).",Non-OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
"This is not the case for the parameters ofthe Weibull distribution, where numerical methods forroot ﬁnding are required (see Supplementary Materialon Dryad at http://dx.doi.org/10.5061/dryad.63pm5 ).",Non-OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
"Thus, we chose to set d=2t o account for the increased expected value of the posteriormean in these cases (see Supplementary Material onDryad at http://dx.doi.org/10.5061/dryad.63pm5 for details).",Non-OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
"In some cases, means of branch length CPDs are decreased by three orders of magnitudeafter applying the move (see Supplementary Materialon Dryad at http://dx.doi.org/10.5061/dryad.63pm5 ).",Non-OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
"7and Supplementary Figure 10 on Dryad athttp://dx.doi.org/10.5061/dryad.63pm5 ), we obtain less extreme ratios.",Non-OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
"After 1,000,000generations, we determined the average standard deviation of split frequencies (ASDSF) of sampled trees to a reference tree set created for the respective data set(see Table 1, see Supplementary Material on Dryad at http://dx.doi.org/10.5061/dryad.63pm5 for details).",OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
"8 for data sets discussed here, and Supplementary Figure on Dryad athttp://dx.doi.org/10.5061/dryad.63pm5 for remaining data sets).",OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
S UPPLEMENTARY MATERIAL Data available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.63pm5 .,OADS,/arxiv_data1/oa_pdf/40/cd/syv051.PMC4678251.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/33/syv065.PMC4678252.pdf
"(2) Taking gto be the gamma density , we have a constant extinction rate /.0022(a)=1//.0018 if and only if k=1, i.e., in the special case of an exponentially distributed lifetime.When k/negationslash=1, there is no explicit formula for /.0022(a), but it can be shown (see Supplementary Text available on Dryadathttp://dx.doi.org/10.5061/dryad.7894h ) that for k<1 the extinction rate decreases with age, while for k>1t h e extinction rate increases with age.",Non-OADS,/arxiv_data1/oa_pdf/38/33/syv065.PMC4678252.pdf
Our Matlab source code and compiled application ﬁlesare available to download from https://github.com/ cevo-public .,OADS,/arxiv_data1/oa_pdf/38/33/syv065.PMC4678252.pdf
"2012 ), yielding a posterior distribution of trees available at http://birdtree.org .",Non-OADS,/arxiv_data1/oa_pdf/38/33/syv065.PMC4678252.pdf
SUPPLEMENTARY MATERIALS Data available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.7894h .,OADS,/arxiv_data1/oa_pdf/38/33/syv065.PMC4678252.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/39/syv074.PMC4678254.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/syv075.PMC4678255.pdf
"The compilation also includes the geologicalage (online Supplementary Data File S1, availableon Dryad at http://dx.doi.org/10.5061/dryad.4nd2j ), determined as accurately as possible.",OADS,/arxiv_data1/oa_pdf/ba/24/syv075.PMC4678255.pdf
"T ypically , this is at alower level than epoch, and using the land mammal ages.The compilation also includes the phylogenetic position(online Supplementary Data File S2, available on Dryadathttp://dx.doi.org/10.5061/dryad.4nd2j ), for which we tried to select the most consensual interpretationfrom the recent literature, although this exercise isnecessarily a bit subjective.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/syv075.PMC4678255.pdf
"ML centralized the data and built thetimetree (with some help from FJ) according to thesedata, and in consultation with the paleomammalogists.These body mass estimates of extinct species andthe phylogenetic tree we used are available athttp://dx.doi.org/10.5061/dryad.4nd2j .",OADS,/arxiv_data1/oa_pdf/ba/24/syv075.PMC4678255.pdf
"S1, available on Dryad at http://dx.doi.org/10.5061/dryad.4nd2j ).",Non-OADS,/arxiv_data1/oa_pdf/ba/24/syv075.PMC4678255.pdf
"S2, available on Dryad athttp://dx.doi.org/10.5061/dryad.4nd2j ).",Non-OADS,/arxiv_data1/oa_pdf/ba/24/syv075.PMC4678255.pdf
"S2, available onDryad at http://dx.doi.org/10.5061/dryad.4nd2j ).",Non-OADS,/arxiv_data1/oa_pdf/ba/24/syv075.PMC4678255.pdf
"S2, available on Dryadat http://dx.doi.org/10.5061/dryad.4nd2j ).",OADS,/arxiv_data1/oa_pdf/ba/24/syv075.PMC4678255.pdf
S UPPLEMENTARY MATERIAL Data available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.4nd2j .,OADS,/arxiv_data1/oa_pdf/ba/24/syv075.PMC4678255.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/2b/main.PMC4678308.pdf
E-mail address: carbo@ifm.liu.se (C. Guerrero-Bosagna).Contents lists available at ScienceDirect MethodsX journal homepage: www.elsevier.com/locate/mex http://dx.doi.org/10.1016/j.mex.2015.10.006 2215-0161/ /C2232015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/51/2b/main.PMC4678308.pdf
Suppor ting informat ionforthisarticle isavailable ontheWWW under http://dx.doi.org /10.1002/anie.,Non-OADS,/arxiv_data1/oa_pdf/48/71/anie0054-9871.PMC4678426.pdf
"[*]Dr.E.A.deEulate, Dr.D.S.Silvester ,Prof.Dr.D.W.M.Arrigan Nanochemis tryResearch Institute Department ofChemist ry,Curtin University GPO BoxU1987, Perth, Western Australi a6845(Australia ) E-mail :d.arrigan@c urtin.edu.au Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201507556 .",Non-OADS,/arxiv_data1/oa_pdf/0a/f5/anie0054-14903.PMC4678505.pdf
"Prof. Dr.H.Abdoul-C arime, F.Berthias ,Dr.L.Feketeov(o;w;, Dr.B.Farizon, Prof. Dr.M.Farizon Institut dePhysique Nucl(o[;yaire deLyon CNRS/IN 2P3UMR 5822, 43Bddu11novembre 1918 69622 Villeurbann eCedex (France) Dr.M.Marciante Institute Lumi(o;zzre Mati(o;zzre, CNRS 69622 Villeurbann e(France)Dr.F.Calvo Universit (o[;yGrenoble 1,CNRS, LIPhy UMR 5588 38041 Grenoble (France) Dr.V.Forquet, Prof. Dr.H.Chermette Institut desSciences Analytiques, CNRS UMR 5280 43boulevard 11novembre 69622 Villeurbann eCedex (France) Prof. Dr.T.D.M(o[[wrk Institut f(o[z[rIonenphysik und Angewa ndte Physik Leopold Franzens Universi t(o[[wt 6020 Innsbru ck(Austria) Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201505890 .",Non-OADS,/arxiv_data1/oa_pdf/ad/49/anie0054-14685.PMC4678507.pdf
Supportin ginformation andORCID(s )from theauthor(s) forthis article areavailable ontheWWW under http://dx.doi.org/ 10.1002/ anie.201506 865.,Non-OADS,/arxiv_data1/oa_pdf/4c/93/anie0054-14349.PMC4678509.pdf
"The[*]Z.Fan,M.Kçhn Serrano ,Dr.H.Schmalz ,Prof.Dr.S.Agarwal, Prof. Dr.A.Greiner Chair ofMacromol ecular Chemist ryIIandBayreuth Centre for Colloids andInterfaces Universit yofBayreuth Universit (o[[wtsstrasse 30,95440 Bayreuth (Germa ny) E-mail :greiner@un i-bayreuth.de Homepag e:http://www .mcii.uni-ba yreuth.de/en/ ag-greiner/ index.htm l Dr.X.Chen, Dr.S.Rosenfeldt ,Prof.Dr.S.Fçrster Chair ofPhysical Chemistry I Universit yofBayreuth (Germany ) Supportin ginformation forthisarticle (including experimen tal details) isavailable ontheWWW under http://dx.do i.org/10.1002 / anie.201506 415.",Non-OADS,/arxiv_data1/oa_pdf/53/4d/anie0054-14539.PMC4678510.pdf
"[*]Dipl.-Chem .M.Jauker ,Dipl.-Chem .H.Griesser ,Prof.C.Richert Institut f(o[z[rOrganisch eChemie, Universi t(o[[wtStuttgart 70569 Stuttgart (Germany ) E-mail :lehrstuhl-2@ oc.uni-stuttga rt.de Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201506593 .",Non-OADS,/arxiv_data1/oa_pdf/1b/25/anie0054-14564.PMC4678511.pdf
Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201506570 .,Non-OADS,/arxiv_data1/oa_pdf/4b/e5/anie0054-13594.PMC4678513.pdf
"[*]Dipl.-Chem .M.Jauker ,Dipl.-Chem .H.Griesser ,Prof.C.Richert Institut f(o[z[rOrganisch eChemie, Universi t(o[[wtStuttgart 70569 Stuttgart (Germany ) E-mail :lehrstuhl-2@ oc.uni-stuttga rt.de Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201506592 .",Non-OADS,/arxiv_data1/oa_pdf/c3/70/anie0054-14559.PMC4678514.pdf
Available  from: http://www.mayoclinic.com/health/diabetes/DS01121/ DSECTIONtestsanddiagnosis.,Non-OADS,/arxiv_data1/oa_pdf/69/ff/CCD-6-443.PMC4678538.pdf
A vailable from: http://www.autism - india.org/afa_autisminindia.,Non-OADS,/arxiv_data1/oa_pdf/2e/e8/CCD-6-500.PMC4678548.pdf
Available from: http://www.ada.org/~/media/ADA/Science%20and%20Research/ Files/Seal%20guidelines/SCI_SealGuidelineChemotherepeutic ProdforControlofGingivitis_2011Nov01.ashx.,OADS,/arxiv_data1/oa_pdf/ca/0a/CCD-6-505.PMC4678549.pdf
Available from: http://www.wpb -radon.com/pdf/Brodhead%20 Cancer%20recommendations.,Non-OADS,/arxiv_data1/oa_pdf/6e/32/CCD-6-529.PMC4678553.pdf
Available  from: http://www.endoexperience.com/filecabinet/Clinical%20Endodontics/Anatomical%20Considerations/MB2%20anatomy/ Castellucci.PDF.,Non-OADS,/arxiv_data1/oa_pdf/34/e8/CCD-6-544.PMC4678556.pdf
Available from: http://www.nhm.ac.uk/ research-curation/research/projects/myiasis-larvae/intro-myiasis/ index.html.,Non-OADS,/arxiv_data1/oa_pdf/54/da/CCD-6-548.PMC4678557.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/25/main.PMC4678776.pdf
"The BC Cancer Agency (BCCA) Information System (CAIS) was used to identify 8008 patients who received 16,277 palliativeContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2015.10.002 2212-1374/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/52/25/main.PMC4678776.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/25/main.PMC4678776.pdf
(2015) (publishedonline July 8) http://dx.doi.org/10.1016/j.ijrobp.2015.06.044 .,OADS,/arxiv_data1/oa_pdf/52/25/main.PMC4678776.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.07.008 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/48/0c/main.PMC4678777.pdf
"After the  discovery  of  TTV,  its  detection  has  been  by polymerase  chain  reaction  (PCR)  with  primers  targeting  the ORF1 (N22  region,  the  ﬁrst  described  sequence),  nevertheless primers  derived  from  the  N22  region  can  detect  only  a  portion of  TTV  variants  mainly  representing  genetic  group  1  TTV (Genotypes 1–6).5,6As  the  UTRs  of  the  viral  genome  are  more conserved  when  compared  to  the  ORF  regions,  UTR-targeting primers (used  later  for  the  detection  of  TTV  DNA)  can  detect DOI of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.07.005 .",Non-OADS,/arxiv_data1/oa_pdf/44/d2/main.PMC4678778.pdf
"These  facts  support  the http://dx.doi.org/10.1016/j.bjhh.2015.07.009 1516-8484/©  2015  Associac ¸ão  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",OADS,/arxiv_data1/oa_pdf/44/d2/main.PMC4678778.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/87/main.PMC4678781.pdf
"Protocol for IP and OP MRI differs depending on the strength of the magnetic ﬁeld: with a 1.5 T magnet, the interval on TE (time to echo) between IP and OPContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2015.10.001 2212-1374/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0b/87/main.PMC4678781.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/87/main.PMC4678781.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/c0/main.PMC4678783.pdf
"We cut the bone in accordance with the pre-operative plan and completely excised the tumor, leavingContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2015.09.004 2212-1374/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c1/c0/main.PMC4678783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/c0/main.PMC4678783.pdf
"Received  5  May  2015 Accepted 5  August  2015 Available  online  4  September  2015 http://dx.doi.org/10.1016/j.bjhh.2015.08.001 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia, Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/c4/cc/main.PMC4678786.pdf
"Some recent  studies  have  suggested  that  RBC  storage length is associated  with  adverse  patient  outcomes  ranging from  death  to  pneumonia  to  increased  length  of  hospital  and intensive  care  unit  stays.4,5RBC  alloimmunization  was  cho- sen  as  an  outcome  in  these  studies  because  it  can  be  both medically and  logistically  problematic.6,7By  identifying  asso- ciations,  it  may  be  possible  to  support  or  not  support  changing DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.07.003 .",Non-OADS,/arxiv_data1/oa_pdf/be/6f/main.PMC4678787.pdf
"The http://dx.doi.org/10.1016/j.bjhh.2015.08.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/be/6f/main.PMC4678787.pdf
The authors would like to apologise for any inconvenience caused.NeuroImage: Clinical 9 (2015) e1 DOI of original article: http://dx.doi.org/10.1016/j.nicl.2013.04.012 .,Non-OADS,/arxiv_data1/oa_pdf/b6/6e/main.PMC4678789.pdf
Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl http://dx.doi.org/10.1016/j.nicl.2015.06.004 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/6e/main.PMC4678789.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/6e/main.PMC4678789.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.07.010 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/6e/9f/main.PMC4678790.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/91/main.PMC4678793.pdf
Wereport the clinical data and the oncological outcome of18 cases of surface osteosarcoma and suggest the appropriatemanagement.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2015.07.002 2212-1374/ &2015 Published by Elsevier GmbH.,OADS,/arxiv_data1/oa_pdf/1e/91/main.PMC4678793.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/91/main.PMC4678793.pdf
"10,11,13 Recent work toward understanding the molecular basis ofCornelia de Lange syndrome (CdLS [MIM: 122470,300590, 300882, 614701, 610759]) has also suggested 1Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA;2Graduate Program in Genetics, Stony Brook University, Stony Brook, NY 11794, USA;3Department of Medical Genetics, Northwest Kaiser Permanente, Portland, OR 97227, USA;4Department of Medical Genetics and Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T3B 6A8, Can ada; 5Center for Human Disease Modeling, Duke University, Durham, NC 27708, USA;6Department of Medical Genetics, Medical School, University of Athens, Athens 11527, Greece;7Research Institute for the Study of Genetic and Malignant Disorders in Childhood, Aghia Sophia, Children’s Hospital, Athens 11527, Greece;8Department of Pediatrics, Division of Genetics, University of Michigan, Ann Arbor, MI 48109, USA;9Department of Human Genetics, Uni- versity of Michigan, Ann Arbor, MI 48109, USA;10Division of Human Genetics, Cincinnati Children’s Hospital, Cincinnati, OH 45229, USA;11Unit on Pediatric, Developmental, and Genetic Ophthalmology, Ophthalmic Genetics and Visual Function Branch, National Eye Institute, NIH, Bethesda, MD 20892, USA;12Centro de Medicina Geno ´mica y Metabolismo, Fundacio ´n Cardiovascular de Colombia, Bucaramanga, Santander 681004, Colombia;13Uni- dad de Genetica, Hospital Universitario y Politecnico La Fe, Valencia 46026, Spain;14Centro de Ciencias Genomicas, Universidad Nacional Autonoma de Me´xico, Cuernavaca, Morelos 62210, Mexico;15Caris Life Sciences, Phoenix, AZ 85040, USA;16Division of Genetics, Pediatric Specialty Care, Maine Med- ical Partners, ME 04102, USA;17Department of Pediatrics, Division of Genetics, Barbara Bush Children’s Hospital, Maine Medical Center, Portland, ME 04102, USA;18Fundacion Cardioinfantil and Universidad del Rosario, Bogota 681004, Colombia;19Deptartment of Clinical Genetics, 6202 AZ Maastricht, the Netherlands;20Department of Clinical Genetics, Leiden University Medical Center, 2300 RC Leiden, the Netherlands;21Gene by Gene Ltd., Houston, TX 77008, USA;22Utah Foundation for Biomedical Research, Salt Lake City, UT 84107, USA;23Tute Genomics, 150 South 100 West Street, Provo, UT 84601, USA;24Department of Radiology, Boston Children’s Hospital, Boston, MA 02115, USA;25Ge´ne´tique des Anomalies du De ´veloppement EA4271, Universite ´ Bourgogne Franche-Comte ´, 21000 Dijon, France;26Centre de Ge ´ne´tique, Centre de Re ´fe´rence Maladies Rares ‘‘Anomalies du De ´veloppement et Syndromes Malformatifs,’’ Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France;27Institut des Neurosciences de Montpellier, Universite ´de Montpellier, BP 74103, 34950 Montpellier Cedex 5, France;28Service de Neurope ´diatrie, Centre Hospitalier Universitaire Gui de Chauliac, 34000 Montpellier, France; 29GeneDx, Gaithersburg, MD 20877, USA;30Zilkha Neurogenetic Institute, Department of Psychiatry and Preventive Medicine, University of Southern Cal- ifornia, Los Angeles, CA 90089, USA;31Research Group Development and Disease, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany; 32Department of Pharmacology, University of Washington, Seattle, WA 98195, USA;33Clinical Genetics Service, Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK;34Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands*Correspondence: gholsonjlyon@gmail.com http://dx.doi.org/10.1016/j.ajhg.2015.11.005 ./C2112015 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e7/54/main.PMC4678794.pdf
"Supplemental Data Supplemental Data include Supplemental Material and Methods, aSupplemental Note, 13 ﬁgures, 7 tables, and 8 movies and can be found with this article online at http://dx.doi.org/10.1016/j.ajhg.",OADS,/arxiv_data1/oa_pdf/e7/54/main.PMC4678794.pdf
A full list of contributing groups can be found at http://exac.broadinstitute.org/about .,Non-OADS,/arxiv_data1/oa_pdf/e7/54/main.PMC4678794.pdf
"Received: July 27, 2015 Accepted: November 5, 2015Published: December 3, 2015 Web Resources The URLs for data presented herein are as follows: 1000 Genomes, http://www.1000genomes.org/data ANNOVAR, http://annovar.openbioinformatics.org/en/latest/ dbSNP, http://www.ncbi.nlm.nih.gov/snp DECIPHER, http://decipher.sanger.ac.uk/ Ensembl, http://www.ensembl.org Exome Aggregation Consortium (ExAC) Browser, http://exac.",OADS,/arxiv_data1/oa_pdf/e7/54/main.PMC4678794.pdf
"broadinstitute.org/ GeneSplicer, https://ccb.jhu.edu/software/genesplicer/ Golden Helix GenomeBrowse, http://www.goldenhelix.com/ GenomeBrowse/index.html HomoloGene, http://www.ncbi.nlm.nih.gov/homologene Human Gene Mutation Database, http://www.hgmd.org/ Human Splicing Finder, http://www.umd.be/HSF/ MaxEntScan, http://genes.mit.edu/burgelab/maxent/Xmaxentscan_ scoreseq.html NHLBI Exome Sequencing Project (ESP) Exome Variant Server, http://evs.gs.washington.edu/EVS/ OMIM, http://www.ncbi.nlm.nih.gov/omim PennCNV , http://penncnv.openbioinformatics.org/en/latest/ PolyPhen-2, http://genetics.bwh.harvard.edu/pph2/ SIFT, http://sift.jcvi.org/ References 1.Papai, G., Weil, P.A., and Schultz, P. (2011).",OADS,/arxiv_data1/oa_pdf/e7/54/main.PMC4678794.pdf
"bioRxiv, http://dx.doi.org/ 10.1101/014050 .",Non-OADS,/arxiv_data1/oa_pdf/e7/54/main.PMC4678794.pdf
"NucleicAcidsResearch,2015,Vol.43,No.22 10833 (RTH) cloning ( http://openwetware.org/wiki/’Round-the- hornsite-directed mutagenesis ).ForrecombinantCascade expression and purification, the N-terminal Streptactin- tag in Cse2 of pWUR480 ( 14) plasmid was changed to a His6-tag using HL005 and HL006 through RTH cloning to produce pDGS010.",OADS,/arxiv_data1/oa_pdf/21/7d/gkv1259.PMC4678831.pdf
"Forward read counts for highly depleted se- quences in the X019 /Delta1cas1and X019 library were system- atically higher than reverse read counts for the same se-quences.Thisphenomenondoesnotappeartobearesultof the demultiplexing strategy, as demultiplexing using alter- native methods (fastx-multx command from ea-utils pack-age (50)o rs a b r e( https://github.com/najoshi/sabre )) pro- duced very similar results.",OADS,/arxiv_data1/oa_pdf/21/7d/gkv1259.PMC4678831.pdf
"Thus, to facilitate hypothesis generation and other anal- yses by the scientific community, we have implemented a simple TSEA tool on our website ( http://genetics.wustl.",Non-OADS,/arxiv_data1/oa_pdf/45/ed/gkv1262.PMC4678833.pdf
The scripts are available for downloading at http://www.cellprofiler.org/examples.shtml .,Non-OADS,/arxiv_data1/oa_pdf/68/d5/gkv772.PMC4678841.pdf
"As general input parameters, we considered the organ- ism specific codon usage bias values (downloaded from http://www.kazusa.or.jp/codon ) and the kinetic constants of translation elongation (Supplementary File 1).",OADS,/arxiv_data1/oa_pdf/4b/8a/gkv781.PMC4678843.pdf
Use of RiboAbacus RiboAbacus is coded in C and available in GitHub at http://fabiolauria.github.io/RiboAbacus/ .,Non-OADS,/arxiv_data1/oa_pdf/4b/8a/gkv781.PMC4678843.pdf
The Mann–Whitney Ut e s t(http://www.socscistatistics.com/tests/mannwhitney/ Default.aspx )wasusedtodeterminewhethermutationrate differences were statistically significant.,OADS,/arxiv_data1/oa_pdf/ff/f6/gkv918.PMC4678855.pdf
ADP accumulation was visualized using the Ty- phoonTrio+(GEHealthcare)andquantifiedusingImageJ(http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/ff/f6/gkv918.PMC4678855.pdf
Gels were visualized using the Ty- phoonTrio+(GEHealthcare)andquantifiedusingImageJ (http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/ff/f6/gkv918.PMC4678855.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.08.003 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/1e/e7/main.PMC4678902.pdf
Patient- speciﬁc  junctional  region  sequences  were  identiﬁed  with  the Blast tool  (http://blast.ncbi.nlm.nih.gov/Blast.cgi )  and  IMGT/V- QUEST  (http://www.imgt.org/IMGT  vquest/share/textes/ ).,OADS,/arxiv_data1/oa_pdf/1e/e7/main.PMC4678902.pdf
The Primer3  Biotools  software  (http://biotools.umassmed.,Non-OADS,/arxiv_data1/oa_pdf/1e/e7/main.PMC4678902.pdf
Recent  reports  by  Kinnebrew3and  Bruminhent4show  high rates of  colonization  by  C.  difﬁcile  at  the  time  of  admission DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.07.010 .,Non-OADS,/arxiv_data1/oa_pdf/c5/60/main.PMC4678905.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.09.001 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/c5/60/main.PMC4678905.pdf
"2015, http://dx.doi.org/10.1016/j.bbmt.2015.07.020 .",OADS,/arxiv_data1/oa_pdf/c5/60/main.PMC4678905.pdf
"In  a  paper  published  by  Colombatti  et  al.,  there is conﬁrmation  that  HP  starts  early  in  children  showing  the DOI of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.07.001 .",OADS,/arxiv_data1/oa_pdf/a1/9d/main.PMC4678906.pdf
"This paper  demonstrates  that  the  population  of  patients with  SCD  presented  cardiac  complications  at  an  earlier  age and  that  the  association  of  clinical  signs  and  symptoms  may guide us.6 http://dx.doi.org/10.1016/j.bjhh.2015.08.005 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/a1/9d/main.PMC4678906.pdf
"A  2008  World  Health  Organiza- tion (WHO)  report,  concentrating  on  pre-school  children  and women,  estimated  that  worldwide  one  in  four  people  were affected  by  IDA,  with  pregnant  women  and  preschool-age http://dx.doi.org/10.1016/j.bjhh.2015.08.012 1516-8484/©  2015  Associac ¸ão  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/a4/94/main.PMC4678908.pdf
Available  from: http://guidance.nice.org.uk/CG39  [cited  15.07.14].,Non-OADS,/arxiv_data1/oa_pdf/a4/94/main.PMC4678908.pdf
Available  from: http://www.ema.europa.eu/docs/en  GB/document  library/ Press release/2013/06/WC500144874.pdf  [cited  15.07.14].,Non-OADS,/arxiv_data1/oa_pdf/a4/94/main.PMC4678908.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.08.004 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/9f/5e/main.PMC4678909.pdf
DOI of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.08.004 .,OADS,/arxiv_data1/oa_pdf/fe/5f/main.PMC4678910.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.09.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/fe/5f/main.PMC4678910.pdf
Available from: http://www.who.int/bloodsafety/voluntary  donation/ Blooddonorcounselling.pdf [cited  02.09.15].,Non-OADS,/arxiv_data1/oa_pdf/fe/5f/main.PMC4678910.pdf
Available  from: http://www.jusbrasil.com.br/diarios/61650953/dou-secao-1-13-11-2013-pg-106 .,Non-OADS,/arxiv_data1/oa_pdf/fe/5f/main.PMC4678910.pdf
"Received 26  June  2015 Accepted 19  August  2015 Available  online  9  October  2015 http://dx.doi.org/10.1016/j.bjhh.2015.08.008 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia, Hemoterapia e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/d9/77/main.PMC4678912.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.07.012 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/94/c0/main.PMC4678914.pdf
Available from:  https://www.bdbiosciences.com/documents/ Multicolor-Bulk-Erythrocyte-Lysing-Protocol.pdf [cited  July 2014].,OADS,/arxiv_data1/oa_pdf/94/c0/main.PMC4678914.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.08.011 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/fe/6d/main.PMC4678915.pdf
Available  at: http://www.brixtonhealth.com/pepi4windows.html 23.,Non-OADS,/arxiv_data1/oa_pdf/fe/6d/main.PMC4678915.pdf
"The  organism’s  ﬁrst  defense  mechanism  against  the harmful  effects  of  free  Hb  involves  haptoglobin  (Hp),  whose primary function  is  to  bind  to  free  Hb  in  the  plasma,  thereby preventing  the  excretion  of  iron  by  the  kidneys  and  protec- ting blood  vessels  from  its  oxidative  effects.6,7In  addition  to being an  antioxidant,  Hp  is  a  positive  acute-phase  glycopro- tein present in  plasma  with  immunomodulatory  properties.6,7 DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.07.006 .",Non-OADS,/arxiv_data1/oa_pdf/c5/ab/main.PMC4678916.pdf
"Thus,  subjects  with  Hp2-2  are  more  prone  to  oxidative stress.6,11,12 Recently, several  studies  have  investigated  the  possibility of the therapeutic  use  of  Hp  in  hemolytic  anemias.4,5,13It  was demonstrated  in  guinea  pigs  that  Hp  is  efﬁcient  at  preventing arterial hypertension  and  kidney  damage  induced  by  plasma free  Hb.4More  recently,  Chintagari  et  al.,  in  an  in  vitro  study and  in  mice  with  sickle  cell  disease  (SCD),  showed  that  Hp http://dx.doi.org/10.1016/j.bjhh.2015.08.009 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/c5/ab/main.PMC4678916.pdf
"This  analy- sis allows  more  accurate  risk  group  assignment  and  tailoring the  intensity  of  treatment,  permitting  reduction  or  intensiﬁ- cation at  the  different  treatment  time  points  according  to  the MRD  level.4–9MRD  monitoring  can  also  guide  treatment  deci- sions  in  relapsed  patients  and  those  who  are  candidates  for bone  marrow  transplantation.4,5,10,11 DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.08.003 .",Non-OADS,/arxiv_data1/oa_pdf/2d/9b/main.PMC4678917.pdf
"In  a  multicenter  retrospective study, this  was  the  strongest  independent  prognostic  factor http://dx.doi.org/10.1016/j.bjhh.2015.08.010 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",OADS,/arxiv_data1/oa_pdf/2d/9b/main.PMC4678917.pdf
"Results  showed  dermal  angiolymphatic  ectasia  and  benign http://dx.doi.org/10.1016/j.bjhh.2015.08.007 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",OADS,/arxiv_data1/oa_pdf/9b/43/main.PMC4678918.pdf
Available from: http://globocan.iarc.fr 5.,Non-OADS,/arxiv_data1/oa_pdf/9b/43/main.PMC4678918.pdf
Available  from:  http://www.inca.gov.br  [cited 04.04.15].,Non-OADS,/arxiv_data1/oa_pdf/9b/43/main.PMC4678918.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.10.010,Non-OADS,/arxiv_data1/oa_pdf/72/57/main.PMC4678919.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/72/57/main.PMC4678919.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/72/57/main.PMC4678919.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/72/57/main.PMC4678919.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/72/57/main.PMC4678919.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/72/57/main.PMC4678919.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/72/57/main.PMC4678919.pdf
(Cell Mol Gastroenterol Hepatol 2015;1:578 –588; http://dx.doi.org/ 10.1016/j.jcmgh.2015.09.004 ) Keywords: HBV; HCV; Infection; Interferon; T Cell.,OADS,/arxiv_data1/oa_pdf/2c/75/main.PMC4678927.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/75/main.PMC4678927.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.09.004,OADS,/arxiv_data1/oa_pdf/2c/75/main.PMC4678927.pdf
http://dx.doi.org/10.1093/infdis/jiv391 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/main.PMC4678927.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by- nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/d7/ezv015.PMC4678969.pdf
"This is an Open Access articledistributed under the terms of theCreative Commons AttributionNon-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution,and reproduction in any medium,provided the original work isproperly cited.DOI: 10.1093/asj/sjv152www.aestheticsurgeryjournal.com",Non-OADS,/arxiv_data1/oa_pdf/c0/8a/sjv152.PMC4678996.pdf
http://www.asit.org/assets/ documents/Prinicpals_in_electrosurgery.pdf .,OADS,/arxiv_data1/oa_pdf/c0/8a/sjv152.PMC4678996.pdf
http://www.utahmed.,Non-OADS,/arxiv_data1/oa_pdf/c0/8a/sjv152.PMC4678996.pdf
"This monomer was first developed as a synthetic estrogen in the 1890s, but only in the 1930s, the estrogenic properties of BPA were reported in the reproductive system of female rats.1Successively, chemical industries used BPA as a monomer in the manufacturing of polymers (eg, polycarbonate and epoxy resins), as an antioxi- dant and inhibitor of end of polyvinyl chloride polymerization, and as a precursor for the synthesis of a flame retardant.2In turn, these materials are currently used as components of many con- sumer products including reusable plastic bottles, feeding bot- tles, internal coating of food and beverage cans, thermal paper, medical devices, dental materials, and so on.2Unfortunately, like other chemical substances, BPA can be released from these materials in dependence of temperature and pH to migrate in food,3,4air,5,6skin,7saliva,8and blood.6To make this picture more alarming, considerable amounts of BPA (ranging from 0.25 to 1.11 mg/kg) have been found in randomly selected fresh food samples from an area of Southern Italy, probably deriving from plastic irrigation pipes.9Consequently, it is estimated that food contributes to more than 90 %of the overall BPA exposure, while exposure through dust ingestion, dental surgery, and der- mal absorption remains below 5 %in normal situations.10Overall, human exposure to BPA is frequent and widespread, and more than 90 %of individuals have detectable amounts of BPA in urine as reported by biomonitoring studies conducted in the United States, Germany, and Canada.5,11-13 However, the US Food and Drug Administration and the European Food Safety Authority have determined that human exposure to BPA is below safe exposure levels (from 50 to 4mg/Kg weight/day).14,15In marked contrast with these reas- suring reports, France has banned BPA in food contact materials (LOI no 2010-729 du 30 juin 2010, http://www.legifrance.",Non-OADS,/arxiv_data1/oa_pdf/62/2f/10.1177_1559325815610582.PMC4679188.pdf
http://www.efsa.europa.eu/en/efsajour- nal/pub/3978.htm.,Non-OADS,/arxiv_data1/oa_pdf/62/2f/10.1177_1559325815610582.PMC4679188.pdf
"http://www.digitaljournal.com/pr/2009287 2014; Accessed October 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/cb/2d/10.1177_1559325815610760.PMC4679202.pdf
"http://scholarworks.umass.e du/dose_response/vol10/iss2/5 (accessed August 15, 2015).",Non-OADS,/arxiv_data1/oa_pdf/bb/bd/10.1177_1559325815611903.PMC4679203.pdf
"http://www.eea.europa.eu/publications/GH-07-97-595-EN- C2/chapter5h.html (accessed November 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/bb/bd/10.1177_1559325815611903.PMC4679203.pdf
http://www.ehjournal.net/content/14/1/54/.,Non-OADS,/arxiv_data1/oa_pdf/bb/bd/10.1177_1559325815611903.PMC4679203.pdf
http://www.fda.gov/ohrms/dockets/ac/ 08/briefing/2008-4386b1-05.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/bd/10.1177_1559325815611903.PMC4679203.pdf
http://www.mn.uio.no/ fysikk/tjenester/kunnskap/straling/radiation-and-health-2015.pdf.,OADS,/arxiv_data1/oa_pdf/3b/d7/10.1177_1559325815615102.PMC4679206.pdf
http://www.precura.de/documen ts/schneebergstudie-final_ abstract.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/d7/10.1177_1559325815615102.PMC4679206.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/3b/d7/10.1177_1559325815615102.PMC4679206.pdf
http://www.epa.gov/radon/.,OADS,/arxiv_data1/oa_pdf/3b/d7/10.1177_1559325815615102.PMC4679206.pdf
http://dos.sagepub.com/content/13/1/dose- response.15-003.Cuttler.full.,Non-OADS,/arxiv_data1/oa_pdf/3b/d7/10.1177_1559325815615102.PMC4679206.pdf
http://www.ncbi.nlm.nih.gov/pmc/arti- cles/PMC2564762/.,Non-OADS,/arxiv_data1/oa_pdf/3b/d7/10.1177_1559325815615102.PMC4679206.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/3b/d7/10.1177_1559325815615102.PMC4679206.pdf
Web sit e. http://www.ncbi .nlm.nih.gov/pmc/ articles/PMC2477723/.,Non-OADS,/arxiv_data1/oa_pdf/3b/d7/10.1177_1559325815615102.PMC4679206.pdf
"What you need to know about Ageing, http://www.who.",Non-OADS,/arxiv_data1/oa_pdf/d0/28/10.1177_2050312115572039.PMC4679216.pdf
Available at: http://www.ajol.info/index.php/hmrj/article/view/52844 OR http://dx.doi.org/10.4314/hmrj.v6i1-2.52844 (accessed 18 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/d0/28/10.1177_2050312115572039.PMC4679216.pdf
"DOI: 10.1177/2050312113518198, http://smo.sagepub.com 2.",Non-OADS,/arxiv_data1/oa_pdf/f7/b8/10.1177_2050312115575937.PMC4679218.pdf
"In: Specification of the nervous sys- tem (Internet), 2005, http://www.wormbook.org (accessed 20 September 2013).",Non-OADS,/arxiv_data1/oa_pdf/26/4e/10.1177_2050312115575387.PMC4679220.pdf
"Guideline for iso- lation precautions: preventing transmission of infectious agents in healthcare settings, http://www.cdc.gov/ncidod/ dhqp/pdf/isolation2007.pdf (2007, accessed 15 November   2009).",Non-OADS,/arxiv_data1/oa_pdf/eb/b4/10.1177_2050312114566668.PMC4679221.pdf
13. http://www.mksinst.com/product/product.aspx?ProductID=195  14.,Non-OADS,/arxiv_data1/oa_pdf/5e/35/10.1177_2050312115569565.PMC4679223.pdf
"Annual reports, http://www.health.",Non-OADS,/arxiv_data1/oa_pdf/98/fa/10.1177_2050312115573654.PMC4679224.pdf
"Māori Provider Development Scheme  (MPDS) 2012/13 purchasing intentions, http://www.moh.govt.nz/notebook/nbbooks.nsf/0/BDC92EC6D1E44AB5CC2 579FA000B746F/$file/mpds-purchasing-intentions-2012-13.",Non-OADS,/arxiv_data1/oa_pdf/98/fa/10.1177_2050312115573654.PMC4679224.pdf
"Faiva Ora, http://www.health.govt.nz/   publication/faiva-ora-national-pasifika-disability- plan-2010-2013 (accessed 1 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/98/fa/10.1177_2050312115573654.PMC4679224.pdf
"‘Ala Mo’ui, http://www.health.govt.nz/  publication/ala-moui-pathways-pacific-health-and-wellbeing-   2010-2014 (accessed 1 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/98/fa/10.1177_2050312115573654.PMC4679224.pdf
"Briefing to the incoming Minister  of Health, December 2011, http://www.health.govt.nz/ publication/briefing-incoming-minister-health-decem-ber-2011 (accessed 1 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/98/fa/10.1177_2050312115573654.PMC4679224.pdf
"Implementing the New Zealand health strat-egy 2012, http://www.health.govt.nz/publication /implementing-new-zealand-health-strategy-2012 (accessed 1 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/98/fa/10.1177_2050312115573654.PMC4679224.pdf
"Better, sooner, more convenient discussion  paper, http://www.nzdoctor.co.nz/media/136363/bsmc.pdf  (accessed 29 August 2014).",Non-OADS,/arxiv_data1/oa_pdf/98/fa/10.1177_2050312115573654.PMC4679224.pdf
"Health targets, http://www.health.govt.",Non-OADS,/arxiv_data1/oa_pdf/98/fa/10.1177_2050312115573654.PMC4679224.pdf
"Research  (ed DA Kindig), http://www.improvingpopulationhealth.org/  PopHealthPhaseIICommissionedPaper.pdf (2013, accessed 19 November 2014).",Non-OADS,/arxiv_data1/oa_pdf/98/fa/10.1177_2050312115573654.PMC4679224.pdf
"Cambridge Automated Neuropsychological Test Battery  (CANTAB), http://www.cambridgecognition.com (accessed November 2014).",Non-OADS,/arxiv_data1/oa_pdf/f4/fb/10.1177_2050312114565198.PMC4679227.pdf
"The Hispanic Population: 2010, http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf  2.",OADS,/arxiv_data1/oa_pdf/c9/00/10.1177_2050312115581250.PMC4679233.pdf
"US Department of Health and Human Services, Office of Minority Health, http://minorityhealth.hhs.gov/templates/ browse.aspx?lvl=2&lvlID=11 5.",Non-OADS,/arxiv_data1/oa_pdf/c9/00/10.1177_2050312115581250.PMC4679233.pdf
"Carbohydrate counting: American Diabetes Association,  http://www.diabetes.org/food-and-fitness/food/what-can-i-eat/understanding-carbohydrates/carbohydrate-counting/car-bohydrate-counting.html?loc=ff-slabnav  32.",Non-OADS,/arxiv_data1/oa_pdf/c9/00/10.1177_2050312115581250.PMC4679233.pdf
"Washington, DC: The National Academies Press, 2003, http://www.nap.edu/ catalog/12875/unequal-treatment-confronting-racial-and-ethnic- disparities-in-health-care (accessed November 2014).",Non-OADS,/arxiv_data1/oa_pdf/c9/00/10.1177_2050312115581250.PMC4679233.pdf
"2014 Global Strategy for asthma management and preven-tion, http://www.ginasthma.org/local/uploads/files/GINA_Report_2014_Aug12.pdf (accessed 2 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/04/e9/10.1177_2050312115586912.PMC4679234.pdf
http://www.osteoporosis.,Non-OADS,/arxiv_data1/oa_pdf/04/e9/10.1177_2050312115586912.PMC4679234.pdf
"The sixteenth annual report: executive sum-mary for commissioners of renal services, https://www.renal-reg.org/reports/2013-the-sixteenth-annual-report/ (accessed  26 November 2014).",Non-OADS,/arxiv_data1/oa_pdf/6a/70/10.1177_2050312115580403.PMC4679235.pdf
http://www.who.int/bulletin/volumes/86/3/07-041715/en/ (accessed 25 March  2014).,Non-OADS,/arxiv_data1/oa_pdf/6a/70/10.1177_2050312115580403.PMC4679235.pdf
"The seventh annual report: Executive sum-mary for commissioners of renal services, https://www.renal- reg.org/reports/2004-the-seventh-annual-report/ (accessed 26  November 2014).",Non-OADS,/arxiv_data1/oa_pdf/6a/70/10.1177_2050312115580403.PMC4679235.pdf
"The seventeenth annual report: executive sum-mary for commissioners of renal services, https://www.renal-reg.org/reports/2014-seventeenth-annual-report/ (accessed 7  January 2015).",Non-OADS,/arxiv_data1/oa_pdf/6a/70/10.1177_2050312115580403.PMC4679235.pdf
"PhD Thesis, University  of Warwick, 2014, http://wrap.warwick.ac.uk/63265/  8.",Non-OADS,/arxiv_data1/oa_pdf/6a/70/10.1177_2050312115580403.PMC4679235.pdf
"Readmissions reduction program overview, https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions- Reduction-Program.html (accessed 1 October 2013).",Non-OADS,/arxiv_data1/oa_pdf/56/3c/10.1177_2050312115577986.PMC4679237.pdf
"Hospital  Value-Based Purchasing, https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/hospital- value-based-purchasing/index.html (accessed 1 October 2013).",Non-OADS,/arxiv_data1/oa_pdf/56/3c/10.1177_2050312115577986.PMC4679237.pdf
"Hospital compare, http://www.medicare.gov/hospital-compare/profile.html#profTab=3&ID=050100&loc=SAN%20DIEGO%2C%20CA&lat=32.7153292&lng=117.1572551&name=SHARP%20MEMORIAL%20HOSPITAL&Distn=7.3  (accessed 1 April 2014).",Non-OADS,/arxiv_data1/oa_pdf/56/3c/10.1177_2050312115577986.PMC4679237.pdf
"The Joint  Commission’s annual report on quality and safety, 2011, http://www.jointcommission.org/assets/1/6/TJC_Annual_Report_2011_9_13_11_.pdf (accessed 1 April 2014).",OADS,/arxiv_data1/oa_pdf/56/3c/10.1177_2050312115577986.PMC4679237.pdf
"Specifications manual for Joint Commission  national quality core measures (2010A1), https://manual.joint- commission.org/releases/archive/TJC2010B/MIF0028.html (accessed 1 April 2014).",Non-OADS,/arxiv_data1/oa_pdf/56/3c/10.1177_2050312115577986.PMC4679237.pdf
"Information on how to access the full questionnaire for research, course evaluation and translation into languages other than English is available on the heiQ website (http://www.deakin.edu.au/health/research/phi/heiQ.php)).",Non-OADS,/arxiv_data1/oa_pdf/1d/04/10.1177_2050312115585041.PMC4679238.pdf
"Multi-factor CFA and ESEM models were fit-ted across sex, age, education level, country of birth and home-language groups separately using the CONFIGURAL and SCALAR ‘convenience features’ available in Mplus 7.1 (see Version 7.1 Mplus Language Addendum available at http://www.statmodel.com/) to achieve the minimal con-straints necessary for identification required by the Raykov and Marcoulides approach.",OADS,/arxiv_data1/oa_pdf/1d/04/10.1177_2050312115585041.PMC4679238.pdf
The chi-square differ - ence test appropriate for WLSMV estimation (provided by the DIFFTEST) (see p. 5 of Version 7.1 Mplus Language Addendum (available at http://www.statmodel.com/).),OADS,/arxiv_data1/oa_pdf/1d/04/10.1177_2050312115585041.PMC4679238.pdf
"Los Angeles, CA: Muthén & Muthén, 2010, http://www.statmodel.com/  42.",Non-OADS,/arxiv_data1/oa_pdf/1d/04/10.1177_2050312115585041.PMC4679238.pdf
Statistical analysis Data from Microsoft Excel® spreadsheet was imported and  analyzed in Stata/IC 13.1 by Statacorp LP (http://www.stata.com/company/).,OADS,/arxiv_data1/oa_pdf/cb/4e/10.1177_2050312115585040.PMC4679240.pdf
"Type 2 diabetes, http://www.healthycanadians.gc.ca/health-sante/disease-maladie/diabete-eng.php  2.",Non-OADS,/arxiv_data1/oa_pdf/cb/4e/10.1177_2050312115585040.PMC4679240.pdf
"Statistics Canada, http://www.statcan.gc.ca/tables-tableaux/ sum-som/l01/cst01/health53a-eng.htm (accessed 12 May  2014).",OADS,/arxiv_data1/oa_pdf/cb/4e/10.1177_2050312115585040.PMC4679240.pdf
"Canadian Diabetes Association, http://www.diabetes.ca/about-diabetes/prediabetes (accessed 12 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/cb/4e/10.1177_2050312115585040.PMC4679240.pdf
"Canadian Diabetes Association 2008 Clinical Practice  Guidelines for the Prevention and Management of Diabetes in Canada, http://www.diabetes.ca/files/cpg2008/cpg-2008.pdf (accessed 12 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/cb/4e/10.1177_2050312115585040.PMC4679240.pdf
"Blueprint for Pharmacy, http://blueprintforpharmacy.ca/ docs/pdfs/2011/05/11/BlueprintVision.pdf?Status=Master  (accessed 1 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/cb/4e/10.1177_2050312115585040.PMC4679240.pdf
"Alberta Diabetes Surveillance System, http://www.alberta- diabetes.ca/AlbertaDiabetesAtlas2011.php (assessed 15 May 2014).",OADS,/arxiv_data1/oa_pdf/cb/4e/10.1177_2050312115585040.PMC4679240.pdf
"The Canadian Council for Accreditation of Pharmacy  Programs: Accreditation Standards for the First professional  Degree in Pharmacy Programs, http://www.ccapp-accredit.ca/site/pdfs/university/CCAPP_accred_standards_degree_2014.pdf (accessed 13 February 2015).",Non-OADS,/arxiv_data1/oa_pdf/cb/4e/10.1177_2050312115585040.PMC4679240.pdf
"Statistics Canada, http://www.statcan.gc.ca/tables-tableaux/ sum-som/l01/cst01/demo62j-eng.htm (accessed 15 May  2014).",OADS,/arxiv_data1/oa_pdf/cb/4e/10.1177_2050312115585040.PMC4679240.pdf
"Adapted from the Canadian Diabetes Association “Are you at Risk?” 316530 08-396 06/09 Q-100M, and the CANRISK questionnaire from public Health Agency of Canada (http://www.healthycanadians.gc.ca/diseases-conditions-maladies-affections/disease-maladie/diabetes-diabete/canrisk/index-eng.php).",Non-OADS,/arxiv_data1/oa_pdf/cb/4e/10.1177_2050312115585040.PMC4679240.pdf
2 SAGE Open Medicine ••American Association of Colleges of Pharmacy  (AACP) (http://www.aacp.org); ••American College of Clinical Pharmacy (ACCP) (http://www.accp.com); ••Accreditation Council for Pharmacy Education (ACPE) (http://www.acpe-accredit.org); ••Academy of Managed Care Pharmacy (AMCP) (http://www.amcp.org); ••American Pharmacists Association (APhA) (http://www.aphanet.org); ••American Society of Consultant Pharmacists (ASCP) (http://www.ascp.com); ••American Society of Health-System Pharmacists (ASHP) (http://www.ashp.org); ••Board of Pharmacy Specialties (BPS) (http://www.bpsweb.org); ••Center for Pharmacy Practice Accreditation (CPPA) (http://www.pharmacypracticeaccredit.org/) ••Commission for Certification in Geriatric Pharmacy (CCGP) (http://www.ccgp.org); ••Pharmacy Technician Educators Council (PTEC) (https://www.pharmacytecheducators.com/).,Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"Council  on Credentialing in Pharmacy, http://www.pharmacycredential- ing.org/Files/CCPWhitePaper2010.pdf (accessed 20 November 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"The Accreditation Council for Clinical Lipidology (ACCL),  http://www.lipidspecialist.org/ (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"The American Association of Poison Control Centers (AAPCC),  http://www.pearsonvue.com/aapcc/ (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"The American Board of Clinical Pharmacology, Inc. (ABCP), http://www.abcp.net/background.html (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"American Heart Association, http://www.heart.org/HEARTORG/CPRAndECC/HealthcareProviders/Healthcare-Providers_UCM_001121_SubHomePage.jsp (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"The Commission for Certification in Geriatric Pharmacy  (CCGP), http://www.ccgp.org/boardcertification (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"The Commission on Rehabilitation Counselor Certification  (CRCC), http://www.crccertification.com/ (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"Health IT Certification, http://www.healthitcertification.com/ overview.html (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"National Asthma Educator Certification Board (NAECB),  http://naecb.com/index.php (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"The National Board of Nutrition Support Certification  (NBNSC), http://www.nutritioncare.org/nbnsc/ (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"National Certification Board for Anticoagulation Providers  (NCBAP), http://www.ncbap.org/index.aspx (accessed 20  July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"National Certification Board for Diabetes Educators  (NCBDE), http://www.ncbde.org/ (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"The American Association of Diabetes Educators (AADE),  http://www.diabeteseducator.org/ProfessionalResources/Certification/BC-ADM/ (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"The National Association for Healthcare Quality (NAHQ),  http://www.nahq.org/certify/content/accreditation.html (accessed 1 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"The American  Pharmacists Association, http://www.bpsweb.org/index.cfm  (accessed 20 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"Directory of  residencies, fellowships, and graduate programs, http://www.accp.com/resandfel/search.aspx (accessed 28 November 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"American Society of Health-System Pharmacists Foundation   Research Boot Camp, http://www.ashpfoundation.org/Main   MenuCategories/ResearchResourceCenter/FosteringYoung   Investigators/ResearchBootCamp (accessed 28 November 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"Australian Association of Consultant Pharmacy (ACCP),  https://www.aacp.com.au/ (accessed 15 December 2014).",Non-OADS,/arxiv_data1/oa_pdf/03/07/10.1177_2050312115584228.PMC4679279.pdf
"According to a press notice by the Committee of Public Accounts of the UK Department of Health, ‘Unused and wasted drugs cost the NHS at least £100 million a year  and almost certainly a lot more’ (http://www.parliament.uk/business/committees/committees-archive/committee-of-public-accounts/pacpn070117/).",Non-OADS,/arxiv_data1/oa_pdf/e2/15/10.1177_2050312115587795.PMC4679280.pdf
"Rockville, MD: Agency for  Healthcare Research and Quality, http://www.ncbi.nlm.nih.gov/books/NBK20579/ (2005, accessed 12 March 2015).",Non-OADS,/arxiv_data1/oa_pdf/e2/15/10.1177_2050312115587795.PMC4679280.pdf
"Final scope 2013, http://www.nice.org.uk/guidance/dg15/documents/highsensitivity-troponin- for-the-early-rule-out-or-diagnosis-of-acute-myocardial-infarc- tion-in-people-with-acute-chest-pain-final-scope2  4.",Non-OADS,/arxiv_data1/oa_pdf/49/cc/10.1177_2050312115577729.PMC4679282.pdf
Full details can be found at https://pub-lons.com/.,Non-OADS,/arxiv_data1/oa_pdf/9e/0e/10.1177_2050312115579320.PMC4679283.pdf
"Surveillance for viral hepatitis—United States, 2011,  http://www.cdc.gov/hepatitis/Statistics/2011Surveillance/ Commentary.htm (2014, accessed 27 March 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/99/10.1177_2050312115612805.PMC4679318.pdf
"Navajo Area—Indian Health Service (IHS), http://www.ihs.gov/navajo/ (accessed 27 March 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/99/10.1177_2050312115612805.PMC4679318.pdf
"Department of Statistics, 2010, http://www.statistics.gov.my (accessed 3 February 2014).",OADS,/arxiv_data1/oa_pdf/7b/35/10.1177_2050312115596864.PMC4679320.pdf
"Ministry of Finance, 2010, http://www.greenbuildingindex.org/News/2009-10/20091023%20-%20Budget%202010%20 Speech.pdf (accessed 24 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/7b/35/10.1177_2050312115596864.PMC4679320.pdf
"A critical look at the proposed national health  financing scheme, 2006, https://hsudarren.wordpress.com/ malaysian-healthcare-a-critical-look-at-the-proposed-natio-nal-health-financial-schememalaysian-healthcare-a-critical-look-at-the-proposed-national-health-financial-scheme/ (accessed 27 February 2014).",Non-OADS,/arxiv_data1/oa_pdf/7b/35/10.1177_2050312115596864.PMC4679320.pdf
"FMT News, 2012, http://www.freemalaysiatoday.",Non-OADS,/arxiv_data1/oa_pdf/7b/35/10.1177_2050312115596864.PMC4679320.pdf
"Ministry  of Health, 2008, http://www.inahta.org/Members/MaHTAs/ (accessed 6 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/7b/35/10.1177_2050312115596864.PMC4679320.pdf
"26–28  August 1998, The Hague, http://apps.who.int/medicinedocs/ en/d/Jwhozip32e/  6.",Non-OADS,/arxiv_data1/oa_pdf/b6/8b/10.1177_2050312115595822.PMC4679322.pdf
"Communicating risks and ben-efits: an evidence-based user’s guide, August 2011, http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/UCM268069.pdf  22.",Non-OADS,/arxiv_data1/oa_pdf/b6/8b/10.1177_2050312115595822.PMC4679322.pdf
"Manila, Philippines: World Health  Organization Regional Office for the Western Pacific, 2003. http://www.wpro.who.int/publications/docs/Improving_Data_Quality.pdf (accessed 16 January 2014)  4.",Non-OADS,/arxiv_data1/oa_pdf/53/d8/10.1177_2050312115594083.PMC4679323.pdf
"Bull World Health Organ 2003; 81(11), http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/53/d8/10.1177_2050312115594083.PMC4679323.pdf
"Accelerating work to overcome the global impact of neglected  tropical diseases – a roadmap for implementation, http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf (2012; accessed October 2014).",Non-OADS,/arxiv_data1/oa_pdf/53/d8/10.1177_2050312115594083.PMC4679323.pdf
"Population by region, district, age  groups and sex, 2010, 2012, http://www.statsghana.gov.gh/docfiles/pop_by_region_district_age_groups_and_sex_2010.",OADS,/arxiv_data1/oa_pdf/53/d8/10.1177_2050312115594083.PMC4679323.pdf
"Accra, Ghana http://www.statsghana.gov.gh/ docfiles/2010phc/2010_PHC_Regional_Analytical_Reports_ Western_Region.pdf  23.",Non-OADS,/arxiv_data1/oa_pdf/53/d8/10.1177_2050312115594083.PMC4679323.pdf
"Drugs: FDA safety communication: important safety label changes to  cholesterol-lowering statin drugs, http://www.fda.gov/drugs/ drugsafety/ucm293101.htm (28 February 2012, accessed 7 January 2014).",Non-OADS,/arxiv_data1/oa_pdf/fb/64/10.1177_2050312115605518.PMC4679326.pdf
"Quality assessment tool for observational cohort and cross-sectional studies, http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascu - lar-risk-reduction/tools/cohort (2015, accessed 5 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/37/68/10.1177_2050312115601122.PMC4679327.pdf
"Brussels: IDF, 2013, http://www.idf.org/diabetesatlas  4.",Non-OADS,/arxiv_data1/oa_pdf/26/7f/10.1177_2050312115610129.PMC4679330.pdf
"WHO, 2008, http://www.who.int./health-info/global_burden_disease/GBD_report_2004update_full.pdf  13.",Non-OADS,/arxiv_data1/oa_pdf/8c/2d/10.1177_2050312115603002.PMC4679331.pdf
"Pharmacy workforce: pharmacy forecast  2013–2017 (Foundation), http://www.nxtbook.com/ygsre- prints/ASHPFoundation/d28547_ashpf_forecastbook2013/#/14 (accessed 26 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/b3/d4/10.1177_2050312115594816.PMC4679332.pdf
"August 2010,  http://www.un.org/esa/population/publications/popfacts/ popfacts_2010-2rev.pdf  10.",Non-OADS,/arxiv_data1/oa_pdf/b3/d4/10.1177_2050312115594816.PMC4679332.pdf
"Report to congress:  the pharmacist workforce: a study of the supply and demand  for pharmacists, http://bhpr.hrsa.gov/healthworkforce/reports/ pharmaciststudy.pdf (accessed 25 March 2014).",Non-OADS,/arxiv_data1/oa_pdf/b3/d4/10.1177_2050312115594816.PMC4679332.pdf
"King Abdulaziz  Medical City in Riyadh, http://ngha.med.sa/ENGLISH/ MEDICALCITIES/ALRIYADH/Pages/default.aspx  (accessed 26 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/b3/d4/10.1177_2050312115594816.PMC4679332.pdf
"King Abdullah Specialist Children’s Hospital, http://ngha.med.sa/English/MedicalCities/kasch/Pages/operation.aspx (accessed 26 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/b3/d4/10.1177_2050312115594816.PMC4679332.pdf
http://www.medscape.com/viewarticle/521115 (accessed 30 October 2012).,Non-OADS,/arxiv_data1/oa_pdf/b3/d4/10.1177_2050312115594816.PMC4679332.pdf
"Concerns about the accelerating  expansion of pharmacy education: time for reconsideration, http://www.ashp.org/DocLibrary/News/Accelerating-Expansion-of-Pharmacy-Education.aspx (accessed 20 February 2014).",Non-OADS,/arxiv_data1/oa_pdf/b3/d4/10.1177_2050312115594816.PMC4679332.pdf
"Vietnam 2012, http://data.worldbank.org/coun- try/vietnam (accessed 18 June 2012).",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/10.1177_2050312115610127.PMC4679333.pdf
"Government of Vietnam, 1998,  http://www.moj.gov.vn/vbpq/en/Lists/Vn%20bn%20php%20 lut/View_Detail.aspx?ItemID=1265  17.",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/10.1177_2050312115610127.PMC4679333.pdf
"Government of Vietnam, 2005,  http://moj.gov.vn/vbpq/en/Lists/Vn%20bn%20php%20lut/ View_Detail.aspx?ItemID=5964  19.",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/10.1177_2050312115610127.PMC4679333.pdf
"Government of Vietnam, 2003, http://www.moj.gov.vn/vbpq/en/Lists/Vn%20bn%20php%20lut/View_Detail.",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/10.1177_2050312115610127.PMC4679333.pdf
"Government of Vietnam, 2009, http://www.moj.gov.vn/vbpq/en/Lists/Vn%20bn%20 php%20lut/View_Detail.aspx?ItemID=10471  22.",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/10.1177_2050312115610127.PMC4679333.pdf
"Joint annual  health review 2012: improving quality of medical services,  2012, http://jahr.org.vn/downloads/JAHR2012/JAHR2012_ Eng_Full.pdf?phpMyAdmin=5b051da883f5a46f0982cec60527c597  27.",Non-OADS,/arxiv_data1/oa_pdf/b5/1f/10.1177_2050312115610127.PMC4679333.pdf
"Instructions for the Cohen-Mansfield  Agitation Inventory, 1991, http://www.dementia-assessment.com.au/symptoms/cmai_manual.pdf  27.",Non-OADS,/arxiv_data1/oa_pdf/cf/9b/10.1177_2050312115602579.PMC4679336.pdf
The trial was registered at ISRCTN for clinical trials ISRCTN82208287 (http://www.controlled-trials.com/ ISRCTN82208287).,Non-OADS,/arxiv_data1/oa_pdf/2a/6c/ansu-263-117.PMC4679345.pdf
Available at: http://clinicaltrials.gov/ct2/show/NCT01019239.,Non-OADS,/arxiv_data1/oa_pdf/2a/6c/ansu-263-117.PMC4679345.pdf
Available at: https://clinicaltrials.gov/ct2/show/NCT01047462.,Non-OADS,/arxiv_data1/oa_pdf/2a/6c/ansu-263-117.PMC4679345.pdf
All sequences were checked for quality assurance using thecalibration popula tion resistance seque nce quality analysis tool (http://cpr.stanford.edu) before further analyses.,OADS,/arxiv_data1/oa_pdf/e6/41/qai-71-e09.PMC4679362.pdf
"The full list of mutations for all genotyped samples along with the VL results fromeach assay, HIV-1 subtypes, and drug treatment details(ART regimen and duration) is presented as Supplemental Digital Content 1, http://links.lww.com/QAI/A751.",Non-OADS,/arxiv_data1/oa_pdf/e6/41/qai-71-e09.PMC4679362.pdf
"Resistance mutations were found in 2 patients (patient ID VIR29 and MAN02) with VL below 1000 copies permilliliter with the m2000rt system but above 1000 copies per milliliter with the G2 generic system, and in 1 patient (patient ID MAB06) with VL below 1000 copies per milliliterwith the G2 generic system but above 5000 copies permilliliter with the m2000rt system (Table, Supplemental Digital Content 1, http://links.lww.com/QAI/A751).",Non-OADS,/arxiv_data1/oa_pdf/e6/41/qai-71-e09.PMC4679362.pdf
"Drug Resistance Analysis Details of the 55 characterized patients are given as supplemental data content (Table, Supplemental Data Content1, http://links.lww.com/QAI/A751 which presents our ﬁnd- ings on DRM).",Non-OADS,/arxiv_data1/oa_pdf/e6/41/qai-71-e09.PMC4679362.pdf
"Available at: http://www.who.int/healthsystems/TTR-TaskShifting.pdf.Accessed February 24, 2015.",OADS,/arxiv_data1/oa_pdf/e6/41/qai-71-e09.PMC4679362.pdf
Available at: http://www.who.int/hiv/pub/guidelines/arv2013/ download/en/.,Non-OADS,/arxiv_data1/oa_pdf/e6/41/qai-71-e09.PMC4679362.pdf
"Avail- able at: http://www.who.int/ihr/publications/who_hse_ihr_2012.12/en/.Accessed February 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e6/41/qai-71-e09.PMC4679362.pdf
Available at: http://www.theglobalfund.org/en/trp/reports/.,Non-OADS,/arxiv_data1/oa_pdf/e6/41/qai-71-e09.PMC4679362.pdf
Available at: http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2014/ september/20140925prviralload.,Non-OADS,/arxiv_data1/oa_pdf/e6/41/qai-71-e09.PMC4679362.pdf
"(b) The relative community size for model organisms,and the mean relative community size for the bacterial and protozoan pathogens listed in A, based on the number of results generated from a Pubmed (http://www.ncbi.nlm.nih.gov/pubmed) search of the species name.Advanced Review wires.wiley.com/sysbio 384 © 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/5e/93/WSBM-7-381.PMC4679367.pdf
"30 Despite the increasing number of proteomic datasetspublicly available for these organisms, there remainsa massive deficit in experimentally validated proteome coverage (i.e., the percentage of protein-coding genes TABLE 2 |Experimental Proteome Coverage for Protozoan Parasites Species StrainTotal GenesProtein-Coding GenesProteomic ExpressionProteome Coverage (%) Toxoplasma gondii GT1 8637 8460 4488 53 Plasmodium falciparum3D7 5777 5542 4104 74 Cryptosporidium parvumIowa II 3886 3805 1320 35 Trypanosoma brucei TREU927 12,094 11,567 6632 57 Trypanosoma cruzi CL-Brener Esmeraldo- like10,597 10,339 3674 36 Leishmania major Friedlin 9378 8400 329 4 Giardia lamblia Assemblage A Isolate WB9747 9667 2166 22 Entamoeba histolytica HM-1:IMSS 8333 8306 2443 29 Information gathered from EuPathDB databases, http://eupathdb.org.",Non-OADS,/arxiv_data1/oa_pdf/5e/93/WSBM-7-381.PMC4679367.pdf
"Examples of this include functional annotation or transcript levels for TABLE 3 |Resources and Databases for Protozoan Parasites General or Parasite Species(s) Database Description Web Address General databases PHI-based: Pathogen-Host Interactions48Expertly curated database of experimentally verified genes frompathogenshttp://www.phi-base.org/ Pathogen Portal Integrative repository linking the NIAID Bioinformatics ResourceCenters (BRCs) and providing-omics data for eukaryoticpathogens, all bacteria, and allviral familieshttp://www.pathogenportal.org/ portal/portal/PathPort/Home ProtozoaDB 54Gene-based protozoan database with emphasis on distantsimilarities (HMM-based) andphylogeny-based annotations,including orthology analysishttp://protozoadb.biowebdb.org/ HPIDB: Host –Pathogen Interaction Database 55Host–pathogen database integrating experimentally derived protein – protein interaction data fromvarious public databases; BLASTPenabledhttp://www.agbase.msstate.edu/ hpi/main.html PRIDE Archive Proteomics Data Repository 56European Bioinformatics Institute repository of mass spectrometryproteomics datahttp://www.ebi.ac.uk/pride/ archive/ EuPathDB (Eukaryotic Pathogen Database Resources) 57Integrative database of eukaryotic pathogens housing sequencingdata, microarray data, proteomicsdata, metabolic pathways, andphenotype informationhttp://eupathdb.org OMIC tools 58Metadatabase providing a compendium of over 4400 web-based tools for the analysis ofgenomic, transcriptomic,proteomic, and metabolomic datahttp://omictools.com/ Cryptosporidium spp.CryptoDB59Part of the EuPathDB family of databaseshttp://cryptodb.org/cryptodb/ Entamoeba histolyticaEntamoeba histolytica Assembly and Annotation60Assembly and annotation of E. histolytica with content imported from AmoebaDBhttp://protists.ensembl.org/ Entamoeba_histolytica/Info/Annotation/ AmoebaDB61Part of the EuPathDB family of databaseshttp://amoebadb.org/amoeba/ Giardia spp.",OADS,/arxiv_data1/oa_pdf/5e/93/WSBM-7-381.PMC4679367.pdf
GiardiaDB62Part of the EuPathDB family of databaseshttp://giardiadb.org/giardiadb/ Leishmania spp.,OADS,/arxiv_data1/oa_pdf/5e/93/WSBM-7-381.PMC4679367.pdf
"Leishmania major —LeischCyc http://biocyc.org/LEISH/organism- summary?object=LEISH WIREs System Biology and Medicine Systems analysis of host –parasite interactions Volume 7, November/December 2015 © 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5e/93/WSBM-7-381.PMC4679367.pdf
)http://tritrypdb.org/tritrypdb/ Plasmodium spp.,OADS,/arxiv_data1/oa_pdf/5e/93/WSBM-7-381.PMC4679367.pdf
PlasmoDB64Part of the EuPathDB family of databaseshttp://plasmodb.org/plasmo/ Full-Malaria Full-length cDNA database of Plasmodium species with web- accessible analysis toolhttp://fullmal.hgc.jp/index_ajax.,OADS,/arxiv_data1/oa_pdf/5e/93/WSBM-7-381.PMC4679367.pdf
"html Toxoplasma gondii ToxoDB65Part of the EuPathDB family of databaseshttp://toxodb.org/toxo/ Trypanosoma brucei on GeneDB66Genomic and proteomic database resources for T. brucei that is part of the Sanger Institute PathogenProgram, GeneDB projecthttp://www.genedb.org/ Homepage/Tbruceibrucei927 Trypanosoma spp.",OADS,/arxiv_data1/oa_pdf/5e/93/WSBM-7-381.PMC4679367.pdf
"TrypanoCyc67Pathway/genome database for T. brucei based on the BioCyc ontologyhttp://www.metexplore.fr/ trypanocyc/ TriTrypDB63Part of the EuPathDB family of databases, resource forKinetoplastid species (including Trypanosoma spp.",OADS,/arxiv_data1/oa_pdf/5e/93/WSBM-7-381.PMC4679367.pdf
)http://tritrypdb.org/tritrypdb/ 02060 40No.,Non-OADS,/arxiv_data1/oa_pdf/5e/93/WSBM-7-381.PMC4679367.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provi ded the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/7f/ckv006.PMC4679391.pdf
"Available at: http://www.gamblingcommission.gov.uk/pdf/Gambling%20participation%20activities%20and%20mode%20of%20access%20- %20year%20to%20December%202013.pdf (8 February 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/f4/7f/ckv006.PMC4679391.pdf
Available at: http://www.gamblingresearch.org.au/home/interactive+gambling+pdf.,Non-OADS,/arxiv_data1/oa_pdf/f4/7f/ckv006.PMC4679391.pdf
"3130 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/a1/btv357.PMC4679392.pdf
"The real datasets used are the ones in the European Nucleotide Archive(http://www.ebi.ac.uk/ena/data/view/SRR309230 and SRR837425).Next, the BWT-based algorithm is again employed to map each oneof these seeds into the reference genome, though this time no EIDsare permitted.",OADS,/arxiv_data1/oa_pdf/93/a1/btv357.PMC4679392.pdf
"All the tests whose results are shown in this subsection havebeen executed on a desktop computer comprising of an Intel i7-3930 K processor (http://ark.intel.com/products/63697), with Fig.",Non-OADS,/arxiv_data1/oa_pdf/93/a1/btv357.PMC4679392.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/89/pcv117.PMC4679393.pdf
The quality of the data was assessed using fastqc from the Babraham Institute (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and the Illumina software SAV(Sequence Analysis Viewer).,OADS,/arxiv_data1/oa_pdf/61/89/pcv117.PMC4679393.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/02/mdu486.PMC4679405.pdf
H3K36me3 signal was calculated as number of reads per million uniquely mapped reads and plotted using the ngsplot software(http://code.google.com/p/ngsplot/).40 ChIP qPCR Nephrectomy samples underwent gross macrodissection with mirrorhematoxylin –eosin staining to ensure that they contained 460–70% tumor then shipped to ActiveMotif.,OADS,/arxiv_data1/oa_pdf/2f/84/onc2015221a.PMC4679725.pdf
"ChIP-RNA-seqPRO: A strategy for identifying regions of epigenetic deregulation associated with aberrant transcript splicing and RNA-editing sites, 2014.Available from: http://sourceforge.net/projects/chiprnaseqpro/.This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License.",Non-OADS,/arxiv_data1/oa_pdf/2f/84/onc2015221a.PMC4679725.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)H3K36me3 in SETD2-dysregulated RCC TH Ho et al 1574 Oncogene (2016) 1565 –1574 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/2f/84/onc2015221a.PMC4679725.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/4.0/       2.",Non-OADS,/arxiv_data1/oa_pdf/74/fd/ajg2015312a.PMC4679751.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/36/67/12325_2015_Article_272.PMC4679778.pdf
2002. http://www2.kidney.org/ professionals/KDOQI/gui delines_ckd/toc.htm .,Non-OADS,/arxiv_data1/oa_pdf/36/67/12325_2015_Article_272.PMC4679778.pdf
https://clinicaltrials.gov/ct2/ show/NCT00793585 .,Non-OADS,/arxiv_data1/oa_pdf/36/67/12325_2015_Article_272.PMC4679778.pdf
https://clinicaltrials.gov/ct2/show/ NCT01989754 .,Non-OADS,/arxiv_data1/oa_pdf/36/67/12325_2015_Article_272.PMC4679778.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e5/14/12325_2015_Article_266.PMC4679781.pdf
http://www.pqaalliance.org/images/ uploads/ﬁles/PQA%20PDC%20vs%20%20MPR.pdf .,OADS,/arxiv_data1/oa_pdf/e5/14/12325_2015_Article_266.PMC4679781.pdf
http://www.micromedexsolutions.,Non-OADS,/arxiv_data1/oa_pdf/e4/53/12325_2015_Article_270.PMC4679782.pdf
http://www.x-rates.com/average/?from= USD&to=JPY&amount=1.00&year=2013 .1262 Adv Ther (2015) 32:1248–1262,Non-OADS,/arxiv_data1/oa_pdf/e4/53/12325_2015_Article_270.PMC4679782.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/31/33/12325_2015_Article_269.PMC4679783.pdf
"2015. http://www.nccn.org/ professionals/physician_gls/pdf/breast.pdf .A c c e s s e d September 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/31/33/12325_2015_Article_269.PMC4679783.pdf
2013. http://www.nice.org.uk/ guidance/dg10 .,Non-OADS,/arxiv_data1/oa_pdf/31/33/12325_2015_Article_269.PMC4679783.pdf
"Seattle, WA: NanoString Technologies, Inc.; 2015. http://prosigna.com/1246 Adv Ther (2015) 32:1237–1247",Non-OADS,/arxiv_data1/oa_pdf/31/33/12325_2015_Article_269.PMC4679783.pdf
